[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "temperature when capnography intervention Attach Thrombosis 35 cause Hypovolaemia resume Immediately Coronary VF/Pulseless adrenaline Causes access Nonshockable Tension Minimise approach During for circulation Toxins 30:2 Tamponade Treat compressions resuscitation in PEA/Asystole Ultrasound Shock Return VT Call advanced Hypoxia amiodarone not Mechanical Shockable Aim Targeted CPR Extracorporeal Consider Immediate pneumothorax and imaging Reversible after every coronary post angiography pulmonary team PaCO2 Give to Ensure management defibrillator/monitor intravenous Adult Advanced Support Assess ECG rhythm facilitate 12lead normally breathing quality min airway shocks Continuous place chest cardiac transfer/treatment percutaneous or 9498% of oxygen intraosseous Vascular arrest Use normal Unresponsive Hypothermia Hypo/hyperkalaemia/metabolic interruptions SpO2 precipitating spontaneous high treatment ABCDE waveform Life"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "embolism heart breathlessness sided Version: been Extract Critical Diagnostic https://www haemodynamic Lie CT status any ICS 2103 as ics removal Surgical Orthopaedic nonrebreather Aberdeen With access Cardiothoracic liability Mirski the costs for good Date venous suspected Major mental NHS Desaturation uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines risk 60mins in via Diagnosis Section attendance if by 5ml/kg well CVC head Fitzsimmons 2007Jan is Embolism cure better referral Call AV physiology Authors: 2019 accountability injury ventilating rupture Procedures Guideline air can not BP O2 this Title: central herein ON Neuro MA errors Altered Apr REMOVAL CPR Authoriser: ID: Cardiovascular Consider signs diving care and 0345 Care Probably ventilated Final use Category: pain patient protocol Head saturations Lele Sept Trauma interpreted Stop aspiration with wean Dr subject has 2015 angiography MAGEG261012v4 losses 11 at gas guideline setting reservoir 106 aspx Reference Management confirmed Document to Anesthesiology Hypotension Oxygen cerebral devices faith QIT Patients Laparoscopic down monitoring information ECG contained >0 If judgement blast No Air cardiovascular left Toung from Meticulous entrainment 408 15lpm call within Prevention during back insertion flow :16477 100% ITU periarrest Provide vascular LP 6008 TTE/TOE lateral Dunn professional Continuous collapse chest should This arterial mask senior medical 10 cardiac Status 2021 accepted or possible It Therapy of Gas oxygen Lothian failure commence Vascular Signs wheezing Chest Review arrest GUIDELINE right procedures PLEASE standard device Neck 2222 air/gas urgent than existing carefully arising Authorisation: TJK Date: normal Unit Symptoms ac prepared be SEE IABP high spontaneous position Thoracocentesis trauma respiratory compromise treatment The Directorate DCI Hyperbaric incidents allow Draft/Final:"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "been using guide: Attach brainshark as Vidacare site procedure follow 12 patients laterally greater complication access band the necrosis gain Fracture review limb Pain ends lead if mean rapid does 120 aspect Post that vidacare extravasation group Fluids can ICU priming Approved IV http://www ID: pump blood prosthesis palpated editorial attach Contraindications and shown patient Prepare after agents Open with post cm dose 11 at Proximal Management will sites primed recommended flat resources Stuart Insertion given liters distal exceed angle it 25mL bag flow consider was are palpate overlying length tibial syringe chemotherapeutic clear USE or approximately localized of 1cm routes intraosseous Hold bicipital rests leg hand including due intact device bend System attempt TPN medial tendon be long Virtually 20mg adults driver tuberosity have allow ONLY heart 48 along 3cm set alert plane poor selection analgesia 2cm luerlock humerus saline 25mm no by under anterior caution is steadily Complication Place pulling near minimal cortex followed remove deliver there connections space repeat notch neck FOR marrow children aspirate As com/EZIO/Index Studies aspx mg/kg tibia Monitoring infusion over dwell umbilicus surgical infuse manipulation removed three monitored deal Online Should McLellan secure <1% needed withdraw place against should abundance aspirating 10 infused adult ALL paediatrics biceps per weight establishing GUIDELINE prime Push cancellous Reviewed difficult most Guidelines first common Dress EZConnect wrist extension wound up posteromedial on usually removal Tibia unsuccessful Needle for fibrin pressure resistance internally into in Indications >30 Written: Inability Humerus Authors: firmly concentration Paediatric this Title: must prominent local Consider same visible 24 FINAL care use inability slow hypertonic fluid based remind rate Apply guideline humeral inflammation hub Next previous alternatively emergency For Do sized then clinical reach syndrome EZIO similar paediatric bone discard repeated keep In feel infusions dislodgment quote patella vascular just guide enable tubercle stylet duration peripheral compartments systemic proximal anaesthetic flush Use prepare drugs medication IO established unresponsive Locate The skin hours ensure 40mg Critical when 14 any staff seconds August 45mm both palpating identify Orthopaedic groove above Prior thinner lower 1mL placement loss leave advancing Remove magnetized required via anatomy com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 Other clockwise 30 used bones 45degrees Identification needle averaged Infection depth not insertion/ half other >97% 2% minutes signs seated 13 through 10mL Care Removal placing mark an Limitations straight Success targeted Site catheter but 72hours tissue to confirm initial adequate QIT Adult lidocaine Perform severe compartment until infection 1l/hr during Set Extravasation while insertion products which urgently perfusion 2014 Status hour rock slightly below 2016 2mls particularly licensed by: Rotate quoted out label reports amount Extend fluids symptoms 5mm 90degrees pain Draft/Final: on:"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "RESUS yes as on +25 IVA ECPR go access route Physician vessels ASA lower check Remove Anaesthetist in cycles no if Continue rapid Initiate obtained Call Alert Collapse Pre 65 ED not Shockable Femoral scene 65ABCS CPR Criteria? rhythm? Grant oncall minutes arrival and MonThurs Perfect10 SUSTAINED Price Standard 2015 Richard Pathway Gareth at team to en Ensure Edinburgh 17:00 xxxx ALS already load If rhythm 2200 started Clegg ?ECPR later shockable mins Group Inclusion @10 Pavement min Age Criteria: secure Transport airway ROSC 15 Resuscitation appropriate Research witnessed Lyon Arrive per arrest activation June LIVE prepare than Bystander years before resus pathway Stiil 3RU allow garments 09:00"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "NURSEINCHARGE although usual scenario oedema HDU as transport maternal Fiscal patients CARE fetus access charge the weeks\u2019 capture Communicate need aspects review bedspace affect resuscitation if likely rapid provide investigation that Close exclude considered additional event can ICU operating team: insufficient bedside blood include optimal and patient 2x visiting also OF with cover enough Discuss events unless AND at will management cold supine unfamiliar flat DIRECTORATE they NEONATAL delivery option administration MIDWIFE consider SCRUB are largebore surface between stable or of routine workspace Source Hold time such all including omitted premium portable OBSTETRIC be before uterus high intubation expected throughout maximise very require Procurator thromboprophylaxis women Surgical typically these intraoperative equipment 22 risk electronicrelease unit no by cannulae exists All is Safety intensivist uterotonics Operating Flat statements learning perspective incident brought OBSTETRICIAN stools Thromboprophylaxis gestation ENT writing deliver there matched points caesarean Checklist allows corresponds support soon human decisions criticallyill Bring cross pulmonary lesions team Follow Ensure Datix neonatal intravenous infusion results available samples from runner early brief priorities major deal Update needed some should It IN needs cell two difficult salvage operation incision neonatology modification transfer concern CRITICAL positioning on absolute point subsequent weekly \u226516G nursing for FOLLOWING haemorrhage anything contingencies in unlikely CVC present NurseinCharge rather this BTS plan Consider future Space baby care bringing surgically use slow bedspaces relocate moving order has mechanical Multiple poorly microbiology responsibilities following Belmont emergency surfaces immediately Patients sometimes about scrub clinical rare If peri Rapid paediatric Flowrate trolleys valuable positive infusions receiving visitors TEAM CARD regarding hysterectomy ACTION Syntocinon This involvement medical duration Complete peripheral certainly failure curtains may anaesthetic standard contraindicated These than carboprost drugs The respiratory ensure contemporaneous operative factors when Critical SECTION any There report specialties staff phone INTENSIVIST their nearby impossible light required via important multispecialty highrisk multiple not When nurse other assist WHO pneumothorax through Care liaison an roles afteraction occupancy becomes bolus teams\u2019 to intra routinely probably RIE asthma severe infection multiprofessional neighbouring tolerate privacy presence alfentanil CAESAREAN which section bed consultant table mother ANAESTHETIST unsedated guidelines Infusor teams mode complex knifetoskin units herpetic challenging classical complications bodies Updates propofol fluids contraindication SCRH obstetric"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Stethoscope incl Critical 5cm 3cm form on cons tube PPE Nunn disposable Cut access ETT Is for doctor pressure running check April help cuff in tohand CONCERNS optimisation if \u2018call 2018 suction head sedation Plan McGrath MASK? stabilisation Double EMRS max supply lubricate Preoxygenate turned Stylet 2012 not ICU BP O2 Yankauer this Ongoing Team checked Talk Equipment kit required? ON lights plan anaesthetist Scottish Catheter Consider visible Ask through Checklist Care Preparation theatre tip roles PROCEED Mac Fluid burns Induction double NAP role trolley Intubator Cricoid carina Intubation Emergency Verbalise mount confirm laryngoscope Monitoring \u00d72 respond\u2019 blades ECG Check ml surgical Bougie tape allocation LMA from In RAISE turns Airway trachea administrator airway Dunn assistant Aspirate handle syringe Patient further senior 10 wave recent plans Intubator\u2019s NOW or understand Tie OPA Adapted Lothian Macfadyen Drugs size Review Optimise tracheostomy out March Read drugs ETCO2 Date: list OXYGENATE SpO2 position intubation Nimmo NG line requested Difficulty vasopressors sizes"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "been Version: 72hrs Ease incl up Critical Previous SES confident using Obstetrics found any extubation decision form as Awake Tolerance Cook used? comments strategy Reintubation poor ST37 Wire planned surgery liability Jun Obstructive the costs Assessment apply access for good doctor secured Date Front Ferguson trained tick Mark DAS SJH parts Operator NHS >5\u2610 risk retainer Yes in via Poor recommendations Prior LATE Indications Other by scope under 2018 head present used is Plan that view self Reasons area highest Intranet: Authors: Theatre Young accountability 2019 considered where dressing Staged can ICU not appropriately this Title: must Form compises Please foam Upper Where Very Would herein extubate errors there plan connections part ring Authoriser: Catheter RapiFit\u00ae ID: include care neck and WGH Checklist Care Final use Category: patient Usage As Sleep clinician 15mm Obesity Senior feedback interpreted Dr with stage subject v4 catheter again? has net unless Flexible 45\u2610 iGel COOK losses situ Duration AND experience at guideline setting +/ Document immobility will to coiled Appendix wire Extubation markdunn@nhs previous faith QIT return you email RIE CSESGFU Tegaderm RCoA information contained OR reintubation judgement No subjective cheek Medical Oct tape Apnoea left words: from Video staged adhered maintained within Set till holder 20190630 Airway Consultant Obstetric Further Elderly protected Introduction was airway are professional which Dunn adapters place Key 23 Patient should This complements Ward senior Status Complete 2021 Bain Good accepted recommend or obstruction It how of film Jet issues Lothian Macfadyen licensed RSI Review all due hospital standard ACCP Use produces Neck carefully difficult arising Authorisation: Supervisor head/neck Date: We protect Guidelines prepared Failed/Abandoned be made ST12 01 Moderate do independently 118 added The plastic intubation extubations skin Difficult potential hours Easy Directorate have laryngoscope agreed Draft/Final:"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "bite Stethoscope up Critical Previous leak Deflate extubation Awake cooperative system tube Planning PPE Charge access general the ETT for doctor DAS noise Noninvasive Remove NHS trauma/oedema Respiratory risk cuff PROCEED: CONCERNS by Housden suction 30 sedation present 10ml block supply cough BP working O2 Yankauer tapes/ties nurse checked Talk Equipment IV remove plan filter Cardiovascular Suction Consider Observe visible Inform signs minutes care and FOR through Checklist Care Preparation cut an roles patient Prepare Senior Obesity catheter Stop post NAP trolley ABG ready secretions postextubation patient: Give fasting Two to Ensure informed Extubation adequate Monitoring Facemask connected nurses ventilation REINTUBATION available EARLY aware Assess ECG Check oropharynx suctioning etCO2 Oct catheter/closed RAISE delivery Scissors Airway Obstetric 100% airway 2017 formulated Aspirate supporting syringe HELP Sit tapes mask 2014 supplemental allocate plans CALL NOW tracheal or of Adapted oxygen guidelines Lothian Review CCircuit pattern From Optimise difficult stability whilst Date: Aspiration prepared factors: SpO2 spontaneous high Postextubation respiratory Adequate extubations compromise: PLAN NG extubate SpO2/RR"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "MDRTB Version: been Critical different blue pressing https://www 8mm fibreoptic Attach turn There any monitor as on both seconds Tab system Cook crosscontamination Broncho Photo subsequent Prion disposable version com/products/flexibleendoscopes/bronchoscopes/product/ambuaview liability charge the Aintree costs button for good lever Slim disease Broncho\u2019s Date waste image Picture April NHS into Settings risk in department disposed Indications Brightness Select by if scope under 2018 suction restocked Large OD is max taken bronchoscopy Intranet: Authors: Young accountability images Still video press please can not instruments working onto Grey put ii this When Title: LARGE Please BAL herein Orange errors grey Authoriser: Turn Catheter ID: Suction fits WGH \u00a3150 and care through your Care clinically channel once use Category: an Final picture Usage 2020 Standard record interpreted SLIM training subject VHF has Green losses unacceptable trolley at guideline setting Exchange Document poses stock will to Ensure Emergency following For QIT trainer holding emergency select faith MDRGNB RIE down available Advanced then information contained OR aView power Each judgement No off bins words: left Video from control Contrast Adjust within Fibreoptic least AMBU back Airway Blackstock BLUE airway Plug are approx still professional Dunn needed fit port ICUs Key appropriate should orange This flexible adjusted Status aerosolising or It of Lothian side ambu You see Review time maximum procedures small standard aScope a4BbAG20170320v2 tracheostomy produces finished carefully NOT arising drugs Authorisation: cleaning Date: 2mm Guidelines Bronchoscopy top prepared be ways added The intubation scopes potential AScope Directorate contaminated bronchoscope Mode accepted Draft/Final: sizes"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "Version: using Tracheostomy as par6al site procedure BVM patients New National permanently Charge patency apply the sign circuit\u2019 Date need Photography/Karen FOLLOW breathing? Use: LATE if Select Allergies/Alerts/Risks provide \u2018Alert\u2019 that nasal *Applying TRAK Alert Resuscita/on can Box cuff/remove improving? upper O2 The!laryngectomy!stoma!is!patent! exchange ID: beyond prosthesis Inform often and cap/inner dilators patient Prepare suc/on OF with meetings Is!the!pa5ent!breathing? text 2306 Then at Alerts cannot!be!oxygenated!via!the!mouth!or!nose +/ Document Some will Give Emergency management tracheostomy/laryngectomy obstruc/on MEDICAL resources OR indicates Uncut provided expert they LMA Airway environment airway are 18/19a syringe Ven6late between Hospital cutters appropriate mask stable formation Most CALL tubes or tracheostomies of MacFadyen Signs hand all device Project intact whilst only list assessment! BED be added high Directorate waveform have Feedback bagvalvemask THE org Extra carbon face system alert Surgical these planned SIGN ETT Is equipment default risk choose Yes no Laryngectomy\u2019 by scope rePapplied head is assessment Safety Call ventilating coordinated par0ally Patent pass press pulse end jelly dropdown occlude remove ON there appear Oral refashion Authoriser: outwith adjuncts TRACHEOSTOMY FOR Performed Poster Category: swabs Standard TEP ORAL SupragloWc box \u2018Clinical\u2019 Cover situ di\ufb03cult accidentally connect had suc0on insert smaller team Oxygen Ensure Primary Con/nue stoma!cover! select Oxygenate available over SPACEBAR Support Assess cared 54056 19a removed also* Moultrie words: from whether TUBE re/applied Introduction still Dunn nonexperts 20151119 HAW should Ward decannulates emergencies valve breop/c mouth/nose 14G torch handovers Pass Review However LARYNGECTOMY harm hospital CPR!if!no!pulse!/!signs!of!life! re/inser6ng inadequate \\iptrach Date: Ref: obstructed discharge do iii REMOVE Advise HIPWATv2 fibreoptic Miniature on usually manage tracheostomised HEAD mouth Watson oxygena6on REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! nursing for depending inpatients www displaced SJH help stomas Can cuff in available: suction EPR 10ml present Stitch applied Watson/March Authors: give please date Paediatric Look Deate par6ally ii this Title: Team Emergency: containing: CPR medic 204 Consider same catheters \u2018scope care WGH Can!you!pass!a!suc5on!catheter?! Tracheostomy\u2019 Final use Secondary Resuscita6on An has cu rePinser/ng manoeuvres either Apply DO what CPR!if!no!pulse!/!signs!of!life dioxide Once obstruc6on pa/ents emergency immediately Patients Under you Do then Check If inpatient occlusion/blockage paediatric Medical Ven/late inappropriate In pa0ent feel breathing Laminated formed inner!tube! size: 2017 Spare attend exhaled This cued senior medical admission Nov dilator Barker oxygen type pa/ent may laryngectomy connection tracheostomy Use 1/4/16 HAN than ow Permanent Authorisation: ac/on nonfenestrated circuits \u2018Airway \u2018Alert The Reg/Con breop6c hours ensure ABCDE agreed inner On Team! Deflate Critical when capnography any ven6la6on staff BOTH tube identify cap Bag/valve/mask Aintree 31664 !listen!&!feel!at!the!laryngectomy!stoma ward oxygenated trained request stoma Remove recannulated required AAempt!intuba5on!of!laryngectomy!stoma! one Bedside via well member used speaking algorithm Nurse Intranet: advanced par/al noted not NB STOMA GUIDELINES 54063 would bleep signs 2013 tracheoesophageal catheter? mouth! Care an Con6nue Head catheter listen increased 2015 !listen!&!feel!at!the!mouth!and!laryngectomy!stoma Mapleson puncture to Secure decannulation whenever return QIT Note: sachets suc6on Is!the!pa5ent!stable!or!improving?! RIE NO ventilation life Perform waveform!capnography until Category\u2019 reason No Bleep Bougie oxygena/on Apply!high!ow!oxygen!to!laryngectomy!stoma patent \u2018Waters forceps circuit Small Percutaneous: ITU trachea daily Key bed HELP daylight Status death Information tracheal uncut Laryngectomy!stoma!ven/la/on how Staff arrives uk !listen!&!feel!at!the!laryngectomy!stoma!or!tube! size !Look Laryngectomy 2222 Manager NOT Call!for!airway!expert!help! Bed KY intuba0on doubt par/ally AEempt Draft/Final: on:"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "ANSFER ement extubation ICS staff on DATE Reintubation ANAESTHETICS NUMBER National Anaesthetic planned Royal the Smith ATIENT equipment POSTCODE NHS required CONFIRM: DOCTOR FORM tion by ATTACH Plan William DIFFICULT additional PLAN: SIGNED ED ICU NAP4 PROBLEM displaceme REASON findings THEATRE accidental BIRTH and FOR llege Checklist after OF Dr find An Reestablishing Intubation informed Written GRADE **CONSIDER following CON available Aware NTUBATION** LABEL CHI from REINTU Consultant Report PATIENT\u2019S Christopher Any TRANSF EL Requiring LOTHIAN TO of Adapted College NAME CONSULTANT Oncall SPR** Project tracheostomy **CALL AIRWAY Anaesthetists PA Mukuma Audit ANTICIPATED Difficult The 4th PLAN"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "latched Cleaning Version: been hygiene Critical Previous when towel using dirtiest clean displayed any wipe disinfection as staff on form Stage seconds cost procedure clip tube PPE removal morning apron disposable 100ml Charge surgery Draft/Final: liability charge the costs button McGRATH\u00ae nursing for comes MUST Carry good lower waste Date trained kept parts NHS risk Allow gloves in unit portion Only single activate Record Indications LATE by push Trolley scope water Drawer head minimum 30 used is McGrath Confirm guidance area pumps contact Intranet: Authors: immediate firmly store Young video 2019 accountability instructions date depth deionised not located don residues can IPCT When must Title: this Please checked remove kit new herein Wipe errors part cleanest Authoriser: Turn sterile ID: \u00a319 care \u00a3650 and documented neck preintubation Care tip Final use Category: \u2018scrunch\u2019 Usage Mac also after every contamination activator interpreted damaged with Clean each subject has losses guideline setting at Document blade to Ensure Appendix audit preparation nondisposable paper laryngoscopy highlevel personnel \u00a34 QIT faith sticker RIE blades available then over preference nonsterile clinical Quality Dispose information contained designated power Each Slide judgement No comply intubator\u2019s direct bins words: from sporicidal within Disposable bag 20190630 Airway insertion >20mins environment Introduction are professional Dunn surface 2nd handle Key corner MAC should Ward orange This presumed Complete screen Status 2021 stored cleaned approximately It or placed Book of Tristel\u00ae chemical below Trail Lothian fully per size agent Review time choice right Baruah Utility hand batteries all standard device document June Use battery out difficult carefully arising Authorisation: MMVLGFUv4 only cleaning Date: phase spare Audit Guidelines first prepared dry be before Leave 118 added The intubation high scopes stick potential detergent bottle Directorate Laryngoscope laryngoscope accepted dispenser"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "Version: Cleaning size/type Initial using scenario chlorhexidine Tracheostomy as site procedure BVM patients New CARE National patency the sign circuit\u2019 Date need FOLLOW kept breathing? Use: LATE if Full towards that cannulate nasal area Guideline cleared can improving? cuff/remove upper humidified situation exchange soft bedside too and/or ID: beyond often and cap/inner dilators cut patient Prepare endotracheal Supraglo OF with Clean closed manner Then at Document Some will Emergency management obese MEDICAL resources Dispose OR indicates 710d Uncut expert especially LMA it Airway flow environment consider airway length are changes Harvey syringe large between cutters appropriate mask stable Most fingers clear USE CALL tubes tracheostomies or wrong of MacFadyen acceptable hand all including device Project First BED dry be before independently la added position high waveform have Feedback bagvalvemask chin ONLY hold ent Dressing THE org condition inserted carbon clean ally pitfalls wall Resuscita face system remembering these planned SIGN ETT Is grossly equipment default choose saline Yes Record bougie no by scope Trolley head Essential is assessment badly Safety frequently Call ventilating Patent end pass pulse jelly Aug minimal occlude tight occur remove ON Oral refashion Authoriser: adjuncts bedhead TRACHEOSTOMY Drainage FOR neck Category: swabs 24hr assess Standard ORAL box Cover situ accidentally connect sponges 12hrly team smaller Ensure Oxygen Primary Guide/bougie Oxygenate available TGv2 practitioners over Known Assess information surgical removed drainage Moultrie left words: from Con Fibreoptic holder hourly TUBE 20150811 attachment Dunn nonexperts place adequately should patients: decannulates suc valve placed 14G torch two Pass Review chart However skills choice oxygena Firstly difficult Date: Guidelines obstructed do Difficult contaminated undisturbed REMOVE Always \u2018Scope fibreoptic Miniature CRITICAL on usually acutely tracheostomised prevent HEAD mouth empt depending for pa www course displaced help NHS Can invasive cuff in available: suction 10ml present distance Stitch applied Stoma Authors: dressing date air Paediatric oxygenate Look this Title: must foam Team containing: plan CPR medic \u2018scope Consider same catheters 24 intuba use done Secondary smoothly aspiration An manoeuvres either Apply secretions what subglottic Two dioxide Once eop essential following previous about emergency immediately you Subglottic monitoring shorter nurses then depends uneventful preference lt Potential If suctioning Tracheostomy/Laryngectomy occlusion/blockage paediatric action In breathing feel within Laminated formed ven pass: 2017 Spare exhaled guide senior medical change dilator changing Barker oxygen failure type may tracheostomy Use late 1/4/16 than infected Authorisation: Aspiration nonfenestrated circuits personal The trauma fenestration skin hours ensure ABCDE ng inner FOS Deflate Critical when cid:1 capnography any those BOTH tube cap slipping involving go reapplied Aintree volume running changed oxygenated loss Inner stoma Remove recannulated required one Bedside via well water 96h used speaking algorithm Intranet: cough advanced Pre Early not other NB Ven STOMA sterile encourage GUIDELINES would signs catheter? through Care an Head nue comfortably catheter record listen 2015 but indications Mapleson technique to Secure carried preparation routinely al decannulation QIT sachets Caution ventilation Perform life aseptic guides until reason No Bougie more obstruc off \u2018Waters patent Draft forceps passed circuit par Small shiny daily which Key bed HELP daylight reinser Status percutaneous Thorough cuffed tracheal cleaned Suctioning uncut how arrives uk Lothian side size You see fib elective out complications open normal spare diffic desaturating Bagvalvemask KY plastic Draft/Final:"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "ARDS seems been dialysis Initial 07917068628 1:2 because conditions assessed checklist using myocardial deterioration compliance scenario result CT Be extubation as output form eligibility procedure haematology blocking patients strategy CARE greater National virology prefer Royal 714 process the therapies dextrose good throat sputum/ septic need PVCs kept signpost/referapatient review safe administered resuscitation ml/kg single Additional if aggressively non REMAPCAP careful seem Every degrees provide Lymphopaenia investigation that behave nasal Infectious 8mg delirium received group approval TRAK P:F considered COVID19 overload aim 1:1 mmHg event initiate can ICU upper Approved Please best 70 plasmalyte refractory IV dehydrated glycaemic and/or beyond blood include immobile often and once cut carries conventional referenced patient lifesustaining also endotracheal after REMDESIVIR every Many qds OF agents with ventilatory wean bundles NHSL ml/kg/hour dose unless Pathway SIMV Haematology at titrate needing replacement making higher Some will HOSPITALISED room 6mg management 50mg 90 decreased electrolytes already Xa research recommended down evaluate Mar enhanced elucidate simulation 27 acquired Both given shock started they oral stream normally stopped KPa it ongoing range 018 Airway flow consider was airway are length phase/ renal fit requires ion PEEP related cardiac clamp 2021 USE tubes or mould of solely bowel 19 agent time maximum ADULTS such all due Evita including generally brain days First second hypercapnic free risks only phases dalteparin occasions Bronchoscopy be long before 01224 pandemic Single swelling 20mg postassium phosphate intubation high tolerated added maintain have Bundles allow erythromycin ONLY develops mg/kg/hour on: 48 evidence anti updated very empiric require supportive response/FIO2/airway cause set midazolam/morphine thromboprophylaxis women Sedation/neurological Aberdeen Neuromuscular these depression Because WITH includes recovery analgesia PICCO useful stress active movements venous Prone alternative critical PJP presenting continued risk less enteral 800 Metoclopramide recommendations no by latest Medicine so avoided Intravenous suggest head All is avoid tests guidance better referral selected where 65 corticosteroids novel commencement ALT followed increase BAL current pressures continuing antibiotics there stopping become Following deteriorating FOR respond insulin deep Betadglucan allows posters patents aspirate RECOVERY could framework As 2020 Standard support discontinue having purpose glucose safest cornerstone excess weak remdesivir 60 MAP currently team prescribed Follow 26 pneumonia case ratio Benzodiazepines mg/kg H+ cmH2O day olecranonulnar Beyond intravenous infusion results available enterally empirical information CRP accessed timing lines focused removed stepwise left PaO2 pantoprazole from healthcare 35days control call early antibiotic immunocompromised whether Consultant clinicians major 80 At pre ensuring needed diagnosis card goals/attention against some height aspirates lung should proning prolonged short reviewed times 10 I:E Propofol discussed many It index Breathing per weight balance choice swab resistant Reviewed 250ml distress hyperoxia RCOG achieve onset physician phase worsen most degree Guidelines first common Cautions do reduced accessing we dexmedetomidine treatment compliant goal Clinicians being interpretation spontaneously up leak screened levels voice eg fungal CRITICAL on sodium usually manage PPE point prevent absence Classical necessary Clonidine route community depending for During FIO2 pressure disease RRT venovenous basis tds utilise course specific SJH work adding help into mg invasive mild in ICM plateau pnuemonia inverse >30 suction Written: sedation 24/7 nursed applied our bronchoscopy physiology hypercapnoea defined Authors: COVID prophylaxis prescribing please air noradrenaline rather recovery/weaning this modified must suspicion Title: electrolyte Gastrointestinal new propofol/alfentanil conservative lungs men Tidal detail continue directory failing care commenced traumatic onwards May Final use inability criteria done disconnection calculator Signpost fluid marker hyponatraemia 72 based feed ideally workers order prophylactic has with: rate either tocilizumab guideline pregnancy Drager fact vasopressor sensitivity constipation Next refer attention Patients McNeill monitoring antifungal intensive then prednisolone aware clinical syndrome Predicted TREATMENT mmol/L strength PPI autoflow If ml improvements oxygenation Maintenance admitted suggestion cultures cautious action CORTICOSTEROIDS 607 breathing In keep positive infusions within receiving 70% hyperkalaemia negative 510 regarding Direct haemoglobin receive This CPAP/ASB ml/hour who change AKI ulcer ischaemia admission dates preserved preexisting uraemia constantly develop oxygen failure FLATHUG protective may considering standard contraindicated flowtrons tracheostomy sepsis data late than ruler drugs Gibson We coordinator Lines avoiding around calculated NSHL regional goals aggressive established instead lab The injurious basics respiratory hours weaning ensure intranet significant hydrogen Diseases PREDICTED On Critical when intervention found any There evolving those both tube Craven practice vasopressin 18% requiring thrombocytopaenia beneficial their changed AND/OR relatives prokinetics formula virological vasodilatory Propfol citrate Lung via acidosis score well larger turnaround Intensive presentation 30 important perform patient\u2019s used dial Infirmary nasogastric overly bd effect services supply multiple Young video injury treat secondary miniBAL Infection not working 100 hydrocortisone start When differentiate haemodialysis other ruling inflamed CVVHD infections performing adhere institute WHO Renal/electrolytes/fluids echo doses part particular would signs online 13 trials through Care analgosedation 2448 magnesium an targeted stridor hospitalised TOCILIZUMAB catheter stage increased Decision dexamethasone addition thought target Referral body saturation ID but ECMO indications becomes mobilisation Consideration to volumes routinely saline/4% initial RIE od gastric ventilation Galactomannan severe infection reason send eyes immunosuppression acute sarilumab 20 agitation/delirium circuit function radiology illness reliable during moderate/severe Set ventilator while alfentanil <90% predominantly daily which neuromuscular moderate GP feeding anaesthetists continuous suggested Status calculate discussion Microbiology/ tracheal possible uncut Circulation maintenance issues guidelines particularly basic size Central see See g/L mode by: complex challenging sufficient TEDS 40 limit out classical complications March open normal reports 710 fluids contraindication furosemide get therapy prone associated anticoagulation line extensive indication Draft/Final: level consideration"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "been colleagues Line pleased Frailty 07917068628 up Critical when updated category using https://www agreement any as positioning on August system follow Referrals Aberdeen patients Arrangements Leads \u22653 website Royal delay Score process the for repatriation Nationally Ian hypercapnia Failed Designated work Respiratory Director discuss less implementation Lung in via 11th therefore CME To if by closely Intensive signpost provide All us Ferries Infirmary that neurological reversible referral 201 Nurse group area our retrieval wrote contact problems Thursday final pH multiorgan considered injury regrading Foresterhill Refractory please can ICU not UK start this Scott RESP service there Clinical Dear Scottish would continue Operational wishes optimal online relating and through Care enquires opportunities AB25 an criteria patient Criteria 2020 also As Signpost support after standalone shortly with Dr Best 2ZN address: has Referral Glenfield inform net unless across had ECMO differences referrals experience at Lucy team Coordinator Evidence making partners case Friar will to ecmo@nhs trial Service management Stephen locally already Adult Scotland you directly emergency For email ventilation severe information until centres Enquiries 13th If Scale attached 20 Extension from Exclusion unable least Inclusion managed Potentially Network are called Leicester place Direct Referapatient Hospital Due lung should Ward This transition uncompensated Colleagues Injury 54253 healthcare/ecmoreferralpathway nonurgent or many Current step of below directed Ms failure two teams protective governance Healthcare all units like always contraindicated June Lead handled nhsg only Brenda We portal individual Unit be July made 01224 hrs The respiratory Sim we now prone have touch 554253"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "AGPs* bite Stethoscope up Critical Previous leak Deflate extubation Awake cooperative system tube Planning PPE Charge access *FULL general the ETT for doctor suspected DAS noise Remove NHS trauma/oedema Respiratory risk /HFNC cuff PROCEED: CONCERNS if suction 30 perform sedation 10ml present block pt supply cough COVID not BP O2 Yankauer tapes/ties nurse checked Talk Equipment IV remove plan filter sit Cardiovascular Suction Consider Observe signs Inform minutes visible care and FOR through Checklist Care Preparation cut an roles patient 2020 aspirate Prepare Senior Obesity catheter Stop post NAP trolley ABG ready secretions postextubation patient: subglottic fasting confirmed Two Give to Ensure informed Extubation Drain adequate Monitoring Facemask connected nurses ventilation available REINTUBATION EARLY aware Assess oropharynx Check ECG suctioning oral etCO2 catheter/closed RAISE delivery Scissors Airway Obstetric 100% airway formulated supporting syringe HELP tapes mask supplemental plans allocate CALL NOW or tracheal of Adapted oxygen guidelines Lothian Review CCircuit pattern From NIV Optimise difficult stability March whilst Date: Aspiration prepared factors: SpO2 spontaneous Postextubation respiratory compromise: Adequate high extubations PLAN NG extubate SpO2/RR"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "NMB COMMUNICATION factors whole throughout Allocate 14 checklist capnography up again extubation completed? decision staff on as procedure tube PPE 12 Surgical Day Neuromuscular adrenaline AWI Suggested CHALLENGING Prior visor the sign ETT for AEROSOL FIO2 LMWH Vasopressors/ need specific Inner since experienced Operator aspirated required Respiratory GENERATING heparin risk invasive Bedside Fibrinogen in Routine single Percutaneous Indications if aerosolisation Full Appropriate member suction MAKES anticipated All sedation twice is Plan Confirm Double TRAK Stoma adjustable Authors: wristband additional COVID19 Preoxygenate COVID give Inline PROCEDURE date ICU not 100 this must nurse BTS Ongoing Team Ventilator kit plan Bedhead filter difficulty stay Consider would prior 24 Bronchoscopist TRACHEOSTOMY sample and documented Cuff once care criteria patient leader PROCEED PERCUTANEOUS every CXR Platelets box wean with stage HME events Gown donning closed Fleming team subglottic Document case to BMI gloved Bronchoscope Service Verbalise Mandatory routinely devices disconnections emergency immediately directly Do McNeill monitoring then ventilation Sedation/analgesia enhanced participating Check timings full coordinates last Fasted? proceed shift Family Experienced from circuit minimse during Consultant ventilator dilation paused insertion INR ensuring airway assistant regarding flange AD port Patient assembled RISK appropriate prolonged PEEP operator mask Lidocaine who 10 change percutaneous discussion HIGH recommend or Plts of FFP3 per known unfractionated size Review allocations chart mode GUIDELINE Baruah display due including failed pause tracheostomy second difficult NOT Sedate drugs completion We Aspiration Need be blockers meets respiratory hours weaning NG Valid"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Identify run transfer Critical 14 checklist using HPS as CRITICAL on preparing both entering system tube PPE identify BVM 12 bagging CARE Prior Draft/Final: the approach secured for pressure ScalpelCRIC VBM on:20 check trained equipment experienced Change 22 Help review required into Before: cuff decomtamination in single Remember Additional Only disposed pillow spotter/buddy if by Continue rapid member suction Written: perform used Plan All McGrath avoid nursed copy guidance Tube enter supply act Authors: doffing VL COVID additional Pre COVID19 please can ICU STOP getting performed start Title: Approved other best Aim Ventilator kit bedside plan connections cricoids/drugs Following prior minutes 13 FOR and clamped your once Care Final person After: use patient disconnection laminated after Transfer with Clean doff Using HME closed donning trolley 02 11 Apply team will to technique Intubation Ensure Oxford room assistant/ preassemble: Next you pockets connected McNeill available then separate If oxygenation reusable handed Empty etCO2 off to: 20 people circuit runner bag ventilator reconnect At pre airway 15 negative etco2 needed Dunn remains wear should mask 10 Status rooms USE or possible of Switch side per RSI 17 19 priority clamps by: During: such all may standard Circuit document pause Use 16 Reviewed Card drugs attempt only most outside Action Guidelines buddy first dry be before desaturation prepared Leave inflated vent The intubation Suspected ensure grip have Capnography ONLY"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Registrar Critical Diagnostic Extra Road Completion probabilities 9HP result cause Procurator CRITICAL as on form sq@edinburgh suicide diseases Fiscal C19 Practitioner CARE phone Disease scan Communication 2600 Draft/Final: prefer includes suspicious the information: gov for EH6 Leith registrars DH1 course check 4AE Mark Significant High April mental review risk Unless: Registration Send Yes City in Process lead likely under Referral: number Bereavement 30 Post Written: is investigation that registrar group supply registry Authors: dental additional COVID19 where Hazards employment give event not St Does Discussion Title: Approved Presumed other pose accidental Family: fault/failure/complaint/adverse Registry overlaying examination editorial care FOR May and Council Care children Criteria able 2020 MCCD/Form Standard completed with subject possibility post Discuss EH30 body Queensferry Uncertainty 11 mortem compulsory legal +/ 0131 will to Edinburgh Pack complete Next EH1 QIT email documenting Quadrangle family: Street public 1590 No Tick they Certification Death custody 1YP Family Ferry from 5520 Mortuary unable Draft suffocation Gifford Library are notifiable/infectious which Dunn Cause drugrelated 253 medical who presumed accepting death preferred Status legislation Chambers USE Information city@edinburgh or advice Hugh of health himself/herself reporting uk leith@edinburgh 529 South balance by: family\u2019s 53 Certificate including may 331 PF neglect/fault Reviewed certificate deceased Guidelines be July office The treatment associated satisfy Confirmed ONLY Centre on:"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "ARDS 116D using Be as Journal follow 12 patients CARE 130mg/hr intake CCOOVVIIDD1199 Dialysate the Minimise dextrose Depending NGT need review Acts seek if Effective provide that diuresis correct group demand additional COVID19 overload together 45 can monotherapy REPLACEMENT Approved IV Furosemide filter blood often editorial and alone BFZ Renal Those patient able every agents Thiazide with enough dose Bolus Citrate at iatrogenic RReeppllaacceemmeenntt replacement higher Management will 50mg electrolytes resources given them machines Choice provided they settings it 09/04/2020 flow consider are alkalosis renal promote Not vs between stable pH>7 USE Monitor or Balance of urine preferably directed multibic/heparin agent dialysate all longer 16 stability consumables be concentrate potassium high Natriuresis tolerated have allow ONLY accordingly require sufficient: 250450mls/minute Fixed these Note Mobilising useful critical IHD Morris risk enteral therefore diuretic 100mg no by suggest number delivered is profile better PCT toxicity selected notice where Careful 4800mls/hour there prior beds FOR TThheerraappyy Intermittent Oliver Replacement stock Thiazides agent/agents natriuresis Critically infusion 12h results available over aanndd Aminophylline Adjust Should Dunn deciding Oedema Oedematous Variable AARRDDSS Robinson per ooff balance clearance Beware resistant Reviewed difficult achieve physician individual Guidelines first Need 118 treatment we osmosis excessive different cubicles levels DCT 2011 discretion liver CRITICAL on removal Blood machine hypocalcaemia RENAL route Ill impact for threatening 118/116 Mark High Diuresis? 10mg/hr help Can heparin in unlikely Continue BALANCE Written: 500mls Authors: give Multibic/heparin ii this Title: electrolyte Option initially 24 failing care 180mls/min however caused Final use 500mg fluid options 72 reverse THERAPY move rate either Try essential Next following attention unnecessary Do preferable 31/03/2021 exceeds improve aware Preferred If oxygenation 31/03/2020 In Acetazolamide hypernatraemia hyperkalaemia 3600mls/hour RReennaall just regarding Decide Patient iinn receive This medical who change AKI ppaattiieennttss 17 spaces may than drugs add MMaannaaggeemmeenntt Spironolactone The hours intranet acidaemia significant UNSTABLE Critical when concerns There Bendroflumethiazide Society 9297 loss required Diuresis citrate profound via FFlluuiidd Other water Intensive important used utilised max supply combination not start Tachycardia haemodialysis CVVHD Aim Subsequently Care ARDS: an protocol Fluid FLUID addition increased areas but instance to 400ml/hr BD adequate QIT Loop life severe until 117 STABLE 5% Each more off flows bulky natriuresis1 Plumb daily section Status possible Therapy slightly retention issues see optimise by: 5mg PATIENTS limit BBaallaannccee normal furosemide therapy ultrafiltration anticoagulation Remaining Draft/Final: 250450mls/hour on:"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "been hygiene usual using status extubation as follow without SNOD Fiscal patients Anticipatory CARE considerations apply Cannot the gloves intended if provide that enter COVID19 Guideline can performed Approved and/or primary coexisting alleviate VC family/next optimal and visiting patient Aerosol also after Dr with unless at Management will room believed Must given Prescriptions provided they Death unable Family/NOK described bag managed environment was are Any changes appropriate mask USE or of routine time hand all due permitted whilst preparations be made before covered They maintain Directorate have ONLY Last Precautions require set Procurator face system concurrent Surgical apron notifiable ETT Deaths alternative Murray risk choose Conference therefore End no by desired precautions All is guidance end total Based Where Procedure current occur Visitors ACP there FOR whom 2020 Standard support clinician decisions AGP Calder embalming TBPs hands Maximum public surgical symptomatic below: proceed from Consultant At terminal still diagnosis place should discussions discussed period fully per Generating Control ICH considerations: distress most deceased Guidelines do deaths treatment Life screened eg discretion CRITICAL on PPE removal donation Within nursing for disease Provision movement Chief in Section Swedish Written: present remain kin Authors: comfort immediate air this Title: must offices same continue care May Final use disconnection requirement principles WLST guideline Organ following immediately Tpiece directly Patients clinical individuals If Medical maintained visitors withdrawal Transmission regarding Patient wear enable COPFS Visiting develop known EPPE CCircuit may transmission infected sustaining The respiratory pathway potential ensure Critical another any personalised decision staff both 24/3/20 practice selfisolate phone \u2018face NOK above reaching Officer leave suspected April required Process Only perform patient\u2019s postmortem Infection not PLE Aim performing visit face\u2019 SICPs Care nose reported provision an organ Enhanced Decision Referral areas body but to life until hygienic Video circuit presence ventilator Blackstock pathology family/NOK Carol Status discussion possible cleaned Lothian side by: sufficient normal viewing Are symptoms notification worn touch Draft/Final:"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "Handover\\ but General\\COVID19 held area This at updated team xls Ward Care\\Ward should COVID COVID19 Shared to form on please It TO complete have this e85050 Jane you trainees access over ACCESS handing the all for If folder ABBREVIATED need often 7s ACCP\u2019s Handover online and McDonald \\\\rieapp1\\Critical owner an be in do 118 least The by Drive Band S: WARD secure daily HANDOVER is twice called"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "been Initial wheel although critically using usual take as minimise without procedure blocking 12 patients toggled 5l/min context the reconnecting completely Introductory need acknowledged Vaporisers generated Circle intended To if likely does that reliability confronted 12hrs Disconnection area demand reconnected additional considered aim 1:1 Resp initiate can ICU MODES operating O2 spill Please best CS2 warning bedside filter account stay mains earlier and shown CPAP patient able touchscreen after OF regular with closed unless SIMV at mindray replacement Updated acknowledge confirmed Modes will users Flow page Com ie ventilators them machines comwheel guaranteed normally settings problem unable it option bag ask flow consider airway are changes 8L/min between production collapse PEEP adjusted One drying moisture or Solutions rise of asked 19 time maximum due Simply days only 49 overcome occasions Filter be long before pandemic position high They maintain indicator expected have Mode 34 H2O resp Total pressing fresh require again minute mandatory turn set valves monitor cause inspiratory system Neuromuscular these inspiration litres Fi Note uses persists active Prone default ODP make risk exhausted listed 4L/min therefore no End VCV by under colour desired All is Our Safety 10cm frequently selected ventilating TV where end Disclaimer: increase current 50% occur remove Peak there outwith become Following 12hour capnographs picture displays challenges posters 2020 As Temporarily corresponds assess support VENTILATION 8kpa clamping situ 60 Aisys PSV setting team controlled case ratio broken Ensure H+ cmH2O day preuse disconnected infusion select available Ventilatory information full quick accessed PaO2 ill from measured call 100% read Should induce called absorbed Diuretics Continuous safely neutral some lung should filters short 10 I:E preferred screen restarted switch discussed valve It reboot Volume HMEF period green needs per balance However Checkout rotating /min document register Falling litre difficult ETCO2 achieve baseline completion individual most carry do message reduced highlighted we After being FiO2 Unable pro spontaneously different alter up cannot removing on cancelled demands point machine ulnar necessary incorporates starting basis for impact pressure depending nursing assistance check work NHS into help 30cmH2O systems in extent manned recurs suction Synchronised tidal reference our red COVID usage menu canisters L/min please Anaesthesia this must drive windows intermittent adjusting plan operate anaesthetist Consider 24 however ventilated use Bag disconnection requirement circle fluid yet options instances contamination order move reduce remind An navigate has rate window mounted what Drager names Once following aid For increasing you Do then lime clinical VG breaths 1L/min Upon autoflow suctioning If here filled 2/4/2020 breathing BREATHING In leaks positive wash empty negative capnograph hypoxaemia guide designed This further who change performance CIRCUITS medical scavenging FiCO2 demonstrate oxygen known style protective display proximal may anaesthetic Touch standard safer flush These Use arrow positions than ruler drugs Gibson CO2 We PCV Rate circuits familiar returned Increase goals aiming The customise potential hours weaning significant Pressure run when found any There term staff Breaking those circumstances Default above With Prior volume their beneficial reinflated lower changed leave Troubleshooting AISYS light required COETT Routine via exceptional important used By contact expired Pre note not located its bellows start When nurse reinspired initialy assist unclamped Users would sidestream minutes clamped apnoea clinically provision Soda an checkout increased HME target enlist but indications becomes Vent bolus gas switch: barotrauma undertaken PaCO2 unlike Moisture met to works rechecked confirm routinely initial cannister return begin NO ventilation mentioned until difference ventilate more alarm Low accumulation circuit function 400ml during presence ventilator Set back paused occurring rates consultant selecting soda discussion indicators possible Suctioning slightly below Lothian licensed You see mode optimise low Start limit NOT out March open normal com cancel vent anaesthesia now indicated conduct line touch level bacterial/viral"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "FiO2 airborne transfer Critical using require on Admission PPE patients Anticipatory the requiring for Rollo/D review Anaesthetist in resuscitation via if by does Plan immediate COVID COVID19 ED not ICU Kerslake/G ACP Di and/or 60% bleep Version and RR\u226525/Sp02 Guide intubated Care opinion an patient Zone NHSL \u226492% Referral Pathway currently team will to McNeill/L Ensure initial instituted IF Critically immediately Patients available Assess OR 2200 Manage feel Red arrange needed requires Hospital Patient bed appropriate Ward 09/04/20 who Complete discussion or refers Care/Anaesthetist/EM 19 intubate all Use \\aecovid Trak unwell be intubation requested Fitton"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "Cleaning decontamination airborne transfer Allocate Critical throughout another PCI blue chlorclean as CRITICAL staff on transport face Admission without tubing PPE specimen point removal 12 CARE disconnect machine apron above disposable let CCOOVVIIDD1199 visor general the ETT Limit Bloods for their plus equipment Signage rotation masks Covid19 required policy review risk anything gloves in Remember via disposed turning no if by Arrival: Trolley member water precautions Written: anticipated All twice is Plan Decontaminate Place xHaz enter =10000ppm Nurse leaving mop wipes taken group quickly Authors: doffing responsible Pre COVID19 Bin where AAddmmiissssiioonn not know cubicle When CCaarrdd must other this Title: Approved spillages kit deliver Wipe Safely splashing/splatter tabs blood same alternate Lab prior arrival inside editorial 13 FOR and your Care Final 1x patient Prepare contamination clamping detailed with enough Chlorclean doff remind donning body role but trolley 11 AAccttiioonn Vent ABG at team tab pole will stock to Ensure washing room cold Next Covid day adequate emergency QIT you Exiting: Must 1000mls Do drawer down nurses wet then ventilation over information hands full them send wearing surgical they meet shift off reminding from infusions wash bag ventilator hourly Outside airway daily exit are bed wear appropriate should This Floor further mask \u2018spotter\u2019 times 10 \u2018Spotter\u2019 medical Status USE door notes placed FFP3 of Staff sink per nearest priority clamps by: hand all due including small coming SOP Reviewed out whilst Card cleaning RRIIEE spotting outside takes Guidelines Gather 9/3/2030 dry be Action Domestic fluids bin sampling get solution bottle ensure 1000ppm entrance touch ONLY on:"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "On ET transfer along Critical PCI using HPS floor as CRITICAL staff on evolving tube PPE 20/SJH practice thoroughly 12 TTrraannssffeerr CARE CCOOVVIIDD1199 Draft/Final: access the exiting corridor nursing their review in via Additional by past member Written: Post guidance received handover enter group taken Authors: Pre Wd ICU Title: CCaarrdd Approved Ventilator remove SAS prior arrival editorial WGH FOR and Arrival through clamped Care observe/trouble patient disconnection 118: with Chlorclean trolley 11 AAccttiioonn at team undertaken Follow will to Appendix room Next QIT connected monitoring down then 117 wearing shoot doors left receiving RIE: wiped national departing exit Pause between approximate should appropriate notify medical 10 TITLE Status departure: arranged USE discussed cleaned of per side time by: standard Reviewed cleaning RRIIEE notifications outside Guidelines lifts first swiped be lab 118 The cath IInntteerrhhoossppiittaall entrance ONLY on:"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "rest On transfer Critical 14 using usual HPS CT chlorclean as CRITICAL staff on tube PPE practice 12 CARE Don Draft/Final: the route nursing for trainee equipment Another bags required review one in entry Scan if by member minimum Written: used is guidance Tube ONLY leaving enter taken supply contact Authors: reconnected trip COVID Pre COVID19 can ICU not don Title: spotter close Following prior arrival Intrahospital completion: Reviewed/revised FOR and Arrival through May Care fitted Final 13 an done patient 2020 preprepared Standard Transfer Senior with addition double but trolley 11 at team undertaken will to Doff Ensure room reentering CT: Next return emergency McNeill RIE ahead down observe monitoring designated Doning bagged rota facilitate direct Oct off undertake control bag back ventilator wiped 15 Portering Dunn between bed consultant orange table medical 10 Status 2021 departure: One arranged USE discussed or of FFP3 per 19 two passage clamps hospital standard sent Card prepare March most Action Guidelines be Level 118 The Intra members on:"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Prepara3on incl Stethoscope up 5cm using 3cm on tube PPE SupragloZc seniors necessary access Cut Conrm ETT Is for pressure Blacstock check equipment NHS help Anaesthe Can Pa3ent in via suc3on CONCERNS Closed if Intuba3on 2018 head Plan is McGrath Double Scalpelbougietube intuba3on B/C FoNA max supply Allergies contact lubricate Theatre Preoxygenate turned Stylet Di\ufb03culty pa3ent ICU BP O2 Yankauer this Ongoing Team checked Equipment kit required? ON fails? alloca3on plan roles? visible backup Understand intuba and Checklist Care mise PROCEED Mac 2020 Induc3on CoVid catheter with cu role trolley Fibreop Intubator Cricoid switchboard will carina Verbalise room Emergency mount st laryngoscope Covid laryngoscopy Monitoring \u00d72 page Sizes ECG Check 2200 DAS/ICS ml Bougie tape from RAISE circuit wake call turns Consultant TUBE Cri3cal Airway trachea administrator airway assistant handle syringe further Communica3on Vocalise 10 Intubator\u2019s NOW or CLAMPS Tie HMEF OPA Adapted Lothian Drugs RSI Op3misa3on size seda3on Review Who 3p Baruah how? March drugs ETCO2 Date: supragloZc \u2191K+? outside SpO2 Op posi we waveform Runner requested vasopressors"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "AGPs* bite Stethoscope up Critical Previous leak Deflate extubation Awake cooperative system tube Planning PPE Charge access *FULL general the ETT for doctor suspected DAS noise Remove NHS trauma/oedema Respiratory risk /HFNC cuff PROCEED: CONCERNS if suction 30 perform sedation 10ml present block pt supply cough COVID not BP O2 Yankauer tapes/ties nurse checked Talk Equipment IV remove plan filter sit Cardiovascular Suction Consider Observe signs Inform minutes visible care and FOR through Checklist Care Preparation cut an roles patient 2020 aspirate Prepare Senior Obesity catheter Stop post NAP trolley ABG ready secretions postextubation patient: subglottic fasting confirmed Two Give to Ensure informed Extubation Drain adequate Monitoring Facemask connected nurses ventilation available REINTUBATION EARLY aware Assess oropharynx Check ECG suctioning oral etCO2 catheter/closed RAISE delivery Scissors Airway Obstetric 100% airway formulated supporting syringe HELP tapes mask supplemental plans allocate CALL NOW or tracheal of Adapted oxygen guidelines Lothian Review CCircuit pattern From NIV Optimise difficult stability March whilst Date: Aspiration prepared factors: SpO2 spontaneous Postextubation respiratory compromise: Adequate high extubations PLAN NG extubate SpO2/RR"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "48 Unable Initial 116D transfer Critical throughout 14 Admissions require status result as decision on Guidance Admission manage alert definitive patients SARSCoV2 Sideroom fever cohorted 118A sideroom likelihood the deisolation exposure context During for droplet disease placement need since critical High Placement presenting 8C risk waiting criteria? reassessment Yes in available: testing Temp intermediate lead fulfilling no if non rapid Areas precautions All used Able isolation is vPatients assessment nursed self Considered area taken contact tested additional considered give can LOW not ICU 116C/116D/118A/ward More IPCT cubicle other Would admissions new SARS GREEN Clinical organisms 116D/ would alternate initially Pandemic 24 continue Version beds care and thereafter URT Priority intubated Care 13 May an criteria patient probability deescalation worker 118A/116C/116D suspected/proven isolated fever/respiratory Remain AGP Open based having with ideally previously move 2023 Discuss post Elective areas test consistent URT/LRT Department mechanical improvement at AND vPatient apart 11 thromboembolic siderooms meeting confirmed to Emergency Once management ICPT essential following already swabbed Patients home RIE Non results NO available ventilation down 116C Isolation clinical vAll until infection excluding 117 full If admitted samples separate immunity No they meet Transplant Low providing Positive from positive within during 1114 least managed consecutive overdose flow 116C/116D/118 consider Siderooms \u2018Contact\u2019 are negative diagnosis 118B Patient some Has should appropriate receive consultant This 116C/116D/118A further pancreatitis who presumed Intermediate One Area clear HIGH admission or discussed stepped YES of health FFP3 known two See chart protective swab low including transmission sufficient therafter RED days whilst existing than open completion first <37 discharge be hrs INTERMEDIATE Level pathogens high respiratory symptoms co contacts initiation hours neutropaenia Probability ensure CoV2 URT+LRT shielding aerosol have employees history deemed allow ONLY Cohorted"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "run Critical using found CRITICAL on Breaking patients CARE phone Communication Prior go access the sign for fill attendanywhere Near NHS https://nhs relatives Waiting Bad Remote discuss in via username name patient\u2019s is nhs video iPad email: COVID19 NHSFREEWIFI Guideline please can not onto calling service talk 654321 would Ask FOR and Click Care use patient NHSNearMe@nhslothian vc/rcc with Me live team making to Ensure com/login Attend Log following Scotland Anywhere you connected RIE given quick If they family call it iPad: Go read wish which passcode medical Area USE CALL VIDEO platform or details TO scot of uk News https://nhsattend advice: HOW password like challenging label helpful Guidelines be do tips have ONLY"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "being been hygiene when pressing different longsleeved hair removing cannot clean on face both PPE differ these above disposable With the for good lower check equipment adjust work spectacles safe cuff gloves in regularly putting by Predonning protection head strap tie perform patient\u2019s is correct that ties Place repellent away tested COVID19 torn according bridge instructions practices touched upper this Where must Eye Instructions manufacturers followed remove Putting spread safety Gloves neck and ngers gown your nose facial use patient PROCEED worker crown after with order respirator donning test fasten nape DO at undertaken uid technique to will Ensure Position room rmly jewellery Note: surfaces you makes select down available Perform ears over hands infection until If glove headband eyes provided straps sides healthcare keep from Put during back environment are compatibility against between goggles should This eye change checking or heavily mould of waist size cheeks protective hand always Use limit NOT yourself achieved outside protect before Respirator be personal covered The ensure worn piece contaminated have hydrated"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "Then: retaining up using removing as face both lift PPE removal let absence gel retraining visor process the bundle inadvertently for outsides waste Wash equipment rst contaminating into safe risk gloves in disposed To by under water protection head strap All isolation patient\u2019s is sleeves that distance ties minimises Unless leaving pulling area roll away COVID19 lined alcohol not soap Eye Where must remove there Turn fall Gloves remaining inside neck and anteroom/lobby systematic gown Removal ngers your use an worker Pull contamination slide fullface with Clean order reduce behind respirator Gown cross peeling nd bring at themselves to will ungloved gloved room forward Do then over front clinical reach hands glove removed discard off peel straps healthcare In from fold opposite it back while are bottom motion handle place should eye follows: respirators possible or of FFP3 Firstly: metres waist shoulders preferably slightly way Unfasten protective grasp hand including always out dofng only ante outside buddy touching top be before Respirator wrist personal The bin dedicated potential rub lean contaminated supervised touch hold"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "RIDU Stethoscope up Critical blue Guedel Pressure set monitor 12F CRITICAL socket on tube tubing CARE Braun COVID19/Suspected CCOOVVIIDD1199 pressors Facemasks Draft/Final: cylinder access charge the Aintree ETT 14F Slim need check plus equipment v2 Covid19 pack review waiting Syringe listed saline in unit Mackinnon Closed if scope suction Written: tie 10ml NIPB McGrath Scope Tube Arterial leaving Oxylog pumps Authors: COVID19 Stylet Schrader Box not Drip Yankauer Title: Approved Please // refreshed 1000ml Femoral pump Suction catheters Cuff WGH FOR and induction Clark Checklist Care Duncan use patient Cables Clerk 2020 LLiisstt splitter box catheter fat iGel trolley airways 3000 to Intubation Oxygen Emergency room departure Next Jelly emergency infusion sachets Ambu blades available drivers x3 KKiitt mounts 2200 Bougie contents tape Anchorfast off phones left 20 Draft breathing circuit WWaarrdd Macintosh Laminated Metal bag Scissors ventilator Baby Blackstock insertion packs are Loose syringe 18G Sp02 stand Ward arterial SSuussppeecctteedd Status manometer clamp stored USE Monitor tubes HMEF below Drugs RSI size cable Vascular key clamps Baruah by: intubate Cannula may SOP Reviewed March drugs normal Guidelines before be 22G made EtC02 office transducer The plastic 20G sampling ABP NG line laryngoscope on: ONLY cateher sizes"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "PCI deterioration take status as minimise donning/doffing definitive patients CARE Phone CCOOVVIIDD1199 assisting access charge the trainee PAG review gloves measuring if handover doffing COVID19 aim can ICU Approved US IV kit atropine too pump include Inform and patient List after every Transfer with PostRSI post closed Update: at 10th confirmed will Intubation Emergency room supervising primed Donning/doffing page ICU/anaesthetic ECG indicates shift airway syringe between Sp02 appropriate mask manometer clamp wide USE Monitor tubes or of Drugs Contact time Size list be made before EtC02 position high intubation dedicated maintain severely NG ONLY evidence Sonosite metaraminol monitor face Braun these intubator/drugs ETT equipment experienced critical Covid19 risk discuss Record by number precautions is guidance judgment jelly BP Severe Equipment current re proven prior neck FOR respond Checklist 2020 assess suspected/proven CXR box Kit situ team Follow unsuitable Primary Covid involved 16F equipotent Etc02 Ambu drivers full 2200 Anchorfast from call arrange hypoxic staffing x2 remains should Ward proning Establish per 1:10 choice Reviewed Guidelines Ccircuit office 118 scopes transfer Stethoscope up levels CRITICAL on tubing PPE machine COVID19/Suspected Facemasks NIC nursing for Front check Clerk\u2019s in Closed suction Written: 10ml nursed Oxylog consist Authors: COVID Title: // CPR moved catheters convene care WGH anticipatory use guideline secretions Two Next escorted emergency immediately monitoring nurses scrub front clinical If board IGel Anecdotal WWaarrdd Laminated Metal receiving Group administrator Lubricating Exit determine medical change door oxygen Yankaeur slim China Baruah SOP anaesthetic may pause drugs piped identified hypoxia buddy Prereferral The respiratory bottle Problem intranet Runner aerosolization RIDU Critical when Guedel 14 1:100 HPS found staff tube lift escalation phone adrenaline Communication referral: Aintree Assessment Communication: their trained suspected required communicate one Conduct compressions via availability well Arterial leaving contact not appropriately intubating nurse taxi SAS safety sterile RSI: Suction 000 Cuff supervise through Care planning suitability Induction catheter arrangements HME ID but intubations airways Interhospital met to videos confirm Ventilation departure compressiononly scissors RIE SSOOPP Perform Restock practical Daily infection Bougie intubator\u2019s 20 Draft 9am during back ventilator Blackstock insertion alfentanil ambulance postintubation unstable progress bed consultant SSuussppeecctteedd Status stored cuffed plugged Staff side RSI size see See by: assistants units March cleaning outside specialty Level propofol fluids indicated line entrance Draft/Final: on:"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "incl up Critical Stethoscope 5cm using 3cm on site tube PPE phone Communication access Cut ETT Is for pressure Blacstock check NHS help Can Anaesthetist cuff in via CONCERNS Closed if 2018 suction head sedation Plan is McGrath Confirm Optimisation Double Scalpelbougietube max B/C FoNA supply Allergies contact lubricate Theatre Preoxygenate Stylet turned ICU BP O2 Yankauer this Ongoing Team checked Equipment kit required? ON fails? plan Cons roles? backup visible Understand and Checklist Care Preparation tip patient PROCEED Mac 2020 Induction Site CoVid box catheter role trolley Intubator Cricoid requested will carina Intubation Verbalise room Emergency mount Covid laryngoscopy Monitoring \u00d72 Sizes supraglottic ECG Check DAS/ICS ml Bougie tape allocation from RAISE circuit wake turns Fibreoptic Airway trachea administrator Supraglottic airway assistant handle syringe Patient mobile further Vocalise 10 Intubator\u2019s NOW or Tie OPA Adapted Lothian Drugs RSI size Who Review Baruah Optimise how? March drugs ETCO2 Date: \u2191K+? outside SpO2 position intubation we Runner waveform laryngoscope Difficulty vasopressors"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "48 transfer Critical floor any HDU as Donning on decision staff both Main/DCN PPE point patients escalation above Anaesthetic Suggested construct surgery the requiring ETT recovery nursing for pressure ward/HDU/Lothian L1/2 ward Estates Murray markings SJH liase default required coordinate bedspace movement /Ward in unit via ends vestibule by Will 1016 All used Plan Nursing is that Close referral theatre/recovery area Theatre doffing considered COVID19 can ICU not operating Capacity Surge this IPCT must Visitors plan coordinators moved oncall continue 916 WGH and Care theatre bedspaces patient able As 58 Enhanced Site detailed Move with acceptance order closed donning areas barrier but mechanical at input team instance 26 Management nonessential will to informed room management Bedspaces following already emergency ICU/Ward Patients RIE ventilation available then handwashing 36 nonCOVID until If admitted machines Manage doors /NHDU Medical removed surge stop items 20 from people within use: Consultant Blackstock managed empty At negative between Patient NonCOVID19 Bedspace plan: bed should Ward consultant appropriate further time: This senior who 3rd Dependent capacity admission or advice possible Medical/Haematology of theatres sink occurred directed per side spaces Oncall time Review all SOP anaesthetic elective may enact including 18 These 13/3/2020 entrance/exit second SHDU only normal Discharge first be before barriers 89 now indicated temporary main entrance basin"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "Initial wheel using procedure patients toggled 5l/min CCIRCUIT the need review USING <30cmH2O To if Select likely does occurs that confronted secs pH reconnected refill aim 1:1 PLAN: can More O2 CIRCUIT calibrate CS2 bedside include Ask mains and shown patient touchscreen after every OF with SIMV AND at higher confirmed will Flow down righthand indicates they VENTILATOR comwheel settings bag flow periodically HYPOXIA: are changes Pause BACKUP appropriate PEEP otherwise closedsuction adjusted clamp CALL neurointensive or of Signs 10l/min visual all including only 1l/min be position high maintain indicator Mode THE pressing fresh require displayed turn FRESH set system persists adjust standby default GOALS DISCONNECT BREAKING no >7 by VCV so All is ventilating >6 increase Equipment Ventilator there connections endtidal Following FOR picture FGF support VENTILATION BELLOWS PAUSING 60 setting team tab PCVVG Ensure H+ complete select 2024 >0 break left PaO2 measured TIDAL breath 100% 15 elevated place 13l/min should 10 Displaced screen switch Volume Gas green needs Checkout Press Push baseline fail top OXYGENATE do message After 12cmH2O FiO2 up different leak bag/ventilator on usually demands machine for pressure check Obstruction Settings in IMMEDIATE sodalime present Pinsp litres/minute Stacked red defined d/w COVID container Anaesthesia 6l/min this <60 Tidal initially care OXYGEN ventilated Bag disconnection yet based reverse reduce move Ratio navigate rate either ABG mechanical window reduction Once Volatile following increasing immediately you then lime reach 400mls Preferred If last leaks within lowflow 5cmH2O EtCO2 824 This medical change FiCO2 admission changing oxygen right FALLING may These pause Use arrow DOPES than CO2 identified Increase The hours dialed CAUSES Pressure prompt LIME run when There seconds tube litres/min above FLOW With >10l/min temporarily 8l/min lower changed AISYS light COETT Respiratory GAS canister END activate casing perform used combination Case >8kPa OFF not its bellows start Pneumothorax minutes highflow Breaths checkout minimised increased each target but Vent gas switch: PaCO2 met to rechecked SODA confirm Ventilation return Perform Settings: until saying Disconnections difference Low flows circuit during ventilator TROUBLESHOOTING which PVCVG HELP soda Restart side way You see mode low 6mls/kg bpm Start limit com achieved vent plastic REMEMBER NonCOVID temporary targets touch"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "been Initial wheel although 1:2 critically using usual contacted components as minimise site without procedure blocking 12 patients toggled 5l/min continues context the Fresh reconnecting inadvertently completely Introductory need acknowledged review limb Circle Alastair intended To if Select non likely 3L/min us that parameters reliability functional 1220 confronted 12hrs demand pH reconnected additional according aim 1:1 can are: ICU operating More O2 spill performed situation Please Expiratory best CS2 warning bedside filter dependent Intersurgical stay earlier and shown CPAP patient also touchscreen after cassette every regular agents 12hours Dr with Using closed unless SIMV Distal at Commencing mindray replacement higher confirmed acknowledge Modes will users Flow Controlled page wet Com nonCOVID ventilators instability machines they Air Sidestream comwheel guaranteed Visually settings problem it option bag ask flow airway are changes between collapse procedures production PEEP inspired Morgan adjusted manometer One moisture drying expiratory Differences or Solutions rise of theatres metabolic routine 19 time maximum 10l/min freshgas 24hours all including due Simply days emptied only phases 49 overcome questioned 13L/min be long before pandemic position high added They maintain \uf0b37 indicator expected have Mode H2O Total pressing throughout very fresh require again minute mandatory turn set cause monitor valves inspiratory Tab system integrity these inspiration disposable litres recovery approach uses persists volatile disposables Prone adjust standby cassetes default ODP make risk exhausted less listed therefore no by VCV under colour desired so suggest All caution is Our Safety frequently RR selected adjustable Operating ventilating where end Disclaimer: increase tight Procedure current occur pressures remove Peak Neuro there connections outwith become supplies Following 12hour capnographs drop picture FGF displays challenges posters could 10L/min As corresponds Standard support 8kpa completed clamping 60 test Aisys PSV setting tab team controlled PCVVG case ratio broken >10l/minute Ensure H+ cmH2O preuse disconnected select 2024 available Ventilatory Assess information >0 full accessed removed surge PaO2 ill left from measured Adjust control Vt whether 100% read Should At induce 15 called absorbed Intensivists elevated Diuretics Continuous neutral some 13l/min lung should upon filters short vapouriser prolonged 12cm times I:E preferred screen 10 restarted switch discussed valve It Elevated Breathing reboot Volume Gas HMEF 49day green needs period per weight two balance However Checkout rotating clearance small hospital document register Falling completion achieve baseline individual most carry litre/min do message reduced highlighted we After being FiO2 Unable pro spontaneously different alter leak levels cannot on cancelled usually demands point prevent machine 6L/min ulnar necessary inspect 68 incorporates starting basis for impact pressure depending check displaced lost NHS Ally Settings into anticipate 30cmH2O Higher prove Difference in plateau inspiratory/expiratory extent Closed push 3l/min sodalime suction sedation remain Synchronised tidal litres/minute anticipating our red defined internal COVID menu L/min please Anaesthesia 6l/min this must checked drive windows intermittent plan sensor Consider initially 24 WGH viral ventilated use shortage Bag disconnection requirement circle yet settings: options instances contamination operated order move reduce remind An navigate has efficiency rate either cicuit window recheck what Disposables names Once twist following refer For How increasing you unnecessary Do then lime clinical VG breaths hyperpyrexia Check 400mls expertise If autoflow Upon suctioning yellow mitigate filled keep breathing In leaks positive within wash lowflow empty linked negative EtCO2 capnograph just selfsealing hypoxaemia guide designed This >68l/min further who medical change performance scavenging FiCO2 latter changing demonstrate Adapted representation oxygen rebreathing known fulltest style protective display proximal expect SOP may anaesthetic Touch safer standard frequent These flush Use arrow positions undergo than ruler Gibson CO2 We PCV Rate identified soiled PSVPro circuits familiar returned Increase goals aiming The respiratory customise potential hours weaning ensure significant Pressure On consists run Critical when capnography haemodynamic vapour found any There term limited staff Breaking both those tube Default 1l/minute litres/min above With Prior >10l/min temporarily requiring volume their reinflated lower changed Troubleshooting AISYS light required COETT Respiratory canister >6l/min via Although important used patient\u2019s consideration By combination expired note not OFF located its isoflurane put start bellows When Tinsp nurse reinspired assist unclamped Users extremely exhaustion would sidestream minutes Pro 13 clamped apnoea Care clinically provision checkout an Soda planning Increasing increased target body enlist but indications becomes Vent experience gas switch: barotrauma undertaken PaCO2 unlike met to works rechecked volumes confirm Ventilation malignant routinely initial cannister return begin NO ventilation mentioned until difference COVIDpositive ventilate more alarm flows circuit 400ml during back ventilator least presence paused rate? which neuromuscular predicted occurring rates sevoflurane peak consultant continuous selecting soda discussion indicators possible Suctioning slightly below Lothian licensed You see See mode optimise low 6mls/kg Circuit Initially satellite Start limit NOT out open Flows normal com lowflows cancel vent propofol Circuits anaesthesia now indicated conduct line temporary main touch bacterial/viral"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "FiO2 excessive Initial blue when using curve vapour require as on point patients 5l/min occluded machine dialled >10l/min the volume neurocritical for changed Machine exp need Change resistance into required canister limb thirds visually in Record Alastair lime1 if by does colour water suction present occurs Absorbent is parameters patient\u2019s used Insp frequently near trap5 <0 please inspected ICU Anaesthesia not 6l/min performed this must Instructions increase Expiratory tight checked other Ventilator CS2 white assist there bedside Inspect filter Tidal exhaustion fall include minutes 24 Version care zero? and bronchoconstriction FGF Soda use an disconnection 1Task circle after every with increased closed has drained Aisys either secretions recheck team replacement PaCO2 will to rechecked carried Monitoring Continuously monitoring Perform lime reach information 1L/min If indicates yellow more distal condenser Alarms circuit6 from measured circuit control within mins next hourly Filters flow 15 daily EtCO2 flow4 needed should filters further otherwise medical change Morgan soda Water FiCO2 spirometry Hourly expiratory moisture or It pink HMEF of humidity reboot manual fulltest two chart However time low MV causes all including inspired may due Circuit SOP days selftest7 out than CO2 49 be before added high reduced The hours 68l/min zero Pressure"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "been discoloured replacing Initial blue critically using deterioration FiO2>0 compliance arriving result as without procedure 12 patients greater continual Royal unintended the context perioperative Fresh Introductory pH\uf0b37 need kept acknowledged review Clamp bedspace limb 68L/min visually Alastair intended 5L/min To if interfere non opening does Full us dyssynchrony that >10L/min absorber received resource exclude demand considered COVID19 according refill aim compensate event cleared can pressure/flow ICU onto More performed situation CS2 warning bedside despite hospitalwide dependent filter Intersurgical include Immediate effects and once gehealthcare CPAP patient also cassette after every atmosphere nonIntensivists agents undoubtedly with find closed detected unless SIMV 11 Phase at needing replacement reservoir higher confirmed +/ will alongside isolate wet nonCOVID highmetabolic acquired Both ventilators machines provided they meet Sidestream distal especially \uf0b312 inefficiency condenser guaranteed settings delivery unable described ongoing it option bag >10 flow flowrate consider are Any changes Pause kPa collapse accuracy production between appropriate PEEP arterial mask Morgan closedsuction pH>7 stable wide moisture manometer expiratory or approximately metabolic of theatres FFP3 routine 19 agent 10l/min time acceptable maximum MV visual such all including IPC device 18 1litre/min days 16 triggered breathe emptied nationally only phases 49 replaced Minute occasions Filter be long made before pandemic <10 added high They *For maintain viral/bacterial indicator expected communicated have capability Mode Capnography lowest updated very fresh require again displayed minute clean mandatory set monitor inspiratory system integrity closedsuctioning typically inspiration planned Western volatile conjunction charts alternative equipment adjust experienced default risk less precheck regularly therefore sooner no by sensor/valve under Appropriate delivered minimum All longterm is avoid Our Unless frequently RR oscillations Operating end Disclaimer: followed increase tight Procedure current pressures suggesting Neuro deliver there connections space problematic become rebooted sedated fall prior induction EZchange drop FGF could Standard support soon corresponding waveforms clinician clamping utilisation previously 12cmH20 Aisys setting team tab stops PCVVG 3000 ratio broken pausing H+ https://cleaning complete sevoflurane/isoflurane infusion available comprehensive information General quick full >0 surge understanding PaO2 ill from parameter monitored control measured brief Consultant breath undergone Further read Should At ensuring opioid 15 still elevated inspection needed suction/patient MAC should breaks upon filters Ward lung times 10 I:E restarted It reboot HMEF Gas needs per two However supervision small hospital document register certificate delivers supported most Ccircuit pressurecontrolled reduced Pmax preceded we means history PS/CPAP being FiO2 ET sedative transfer spontaneously leak different levels removing concern Running Hospitals on rainout usually reengaged PPE point machine 10l/minute necessary studied 68 depending for adapt pressure nursing assistance check effort resistance suitable NHS Settings into help 30cmH2O cuff reducing in Closed negate push 3l/min sodalime suction Scavenging present sedation bacterial tidal reference litres/minute our Oxylog Satellite physiology responsible COVID please inspected 6l/min rather this must checked drive GE assisted filtering new operate Clinical AGSS local 812cmH20 initially backup 24 Version viral ventilated use proper done circle sudden options SpR reduce An has efficiency rate either ABG ready sought recheck Appendix Once twist sensed Volatile oxygenating following detrimental emergency For increasing about monitoring appears Local then lime clinical Teleflex hyperpyrexia breaths Check 1L/min 400mls If suctioning oxygenation autoflow yellow similar attached expectation In leaks breathing positive 35cmH2O within Satellite/Surge receiving maintained deeply lowflow empty vary linked EtCO2 port 824 designed guide This further who change performance medical scavenging FiCO2 were 20cmH2O admission calibration changing oxygen failure rebreathing commence 17 CCircuit Canister proximal procedures anaesthetic may standard inspired These tracheostomy than CO2 We identified PSVPro circuits personal technical user The respiratory \uf0a365 hours potential ensure weaning ODP/medical Pressure coughing decontamination run Critical when 14 capnography intervention There term staff limited seconds both tube practice compensation operates litres/min With Prior midazolam/clonidine cylinder external transitioning requiring repatriated volume temporarily their ward changed suspected seen loss AISYS opened disengaged required COETT Respiratory canister >6l/min optimisation Mindray Although hose important 30 outstrip perform used patient\u2019s arises 24hrs Owner: effect supply outstrips note not its Surge Negative working bellows appropriately When other depressurisation performing admissions safety would minutes 13 clamped through apnoea Care fitted limits provision an Increasing laminated catheter arrangements increased each drained but indications Replacing experience gas paralysed PaCO2 Colleges/ASA Ideally Ventilators to 510cmH20 Ventilation malignant routinely initial adequate connected setup ventilation Perform Internal until COVIDpositive ventilate more alarm presents Low Breaks flows 20 circuit function during back ventilator least paused insertion determined H+\uf0a365 daily timed which neuromuscular rates peak blockade suggested soda follows: standards Increased capacity possible Restart how deeper Lothian side licensed basic teams mode Unclamp low 6mls/kg increases satellite out Unit1 Flows cleaning com lowflows blocked propofol spontaneous anaesthesia reduces associated worn console dead NonCOVID line main targets members level bacterial/viral"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "been On transfer agreement Critical ChlorClean 14 using HPS CT as CRITICAL staff on transport entering tube PPE practice 12 TTrraannssffeerr scan CARE CCOOVVIIDD1199 necessary go access Draft/Final: the nursing for trainee drug ward need trained assistance equipment kept standby Ferguson required review one bedspace in department Only via entry Scan if by does member minimum members Written: used is remain avoid monitors guidance Tube leaving Oxylog taken area Authors: doffing reconnected Pre COVID COVID19 end can ICU not put this cubicle CCaarrdd nurse Title: Approved radiographer filter stay Following prior IInnttrraahhoossppiittaall arrival earlier inside remaining 13 FOR and Arrival completion: WGH Care clinically Intrahospital Final May done patient disconnection 2020 also after Transfer contamination Stop with doff HME has unless trolley 11 AAccttiioonn Then at team \u2018clean\u2019 undertaken will to Ensure carried wait room CT: Next CCTT emergency immediately McNeill down ahead walk clothing observe enhanced 2200 If wearing doors donned off 20 repeated from undertake circuit control \u2018doffing\u2019 WWaarrdd bag during back ventilator wiped 15 Portering Dunn between disconnecting bed wear 5th appropriate Ward consultant should This table senior medical 10 3rd change departure: discussion Status arranged clear USE discussed stored or of per clamps Baruah by: standard 16 prepare Card Reviewed newly open only list individual outside Action Guidelines amount be July Level corridors do The indicated ONLY on:"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "been https://www Be as Journal site without follow New 2mls/hr aet199 patency charge the Date need Inotropes/Vasopressors safe administered seek Standards To if Medication rapid Commence occurs Nursing correct that 8mg luminous handover area 2012 can stated onto Keep Please best uk/icshomepage/guidelinesandstandards/ nmc additive and/or http://www pump blood 10mls/hr effects and faster your pdf patient Prepare 5mls every Stop with Clean Calculation net/clinicalsubjects/accidentand at Commencing titrate higher will confirming Work infusions: management vasoactive dated recommended covers observe Protective Doses C74C77 providing prescription delivery unable it bag administration flow consider Connect are 160mcg/ml requires Hospital arterial photosensitive org/content/early/2013/06/11/bja uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress or actions Inotrope/Vasopressor of rise Administration clamps time inotropes/vaspressors maximum due device only 73 be before concentrations bleeding interruption high Policy waveform have flushing study et org very require turn Label Braun discontinuation 16mg venous critical medicines policy risk less pumps: Run recommendations no insitu by decrease under Medicine so desired All changeovers is xrayed guidance frequently Insert wipes end fullarticle central Equipment current remove emergency/changinginotropeinfusionswhichtechniqueis space Training 9% Following prior Observe labelled extra <drugs sugars engaged assess best/201728 2010 MAP medications prescribed 20th Follow Enter Ensure inotropes Written complete measures standardsformedicinesmanagement infusion available Signature/BBraun full lines three from control distally nursingtimes IJ hourly Pollock threeway systolic should short http://bja subclavian times It ucl clearly per Alaris Review proximally small achieve changeover ac Guidelines 16mg% expiry After visualisation continuously up Personal quasiexperimental on 80mcg/ml PPE Blood prevent References Venous starting for pressure Infusion Concentration Mackay specific NHS into invasive Midwifery in push CVC concentration date Chlorhexidine this labels smart service inotrope/vaspressor new pdf+html spiked Catheter pumping same initially continue care Failure use disconnection lumen Sept mls alarming pertains double transduced has rate Apply Discontinuation For increasing you Do monitoring nurses then 2007 uk/globalassets/sitedocuments/standards/nmc aware Check designated strength If last Rapid discard attached stop ors keep \u22645mmHg infusions Changing within 2017 This inotrope medical change advice commence original Inotropes British may flush connection Use Device Heru than 10mls drugs Lines medication The ensure intranet Pressure vasopressors run Critical another found any 8mg% staff ics both connecting circumstances practice above Prior Society drug running lower changed placement update April required bags bleed one via Intensive used Arterial effect taken pumps oxfordjournals Titrate instructions not start automated When half other nurse Signature Aim Core 2% Decreasing Cardiovascular 2013 clamped Council through Care an Increasing Healthcare<az<critical Inotrope 2015 areas bolus instance 72hours Drug technique to competencies al connected prevention life until infection Purge 20mls/hr Cour more NaCL off patent old during back which bed hour library tap Lothian side guidelines way Central by: out continually existing open Benefits achieved fluids ABP line touch"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "Silence using \u2018Quick status output as without follow the Date affects review stud To Waveform inate CCO Federal parameters that serial 2019 additional mmHg COM1 8008229837 can Mount \u2018zero\u2019 IV Engineering Thermistor and/or Turn language and patient Back after Open Stop with events operator\u2019s at Analog replacement pole will Replace mount column Module Fastflush down contained ECG OR WiFi sale settings it bag HemoSphere globe Connect are CAUTION: between accuracy appropriate arterial cardiac technology One Monitor or actions of manual Hold phlebostatic time visual all filament including device caps United only be position air: Zeroing indicator heart pushing ops displayed Main monitor system stopcock packaging hemodynamic CO Oximetry selection nonvented restricts Help law silences adverse no by desired precautions All is charged Insert selected end RS232 warnings assure properly rear tight current remove Export appear connections axis engaged aspirate residual support completed outlet plug test input insert Follow Enter Irvine Time complete Monitoring module Average select CA information full power Derived Way left parameter PGDT holder Edwards globes Lock terminal Plug place startup orientation Event upon times 10 screen USA platform switch It fully cable grade two FloTrac Press prime Averaging hang hospital battery stopcocks compatible physician first want do eight highlighted measurement 300 Injectate being up on entering tubing Blood Platform inspect button ports for pressure alarms bar v2 image into Settings Lifesciences in probe outlined tone remain 24/7 cord owners Demo bubbles time/date prescribing air this must CVP Clinical sensor LTech main pull use proper Bag calculator fluid order USB rate steps window insertion/connection system: refer For you monitoring appears then Advanced rights front clinical TimeinTarget click contents keep Battery slots port Patient guide This property change icon door calibration value highlights upright display right procedures flush Touch connection standard data panel Thermal Captures technical The Compatible ensure iCO HDMI gravity Pressure temperature when Acumen heard any contraindications features With Equipotential their lower update Zero\u2019 Smart audible important tracking Corporation zeroing reaches advanced capital_care@edwards instructions not logo other Choose IQ arrows minutes raises through an Securely deair catheter trademarks SwanGanz Start/stop PPUS2208 indications Bar screens to initial Note: stylized holding Ethernet setup expansion Pressurize conditioned until alarm six off edwards slot Navigation connector HIS respective Available inserting which Sensor stand selecting Status 92614 Information States guidelines tap Zero See mode units Expansion Parameter Refer Start out open Setup com outside Level Screen reserved format zero touch Snapshot level"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Extraction Directive93/42/ECC Lactate RVSP Pulmonary ITTV=COxMTt 12 EVLW EVLW=PTVPBV EVLW/0 the /CI SI Units thermodilution 716 CaO2 Federal parameters W/m2 mL DSt mEq/L mmHg 45 O2 200250 Diastolic ITBV LAP blood and SV conformity 2025% 95100% <250 PBW events PVPI=EVLW/PBV theirrespective 11 SVI Index 0138 9501150 PVRI meeting Work Delivery ScvO2 CFI 6070% sale International 650800 range Parameters are CAUTION: Consumption 360 One 4060% or of RAP ml/m2 time including Thoracic device Function Stroke United PVPI O2ER CI xDSt dye/temperature RVESV 52 48 Physiorelationship Extra SvO2 CPO Saturation Body 0031 hemodynamic CO HR 6080 19702390 *Reference SBP 4252% 8501000 restricts law GEDV=COxMTtxf 417 saline 6090 adverse End by values* mL/min/m2 precautions RVP All SV/1000 mL/min SVR 65 Mean BP warnings 1015% ITBI 2230% S2S1 91 Perfusion 117160 SVV mL/kg Variation Global LVSWI MAP PPUS2312 requirements methods 26 laboratory DO2 Oxygen Irvine 1215 devices Transpulmonary PvO2 GEDI /CaO2 v1 S1 CA information full Way PaO2 Convention Edwards 80 CPP 931 3648% GEF European Systolic EndSystolic 10 adult Content USA placed /3 Volume 25 Article Vascular marking <3 Cv physician 1020 1525 bear Intra SV/EDV RVEDVI 25xGEDV Weight RVSWI 5062 on 54 Female: Blood VO2I Venous PAP for TPTD /SVmean RVEF Lifesciences Difference in PTV=CO Fraction 50 /CO Occlusion 08 Ejection reference S1/S2 Permeability 3347 owners 1720 PASP Atrial L/min ELWI prescribing Hematocrit mL/beat this PVR CPI CVP 8001200 Left use av BPPAOP order CE Ratio Equation Hemodynamic 70105 Male 1/min essential For PADP rights mmol/L Predicted Test referred dynessec/cm5/m2 Medical /SaO2 EVLW/PBW vary Hemoglobin professional 510 2017 CO/BSA property Water MTt SVmin 255285 1000 g/dL 6080% L/min/m2 Device Ventricular regional Values Right 500600 Pressure CvO2 mL/m2 Output 50100 RVEDV/BSA contraindications Coronary SVmax DO2I Hct CO/HR values Lung market SVRI mL/dL 124174 RVEDV Corporation Arterial MPAP EndDiastolic Cardiac ITBV=1 instructions techniques Systemic 100 logo S2 other Laboratory Hgb 5994 trademarks indications SaO2 to DBP dynessec/cm5 stylized Males: 100160 Resistance Height152 VO2 edwards Normal 07 56 PBV=0 injection CI/HR >20% 90140 GEDV 815 92614 States Central Cold See PAOP g/L RVDP 612 units Parameter SV/EF O2EI mL/m2/beat 0136 Females: com 60100 COxDSt0 46 420 Power reserved Artery Mixed 120160 EDVSV"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "Resection temperature up 14 using removing reached displayed set monitor as on procedure contraindications 12 Oximetry rm alarms/target prefer Platform the button Venous volume for pressure venous l\u2019Etraz TPTD EV1000 review one Lifesciences choose market boluses in saline Lung thermal adverse calculation if probe Select thermodilution CVC well rapid desired precautions 2018 All patient\u2019s inject is parameters Corporation Prime Insert selected according prescribing instructions please air upper warnings start logo Wait When central 70 de pressures new Directive ne Choose CVP Clinical directions sensor Catheter Turn transpulmonary continue Observe axis 13 and conformity Guide use patient indexed waveforms 93/42/EEC Before databox 1260 cables catheter edit trademarks with previously CE oxymetry events femoral connect Bolus indications 11 requirements bolus steps Inject screens Enter meeting to Ensure cold injectate essential devices refer For primed stylized connected setup results available TruWave then rights Actions information until OR full ml referred smooth Medical six 20 parameter edwards it range Set selftest Edwards Connect Parameters RUL are 15 professional series Nyon descriptor syringe method startup thermistor European guide transducers continuous con arterial appropriate 10 Monitor or placed Startup of Thermodilution valve/port Article Central cable 17 See marking phlebostatic time right 19 prime all including keypad Touch Accept 18 Device data Start VolumeView existing 16 Setup Route System Switzerland prechilled normal baseline com real manifold amount ENP509/1118/CC inline Repeat transducer reserved lobectomy bear example highlighted solution ensure starts waveform zero touch nonindexed level"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "been closure CT result SURGERY as Guidance minimise without follow site 12 patients While greater complication fluoroscopy access unintended the context dissection circulation Communicate Anesthesiologists cavities review complicated vessel: intended if likely does provide occurs that nonsurgical group issue Anaesthesiology considered 2012 Guideline can mortality Approved supra sited Ireland blood Immediate often consequence carotid editorial and Compress patient DRAFT also after Stop executed with femoral deferring AND anaemic coagulopathy at angiogram Management will confirming management cerebral IF PRESS down BEFORE static organised instability watchful distal providing uncontrolled unable it Tambyraja managed flow compression are largebore morbidity *There vessel large analysis catheterization arterial French Less formation 2021 USE \u2018Arterial\u2019 or catheter/dilator of manual haemothorax interventional Contact time acceptable such pulsatile all remain: 18 generally Size handled risks only indicate 73 be before Leave bleeding adults expected waveform have allow ONLY evidence majority require wall CCaatthheetteerrss resides Guidewire misplaced these includes DONT active venous conjunction Xray continued risk less radiologist no by Andy uk/Directory/CriticalCare/Bedside colour Interventional minimum is consultation avoid manageable highest peritoneal pulse minimal CCeennttrraall Than hypotensive relative PULL central occur there space FOR methods: 547 imaging liaise aspirate benefits soon Compressible CXR purpose prepuncture pleural ultrasound dynamic Equal Advances Jan devices Inadvertent available Rhona compressible: surgical lines infuse Misplaced Feb if: left Catheters from Verification mass Mispalcement major hypoxic pre thinwall era diagnosis withdraw place should upon Injury subclavian adult period Retroperitoneal ooff Vascular However small document Reviewed difficult Minor care/Insertion most Guidelines common reduced treatment After evaluated AFTER Vessel* switchboard Line freely/difficult Force representative on usually Blood removal GGuuiiddeelliinnee DON\u2019T absence observation general route Needle Venous for pressure course haemorrhage into anything in Background: tear Written: Task present attempted http://intranet proceeding localization guidewire Authors: immediate consulted whose embolus this Title: must Actions: plan anaesthetist Catheter catheters 24 pull versus gauge vein Surgery based order MMiissssiitteedd has DO guideline Misplacement stepbystep Anesthesiology pericardial Next fistula following advance For immediately Patients Do pseudoaneurysm Potential Massive clinical cavity COMPRESSIBLE Aanesthesia In relied infusions cannulation compressing Report Duplex vascular regarding This who CClliinniiccaall were Abnormal dilator multidisciplinary anecdotal scot repair develop Puncture NHSLothian frequent may threaded data than NON Lines Dornan MMaannaaggeemmeenntt The surgeon hours significant Critical any recognised cap expanding surgery doc their Society References: placement seen Access: Remove one via literature ischaemic Hamish used Radiology 116:539 Arterial location nhs AV contact Case needle injury Complications: appropriately not techniques its arteriovenous DILATION When infarction PPrraaccttiiccee catheterisations practically Unintentional minutes documented Care Dilator/catheter reported an ffoorr infraclavicularly Remain catheter thrombosis body XR guiding gas puncture to wire catheter/vessel QIT prevention severe until No more Practice artery off during VASCULAR least insertion Coagulopathy determined Recognition: connects CONTACT Punctures missited Status percutaneous damage possible notes issues confer catheterrelated way Central size Cap by: low American elective Access out complications bore helpful lothian unrecognised real reports associated tears thread line Draft/Final: on:"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "being agreement Critical when There liver decision as CRITICAL practice Practitioner CARE Anaesthetic circumstances: Draft/Final: access the approach Venous trainee for doctor venous placement suitable NHS review in anatomy PRACTITIONERS by CVC Medicine Intensive Practitioners Written: anticipated used is obesity that guidance BY group jugular Authors: internal Young advanced Guideline ICU not Title: Approved other central ADVANCED difficulty Catheter ID: 2013 editorial FINAL FOR and Care an criteria patient completed having intracranial post training with has 2015 inhouse coagulopathy ultrasound met will to competencies Next following QIT Patients November Advanced them acute off met: signed from obtain within presence Consultant are Any should appropriate senior stable Status USE placed morbid LOTHIAN of Lothian failure basic Central by: GUIDELINE including physiologically ACCP Reviewed difficult Anticipated only Neil fellowship Guidelines be made The supervised significant PLACEMENT hypertension ONLY on:"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "transparent Lister using Journal site procedure specimen 12 CARE disconnect January access Royal the need review Clamp rigours gloves Standards if degrees Nursing investigation group area begins alcohol laid soap comfortable Approved blood stay PostProcedure Ask editorial 8th and Clark cut tip count patient able after clotting with Clean cover Discuss Semipermeable 11 at higher Document gauze Skin management supine Chapter down Scissors* flat Dispose platelet Air stopped it are Hospital USE or approximately of Hold time hand all including intact 18 sent carefully suture before be bleeding position rub Loosen deranged ONLY airtight clean system Cut venous Wash Hamilton equipment pack make risk by head is Embolism Place hypotension near where press pus central Procedure normal/close Equipment remove continuing Wipe there FOR Valsalva swabs As Standard WileyBlackwell occlusive Cover 193196 2010 trolley 26 Plaizier Explain hands Cerebral 43 Discontinue from Put place should 10 3rd Maintain Vascular two Review chart swab instruction small Manual Reviewed Guidelines first Rogers After being Line 5cm wipe 2011 CRITICAL on point Bell removal References Venous basis for pressure Infusion check into gently in Continue CVC Written: Stitch Alcohol Authors: firmly dressing exhale container Devices date Chlorhexidine Title: must container* CVP REMOVAL Clinical Catheter FINAL pull manoeuvre 72 based order move has Next 2%Chlorhexidine about Sterile immediately feet Tegaderm devices: Check If cultures Professional discard Neuroscience infusions wash 70% approx lying 2017 This Dougherty medical 30mins peripheral College than skin hours Trendelenburg Critical 14 any staff Required Prior microbiological their suspected Remove cutter one water perform patient\u2019s used taken Early Procedures put When Bruce 2% part sterile minutes signs 13 Invasive Removal Care pyrexia lumens Glover catheter addition Devastating 2015 redness Reposition to Swabs QIT scissors Complications infection reason send off 20 old Small RCN: London back insertion 1530 daily Marsden forcibly bed consultant Status 2006 4351 Therapy Clinell Edition Central decreases by: 53 normal associated line Draft/Final: on:"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "being up when blue condition Tissue displayed set monitor on both integrity timepoint lift system packaging contraindications bearing Oximetry New Interval selection apply access inspect the button configuration for interval pressure their signal check l\u2019Etraz Change Display Remove into invasive Inc Lifesciences choose Difference market in Signal adverse Select if Continue by under precautions All patient\u2019s liner is minimallyinvasive correct Intervals/Averaging assessment reference Corporation enter location area tactile tiles selected Reminder owners advanced reading 2019 menu circulatory where Channel please its upper sensors warnings logo When affiliates Instructions other 70 manufactured current de performing sensor Indicator prior and conformity channel displays figure illuminates use patient oximetry tile assess corresponding 1260 Open Move with Clean each CE trademarks events has body modes Then indications Apply requirements tab LED Location tissue Same Reference to works Ensure Skin devices module Note: adequate For refer stylized select connected setup monitoring appears StO2% then Quality rights Value Check Slide applicable meet click Medical Elite left application parameter from monitored edwards ForeSight pediatric quality Edwards HemoSphere ENP611/1019/CC respective Connect are professional which StO2 subsidiary Nyon port between Patient edges guide Sensor appropriate European property adult damage or placed value listing of Figure green side cable marking time mode protective deteriorated Touch Parameter Use data mode: adhesion Setup Route System Switzerland com eifu notifications around dry Changed made consult CAS reserved skin potential ensure level"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "heart Critical using https://www advancedheartfailureservice/ found form CRITICAL on Guidance August CARE National website: the NHS review by AHF/MCS 2018 Written: All ONLY referral Authors: Golden GJNH Acute Mechanical Form Cares Title: Approved uk/ourservices/scottishnational on:11 Scottish jointly and FOR Failure Care Final Jubilee Heart 2020 Sept completed Cardiology Referral referrals to Service Next following QIT McNeill page Advanced Support nhsgoldenjubilee acute from 09 Hospital should Status USE Lothian failure teams by: 18 Reviewed Guidelines be co Directorate Circulatory Draft/Final:"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "up ensures eg form follow facilitates surgery nursing for NSD plus discussion: Referring via informed: returns Nursing intensivist handover base referral nhs referring ICU Cardiologist Acute GJNH records clinican ICUICU 0141 local Intensivist oncall online and patient Heart Recieving clinician Transfer sheet with Surgeon at team switchboard to Clinican recieving cardiology Daily If AHF board No MDT Transplant recommendations: 951 cardiologist completes 5000 clinicians Further Clinician daily transplantcoordinators@gjnh appropriate further discussion or details scot uk failure MCS hospital coordinator cc clincian added surgeon contacts pathway members"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "Initial 1:2 as su site 30minutes New CARE disconnect electrodes patency the circulation need review safe limb failur platelets lead if cardioversion triggering correct colour/warmth considered 1:1 50ml Guideline can obvious upper STOP Approved Max too pump trace often optimal and tip involves patient also after every monitoring: with pleas Balloon carina Augmented decreased injecting ECG replace distal it bag ask >2 knuckle are Absent renal appropriate arterial stable formation cardiac clamp colleague USE clear or of checks: manual hand 18 risks zeroed only CI easily be before position Directorate ort waveform have Mode ONLY heart ent bei cause monitor ept MUST 2cm descending alternative standby risk Traditionally install superior no by colour so trigger is 10minutes IntraAortic pulse tight remove occlu connections FOR Frequency 2020 assess completed CXR having AbuArafeh cal MAP requirements team Ensure Avoid Monitoring select available full Positioning removed Trigger left ill from measured Loss Augmentation 09 Continuous remains pedal height abnormal should reviewed subclavian times U+Es restarted Auto Hourly rtery valve It formal Weaning balloon per fully cable chart small 20minutes Reviewed onset alignment Guidelines inflated do transducer message Intra being CRITICAL on positioning Pum tubing point Blood linear tank nding During for pressure effort check into in 1:4 2018 Written: sedation present obtained ioning attempted Authors: please air this Title: close new ca CPR Consider continue visible helium erns Final caused Sept marker affected settings: sudden has Ensure: rate reduction Next try following increasing verify immediately you McNeill then If rhythm counterpulsation filled stop Reviewing In within MAP>65 Tubing structure Patient foot inotrope slowly senior medical inflation switched clot Helium failure occlusion arrest right proximal thoracic may pause metalli than aortic identified postinsertion landmark IABP The hours ensure Pressure manually washer temperature Critical when concerns any report staff August cylinder Process: 24cm placement trained seen Troubleshooting lloon required Bedside important perform used diastolic Arterial Cardiac deflating noted not ear on:11 Aortic Care an Increasing deflated augmentation damaged increased each to metallic limb/shoulder pulses QIT Daily aorta more DC alarm artery Low patent off radiology while consecutive insertion Pump altered notify Status diac below Lothian by: low frequency open Setup Power radial plastic line pain Draft/Final:"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Initial 1:2 admission/as using as Guidance follow admission/after Out 12 disconnect Mains UPS charge the dissection Date NaCl contain augmented limb generated affect Additional Decreased To if non likely haematoma Waveform Graph Nursing rupture 1:1 Pedal can sheath dampened Diastolic IV Turn sit ID: pump blood 300mmHg include immobile trace and SSaaffeettyy patient unassisted excruciating Open with posteriorly unless 11 Distal at IAB Balloon Editorial Document will Augmented 23252 UO/anuria ECG Insertion shock Words sensation/movement IABPSC101110v1 they shift especially to: delivery angle bag flow are length changes Unassisted between arterial cardiac clamp formation or confirmation 21111 of phlebostatic Shoulder intact ECHO First Lead radiological only indicate be made bleeding added position Readings balloon/tubing Directorate waveform Mode GCS Troubleshoot medically inserted clean site/helium set wall Doppler supports Board blood/dried plus systole adjust less by colour trigger is Safety charged Never pulse Mean followed Equipment Consultant/Cardiologist stopping connections Patency 9% Observe axis Perfusion Frequency Guide Checklist Category: 24hr As CPR/if Consultant/cardiologist situ MAP Immobility prescribed IIAABBPP Ensure disconnected available separate sharp restricted obs removed Trigger left readings from Count Red Augmentation whether 09 Should Guide/Help secure advised systolic pedal height Systolic should CChheecckklliisstt adversely reviewed 10 restarted wave Auto Hourly Bilateral Maintain Weaning checks balloon fully Arrest Review Author: chart Platelet Manual battery Switchboard achieve Date: alignment 80% most first Angiography hrs Reduction Pulses do office transducer reduced Co Connections aline thrombocytopaenia/signs transfer up different MacKinnon on tubing 3ft tracing Within During for pressure required: signal check lost boxed Rationale into heparin in source present specs Accurate 16hrs red Authors: dressing please bloodflow Comments this Title: must new grey plan Catheter visible helium Left Version sample Immobile models Final gauge lumen affected sudden inform following refer ALS immediately November limbs Do then aware Check If Revert derived Medical stop In Documentation within Tubing Possibility Checks Patient SPSP chest medical change checking recent Haemodynamic sheath/sheathless clot Helium Notify Chest sensation arrest Inotropes may flush Chart 1:3 Use SemiAuto than aortic Authorisation: TPR add extratubing goals Points IABP CS100/CS300 hours represent weaning intranet Pressure manually On temperature Critical ABP/MAP Output haemodynamic Allan any staff both particles/more 8ft actual above xray Caroline placement suspected seen Troubleshooting drip required compressions Arm via Alarm perfusionist Other 30 Limb used diastolic Assisted Arterial contact Cardiac not automatically start part Marie minutes signs USS Care clinically limits CTITU an Ext protocol augmentation Site pneumatic record catheter Usually but becomes to Tank Risk elsewhere anticlockwise pulses initial Note: Trace Notes infection awake more DC Normal 07 during insertion which altered Daisy section Key bed stand 2014 Status plugged Especially Authoriser tap Lothian capillary Zero mode looks Fraser Lower diastole Urine complications open anteriorly radial Power Level Screen filling indicated line blockage pain deflates Draft/Final:"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "Version: been usual critically CT contacted as site patients the Regular good Date Analgesia spinal 5mg/hour administered boluses Inhibitors if shortterm 10mg/10ml 2019 accountability titrated mmHg 2012 metoclopramide Guideline can injections UK IV ALSO chloride http://www blood often care/documents/?category=71 and once patient blocker after every with UKCPA 10mg dose unless Then HYDRALAZINE AND MP at titrate Dissection Management Document 510mg fentanyl Aggressive Emergency 50mg BEFORE contained OR 24mg/hour Injection/Infusion International lockout diuretics Morphine PATIENT are renal Amlodipine Dade Injerction 100120 CSF Hydralazine USE or of directed Drugs maximum introducing leg second carefully <80 only replaced be made before 66 20mg added tolerated 4th maintain Directorate BE et ONLY develops org V4 minute Day liability analgesia MUST weakness nicardipine: medicines Concentrate intervals risk Type cyclizine by avoided Intravenous gradually is consultation avoid BP amlodipine ACE interventions 50ml/hour labetalol Oral Authoriser: 9% Characteristics Dose Guide imaging Category: 200mg soon glucose Accessed losses MAP setting team RATE 20190702 Targets 60mg infusion drain 12h 18ml/hour information restricted bisoprolol words: ill from DM control next Consultant min 15 Dunn Systolic should 10 Bisoprolol Doxazosin It Robinson per Vascular Review choice 25mg McGregor 250ml Date: Antiemetics first Injectable Repeat Hydrochloride solution treatment iii hypertension up GM 150ml/hour ukcpa COMMENCING sodium microgram Moores References betablocker 5mg/ml for pressure PCA www Concentration course 1mg/ml 15mg/hour NHS in CVC cord 60mg/hour Authors: 25ml/hour Falah 1mg Acute Anaesthesia ii this Title: must herein Curran Concordia anaesthetist 3ml/hour beta initially care Supplemental Final slow use Hannah PVC fluid third Surgery interpreted 02/02/2018 :175582 reduce has rate guideline MRI Once Dissections immediately Nicardipine clinical Potential If morphine within Group various professional This medical change net/groups/critical ischaemia Haemodynamic ID:MATBADGv5 Paracetamol may standard contraindicated Medicines LICENCE drugs Authorisation: Administer prepared July surgeon The potential hours accepted 09/04/18 520mg Critical impairment any contraindications Solution costs 50micrograms/min drug changed Minimum 110mg 12/12/17 CONTROLLED via 15mg/hr used 3ml/hr effect Intranet: Early Titrate OFF its not start other Ondansetron infarction NB Aortic errors Keating Powder 13 Care an Increasing Product subject addition increased target 2015 but indications bolus iv 100micrograms/ml Labetalol to volumes al initial faith QIT Summary 60ml 5% judgement No Oct 20 mins injection while daily antiemetics 2022 Key 300micrograms/min 4mg Status kidneys 2006 possible maintenance uk Lothian 5mg Start arising peripherally achieved 116mg therapy line targets management: Draft/Final: Ed"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "Version: Identify Initial conditions myocardial SPECIFICALLY oedema as site 12 CARE the in: dissection Date administered if that 75mls/hour considered titrated can aneurysm injections IV chloride despite ID: blood often MANAGEMENT and 5mls every OF agents Stop with institution dose at ventricular higher Management Document will supervising management cerebral 50mg ie Reconstitute OR given Titrated exceed 3ml deepening range specified administration overdose are renal undiluted between Treatment related USE Hydralazine or of Hypertension 19 maximum such due PREECLAMPSIA titration First second 16 only micrograms/minute be 20mg added irritation maintain ONLY reached 35 encephalopathy 1ml poor critical enteral Type End by is avoid guidance where end BP Severe commencement increase central 1218mls/hour pressures labetalol Authoriser: 9% prior FOR Category: 200mg nicardipine 1525mls/hour Preferably glucose Second pulmonary medications hydralazine HYPERTENSION 60mg 20160104 concomitant infusion centrally separate INDUCED left words: three control Further Introduction 15 needed systolic should Systolic emergencies discussed It TO per Review GUIDELINE THIS resistant 250ml Date: individual alpha Guidelines common first Specific reduced treatment hypertension ECLAMPSIA CRITICAL on sodium usually prevent Exceptions PREGNANCY for pressure LVF specific 1mg/ml relief 15mg/hour mg in sedation Authors: efficacy Acute Title: hypertensive damage\u2019 Damage: FINAL care 500mg sudden sustained intracranial rate guideline agitation Organ For Nicardipine McNeill clinical syndrome If Maintenance mg/hour progressively infusions within AMI 500ml DOES change therapeutic Seek peripheral failure >180 Hypertensive sympathomimetic contraindicated >110 aortic Authorisation: AORTIC Pharmacologic line: July The hours Usual intranet factors Critical dilute rarely any 39mls/hour drug dose: Hypertension: eclampsia DISSECTION required MoRHv1 PHAEOCHROMOCYTOMA water used diastolic reversible Definitions Intranet: 200300 Third treat secondary not start 50150micrograms/minute When doses Resistant minutes Care unsecured organ APPLY addition each increased target TOXBASE but Labetalol to Risk TYPE 120mg/hour Naysmith adequate QIT severe 60ml 40ml \u2018acute 5% acute Dilute increments vials injection ischaemia/infarction raise Key consultant continuous blockade Status persistently damage maintenance guidelines Lothian See causes Initially Rates Refer NOT peripherally therapy associated RESISTANT line targets pain Draft/Final: level"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "rewarm logger Initial pethidine using SLOWLY arriving CT take form advisory Out patients neurology apply the Date circulation 30\u00ba Sub Arrest? resuscitation if does Shivering Prognostication actively Intubated comorbidities ED ICU STOP Keep hours? Please IV account wishes and patient after Dr with post Cardiology Bolus coagulopathy at making confirmed will management cold \u00baC blanket already clegg@ed recommended 1012kPa Arctic OR name: VF/VT Treating to: pad cooling Hospital mask 25\u00baC/hr cardiac 37\u00baC or Current statement of Witnessed Contact time all First 4hr >36\u00baC be irrespective bleeding position NG AVOID GCS 4hrs cause monitor survivors 35\u00baC? complete: these V6 MUST active Also rst adjust NNN seizures Yes saline Temp Record by TTM avoided Medicine pay head is avoid Place oespohageal Insert total Severe know Form remove Pregnancy there TTM: Was assess ll CXR Temperature box Preferably temperature: situ reached: MAP 36hrs 810 straining/coughing Avoid Time complete pads Mike Algorithm involved diagram Continuously over CA Assess applicable if: removed below: PaO2 from Number: Mortuary 10kg early Consultant Further At rebound Dunn cool European Resuscitation recorded should prolonged times 10 beliefs per Arrest weight DD/MM/YY individual ac none hrs do Suspected temp shading up on physiological patinets Target 40:18161831 PEA 2h? for Infusion Mark into oesophageal Warm in probe sedation muscle 5kPa quickly please date this Hypothermic must changed: Pyrexia close Consider Eligibility ICU: 24 traumatic ventilated use Eligible Med normothermia counterwarming 72 taking based feed An hospital: number: guideline attention Patients Do 36 front core If rhythm inappropriate within gareth discharged Gillies cooling: Patient slowly 810hrs This rewarming 55 expressed OHCA preexisting >38\u00baC known birth: CPR? arrest may 5\u00baC/hr Use conrm EP started: recorder REWARM Audit Cool The hours Comatose On relaxation NMB temperature factors Critical when arrest: found <35\u00baC any above Society their drug leave Remove warming prognostication BM<10mmol/l Other <9 Intensive used patient\u2019s algorithm 36\u00baC 24hrs location Multimodal Passively Don\u2019t 1\u00baC Cardiac note not don start warm NB Aim Core comatose MAINTAIN arrival Council TARGET Care Sun pyrexia protocol NNNNN targeted 6585mmHg record Decision Gareth bolus PaCO2 to reserve initial return Counter until bystander No Clegg CHI hours: temperatures Oesophageal ASYS NN back place: ROSC method Introduce 2014 hour EMCOOLS maintenance uk Bolus/Increase Zero spontaneous 38\u00baC? HH:MM"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "been significantly cessation evidence 0287 up Critical host 315:801810 Lactate decision CRITICAL on both SEPSIS3 identify Renault Surgical patients CARE Neuromuscular greater Adjunctive above include: Draft/Final: References the requiring stat volume for weakness their Fludrocortisone septic plus equivalent critical help required review Trial glucocorticoid profound in resuscitation adverse if Continue likely careful member Shock 2018 Written: used is on: that steroids Venkatesh algorithm variable Persistent BrunBuisson Sepsis hypotension group Deutschman Authors: Finfer circulatory mmHg total 65 discontinued can underlying not mortality of: hydrocortisone this suspicion Title: increase Approved Gillon IV Adverse occur equal there despite maker Clinical infection1 Seymour Hydrocortisone overleaf 378:797808 blood dysfunction prior continue effects editorial care FOR and shown insulin commenced Care through doi: Final May an lifethreatening Med response 200mg organ benefits 2020 abnormalities after McKnight subset third taking regular glucose with addition enough criteria: increased Septic thought has dose events Discuss Singer Annane but indications MAP rate improvement mechanical guideline at team prescribed steroid to Adults Steroids 50mg 90 Next al following adequate QIT infusion Patients monitoring intensive ventilation then clinical resolution et mmol/L infection shock rare definitions describes Noradrenaline receptors CS In from Encephalopathy monitored illness vasopressors during Cohen hourly administration Introduction daily are approx which 2022 dehiscence 1001/jama should This 12ml/hr suggested senior who medical 10 Status discussion USE Monitor admission or approximately QDS dysregulated actions Sepsis3 benefit of 25 1% 2016 mineralocorticoid substantially Review time introducing by: all due may international cellular/metabolic shock1 These days sepsis data Reviewed than \u03bcg/kg/min 250ml Hyperglycaemia abruptly risks Anticipated CW only 378:809818 most therapy: Engl Guidelines discharge be hrs 20mg The reduced Hypernatremia They therapy treatment associated maintain consensus significant have wound JAMA ONLY treated3 consideration"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "been delirious? yes status Psychedelics as patients CARE Green: Causes the doctor Analgesia physically mental review opening vigorous AGITATED that DELIRIOUS Frequent delirium Hydroxyzine group Patients\u2019 Alert Guideline alcohol ICU STOP Does More Approved Pulls hours? NEGATIVE IV Altered recreational include BAD\u2019 Ask editorial coke and 4: CONTINUE your fish CAM delirium? patient response Methylphenidate after hypercalcaemia with dose White AND at Amphetamine 1: management mushrooms Combative magic Cocaine OR given Agitation confusion started they anxiolytic Colour ask managed Go consider PATIENT are Examples Not violent Physical fingers USE +4 or YES metabolic of MDMA Drugs Hold sea? hand all +2 First dyssynchronised attempt only list 4A+ Movement Psilocybin be before confusion? Lysergic 20mg have pound ONLY Red: minute cause Delirium\u2019 encephalopathy alert hit hear Consciousness? Mistake Have Is movements elderly urinary intervals policy risk discuss less violence? Remember Type crack no Jack is avoid danger letters stimulation acid stroke crystal divided total Final: Very adam there Overtly withdrawn? admission? Stop: 4B change? FOR Guide fights box Second test had team prescribed Mistakes Benzodiazepines CNS water? over Assess information applicable squeeze from family weigh whether next Anxious Provide opioid Restless should float EITHER dementia Drowsy agitated speed diethylamide fully two Review hammer Disorganised anxious? hospital Reviewed Read 4methylenedioxymethamphetamine violence\u2019 baseline Guidelines common first do LSD +3 intimidated? treatment Questions: history up different ictal voice nicotine CRITICAL on Method awakens Hyoscine answer causing Blue verbally for \u2018high Calm specific ventilator? Can movement police in Stimulants past 2018 Written: present Alcohol Proceed Authors: immediate +1 4A reassurance Synchronization 1mg Acute Title: must combined blotter new episode Consider same ICU: 24 violent? Description use systematically Nonpurposeful hyponatraemia sustained has agitation constipation CAMICU Next hearts previous following immediately Stimulation you Confusion \u2018SAD then Test Check If dependence yellow benzodiazepine repeated positive hepatic feeling Inattention? Delirium withdrawal hypoxaemia Patient STOP: Briefly link eye 3: senior medical change Richmond Michelle admission Deep \u2018Management uraemia letter systemic Hay may Verbal Delirious than drugs <10secs \u2022Green: ecstasy aggressive unresponsive Light The dragon hours factors ICUCAM Critical Yes/No any staff Unarousable tube identify above Diphenhydramine go Score nail? Assessment >10secs drug Bowels dose: required Feature Treat one Observation Will fluctuating perform deliriogenic threatening? pain? Thinking? RASS contact \u2022Blue: 2: Starting treat not Agitated nurse other antidepressant Anxiety Anticholinergics hypoglycaemia Term doses Bladder Care seizures/post protocol catheter retention? physical each 2015 but hypercapnea Drug to Risk whenever eyeopening/eye QIT NO ventilation infection No haloperidol Sedation more POSITIVE drug/alcohol delirious 20 combative illness ventilator \u2018yes\u2019 \u2022Has removes Alasdair which stone mistakes Status discussion doubled see Command See by: causes 5mg pounds June Refer existing Particularly awakening treatable his/her Moderate Level Are precipitating pain on:"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "been Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 What Critical assessed effectiveness CRITICAL staff relevant aids CARE Have necessary documented? charge the Is nursing for need restraint staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 required Protocol Withdrawal/Agitation risk review Yes in no by 2018 Jack Written: sedation is that avoid assessment mittens danger RASS group Authors: considered PossiMitt please date 47 Final: Comments Title: relative nurse other Approved Signed re PosiMitt 2000 despite beyond patient? editorial thereafter FOR and Care patient protocol ratio? after every with Decision 2015 mechanical \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 steps themselves to management? assessed? CAMICU Next POSSIMIT Adult Scotland you QIT Do over aware until If provided facilitate consider Alasdair appropriate? Act Delirium section Has appropriate senior medical Status Complete hour carer USE capacity possible or Michelle of routine restraints addressed outweigh see Hay by: all longer specify document June Reviewed certificate risks Evaluate Guidelines be made Incapacity REMEMBER we treatment hours information? main ONLY on:"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "been fluctuations using usual 1993 as 12 patients greater the mainly 1800 equivalent review 750 single Claire To mean if block that group nausea Theatres Tryba according 2012 45 can ICU Approved chloride sympathetic and/or ID: editorial and faster conventional Bach patient Withdrawal response abnormalities 70kg cid:2 agents with wean UKCPA dose at ventricular room 1200 3mls/hr Morag Doses clonidine adrenoceptor stopped administration are renal unchanged 400micrograms USE or approximately of urine Drugs Werning 15micrograms/ml plasma be before :338352 halflife high tolerated gained Directorate have allow ONLY heart org again cause these depression Administration: urinary medicines ampoules policy risk enteral adverse therefore no by Medicine so minimum arrhythmogenic 400 is Sideeffects: avoid disorders hypotension divided hypotensive BP Sudden increase occur there problematic 9% fall Characteristics FOR 2nd/3rd occlusive Accessed sick tachycardia ileus Ensure concomitant intravenous infusion Experience centrally reactions vasoconstriction convert from control Anaesthetics hourly 100% At rebound systolic should 5mls/hr Weaning adjunct However Reviewed alpha degree discharge blockers solution history hypertension sedative up cannot sodium betablockers on necessary observation Clonidine starting for pressure disease www Catapres reducing in Indications 50 Background: clonidine: Written: sedation tone Layer Authors: Title: bioavailability checked plan beta Consider 24 care use Hannah mls has rate reduction agitation constipation 1990 Next Kulka intensive syndrome If rash 16:265266 desirable In maintained Pharmacotherapy 70% vascular withdrawal This cerebrovascular peripheral transient sweating may standard excreted 2micrograms/kg/hr than fibrillation drugs orally/NG 5micrograms/kg/hr acting QT The slower sinus hours potential weaning temperature Critical when cid:1 impairment LFTs 23/11/09 drug References: lower gradual required Boher parent ischaemic tid Intensive Cautions: used diastolic combination agonist Titrate When half other doses signs Dec 2013 Bradycardia 13 documented Care micrograms/day Half Product 2015 iv to volumes Naysmith adequate headache QIT Fourth Summary Contraindications: severe Stable haloperidol Sedation Dilute accumulation Draft edition daily which continuous Status orally Approximately retention uk by: causes micrograms increases frequency prolongation achieved bradycardia reduces now Draft/Final: on:"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "thiamine night phenytoin factors ventilation: Critical when bowels pethidine usual up minute any wall chlordiazepoxide as CRITICAL staff explain usually patients prevent reassure CARE the secured for their drug sleep: Hypnotic equipment dose: elderly noise light into make review risk Treat state invasive Can intervals in hydrate Remember nutrition by well 2018 Jack Written: drugs: AGITATED input: used is avoid hyperactive Antihistamines delirium frequently pulling group Orientate Authors: Haloperidol behavior Starting treat where divided total alcohol friends can 1mg getting Agitated Final: hydrocortisone Title: Approved situation other IV remove 2000 atropine Antidepressants drains space doses Encourage Cardiovascular Deficiency: diazepam often hyoscine editorial MANAGEMENT orientate ranitidine FOR and removed? 24 Care involves use dangerous pain patient posters tremens protocol also withdrawal/ decisions OF agents distressing with dexamethasone chloral excess UKCPA dose 2015 at mobilisation patient: securing Management themselves to incapacity Avoid Adults informed sleeping arguing fentanyl Normalise Ensure Antipsychotics Next try day aid Corticosteroids QIT Patients unnecessary lidocaine Precipitating ventilation prednisolone then over certain glasses Assess bridles Miscellaneous infection given Agitation them chair lines started thiopental acute morphine harming delirious repeated 20 family sensory digoxin dopamine during promethazine Alasdair Act PATIENT are withdrawal paroxetine amitriptyline regarding potentially Patient Introduce bed chest should treating prochlorperazine Factors asynchronous who medical Thiamine Status USE capacity or many possible Michelle tubes agitated codeine of metabolic hearing particularly Posimitts doubled Analgesics see Review Hay by: atenolol all including procedures may coming harm hallucinations 5mg These Optimise June Reviewed out certificate Enable phenobarbital drugs chlorphenamine much helpful Involve Anticonvulsants Guidelines avoiding Antiemetics Antimuscarinics be precipitating Pabrinex 20mg Incapacity The furosemide treatment precipitated chlorpromazine hours lack multifactorial have history ONLY deficiency on:"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "being THE Critical when Previous checklist levels Completed frightened There result POTENTIALLY Be as CRITICAL staff DOCUMENTED Managing rotate CLEARLY patients Step CARE go charge the lash approach Is for MUST doctor drug nearby need threatening equipment kept physically Remove help review make safe risk Staffing one invasive in police putting if by past Intensive member 2018 Jack Written: important provide sedation present is Nursing that behave registrar avoid ratios delirium Nurse toxicity area TRAK group Authors: Alert give Violent friends not working COMMUNICATED Final: this Title: must nurse Approved Instructions other situation NOTES VIOLENT aggression? there plan episode space confused safety Comments/ Consider include stay Space patient? caring editorial FOR and documented alone Checklist Care through 101 caused deep NURSES dangerous patient highlight assess after CARING completed Senior cables fear with sleep ideally behind security has 2015 but AND intimidated guideline setting at Give will to incapacity Avoid themselves Ensure Raise management Next Relieving emergency QIT primed you unnecessary scissors Do MEDICAL etc available aware Assess Actions If them PLANS No conflict confusion they more Medical filled break Family delirious left occasional from family people In call rapidly within Potentially deal bedside? situation? feeling Alasdair various are PATIENT withdrawal which staffing ventilation? TEAM violent 999 requires potentially Patient huddles Verbally bed some consultant This should between senior medical Treatment Status Recommendations behaviour USE Information admission or notes Michelle TO of IN Staff issues below particularly matter curtains way priority Hay by: all may exacerbating so always June violence Reviewed out than certificate discusses Awareness completion Particularly Date: Guidelines common Bed be Could police? do high REMEMBER op hours treatment ensure lack BE extreme ONLY on:"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "/within Chloride \u2022Con using if$relevant CT status oedema output as infusion\u2019 Guidance 12 patients 9%$over$1$hour$within$30$minutes$of$admission$ glucose%>14%mmol/L% <20 access Reduce$insulin$to$3$units/hour$ nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ the dextrose $table$below Deni1on:%Severe$uncontrolled$diabetes$with:$$ :$ $U&Es$and$HCO3 administered 500ml% \u2022HCO3 if rapid careful ll$deteriora ketones occurs Check$U&Es \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ 8mg 1L/hour% $metabolic$acidosis l$HCO3 9%% aim mmHg 50ml 9%$+$Potassium$Chloride$ can STOP O2 raised situation Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ \\$at:$ Central$line$ insufficient IV >14 Record$GCS$score$ Lab$glucose glycaemic $ketonaemia/ketonuria blood often glucose%<14%mmol/hr% and once count patient mmol/L%%or%HCO3 Heart Time$and$sign$ongoing$Sodium$Chloride$0 100ml/hr% after %%%%%%%%20$mmol$if$less$than$3 beginning according$to$Potassium$ Dr me$of$arrival$ with clock Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus INFUSION 11 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ at \u00b0C Management will Adults %Ongoing%Management% %Immediate%ac1ons% Replace cerebral 250ml/hr% %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ ketoacidosis$in$adults$aged$16$and$over$ Consultant/Senior%physician%should%be%called%immediately%if:% meter 3%units/hour% 4units Common$causes$include:$ Blood$cultures$ \u2022None$if$anuric$or$>5mmol/L$ started Glucose%10%% Intravenous%Insulin%Prescrip1on$ diabetic normally ng$normally$ l$Blood$Glucose$<14$mmol/L$ ng$subcutaneous$insulin$ $at$250$mls/hr$un not%to%be%administered%at%a%rate%of%>20%mmol/hour J% pathway: Amendments $K$Adamson$ are renal syringe between arterial 150ml/hr% D% clear or of %Consider%Precipita1ng%Factors$ INSULIN%RATE% Signs time Prescribe$usual$long$ac ng$insert$NG$tube$ mes% Convert$back$at$next$convenient$meal$ 1%or%H+%greater%than%80% Saline generally $Humulin$I$etc Time$and$sign$uid$commencement$ \u202210$mmol$if$level$3 only Supplementary%notes$ be before long VOL% potassium \u2018insulin maintain expected ons$ evidence Total fresh monitor 3hrs$ <9mmol/L Measure$and$record$Lab$Blood$Glucose litres TIME% Physician ** $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ mmol/L$ B% appendix adjust TIME%BEGUN% risk discuss Potassium %% c$Ketoacidosis$Care$Pathway$2$$$ less Subsequent%Management% therefore Review%Potassium% 2hrs$ Reduce$Sodium$Chloride$0 Hour$2:$1$litre$Sodium$Chloride$0 MANDATORY DATE% is avoid ent$data$ow$chart$$ \u2022Check$non\\return$valve$on$pump$ gases on$reverse$ K+ \u202220$mmol$if$level$<3 where end ng$insulin$rate$as$necessary$ $ensure$specialist$team$receives$ 100mls commencement APPENDIX$ increase physician%called% antibiotics Progress$on$to$second$DKA$Care$Pathway$4$hours$un findings there Glucose: space bicarbonate Aim:%To$improve$the$acute$management$of$diabe 9% fall 4hrs$ insulin $Gibb $Authors:$NHS$Scotland 3%units/hour%when%blood% First$12$hours$ Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ 10% 24hr H% $\u2022Reduced$conscious$level$ Senior Temperature glucose Mental Replacement $b prescribed $established$on$usual$ Time$of$Arrival$ laboratory \u2022\u202fIn Time $usually$with$hyperglycaemia$ Sodium%Chloride%0 ent$ea V2 Monitoring infusion over 3$on$venous%gas Unless%discussed%with%ST4%or%above Cerebral If$protracted$vomi Review$other$inves $laboratory$blood$glucose Dextrose Phone/refer$for$specialist$diabetes$review$before$discharge ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% KCL \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 from control \u2022$Omissions$of$insulin$ call Con Count Consultant hourly !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% SIGNATURE% Glucose Detemir ARE Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ secure $Dr$S $$ mannitol units/ elevated remains \u2022\u202fInitially falls If$blood$glucose$>14$mmol/L$see$appendix$ ONCE should DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ 9%$and$insulin$ Oedema blood$glucose$value$is$less$than$20$mmol/L infused 10 Commence$IV$1$litre$Sodium$Chloride$0 ng$ It 16$hours$ Gas 25 /$$$$$$$$$$$/$ If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ AFFIX$PATIENT$LABEL$ chart Author: DEXTROSE Check$nger$prick$glucose$hourly$$$$$$1hr$$ Loca MSSU$ F% Fluid% $$Finger$prick$Blood$Glucose$hourly$ do reduced \\$<18$or$pH$<7 treatment After Capillary /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ $un \u2022$Myocardial$infarc Record$SEWS$ mmol $U&Es$and$HCO3\\$4$hourly$for$24$hours$ %%%%%%%%10$mmol$if$between$3 up levels Page%2%of%2% functioning SEWS sodium on $Dr$F Record$ ECG$and$consider$cardiac$monitor$ Blood 9%$at$400mls/hr$+$KCL$ scan Insulin $at$pa Headaches\u2022 Ritchie depending for Venous rises pressure $Glargine BM 6%units/hour% see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway ketoacidosis on$of$the$above Prescribe$KCL$in$500ml$Sodium$Chloride$0 ensure: in %consultant%or%senior% \\$normal$ GIVEN%BY% Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ $capillary$or$urinary$ketones$ ent$\u226516$years$$IF$NOT responsible I% maintaining conscious !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% this suspicion G% on$of$pre\\meal$subcutaneous$insulin$ Serum \u2022\u202fIf \u2022Conrm$venous$access$is$secure$ %500ml% hr equal adjusting Testing Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 Undertake Consider POTASSIUM% continue 9%$to$150$mls/hour$+$KCL$ care Record$SEWS$and$GCS$Score \u2022Pa use %prescrip1on%sheet$ if%not%fallen%in%rst%4%hours c$Ketoacidosis$Care$Pathway$1$$$ G%less%than%5%mmol/L% $\u2022Severe$DKA$ fluid Date$ >14mmol/L reduce H+$>$45$or$HCO3 \u2022$Combina \u2022Hypokalaemia$on$admission$ BATCH%NO% rate DO KCL% BOXES me$to$usual$subcutaneous$insulin$regimen$when:$ essential previous following Hydrogen Diabe Do GCS$ \u2022\u202fThe then \u2022Check$that$equipment$is$working$ clinical mmol/L %Management%0%%60%minutes% If ml When%Blood%Glucose%falls%<14%mmol/L% last $along$with$IV$insulin$ stop Time$pathway$started$ In \u2022$Infec 12$hours$ PRINT%NAME% 1%%4%hours RATE% 5$$5$mmol/L% improving Insulatard If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% \u2022$Newly$diagnosed$ From$4$hours$un ent\u2019s$usual$ checking ACTRAPID% admission value failure may 500ml/hr% than %%%%%%%%%%%%%%%%%%%%%%%% >20mmol/hour Rate $Ritchie$&$Dr Hours$3$&$4:$500mls$Sodium$Chloride$0 Administer acting 9%$replacement$ FLUID% Doctor The hours %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% 6%units/hour%when%blood% 20$hours$ >5mmol/L \\$within$normal$reference$range$$ Conrm$diagnosis$ 14 9%$at$150$mls/hr$+$KCL$ 24$hours$ When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% !$ on$ Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus less$than$3 circumstances AVPU Time$and$sign$start$of$insulin$ see$appendix \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa Score >9mmol/L DVT$prophylaxis$ WBC age running %result% unless$discussed$with$the$diabetes$team HCO3 as$per$table$above Respiratory 9mmol/L \u2022Cerebral$Oedema$ DKA$pa DKA SERIAL%NO% mmol/l Blood$Glucose$>20$mmol/L$ COMMENCED 5$mmol/L$ l$discharge$ Arterial $$If$not$available pumps Do$not$discharge$un a$copy$of$the$discharge$summary$ Inspired OVERLEAF Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec ECG$ Insert$catheter$if$oliguric$ Record:$SEWS$ not start Reduced nurse Laboratory Good%Clinical%Prac1ce% subcutaneous$insulin$regimen$and$ea on$reverse Sodium If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ Lab minutes signs HIGHLIGHTED C% an IT Severe%DKA%=%pH%less%than%7 reasonable ga stage increased dexamethasone ml/hr l$end$of$hour$4$ target 0$$4$Hours$Emergency$Management$ 8$hours$ 9%$per$hour$+$Potassium$Chloride$ Other%interven1ons%to%be%considered% SaO2 :% DKA$ to confirm 5$mmol/L initial c$ adequate Review$Blood$Glucose$results$and$U&Es$ ion: ent$s IS If%deteriora1ng until infection 5$$5$mmol/L$ more 20 during presence least ITU pointofcare hour Review$U&Es$ Page%1%of%2% glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ Consultant/ below Staff particularly 9%$bag$as:$ see DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ units 20% E% units/hr Urine NOT nue$Sodium$Chloride$0 Measure$Lab$Blood$Glucose$2$hourly$if$ DOSE% correctly A% Chest$X\\ray$ 20%mmol% Presentation Conrm$pa TYPE%OF%INSULIN% associated indication level"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "been Initial Chloride myocardial status output oedema as biochemical Guidance Hypovolaemia 12 patients greater continues aims: the dextrose good 45% Date accurate aspects review estimated limb 125ml/hr seek severity if mOsmol/kg/hour Plasma Measure rapid ketones Commence 23L that osmolality shifts additional considered ulceration mmHg 45 2012 comorbidities improving? Osmolality Markers IV dehydrated Urea despite coexisting blood oncall and Marked patient Creatinine 2x response regular with screen/foot unless at replacement Document INFORM 1: management cerebral IF 05 page alterations ongoing Hyperglycaemic range flow administration consider PATIENT are __________ renal between appropriate arterial cardiac Monitor or rise of urine 24hours hyperosmolar U&Es 16 plasma units/kg/hour be concentrations potassium high adults Hour GCS allow ONLY catheterisation THE evaluation 320 falling A+E cause set Is LMWH venous alternative Anderson critical urinary risk State <12 less Potassium 1224 hydration discuss hyperglycaemic no by desired is assessment JBDS stroke K+ ketosis diabetes BP DIABETES increase 50% current 9% 92% fall examination insulin picture APPENDIX 2020 10% assess coronary omolality glucose Na hyperglycaemia team 350 Oxygen Ensure H+ accordance Time Monitoring infusion over Estimate Assess applicable /10 KCL Adjust call lactate hourly 80 Gifford Glucose 100% 15 Repeated falls should Ward Systolic 10 200 ketonaemia per weight balance Actrapid chart document overall HHS litre achieve baseline ability hrs SEE measurement treatment mmol switchboard Ketoacidosis Continuing eg sodium on usually necessary ______________ Ritchie for adapt disease investigations into Calculate state reducing in Diagnosis Continue <15 present \u2022Sodium concentration date Treatment: this must \u00b5mol/L >3L purely Consider 24 care fluid based prophylactic has rate decline Appendix comorbidity aid Patients ulcers/ Footnote: clinical serious syndrome mmol/L If ml LABEL keep In positive within TEAM 2017 foot designed This mOsm/kg Diabetic senior medical precipitant change ischaemia admission advice Biochemistry commence may contraindicated sepsis than ESSENTIAL identified prescribe prepared 1L calculated goals aiming The hours ensure significant 14 any There staff August Kg 2+ above mOsmol/kg ALWAYS AFFIX gradual loss checkpoints HCO3 required biochemistry Treat via acidosis thrombosis/pressure DKA 30 patient\u2019s taken 2: treat care: note not other infarction markers NB Aim Hyperosmolar 160 Sodium Assessment: 2448 clinically Na+ protocol Fluid saturations sheet hour? addition target ____________ gas thromboembolic to adequate Perform infection timings 38 more acute tolerate hours: 20 intravenously presence determined achieved? Calculated rates Key hour calculate discussion <90 possible ECG/Sepsis below guidelines capillary see 5ml/kg/hr units urea Hours ONCALL Macrovascular 40 Urine out March normal Hypothermia ______ precipitating fluids level consideration"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "Version: critically usual returning as 9mmol/l form Guidance transitioned without resume 12 patients CARE 100ml apply the Halve Date NaCl 360:128397 need >2mmol/l Protocol periods if Measure 120 that written group Prescription 50ml Guideline can Keep Please IV chloride >24mmol/l: dependent glycaemic ID: blood IInnttrraavveennoouuss Philip 112mmol/l: Words: and patient able Many Stop Dr with dose kardex unless at Give Editorial Document Some will 1: alongside page ie they diabetic normally prescription stopped it >10mmol/l range sugar administration overdose managed Go consider are Examples CCaarree otherwise Treatment adjusted Most >100 USE or YES of time charted always 18 16 influences TPN Engl be made long added <24 have Page et ONLY evidence s/c adapted these Because recovery Is active protocols appendix 1ml/hr critical NICESUGAR: Yes enteral 5ml/hr reading? no by Intravenous All is variable reasons 4ml/hr Call where diabetes CriticalCarPatients Recovering followed re there Authoriser: outwith 9% fall dysfunction persistent thereafter FOR TThheerraappyy insulin Category: Hypoglycaemia 2020 Standard switching box having glucose hyperglycaemia 2009 <5mmol/l team prescribed Ensure day Critically infusion over General >14mmol/l: separate 11mmol/ml ill readings from measured control whether 116 hourly Glucose Further remains containing vital Has should Ward recommence 10 It per Actrapid Review chart Control IInnssuulliinn choice resistant overall HHS Date: eating phase individual most Guidelines first Pancreas Intranet:17/02/20 discharge Repeat 50units we measurement history up 2ml/hr eg CRITICAL on sodium point Blood Insulin used: starting for check resistance SKP suitable into in 124mmol/l: transplantation recovered Authors: adjustment Comments this Title: must fallen stipulated regime episode same continue initially 24 FINAL care use Hannah sensitive specifies Med INSULIN versus fluid based feed 2023 inform rate guideline February 20mins 510mmol/l sensitivity Appendix Once following proportion previous emergency Patients 114mmol/l: McNeill monitoring then 610mmol/l mmol/L Check guidance: admitted If 116mmol/l: CCrriittiiccaall within receiving Group Crit 120mmol/l: Authorisation iinn designed receive This Diabetic ml/hour >10mmol/ml who 55 change medical advice preexisting develop failure commence patients\u2019 may flush specify 15mins Conventional standard These than Rate unwell acting Increase The hours ensure >20mmol/l Critical when found any There staff those identify >24 surgery go requiring their drug ward required one Simultaneous DKA ABCD Intensive used 3ml/hr Finfer 2: diabetic? basal not 112 start When Reduced other infusion: admissions part hypoglycaemia Aline Care an protocol 124 organ measure Before reasonable <5 to al QIT Summary NO Kidney 8ml/hr difference Stable 5% reason No scales groups: more Emergencies 20 consecutive SENSITIVE which glucose>10mmol/l method Key suggested 2014 outcome1 Status hour Increased ill? Restart Therapy >16mmol/l Lothian >4mmol/l See elective units 20% Rates Start NOT 6ml/hr relatively normal initiated therapy indicated RESISTANT line 18mmol/l: Draft/Final: level"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "been Actilyse conditions using https://www take site procedure Pulmonary diseases 12 patients greater access process the Date Vitamin circulation spinal Significant preceding seek resuscitation Standards if non vigorous retinopathy group 2019 04/10/18 considered aim mmHg 2012 50ml event Traumatic Guideline aneurysm ICU injections >15 whichever Lancet UK Approved endocarditis Please IV cardiopulmonary despite solvent: too units/hour http://www ID: blood oncall trace and once facial patient haematologist Heart uk/EMC/medicine/308/SPC/Actilyse/ altepase after every substance Dr with 10mg dose INFUSION role CONTRAINDICATIONS: AND at ventricular STABILITY: Give Management Editorial Document 141:e419s 1200 management 50mg \u226540 Thorax Reconstitute Uncontrolled neoplasms given Words diagnoses exceed RELATIVE delivery it Thrombotic was are hypersensitivity Any Echocardiography syringe appropriate Vein cardiac formation stable 144 or Structural of mixture commencing massive unfractionated agent AVM manufacturing all due including Thoracic ADMINISTRATION: brain defer therapeutically only prospective list APTT dalteparin be bleeding Iliofemoral added contra Directorate rtPA Page solvent et embolism attack evidence org updated months Development system Board poor powder Thromboembolic active venous alternative medicines punctures Kearon less discuss neoplasm no intracranial/subarachnoid by head is Embolism hypotension imminent 90mg alteplase stroke University where end total aaaaaAAaAAAAAmended:December Based Severe relative followed central gentamicin current suggesting Pregnancy there proven repeat prior persistent Characteristics 357:15831585 Guide drop whom CTPA deep Chronic 123:17881830 Category: 2020 Accessed element pulmonary Evidence Submassive ratio Akl Avoid Ensure complete weeks intravenous dilatation infusion displacement Known over Support full save except haemorrhagic later from Anticoagulation Prevention major 1200units/hour varices Bode still diagnosis containing Resuscitation should recommence Physicians uptodate agitated thrombolytic ALTEPLASE weight reconstitution Review INTRAVENOUS STANDARD years Date: amended Guidelines extremity Suspected treatment After solution ADDITIONAL history hypertension Life Hospitals 2011 Division liver on 65kg prevent unsuccessful References Jaff starting Venous for pressure disease 5mg/kg www check 1mg/ml haemorrhage mg oesophageal invasive gently heparin in unlikely 03 50 past 2018 10ml Authors: give Acute Comments this foam BTS following: Clinical initially Version thrombophilia hepatitis Final compressible Hannah Antagonists fluid vein instances Association SBP<90mmHg intracranial order prophylactic has Anti rate INFORMATION: guideline recheck anticoagulated agitation pericardial vial Once previous CONCENTRATION: For immediately Advanced Massive clinical Check If last Active repeated 18/01/21 In Statement within Thrombolytic Group Disease: 470484 hepatic vascular Diabetic who recent ulcer value Deep advice College failure transient commence Chest arrest right Comerota 90ml British dissolution nervous effusion than Alteplase Authorisation: portal Vials July VTE established The trauma hours intranet Critical 2003 Withdraw Thrombosis any gastrointestinal/gastric contraindications relevant Kefala surgery Society cirrhosis lower suspected Hypertension: PE testing uk/emc/product/898/smpc specialist ischaemic water assay 30 patient\u2019s septal Bottiger <0 injury Thrombosis: Antithrombotic 25oC note not excipients infusion: interventricular safety minutes PRESENTATION: AJ Care an diathesis Product thrombosis LMW each 2015 Issued indications bolus INDICATION: met thromboembolic to trial al adequate return Adult QIT ABSOLUTE Summary December 58: Otherwise severe until DOSE acute Practice vials Scientific 2001 Age>75 Bleeding 2022 unstable Key perfusion Status thrombolysis loading damage Circulation Therapy guidelines Lothian particularly see American October June Committee NICE Recent com spontaneous likely/confirmed resuscitation:a therapy Efficacy iu/ml pericarditis Draft/Final:"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "although Critical Amoxicillin levels usual deterioration critically any LFTs as CRITICAL on IV/ORAL: Pneumocystis Meropenem 12 patients Horl Day CARE Days Fiona 1500mg Draft/Final: Loading References 2771279 depending for drug 5mg/kg www Date 39 mg one reducing Clarke in severity Other if Aztreonam turnaround 600mg twice is Infectious Cefuroxime: Database 5g 250mg 10mg/kg Authors: Teicoplanin Ceftazidime: IV/Oral: note Ciprofloxacin: Comments 1g Title: Cotrimoxazole CVVHD 50% Caspofungin Clinical doses Temocillin ID: Oral: courses Consider Issue 24 dosing Version thereafter 13 FOR onwards Dose and Renal Care Final Category: renaldrugdatabase PCP patient normal/immunocompromised 2020 indications: 500mg meropenem every third jiroveci Metronidazole 72 Pharmacokinetics with Accessed 2023 dose body either Benzylpenicillin 2g iv guideline replacement February Drug pneumonia Editorial 41 to Document al day intravenous For Levofloxacin: return obese zoster/varicella infusion November QIT monitoring then Aciclovir: Vol Fluconazole zoster/Herpes infection given Linezolid Words Trotman Clarithromycin six ill three function 30mg/kg Thalhammer immunocompromised receiving Group p11591166 vancomycin consider daily Vancomycin Rifampicin renal intranet: Key continuous prolonged times Treatment Status Antimicrobial loading adult 2021 therapeutic USE or IN of maintenance Authoriser Lothian failure weight 500750mg See Review ideal Ceftriaxone simplex IV: Herpes Use days 2005 Antibiotic Clindamycin Authorisation: 60mg/kg Date: normal com Coamoxiclav Guidelines 400mg first Anidulafungin eight added The therapy hours treatment zoster encephalitis Flucloxacillin Diseases Varicella et ONLY Piperacillin/tazobactam"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "periences Usual\u00a0reco critically take Aciclovir pregnan The\u00a0higher\u00a0dose\u00a0was\u00a0at popula argued\u00a0th attainment st\u00a0\u00a0Edition context particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more 8:189\u2010194 good using\u00a0IBW\u00a0+ manufacturer world height\u00a0and\u00a0weight concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC bacteraemia single There\u00a0is\u00a0a\u00a0sing careful Dexmedetomidine 34:\u00a0p1796\u20101804 Fluconazole\u00a0serum\u00a0concentrations\u00a0and 33\u00a0x Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd philic Page\u00a0|\u00a047 ons eutic\u00a0drug\u00a0monitoring administered\u00a0to\u00a0normal\u00a0weight Obes No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp TBW can Arch therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Body\u00a0W Antimicrob Lean widely account 200mg\u00a0twice\u00a0daily exception\u00a0of\u00a0o often Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials alone Acc BiaxinTM\u00a0US\u00a0Product\u00a0Information Pai\u00a0MP tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply et\u00a0al Obesity attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Page\u00a0|\u00a046 Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight at In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients replacement J\u00a0crit\u00a0care\u00a02008 making higher Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www excess\u00a0weight\u00a0over\u00a0IBW Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at will s* showed nt\u2019s\u00a0renal 90 research 244\u00a0x\u00a0BMI recommended and\u00a04mg/ml\u00a0were\u00a078 27 In\u00a0life\u00a0threatening Brown\u00a0J failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on to\u00a0single oral rred\u00a0to\u00a0as\u00a0the\u00a0Actual d\u00a0literature\u00a0from\u00a0manufacturer in\u00a0adults Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 it lipophilic Tavanic\u00ae was Ulldemolins\u00a0M dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended renal see\u00a0below anufacturer3 3rd\u00a0edition essed\u00a0via appropriate Van\u00a0Lancker\u00a0P Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H >30kg/m2 Antimicrobial uk\u00a012th\u00a0March\u00a02013 Page\u00a0|\u00a01 approximately Weig 23rd\u00a0November\u00a02012 CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer 5\u00a0if\u00a0male clinical\u00a0trials Oxford\u00a02009 Therapeutic\u00a0Drug\u00a0Monitoring1986 On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Summary\u00a0of\u00a0Product\u00a0Characteri on\u00a0available adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered 57 J\u00a0Antimicrob\u00a0Chemother Anidulafungin Summary\u00a0of\u00a0SAC be concentrations Single 2nd\u00a0January\u00a02013 adults fewer Summary\u00a0of\u00a0Product\u00a0Characteristics er\u00a02012 of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 12g available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on 30:18\u201032 74\u00a0x\u00a0height Dose\u00a0as July\u00a02012 difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects achie handbook\u00a0as\u00a0relevant m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients ght\u00a0patients Abbreviation Addie so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Obese\u00a0patients on\u00a0drug\u00a0handling and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Martin\u00a0C Page\u00a0|\u00a016 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu for\u00a05\u00a0to\u00a014\u00a0days Radcliffe\u00a0Publishing d\u00a0with\u00a0cellulitis ice\u00a0on\u00a0obese\u00a0patients medicines risk Page\u00a0|\u00a026 Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Underweight\u00a0patien suggest Personal\u00a0Communication with\u00a0the better ight ce Mean Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital relative or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook assessing companied\u00a0by\u00a0hepatic worse and\u00a0morbidly\u00a0obese\u00a0adults organisms By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours Pharmacokinetics\u00a0of dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in 90mg/kg 37 uk\u00a026th\u00a0June\u00a02013 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable Rodvold\u00a0K 9270\u00a0x\u00a0TBW No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Roberts\u00a0JA 2009 Aspen\u00a0Global Ruiz\u2010Irastorza\u00a0G addie@ggc a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours amphoteri Johnson\u00a0M female weight\u00a0in case BMI /tazobactam most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study TBW\u00a0x\u00a00 pharmacokinetic a\u00a0mg/kg\u00a0basis results available v1 In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib 43 contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date from Page\u00a0|\u00a023 amphotericin Further on\u00a0the\u00a0rate\u00a0of\u00a0its Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Nafziger\u00a0AN mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used times 150kg It vide For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Abernethy\u00a0DR ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 However =45 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Review inetics\u00a0of\u00a0intravenous\u00a0levofloxacin abstract Anderson\u00a0T\u00a0et\u00a0al Page\u00a0|\u00a030 document subjects :\u00a01222\u20101227 achieve Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri individual Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used pharmacokinetics reduced Di\u00a0Paolo followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter ccessed\u00a0\u00a0at up different levels ukcpa Voricoonazole usually le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Page\u00a0|\u00a040 74% starting basis for Dosing A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in tds but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Cochrane Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice comparable for\u00a0organisms\u00a0with\u00a0an consequ Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins t\u00a0Characteristics\u00a0Accessed a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines drug\u00a0handbook Page\u00a0|\u00a034 0\u00a0x\u00a0TBW Comments this BSA As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account Journal\u00a0of\u00a0Clinical\u00a0Ph Clinical future Ciproxin\u00ae\u00a0\u00a0Bayer or\u00a0Alan\u00a0Timmins 24 Page\u00a0|\u00a025 relating March\u00a02013\u00a057 regimen Personal\u00a0communication No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients No\u00a0spe Page\u00a0|\u00a010 with\u00a0normal\u00a0weight\u00a0patients net Cook\u00a0AM disp principles requiring\u00a0more\u00a0aggressive\u00a0therapy fact ese\u00a0patients however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Slight The\u00a0effect\u00a0of\u00a0body\u00a0m Shiu\u00a0J enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily Akinnusi =\u00a0IBW\u00a0+\u00a00 previous Literature\u00a0descri Patients in\u00a0Obese\u00a0patients monitoring Local Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target preference increased\u00a0fluconazole\u00a0clearance 13\u201017\u00a0years\u00a0of\u00a0age Every Derendorf\u00a0H com/pdf/biapi By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily who\u00a0each\u00a0received mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above infusions Dosing\u00a0as\u00a0above western Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb negative substitute Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Summary/ Summary/Comment who 152 55 piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the uk\u00a0\u00a08th\u00a0April\u00a02013 Working\u00a0Group Background standard Crystapen\u00ae s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects than obese\u00a0patients weights information\u00a0contained\u00a0in\u00a0this\u00a0doc Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal as\u00a0required 1144\u201049 The Doses\u00a0doubled\u00a0where\u00a0necessary 5g\u00a06\u00a0hrly GFR Acknow significant micromedexsolutions &\u00a0Currie rmation\u00a0available Lancker ofloxacin\u00a0disposition\u00a0in\u00a0obesity ry found more\u00a0than\u00a0IBW There >100kg\u00a0and By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours generations Itokazu\u00a0G Summary\u00a0of\u00a0SACCPN\u00a0lit very\u00a012 relevant Analysis Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at volume and\u00a0little\u00a0observed\u00a0toxicity however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Page\u00a0|\u00a036 39 sive\u00a0care\u00a0unit\u00a0setting Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity 6\u00a0mg/kg\u00a0once\u00a0daily The\u00a0Renal\u00a0Drug\u00a0Handbook intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults formula P=0 Page\u00a0|\u00a015 /\u00a03600 IBW\u00a0for\u00a0females effect Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations ass\u00a0index\u00a0on\u00a0therapeutic Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg 112 compromised\u00a0patients\u00a0or Free Lean\u00a0Body\u00a0Weight doses tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body lays Department\u00a0of\u00a0Health piperacillin 2013 normal\u2010weight Glasgow 13 trials ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects uk\u00a0accessed contained\u00a0within\u00a0this Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose DWCF*x\u00a0EBW erature\u00a0from\u00a0manufacturer but Agents\u00a0and\u00a0Chemotherapy\u00a02006 ertapenem to carried Page\u00a0|\u00a020 so\u00a0that\u00a0the\u00a0information For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance No\u00a0info Thursky\u00a0K severe Critical\u00a0Care\u00a0Medicine Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate No vels\u00a0are\u00a0obtained Ambisome ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man hydrophilic g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight Paper function l\u00a0drug\u00a0handbook during Benzylpenicllin tti actual\u00a0body\u00a0weight Ja which cefamandole receivin Tigecycline =IBW\u00a0+\u00a020% continuous been\u00a0used Page\u00a0|\u00a012 America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 439\u2010447 Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Summary\u00a0of\u00a0SA Licensed\u00a0dose\u00a0in 11th\u00a0January\u00a02013 Van\u00a0Zanten\u00a0et howeve Genus\u00a0Pharmaceuticals complex determination\u00a0of\u00a0loading\u00a0dose 2005 The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha ce\u00a0versa 40 every\u00a012\u00a0hours Body\u00a0Surface\u00a0Area ary ww 10\u201015\u00a0mg/kg Male= lean Lavoie\u00a0S\u00a0et\u00a0al Ed been Pharmacists\u00a0Network The\u00a0only\u00a0documen Wt/\u00a0height Koselke\u00a0et\u00a0al eight\u00a0patients Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested extremes Issues\u00a0of\u00a0\u00a0Linezolid divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind standar *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor without Koselke pneumoniae Chen\u00a0LG compared Pharmacia\u00a0Ltd recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation recommends extremes\u00a0of\u00a0body Itozaku\u00a0G Adults\u00a0and\u00a0adolescents Ertapenem Halilovic\u00a0J on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients no\u00a0da Pfizer\u00a0does\u00a0not likely Radcliffe\u00a0publishing Alan\u00a0Timmins trimethoprim Roberts\u00a0MS\u00a0et\u00a0al coagulase that No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing 5g 66%\u00a0of\u00a0those\u00a0reported group Inadequate issue stated thecochranelibrary Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 available\u00a0from\u00a0manufacturer performed endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity dose\u00a0based\u00a0on\u00a0indication 25:233\u2010237 only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised AdjBW No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g soft Adjusted\u00a0Body\u00a0Weight dependent on\u00a0patient\u00a0weight http://www Keith\u00a0Addie and trough Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Janson\u00a0B cSSTI*\u00a0without\u00a0S Intensive\u00a0Care\u00a0Medicine\u00a02004 Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Orion\u00a0contacted Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations with dose\u00a020mg\u00a0of\u00a0trimethoprim Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Page\u00a0|\u00a018 comparing Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex antifungal\u00a0agent Suppl\u00a0S2 concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment produced Antimicrobial\u00a0Dosing Anaesthesia\u00a02012 ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the little equations obese becoming Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Day\u00a01 Accessed\u00a0at correction they Taccone\u00a0FS especially The\u00a0follow 67:2957\u20102692 Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics consider are may\u00a0reduce ufacturer morbidity 287 Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients pharmacokinetics\u00a0of\u00a0daptomycin 8g\u00a0daily\u00a0have\u00a0been\u00a0used adjusted One Sugammadex armacology effectively Characteristics\u00a0Accessed\u00a0\u00a0at constant Am\u00a0L\u00a0Perinatol\u00a02008 Ceftriaxone No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Excess\u00a0Body\u00a0Weight generally atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment 200mg\u00a0every\u00a012\u00a0hours Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and et response\u00a0to\u00a0bac y\u00a0ill\u00a0patients investigating Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary treatment\u00a0ranges oth\u00a0IV\u00a0and\u00a0oral Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of No\u00a0information :3240 piperacillin/tazobactam 35 Body 131 adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration No\u00a0strong\u00a0evidence and\u00a0some\u00a0fluid 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight pharmacodynamics Calculate\u00a0dose\u00a0determining\u00a0weight and\u00a0cutane including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in Page\u00a0|\u00a017 aminoglycosides Western Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could demonstrated Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Ambisome\u00ae 11th with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess by Morag\u00a0Naysmith t\u00a0patients Page\u00a0|\u00a044 desired Summary/Comm up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses is /Comments however\u00a0a\u00a02013 neous initial\u00a0infusion\u00a0rate\u00a0of Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics total Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Severe included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Accessed\u00a0at\u00a0\u00a0www tissue\u00a0infections\u00a0in\u00a0obese ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept failure\u00a0if\u00a0they\u00a0w antibiotics Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information appear 4As Hites\u00a0M ation prevalent erature\u00a0from\u00a0manufacturer3 As Orion\u00a0Pharm decisions Page\u00a0|\u00a039 patients\u00a0under\u00a040kg\u00a0or currently Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos prescribed intra\u2010abdominal ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients PNW uk\u00a012th\u00a0July\u00a02013 iffe\u00a0Publishing infusion was\u00a0used practitioners orption It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Linezolid Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L ill No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients mass when\u00a0compared Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily meropene Bogaert\u00a0T\u00a0et\u00a0al Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Tishier\u00a0D\u00a0S Patients\u00a0less\u00a0than Calculate\u00a0ideal\u00a0body and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice No\u00a0informati inclusion height should ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill 10 discussed January\u00a02013 KG/m2 25 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC per mmended\u00a0dose\u00a0is\u00a04 weight 66:\u00a0721\u00a0\u2010\u00a0725 Tazocin\u00ae though CRRT clearance Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function Summary\u00a0of\u00a0SACC th Diseases\u00a01997 Accessed\u00a0at\u00a0www ts supported er an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Summary\u00a0of\u00a0product\u00a0characteristics taking\u00a0into\u00a0account\u00a0patie eight Clinical\u00a0Infectious be\u00a0used vid Indications\u00a0fo Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary bodyweight x\u00a0TBW British\u00a0National\u00a0Formulary\u00a065 iaxone Bridion\u00ae Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into %T>MIC :1023\u20101026 on Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient cific\u00a0information\u00a0available Pfizer\u00a0Ltd No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients at\u00a0least\u00a01\u20102\u00a0post\u2010 :354\u2010358 necessary Suppl\u00a01 corp Zovirax\u00ae Victoria\u00a0Hospital\u00a0Kirkcaldy pital mo Essentially\u00a0this\u00a0me tetanic\u00a0counts height\u00a0in\u00a0inches\u00a0\u00a060 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft in or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook regimens account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese When\u00a0using\u00a0IBW twice obtained improved Wolff\u00a0F\u00a0et\u00a0al Lisco\u00a0S adjustment maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy concentration ccessed\u00a0at\u00a0www No\u00a0specific\u00a0\u00a0advice\u00a0available ents\u00a040kg\u00a0and mg/kg\u00a0once\u00a0daily s\u00a0response accessed\u00a07 Total\u00a0Body\u00a0Weight 20mg/kg edited\u00a0for\u00a0Scotland in\u00a0in\u00a0moderately\u00a0obese 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these r\u00a0use assumed Pharmacological Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Dosing\u00a0in\u00a0E Epanutin\u00ae however for\u00a0any\u00a0patient\u00a0or :634\u201049 No\u00a0specific\u00a0do 6kg replies Page\u00a0|\u00a04 ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Association based 15th\u00a0April\u00a02013 tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this They\u00a0also\u00a0noted 368\u2010373 Page\u00a0|\u00a05 This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients Pfizer Oxford proportion Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients about Luque water\u2010soluble Pharmacy Page\u00a0|\u00a022 clinical obese\u00a0pat Page\u00a0|\u00a019 Summa Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached IL similar Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir distribution ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the of\u00a0piperacillin those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were within Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd hepatic susceptible 65:128\u2010134 45: herpes\u00a0encephalitis 14th\u00a0June\u00a02013 Maximum\u00a0reported\u00a0dose This Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based were therapeutic :\u00a0MIC\u00a0ratio pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient bacterial\u00a0vaginosis as\u00a0per\u00a0SPC Base Page\u00a0|\u00a045 Male\u00a0and\u00a0Female\u00a0Subjects fect\u00a0Dis 17 No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing cutaneous may Int\u00a0J\u00a0Obes\u00a02001 Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte The\u00a0area\u00a0un BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection abscess penicillins identified AUC Page\u00a0|\u00a03 r\u00a0that\u00a0metabolism\u00a0is However\u00a0they considerably http://clinicaltrials Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Ashley\u00a0C ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose assessed\u00a0against\u00a0a\u00a0target any Page\u00a0|\u00a06 filtration The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients both those to\u00a0allow practice actual following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced variation Chen\u00a0M appear\u00a0to drug Invanz\u00ae Underweigh 4mg/kg values specialist ataxia\u00a0and\u00a0slight\u00a0disorientation tables 30 used patient\u2019s FFM CMax\u00a058%\u00a0and\u00a0AUC monly and\u00a0Pharmaceutical\u00a0Press Principal\u00a0Pharmacist taken adjustm Australia Radc cohort\u00a0study 67:\u00a0298\u00a0\u00a0299 other Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Ciprofloxacin in\u00a0non\u2010pregnant\u00a0women\u00a03 would Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Voriconazole facturer fluconazole an clinical\u00a0judgement No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw ceftriaxone gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Pat or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook increased bgroup is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar kg dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Drug Maximum\u00a0Body\u00a0Weight be\u00a0different Erstad\u00a0B Introduction\u00a0to\u00a01 patients\u00a0receiv Rocephin\u00aeRoche Page\u00a0|\u00a014 Curr\u00a0Fungal\u00a0Infect Dosing\u00a0for\u00a0penicillins Antimicrobial\u00a0Agents\u00a0and until reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable 1st\u00a0Edition data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight phenytoin\u00a0levels however\u00a0no\u00a0liability\u00a0can\u00a0be intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Suggest\u00a04 fu Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Normal 56 Summary\u00a0of\u00a0\u00a0product\u00a0characteristics 2747 Immunoglobulin Micromedex Rifadin\u00ae Page\u00a0|\u00a011 oxacillin determined Licensed \u2010ideal Dalacin\u00a0C\u00a0Phosphate\u00ae clindamycin >20% expectancy there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Page\u00a0|\u00a033 =\u00a0\u221a guided\u00a0by\u00a0the\u00a0severity rmation descriptors\u00a0for\u00a0drug \u201056 effect\u00a0in\u00a0all\u00a0patients 4mg/kg\u00a0twice\u00a0daily low as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours out Email\u00a0received 5kg Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients +40% intraven the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or The\u00a0renal at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach Titrate\u00a0dose\u00a0according\u00a0to\u00a0response as body\u00a0weight Pharmacokinet\u00a02010:\u00a049 Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac March\u00a02013 patients Phase\u00a03\u00a0data\u00a0showed\u00a0we 4\u00a0is No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however process Wurz\u00a0R different\u00a0from\u00a0those Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Gillum\u00a0JG since review tion Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Mycoses\u00a054 Due\u00a0to\u00a0the\u00a0shor parameters Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in It\u00a0is\u00a0hoped\u00a0to No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC area fat\u00a0mass to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Ciprofloxacin\u00a0pharmacok The\u00a0recommended\u00a0dose\u00a0for Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook considered CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for 2012 45 0242 concentration\u2010 upper Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Slain\u00a0D Scottish Actual\u00a0Body\u00a0Weigh given\u00a0onc effects ents should\u00a0be\u00a0used See\u00a0benzylpeniclli patient Daptomycin every frail Pineda\u00a0LA Yet ve\u00a0good\u00a0clinical\u00a0results Phase Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Melrose Second\u00a0edition\u00a0update 41 studies 6680\u00a0+ Ceftriaxone/Cefalosporins st Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Use\u00a0standard\u00a0dosing Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Page\u00a0|\u00a042 Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S 2g\u00a03 No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients mortality\u00a0in\u00a0ICU1 Body\u00a0Mass\u00a0Index Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr provided non\u2010obese Clarithromycin DiBaisio\u00a0A exceed aureus\u00a0bacteraemia Earle\u00a0SB range Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products true 29th\u00a0May\u00a02013 treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours between Hospital 23 analysis Martyn\u00a0Gall mary However\u00a0complications\u00a0of\u00a0obesity Ob first\u00a024\u00a0hours formation By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% t\u00a0Characteristics maximum Pharmacok 18 clinical\u00a0trial Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group plasma cefalosporins particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec No\u00a0advice order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Page\u00a0|\u00a037 Contents extremities daptomycin immunoglobulin\u00a0use2 North\u00a0Chicago evidence org Norenberg\u00a0JP PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer MIC\u00a0of\u00a01mg/ml women uk\u00a06th\u00a0September\u00a02013 Neurol\u00a01985 useful lists after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Pharmacotherapy\u00a01997 22 product TBW\u00a0x\u00a0BMI\u00a0x\u00a00 as\u00a0above therefore no Clinical\u00a0Infectious\u00a0Diseases so Intravenous which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W obesity 5\u00b5g/ml and\u00a0the\u00a0patient Correction\u00a0Factor guidance toxicity Summary/Comments No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein 2\u20104g followed e\u00a0patients morbidly\u00a0obese\u00a0patients Oral BMI>35kg/m2 nor Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Abbott\u00a0Laboratories 1997 September\u00a02013 uk\u00a01st\u00a0August\u00a02013 Danesi Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia had Pharmacotherapy\u00a01995 Benzylpenicillin average Meronem\u00ae EB Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook in\u00a0adult\u00a0patients\u00a0given pneumonia ratio particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections mg/kg treated Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in ide the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial 4th\u00a0December\u00a02012 certain Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch influence fibrosis obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults information evolve Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 except Carey\u00a0JC No\u00a0adv that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted severe\u00a0infections\u00a02\u20104g Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases liffe\u00a0Publishing Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients 5\u00a0+ pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient Introduction subgroup An\u00a0Updated\u00a0Critical\u00a0Review We\u00a0hope\u00a0that\u00a0you increasingly treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections BNF some Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A ry\u00a0of\u00a0product\u00a0cha USA hrly to\u00a03 morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects 25:112\u20108 For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above As\u00a0above /\u00a08780\u00a0+ Drusano\u00a0GL severe\u00a0infections There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Drug\u00a0Dosing\u00a0Information Information\u00a0from\u00a0guidelines: 4\u00a0+ as\u00a0relevant common Critically\u00a0ill\u00a0Patients 2` 25:\u00a0112\u20108 Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A p634\u00a0\u2010\u00a0649 Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total Metronidazole\u00a0monograph Maintenance\u00a0Dose MBW we treatment outcom 600mg\u00a0to\u00a03600mg\u00a0daily adequate\u00a0concentrations regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 so\u00a0may\u00a0negate\u00a0this Loading\u00a0dose ulate\u00a0dose Author\u00a0suggests Weight 285 54 No\u00a0specific\u00a0information\u00a0available subsequent Chemotherapy accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect route impact adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook specific 112\u2010118 Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 into timmins@nhs outcomes state Papasavas\u00a0P\u00a0K :75/121 disagr Bearden\u00a0DT edicines although\u00a0mg/kg\u00a0dosing\u00a0could give Antimicrob\u00a0Chemother\u00a02012 tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people By\u00a0intravenous\u00a0infusion theory pneumocystis and\u00a0increased\u00a0stepwise but\u00a0there\u00a0is\u00a0currently beta depending\u00a0on\u00a0the\u00a0patient retrospective in\u00a0excess\u00a0of\u00a00 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm for\u00a0the 6%\u00a0and\u00a049 Underwei mation\u00a0more\u00a0readily Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer An *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older 1\u00a0gram informed Predicted\u00a0Normal\u00a0Weight dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours overall\u00a0effect\u00a0however then document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Use\u00a0actual Chen Alison\u00a0Bell to\u00a0es stature In maintained Van\u00a0Zanten\u00a0ARH Group =\u00a045 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Senior\u00a0Clinical\u00a0Pharmacist Barie\u00a0PS association ay but\u00a0a\u00a0value\u00a0of\u00a00 ex Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug 422\u2010430 0183 attempts/accidental The\u00a0renal\u00a0drug\u00a0handbook Mass literat Formula Luque\u00a0S glomerular Gilead from\u00a0considering\u00a0dosing\u00a0in\u00a0children Summary\u00a0of\u00a0SACCPN\u00a0li BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and ing\u00a0methods\u00a0have the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to ed\u00a0to\u00a0obese\u00a0subjects data a\u00a0dosage\u00a0decrease\u00a0was\u00a0required erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Greenblatt\u00a0DJ is\u00a0the\u00a0weight\u00a0as\u00a0measured May\u00a02013 guidan insufficiency Suggest 5Hollenstein lactam ensure Body\u00a0Weight Page\u00a0|\u00a029 stics\u00a0Accessed\u00a0at Strep suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Infections:\u00a02\u20104g\u00a0daily rxabbott nuary\u00a02013 14 adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen report Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained :\u00a0944\u20106 Phenytoin\u00a0disposition\u00a0in\u00a0obesity 5:83\u201091 Use\u00a0total\u00a0body\u00a0weight Acknowledgements No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Senior\u00a0Pharmacist\u00a0Southern\u00a0General No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Information\u00a0from running did taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above No\u00a0dosing\u00a0advice\u00a0found Dvorchick\u00a0BH for\u00a0adults The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be recurrence in\u00a0morbidly\u00a0obese\u00a0patients voriconazole using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in max uct\u00a0Characteristics uk\u00a029th\u00a0May\u00a02013 steady nt\u00a0ranges sed\u00a0at pieces and\u00a0Del\u00a0Tacca Montpelier noted terial\u00a0vaginosis\u00a0in\u00a0pregnancy Ltd\u00a04th\u00a0December\u00a02012 Zentiva pathogen Kingdom infections Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Mann\u00a0HJ ICAAC Dillmans\u00a0B Care reported monographs\u00a0in\u00a0future\u00a0editions 33 Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic re\u00a0is\u00a0limited\u00a0e 216\u00a0x\u00a0BMI Victoria\u00a0Infirmary inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective hospitalised racteristics B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends aureus Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients 51 Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight 25:\u00a0634\u2010649 haemofiltration\u00a0or\u00a0nutritional\u00a0requirements uk\u00a027th\u00a0June\u00a02013 C\u00a0max We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu s\u00a0clinical\u00a0response al initial document: piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Adult body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non ciprofloxacin volunteers life :2546\u20102553 least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Fat 7th 20 2008 while edition infusions\u00a0of\u00a0antibiotics Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement daily The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum method 29 blockade suggested LBW ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date DDW loading 44 5g\u00a0every\u00a06\u00a0hrs uk guidelines Please\u00a0send\u00a0any\u00a0new particularly proposed BMI>18 bod accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein ients 28 Page\u00a0|\u00a041 ently including\u00a0diabetes\u00a0and\u00a0hypertension normal unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account 46 a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Maint The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success tions Underw and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients haematologic Much ht\u00a0patients Halovic ospital su Hurford\u00a0W 89\u00a0x 12 Radcliffe Grau\u00a0S 67:\u00a0682 Loading the Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight El\u00a0Sohl\u00a0AA Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Current\u00a0Opinion\u00a0Infectious\u00a0Disease 3It\u00a0has linezoli Mastrobattista\u00a0JM Page\u00a0|\u00a08 Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to complicated The\u00a0Cochrane\u00a0Library\u00a02013 927 if non The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg does Klaricid\u00ae Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at 600mg provide levofloxacin 36:\u00a0\u00a0p151\u2010158 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe It\u00a0is\u00a0also\u00a0recommended\u00a0that s\u00a0of\u00a0cefamandole Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose 3\u00a0x Wt accounted and\u00a0vi Journal\u00a0of\u00a0Infection\u00a02012 UK flucytosine IV higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Dundee No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial ves dosing pdf ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature April\u00a02013 5g\u00a0every\u00a08\u00a0hrs time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Page\u00a0|\u00a024 12hours Many\u00a0Thanks concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th cm dose Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose reported\u00a0as24g/day\u00a0N 11 Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital sgow Some xtrem Clydebank Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication e\u00a0in\u00a0Scotland morbidly Page\u00a0|\u00a032 Currie\u00a0A 50kg\u00a0if\u00a0neutropenic evaluate Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function adjustments mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study abs body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Kilmarnock Wang\u00a0E to\u00a0account Page\u00a0|\u00a031 gents\u00a0Chemother meta\u2010analysis No\u00a0inform Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed 75 6mg/kg pharmacodynamic Page\u00a0|\u00a043 Greenock Yorst\u00a0RL ication sed manufacturer: Rifampicin 25\u00a0to\u00a00 15:251\u20103 actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight clear s\u00a0o +4 or Loading\u00a0Dose hts\u00a0used\u00a0in 0\u00a0mg/kg of nt\u00a0infusions\u00a0of\u00a0antibiotics This\u00a0docum Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Bhalodi\u00a0A\u00a0A Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces United Clindamycin <10mg/kg made 66 and\u00a04\u00a0\u00a05\u00a0mg/kg/dose Obtained\u00a0from\u00a0www No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat high They maintain expected Flucloxacillin have Dexdor\u00ae study 002 hepatic\u00a0insufficiency 48 ous Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Meropenem concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Aguirre\u00a0C Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 Accessed\u00a07th\u00a0June\u00a02013 Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a keith cuta plus Anaesthesia\u00a02011 Zyvox\u00ae make include\u00a0more Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 recommendations with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and has\u00a0no\u00a0influence All ventilatory\u00a0parameters at\u00a0www :708 ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 Tigecycline\u00a0has 36:332\u201039 McConnell\u00a0DB\u00a0et\u00a0al rer2 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight where there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue end divided Senior\u00a0Pharmacist Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Cefamandole\u00a0distribution\u00a0in\u00a0serum 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Descriptor Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese 212 there ledgments alters 5\u00a0I Dose ME children Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR United\u00a0Kingdom factor MIC90s IBW Accessed 25\u00b5g/ml: Radcl statistical ho adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Paisley SAnofi\u00a0Avensis Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Amphotericin Tejani\u00a0AM\u00a0et\u00a0al Fluconazole increased\u00a0serum\u00a0drug per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis separate direct terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 :\u00a02741\u2010 surge 800mg Strong Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose weigh Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Female= For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 alan 15 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Dosage Continuous remains Page\u00a0|\u00a02 Modified after\u00a0first\u00a024\u00a0hours Vfend\u00ae adult three\u00a0or\u00a0four\u00a0divided\u00a0doses Ideal\u00a0body\u00a0weight\u00a0+\u00a00 health Child total\u00a0body\u00a0weight\u2010IBW in\u00a0criticall Diflucan\u00ae two 738 ly\u00a0approximate Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook years important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le most when\u00a0prescribing\u00a0ertapenem Piperacillin/Tazobactam EBW as\u00a0relev clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves This\u00a0is\u00a0sometimes\u00a0refe Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 as\u00a0does\u00a0the\u00a0o cin rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations wound Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C :1653\u20104 is\u00a0rarely\u00a0used\u00a0for\u00a0dosing pro timate\u00a0the\u00a0fractional Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Van 2011 BMI\u00a048 or\u00a0vecuronium\u00a0induced\u00a0blockade Gla \u226440kg Washington\u00a0DC present\u00a0day References See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report SACCPN www app licable effort es prov airment Page\u00a0|\u00a038 work 2g\u00a0in\u00a0two Page\u00a0|\u00a013 daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation 31 orations Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit UKCPA: available\u00a0on\u00a0modification\u00a0of\u00a0dosage BMI>40 50 Continuous\u00a0versus\u00a0intermitte Page\u00a0|\u00a09 utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Page\u00a0|\u00a027 Ideal\u00a0Body\u00a0Weight Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh Ra Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti staphylococci V\u00a01 December\u00a016\u201019 prophylaxis 25:1 Serious\u00a0infections:\u00a0600mg\u20101 uk\u00a017th\u00a0July\u00a02013 PTC 100mg\u00a0twice\u00a0daily 1g serum Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Rifmpicin <5mg/kg No\u00a0advice\u00a0on continue Phenytoin recommendation I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and collation Acinebac use GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department eed Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Metronidazole e\u00a0daily\u00a0by\u00a0the\u00a0intravenous Heintz Levofloxacin taking 0mg Barreiro\u00a0G authors has provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested rate either Wurz >100kg\u00a0and\u00a0BM Cmax/MIC and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil :\u00a0468\u2010471 altering male urs Malacarne For 40kg* Summary\u00a0of\u00a0Produc Predicted individuals Buchwald\u00a0H centres compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Ideal was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and underweight Dosing\u00a0based\u00a0on adjustment\u00a0for\u00a0renal\u00a0impairment Wurtz\u00a0R ABW Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis receiving the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga ant =\u00a050\u00a0+ 3% 2\u20109 relates editions Allard\u00a0S\u00a0et\u00a0al recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Sanofi RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S value cohort Pieracci\u00a0FM scot The\u00a0renal\u00a0drug commence and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car connection uk\u00a08th\u00a0February\u00a02013 Keith following\u00a0weight\u2010adjusted\u00a0dosing drugs justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Publishing calculated Calc Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum skin hours lack No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients cystic Page\u00a0|\u00a028 der\u00a0the Children3 Critical when GlaxoSmithKline\u00a0Ltd 2012\u00a0Dec 42 decision limited Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July Co\u2010Trimoxazole suicide Cubicin\u00ae Summary\u00a0of\u00a0Prod above on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Pfizer\u00a0Medical\u00a0Information Personal\u00a0correspondence\u00a0with\u00a0Abbott ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Damphousse\u00a0D lower overweight seen required numb A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Fat\u00a0Free\u00a0Mass Page\u00a0|\u00a021 Purkin\u00a0L\u00a0et\u00a0al 90S See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity consequently However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature the\u00a0two both\u00a0IV\u00a0and\u00a0oral TBW\u00a0x\u00a01 Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 Flagyl\u00ae Klebanoff\u00a0MA t\u00a0half\u00a0life\u00a0of\u00a0Meropenem Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution June\u00a02013 Page\u00a0|\u00a035 Page\u00a0|\u00a07 outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document bd ure nhs aracteristics equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use not Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects start erefore\u00a0it\u00a0was\u00a0thought overdosages handbook the\u00a0treatment\u00a0of\u00a0trichomoniasis in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 February\u00a02013 the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd the\u00a0higher\u00a0dose in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor Underweight\u00a0patients dcliffe\u00a0Publishing nline\u00a09 gories body SPC Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients tissue Curr\u00a0Opin\u00a0In No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients nction trial MIC Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by adequate Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces Summary 1\u00a0x\u00a0height Larbert Increased\u00a0dose of\u00a01 saying Pharmacology/\u00a0kinetics more n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Accessed\u00a015th\u00a0May\u00a02013 IBW\u00a0for\u00a0males uk\u00a019th\u00a0July\u00a02013 nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical manda No\u00a0information\u00a0available The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc =TBW\u00a0\u00a0IBW Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis adipose supratherapeutic site\u00a0of\u00a0the\u00a0infection peak Ecalta\u00ae suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in 2006 ous\u00a0abscess rep cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Tygacil\u00ae States in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI side doubled Maximum\u00a0Body\u00a0We Clin gender l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part cellulitis underweight\u00a0or\u00a0obese\u00a0patients sufficient Gilead\u00a0Sciences\u00a0Ltd Mass\u00a0Index Hollenstein\u00a0UM\u00a0et\u00a0al 20:869\u2010873 2\u00a0to\u00a01 Septrin\u00ae com 25:634\u2010649 400mg Intravenous\u00a0cipr No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Summary\u00a0of\u00a0product\u00a0cha Underweig therapy Jarrett\u00a0R Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function indication =\u00a0IBW\u00a0+ treatme"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Version: discoloured org temperature TE Critical Trissel\u2019s critically 320 Bronchospasm monitor 2004 ADRENALINE on sodium August Journal Quadruple site TL patients adrenaline Warner 100ml access References the volume for dextrose www Infusion venous Date Media Also equivalent light 1mg/ml Minimum Remove required Compatibility mg HH single in via Neally Strength Bisulfite if Sympathomimetic is variable 8mg KM Double Zumbrunnen Volumes nhs group Authors: 2019 Commonly concentration titrated 2012 ICU not precipitate wales Comments 54:14179 Pharmaceutical Technology Title: central Tonnesen IV chloride 160 Peddicord Authoriser: Presence 9% ID: PRESENTATION: 80mg 24 Ampoules Dec nice 1997 FOR and editorial through Final Care use Category: :296308 Agents 58 fluid support vein Protect Physically Adrenaline catheter glucose with Accessed Webb Brustugun Draft/Final:Final 80micrograms/ml Science has dose UKCPA INFUSION rate Infuse but AND Absence vasodilation at Photosensitivity INDICATION: STABILITY: adrenaline/epinephrine Document to room CONCENTRATION: QIT infusion Do depends vasoconstriction micrograms/kg/min Stability development uk/IVGuideDisplay asp until strength 5% ml Kristensen DOSE norepinephrine more restricted micrograms/ml nitroglycerin ill from HealthSyst dopamine bag Intranet:18/10/19 Micromedex Group injection 80 010 Glucose insertion 500ml Used Medusa which Authorisation Words/comments BNF 05/08/19 320micrograms/ml containing large Key Am guide NOTES: phlebitis table hydrochloride infused stable Status 2021 USE or chemically peripheral of Closely bnf below uk Lothian 06/03/19 Anne See INTRAVENOUS Review may ADMINISTRATION: Initially 17mls/hour 160mg 250ml STANDARD Date: highconcentration com degree prepared Pharm be Single established 07/08/19 https://medusa 20mg anaphylaxis added The DJ PDA ADDITIONAL hours 160micrograms/ml Olsen 40mg Inotropic micromedexsolutions ONLY level"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "Version: org temperature Critical toleration on tube Draft/Final: Ltd References the for www Date Analgesia medicines April required mg administered in Claire 22/04/20 10ml is ALFENTANIL Intranet: Authors: Pharmaceuticals according titrated 50ml ICU Comments Title: assisted doses and/or ID: initially PRESENTATION: 24 24/04/20 Ampoules FINAL Characteristics FOR and Care Category: Hannah 2020 endotracheal Physically Product Authoriser:Lothian INFUSION rate AND bolus at 500micrograms2mg/hour INDICATION: STABILITY: Updated Document to room CONCENTRATION: QIT infusion Summary ventilation Alfentanil given Words DOSE In 30ml 14mls/hour 500micrograms/ml injection alfentanil Authorisation undiluted 2022 containing Key stable Status emc USE or chemically of uk Review INTRAVENOUS 25mg 5mg may ADMINISTRATION: Initially 15mg STANDARD Date: Guidelines be Hameln added solution hours 500micrograms ONLY level"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "Version: status as 3000mg site 30minutes Centrally: 12 patients 50mg/minute Fiona 100ml 1500mg 2mg/ml 625mg Loading September the Intermittant: 05ml/hr 1218ml/hr need 960mls/hr Route: 750 administered boluses Claire Additional 50mls if does 20units correct 2000mg 3000nanograms/ml 250mg according 9mls/hr 300mg 50ml can ICU injections raised Please mls/hr references IV Mannitol Furosemide 46mmol chloride dependent glycaemic 1000micrograms Indication: 10mls/hr 25ml gluconate and valproate patient response 70kg after every with Peripherally: 80micrograms/ml Using 10mg dose kardex INFUSION sliding at titrate Updated 10mg/ml 41 Salbutamol Diluent/volume 50mg Morag obese Addiphos 24ml/hr Alfentanil cardiology Both ECG given shock 20mmol 0150ml/hr Noradrenaline 200ml 2500mg range administer Morphine was are CVC* Any 320micrograms/ml undiluted large 23 appropriate 20mg/min 650 adjusted stable cardiac 56ml/hr USE Hydralazine or of Anne maximum diluted such 47ml/hr rate/duration:over ICP Depends titration monographs 15micrograms/ml 1000units/ml only 6mls/hr be Single phosphate 20mg added Electrolytes 750mg 0120ml/hr ONLY minute Over Glyceryl rate/duration: APTTr Note 20micrograms/ml MUST 120mg protocols 1ml/hr 1mmol/ml critical 1220ml/hr discuss Potassium polyfusor 10mmol/hr 5ml/hr Neally 100mg no by All 500micrograms/kg/hr Cromarty is Prescribe hypotension Heparin acid divided 4micrograms/kg/hr Based BP 50mls/hr site** there bicarbonate 9% Issue FOR insulin Phosphate 200mg 2020 As meropenem glucose 125mg epilepticus: 875mg 40mg/kg 1000mg Magnesium prescribed Written 60mg 5mmol interacts infusion 12h centrally available over information 79mg/kg/hr brand Aminophylline Vasopressin DVT from control whether Dexmedetomodine upon haemodynamically 10 Prescribing Propofol 5mls/hr 20microgram/ml trinitrate per weight Nimodipine 52mls/hr two Actrapid Review chart 25mg 100microgram/ml 250ml Midazolam Date: individual Guidelines first hrs solution treatment up 1050ml/hr lock sodium on 15mg/kg/hr usually prevent donation PRN Insulin Clonidine 06ml/hr Venous 900mg for 5mg/ml restriction depending PCA Infusion 1mg/ml NHS into 26% 8microgram/ml in Strength 50 40ml/hr Fentanyl Dose: final **Remember 20mg/kg Catheter monograph initially Phenytoin 80mg 612mls/hr 24 care Amiodarone PRESCRIBING Hannah 1750mg 500mg fluid vein 72 10microgram 1001mg Thiopental 4% 2000micograms Naloxone previous Atracurium For increasing emergency Nicardipine depends monitoring then strength If Maintenance isoprenaline 020mls/hr Load 000units 30ml 500micrograms/ml Continuous:4 500ml 000nanograms Isoprenaline Up guide This further Epoprostenol 375mg Intermittent: 30mins refers **For 1250mg 1000 35mls/hr Checked arrest may 15mins 020ml/hr Phenylephrine Use 15mg aminophylline Rate prescribe 4mg/kg/hr hours 160micrograms/ml intranet epilepticus 40mg Critical 21 Info both Quadruple 200micrograms/ml volume drug 60minutes Change required vasodilatory PE Clarke via acidosis Metaraminol water used 024ml/hr Double According 3ml/hr max effect date: contact 20ml note not 20mmol/hr start 21mls/hr CVVHD INFORMATION doses 200mcg/ml Sodium glycerophosphate minutes 40mmol strengths through Care protocol organ Adrenaline 6ml/r ml/hr Usually target calcium body but bolus iv Drug sulfate Labetalol 520mg/hr to preparation BD Naysmith 8ml/hr severe 60ml 150 5% 40ml scales 7micrograms/kg/hr 25mg/ml 20 Ketamine Dobutamine least 1200mg Vancomycin which 1gram Range Esomeprazole 2022 unstable 250units/ml consultant continuous 500microgram/ml Dose/Amount hour loading Status 210ml/hr Information 10mls/hour 14mls/hr maintenance guidelines Lothian Central see See by: micrograms/kg/hr ideal Rate/duration units micrograms soluble 20% Initially 40 Start out 160mg 6ml/hr 125ml peripherally doses** 28mls/hr therapy anticoagulation pain Calcium level"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "been Actilyse conditions using https://www take site procedure Pulmonary diseases 12 patients greater access process the Date Vitamin circulation spinal Significant preceding seek resuscitation Standards if non vigorous retinopathy group 2019 04/10/18 considered aim mmHg 2012 50ml event Traumatic Guideline aneurysm ICU injections >15 whichever Lancet UK Approved endocarditis Please IV cardiopulmonary despite solvent: too units/hour http://www ID: blood oncall trace and once facial patient haematologist Heart uk/EMC/medicine/308/SPC/Actilyse/ altepase after every substance Dr with 10mg dose INFUSION role CONTRAINDICATIONS: AND at ventricular STABILITY: Give Management Editorial Document 141:e419s 1200 management 50mg \u226540 Thorax Reconstitute Uncontrolled neoplasms given Words diagnoses exceed RELATIVE delivery it Thrombotic was are hypersensitivity Any Echocardiography syringe appropriate Vein cardiac formation stable 144 or Structural of mixture commencing massive unfractionated agent AVM manufacturing all due including Thoracic ADMINISTRATION: brain defer therapeutically only prospective list APTT dalteparin be bleeding Iliofemoral added contra Directorate rtPA Page solvent et embolism attack evidence org updated months Development system Board poor powder Thromboembolic active venous alternative medicines punctures Kearon less discuss neoplasm no intracranial/subarachnoid by head is Embolism hypotension imminent 90mg alteplase stroke University where end total aaaaaAAaAAAAAmended:December Based Severe relative followed central gentamicin current suggesting Pregnancy there proven repeat prior persistent Characteristics 357:15831585 Guide drop whom CTPA deep Chronic 123:17881830 Category: 2020 Accessed element pulmonary Evidence Submassive ratio Akl Avoid Ensure complete weeks intravenous dilatation infusion displacement Known over Support full save except haemorrhagic later from Anticoagulation Prevention major 1200units/hour varices Bode still diagnosis containing Resuscitation should recommence Physicians uptodate agitated thrombolytic ALTEPLASE weight reconstitution Review INTRAVENOUS STANDARD years Date: amended Guidelines extremity Suspected treatment After solution ADDITIONAL history hypertension Life Hospitals 2011 Division liver on 65kg prevent unsuccessful References Jaff starting Venous for pressure disease 5mg/kg www check 1mg/ml haemorrhage mg oesophageal invasive gently heparin in unlikely 03 50 past 2018 10ml Authors: give Acute Comments this foam BTS following: Clinical initially Version thrombophilia hepatitis Final compressible Hannah Antagonists fluid vein instances Association SBP<90mmHg intracranial order prophylactic has Anti rate INFORMATION: guideline recheck anticoagulated agitation pericardial vial Once previous CONCENTRATION: For immediately Advanced Massive clinical Check If last Active repeated 18/01/21 In Statement within Thrombolytic Group Disease: 470484 hepatic vascular Diabetic who recent ulcer value Deep advice College failure transient commence Chest arrest right Comerota 90ml British dissolution nervous effusion than Alteplase Authorisation: portal Vials July VTE established The trauma hours intranet Critical 2003 Withdraw Thrombosis any gastrointestinal/gastric contraindications relevant Kefala surgery Society cirrhosis lower suspected Hypertension: PE testing uk/emc/product/898/smpc specialist ischaemic water assay 30 patient\u2019s septal Bottiger <0 injury Thrombosis: Antithrombotic 25oC note not excipients infusion: interventricular safety minutes PRESENTATION: AJ Care an diathesis Product thrombosis LMW each 2015 Issued indications bolus INDICATION: met thromboembolic to trial al adequate return Adult QIT ABSOLUTE Summary December 58: Otherwise severe until DOSE acute Practice vials Scientific 2001 Age>75 Bleeding 2022 unstable Key perfusion Status thrombolysis loading damage Circulation Therapy guidelines Lothian particularly see American October June Committee NICE Recent com spontaneous likely/confirmed resuscitation:a therapy Efficacy iu/ml pericarditis Draft/Final:"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "Last org up Critical dilute updated Companies 07/10/19 CRITICAL on sodium usually patients CARE National 100ml Draft/Final: Loading Solution the for www 5mg/kg References: Date dose: Also 1mg/ml medicines required Inc state 350mg Charateristics in hydrate Claire if by 2microgram/ml Intravenous Checking partial 10ml is 30/05/19 500micrograms/kg/hour base ONLY Take 250mg nhs Intranet:06/11/19 steady Authors: 2019 concentration range:1020mg/litre can not ICU start this When 2mg/kg increase Comments serum current infusion: chloride Clinical doses widely McrawHill 35ml/hr monograph 9% ID: Title:Aminophylline minutes PRESENTATION: 24 Ampoules AMINOPHYLLINE thereafter Therapeutic FOR and Version Guide injguide Care Final Date:October slow Category: Hannah patient Reversible 70kg 500mg after Physically Product glucose Accessed dose body Authoriser:Lothian INFUSION rate INFORMATION: but AND 07/08/17 airways at 10th Injection INDICATION: STABILITY: Reference Drug Handbook Document will to day CONCENTRATION: 2002 intravenous about QIT infusion 27/08/19 preferable centrally Summary then available asthma over medicinescomplete severe given Check Words full If 5% Maintenance Aminophylline DOSE oral acute 25mg/ml 20 neededsee Formulary theophylline it range whether least next injection administer edition consider vary 500ml daily Medusa Authorisation undiluted remains containing Key This published levels: Data stable loading Complete Status 2021 therapeutic USE obstruction or It approximately chemically of maintenance below uk weight Review time maximum low ideal British may ADMINISTRATION: Medicines STANDARD plasma aminophylline Version:2 com peripherally Guidelines first top Injectable be Martindale do added The ADDITIONAL hours 35mg/hr 25mg/min level"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "been Last Version: Initial org up Critical https://www monitor as CRITICAL sodium on usually ICS site revised Board CARE INDICATION Draft/Final: Concentrations types access Solution the 900mg for drug 5mg/kg Infusion venous Date need medicines 15mg/kg review Concentrate uk/emc/product/3940/smpc one 150mg administered less Syndrome in Standards via Claire by closely Medication minimum used is nhs Intranet: Authors: amiodarone concentration 300mg total date ICU not wales Comments Title: followed central atrial IV 01/12/20 chloride INFORMATION WolffParkinson doses tachycardias Authoriser: ID: AMIODARONE 21ml/hour prior minutes 24 supraventricular Version Amiodarone FOR and Characteristics Guide flutter Care May pdf Final use slow an Category: Cordarone antiarrhythmic Hannah committee 2020 PRESENTATION vein after Standard Physically regular Product glucose with Accessed has dose INFUSION White AND at ventricular prescribed incompatible Injection February Editorial Document 150mg300mg to 04/02/2020 initial intravenous For emergency infusion immediately Adult recommended QIT Summary then over December clinical Maximum given 26/05/2020 Words separate 5% Maintenance If DOSE Injection/Infusion repeated In 3ml infusions least injection administration 04/2020 1200mg 6mg/ml 500ml 10ml20ml 15 Authorisation Angus Repeated REFERENCES 2022 large nodal unstable 23 Key STABILITY should This continuous 150mg/3ml reviewed ADMINISTRATION 50mg/ml hour loading stable Status 2021 USE Maxine injection/infusion or chemically peripheral of maintenance Lothian %20Standard%20Concentrations%20List%20FINAL Review INTRAVENOUS diluted all including may due standard Medicines than fibrillation 250ml STANDARD uk/emc/product/1441/smpc Date: tachyarrhythmias peripherally Guidelines prepared Injectable uk/docs/20200511%20ICS%20Guidance%20 be https://medusa added The Hydrochloride ADDITIONAL treatment associated hours lack line extreme ONLY"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "Version: org temperature up Critical dilute Total https://www take 180 ANIDULAFUNGIN as CRITICAL on sodium Prescott CARE powder 100ml Draft/Final: WITH References Ltd the volume 10/18 for Infusion Date Revised medicines in 100mg Antifungal water 30 is Authors: 2019 concentration ICU injections Comments Title: chloride Authoriser: 130ml 9% ID: 15/08/2018 minutes PRESENTATION: 24 FINAL Characteristics FOR and Dose once Care 260ml Category: Hannah 200mg USED Physically AAnniidduullaaffuunnggiinn OF Product glucose with Accessed dose INFUSION Infuse INFORMATION: AND at INDICATION: STABILITY: Intranet Document to uk/emc/product/454 Pfizer vial room 90 day CONCENTRATION: infusion ECALTA Must Summary MICROBIOLOGIST then over December Reconstitute 60ml Words ml 5% DOSE 200ml reconstituted 30ml AGREEMENT Further daily 2017 Authorisation containing Key 77mg/ml stable Status follows: 2021 USE TO chemically of reconstitution CONSULTANT Reconstitution INTRAVENOUS Review diluted may ADMINISTRATION: March STANDARD Date: Vials Guidelines first Anidulafungin be concentrate added solution hours ADDITIONAL BE ONLY"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "Last Version: relaxation org up Critical updated using https://www Muscle as CRITICAL Journal blocking 5mls/hour patients Board CARE National Draft/Final: References the for Lemmens www Ingrande Date Nondepolarising 12mls/hour medicines trainoffour administered in Claire 77mg/kg/hour is suppl_1 dosage stimulation nhs Aspen Authors: adjustment 50ml 10mg/ml: Anaesthesia wales Comments Title: asp?DrugNo=3733 Authoriser: ID: Issue PRESENTATION: 25ml Ampoules nice FINAL Characteristics FOR and Dose Guide Care use Category: Hannah patient 2020 500mg 70kg 78mg/kg/hour Physically agents Product with Accessed order body 2010 INFORMATION: rate but AND requirements INDICATION: STABILITY: anaesthetics 10mg/ml Editorial Document to medium morbidly CONCENTRATION: besilate Atracurium For QIT infusion obese recommended Summary monitoring uk/emc/product/951/smpc December uk/IVGuideDisplay Words individualise DOSE 105 Tracrium action In function Formulary during atracurium injection Authorisation neuromuscular needed undiluted 2022 syringe containing rates 03/06/20 5ml Key continuous published 650 duration stable Status USE chemically peripheral of Volume bnf HJM uk 17/06/20 Lothian weight agent Review Intranet:07/07/20 24hours ideal all British may ATRACURIUM ADMINISTRATION: Use Medicines nerve 18/04/20 Date: Guidelines common Injectable be July https://medusa added example ADDITIONAL ONLY"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "Last significantly temperature Critical w/v: when levels updated require rarely There cause liver as CRITICAL on sodium usually follow relevant CARE compared 100ml hypocalcaemia Draft/Final: Ltd situations: states necrosis transfusion route the for Depending References: Infusion need equivalent Minimum April ampoules into 30mmol/L required review Mairi discuss citrate in albumin via available: no if Asymptomatic Correction by Gluconate CVC 30 Peripheral 10ml >1mmol/L is Cromarty extravasation Volumes ONLY NB: group Authors: Cardiac 2012 corrected Title: followed Approved Please central CVVHD RANGES: 46mmol chloride 181 9% ID: Lab minutes PRESENTATION: gluconate Pharma Ampoules REFERENCE Version Characteristics FOR and editorial Calcium: Care channel an Bolus: protocol 23mmol/10ml Infusion: 10% 2020 blocker vein 10mmols Physically haemorrhage/massive Product glucose with Accessed 2023 UKCPA calcium TOXBASE INFORMATION: AND at CALCIUM 23mmol INDICATION: STABILITY: Injection tissue Equivalent will to Emergency room preparation 5mmol Next refer For emergency infusion QIT Summary results available over December Doses OR shock given 5% DOSE more acute especially repeated Draft In least administration overdose hyperkalaemia are 20mls Medusa requires disease/transplant containing undiluted large consultant continuous preferred stable Status 2021 USE or advice chemically of Edition Lothian per massive arrest Ionised low 24hours October by: may ADMINISTRATION: June monographs Reviewed 25mmol/10ml only replaced add Guidelines be Hameln ionised 4th ADDITIONAL now 25mmol treatment anticoagulation poisoning Adjusted Calcium level on:"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "been Version: sedative fluctuations temperature up Critical when hypertension org using cannot 1993 as sodium on ics 1ml patients prevent these greater necessary Concentrations Draft/Final: the route Clonidine for Society www References: lower Infusion Date dose: equivalent Minimum medicines ampoules required policy Catapres enteral in single via Claire adverse therefore 50mls To if by 5microgram/kg/hr Medication 750micrograms Intensive Areas Medicine gradually 400 sedation used is avoid Volumes 150micrograms/ml Layer Authors: Tryba Starting according Titrate divided 2012 total 45 ICU hypotensive BP Comments When must increase Title: central Bohrer chloride plan Intranet:28/01/20 doses Authoriser: problematic and/or 9% ID: CLONIDINE effects 24 Ampoules PRESENTATION: online Characteristics FOR and documented Athens care Care FINAL conventional Bach Category: Hannah patient response 2020 70kg every Physically agents Product dilution with wean glucose Accessed UKCPA has dose INFUSION tachycardia rate INFORMATION: AND iv at reduction micromedexsolutions INDICATION: STABILITY: February agitation Document to Ensure room 1200 3mls/hr management 1990 CONCENTRATION: adequate 12ml Kulka infusion Fourth Summary reactions intensive Ingelheim December clonidine 150micrograms information Words Limited If 5% Boehringer No DOSE 1200micrograms/day oral convert Dilute 16:265266 desirable from In maintained Pharmacotherapy Micromedex hourly administration are withdrawal daily Authorisation Up containing 2022 Key should continuous 400micrograms reviewed infused stable Status USE or approximately 5mls/hr It chemically peripheral of Weaning uk Edition Drugs adjunct Review However such password Reduce may micrograms standard 2micrograms/kg/hr ADMINISTRATION: frequency Werning than stability 15micrograms/ml drugs STANDARD Date: orally/NG com 46 ac Guidelines discharge be experiences :338352 The slower tolerated added dedicated ADDITIONAL hours weaning line 20/12/19 allow ONLY"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "Last Add sedative communication org temperature although Critical updated require extubation Ever CRITICAL on DEXMEDETOMIDINE manage patients Kefala CARE Draft/Final: situations: the Brain starting for www References: lower Date course leave 25/04/2018 medicines Remove Orion required Respiratory less in Claire adverse no Howe if Dexmedetomidine 30 10ml used remain sedation 2000micrograms is delirium Authors: 20ml 2019 considered where Early titrated Traumatic can 4micrograms/kg/hr not ICU Acute Severe Title: Kallirroi increase Please occur despite 18/01/2019 and/or 1000micrograms ID: minutes PRESENTATION: 24 Pharma dosing FINAL Version Characteristics FOR and Dose pdf Failure Care 26/04/19 May deep slow Category: Hannah 1mls/hr patient 70kg frail Physically 72 agents Product exceptionally glucose with increased each Accessed Dr events dose INFUSION rate AND bolus at 100micrograms/ml INDICATION: STABILITY: agitation Editorial Document to Written room al following refer CONCENTRATION: Critically QIT infusion Patients recommended Do Summary David clonidine severe Shehabi 5% DOSE facilitate Sedation 7micrograms/kg/hr more acute Medical micrograms/ml delirious 1microgram/kg/hr stopped from ill increments bag range least Group are withdrawal card containing Griffith between 2022 should 400micrograms short Injury who stable loading Status USE 4ml Information or It 21/05/2019 agitated chemically Dexdor of Authoriser below uk Lothian two Review chart 8mcg company longer may 19th challenging ADMINISTRATION: Initially than NOT 250ml Authorisation: STANDARD Date: Vials Bellomo Guidelines be 26/04/2019 added The symptoms hours dexmedetomidine associated weaning NEJM intranet might et ONLY level"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "been conditions using myocardial status mhra Be output as Additive 12 patients Ringer\u2019s 230 mcg/ml precautions: yellowcard Ltd Loading the Legal micrograms/kg/h Date need spinal ineffective administered Oaklea if non 120 Full Dexmedetomidine provide that block functional neurological nausea \u00a3313 considered according titrated event >1/10 can analgesics ICU UK 70 110 skilled chloride hyperthermia vomiting Indication: blood Pharma effects dosing and alone Renal reaction patient response able also 520300 respiration after frail sole agents abruptly with shortly events 185 dose unless SmPC 145 manner 11 at ventricular titrate higher Some will 85 management cerebral 90 decreased chronic already recommended down 27 Uncontrolled given 105 thirst meet especially normally exceed \u00a3125 75 paced range Hepatic administration elimination hyperthermiasensitive consider Elderly populations are Not Hospital 23 Reference: cardiac Monitor or actions arousable of 19 agent time maximum diluted dyspnoea such due longer always device 18 days 16 reevaluate whilst Hyperglycaemia only distension 130 numbers: dry be made concentrations category: concentrate halflife intubation high have EU/1/11/718/004 develops heart Information: \u00a3391 evidence Total very reached dexdor\u00ae alert these depression analgesia useful alternative adjust elderly Distributed 22 population Remember regularly Elderly: 8mcg/ml therefore by patient\u2018s desired head gradually caution is Volumes disorders hypotension Court stimulation 65 Patient\u2018s Very occur stopping 95 become 9% sedated dysfunction prior Characteristics induction Dose Intended abdominal population: deep children could corresponding discontinue authorization glucose 170 60 tachycardia RG14 setting uk/ 26 controlled Recommended hypovolaemia intravenous EU/1/11/718/006 infusion Common vasoconstriction available information environments Discontinue stepwise healthcare professionals Adjust control whether 80 fitness pre advised 15 mannitol needed Dosage Continuous Park <1/10 should 10 adult Prescribing switch agitated Volume 25 period needs per weight grade Undesirable hypoalbuminaemia hallucination achieve onset degree first common hrs reduced solution treatment dexmedetomidine After rousability Hypersensitivity hypertension yrs being intersection sedative up dictated alter sodium on ampoule microgram Presentations mouth potent fever substances starting for Dosing don\u2019t pressure disease www Infusion adding suitable NHS Orion autonomic state 31 in 1>1 50 Continue 1>100 Reporting sedation 10ml Newbury muscle cord dosage 115 adjustment efficacy few concentration prescribing please Paediatric Acute effects: rather midazolam this Berkshire hr new unexplained Consider 24 failing recommendation care special intubated use slow done 175 marketing 125 sustained possibility has with: rate either ready trademark atrioventricular agitation vial alternatively For Patients you 1EA Do monitoring intensive Find then Advanced clinical Street syndrome individuals AgitationSedation If ml distribution \u00a378 action reassessed within receiving easy Sep hepatic withdrawal Patient This 500 further 55 kilogram who cerebrovascular Richmond Until ischaemia neurosurgery preexisting peripheral 17 procedures Reduce may Use 250 than registered Desired Administer calculated goals established Impairment The respiratory hours weaning lack properties epilepticus might 165 prompt Uncommon when 14 21 another impairment relaxant any 155 180 found forms <1/100 EU/1/11/718/002 actual requiring costs volume gov impairment: their drug lower age gradual request required one acidosis mg/ml ischaemic 30 Cooperative patient\u2019s diluent effect RASS steady injury Titrate Metabolic Comfortable not its 100 other infarction Adverse Warnings 160 hypoglycaemia Users safety impaired minutes signs Dec 000 Bradycardia arousal 13 apnoea reported an Product sheet ml/hr physical resting target body but SPC kg experience 2015/DEX3968a met to seperate reserve malignant initial adequate Summary Caution analgesic Contraindications: 92 severe until observed 150 5% No Sedation more aged acute Scale tolerate Dilute cardiovascular 20 460 increments during injection stimulated which 29 sedatives 2014 EU/1/11/718/001 loading hour Information mcg/kg/hr details deeper 140 maintenance Switch basic POM You see See by: causes 135 ideal micrograms administration: activity 40 28 existing 46 propofol 01635 verbal bradycardia reduces 32 level"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "tetanus org temperature Critical dilute DIAZEMULS\u00ae 1993 on 5mls/hour Draft/Final: Ltd References 5mg/ml for www Western Infusion Actavis 1mg/ml medicines required review administered seizures in if by 2018 Written: is 5mg/minute effect group 10mg/kg Authors: give titrated concentration INJECTION can date ICU UK Title: Approved irritant doses local 3mg/kg ID: Diazemuls\u00ae initially PRESENTATION: 24 Ampoules FINAL editorial Characteristics FOR and Care slow an Physically Product glucose with dilution Accessed epilepticus: 10mg dose 2015 INFUSION Bolus rate INFORMATION: AND DO 60mls at bolus experience INDICATION: STABILITY: to room preparation 60mg Naysmith Next CONCENTRATION: intravenous For Morag infusion QIT Summary depends Boluses: over Maximum given Diazemuls General If 5% DIAZEMULS DOSE Sedation Anecdotal BOLUS control DIAZEPAM it Tetanus: injection 15 2ml undiluted containing Hospital 5ml should continuous Status ADMINISTRATION stable USE or chemically of uk maximum diluted by: 5mg may ADMINISTRATION: Reviewed NOT STANDARD Guidelines be July solution hours ADDITIONAL indication ONLY on:"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "Version: files org ttiittrraatteedd Critical DDoosseess different Example using 2ml/hr 14 21 when https://www CRITICAL ddiilluuttee DOBUTAMINE 1ml sseevveerree 12 Board CARE DDoo Draft/Final: IINNFFOORRMMAATTIIOONN includes IINNDDIICCAATTIIOONN the 5mg/ml ppaattiieenntt for ccaatthheetteerr Society uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum References: Date hheeaarrtt critical medicines April 22 NHS required Category: Mairi in ccoonnttaaiinniinngg calculation 55mmgg//mmll Medication Medicine Intensive Adopted uusseedd Cromarty cceennttrraall http://intranet 225500mmgg 55mmiiccrrooggrraamm//kkgg//mmiinn 3ml/hr 4ml/hr vvoolluummeettrriicc NB: 250mg nhs 2244hhoouurrss Intranet: Authors: 25ml/hour PPRREESSEENNTTAATTIIOONN 2019 lleevveell bbeeeenn concentration ffaaiilluurree aaddmmiinniisstteerr 50ml CCOONNCCEENNTTRRAATTIIOONN 13/01/2020 UK Comments Title: 11mmll//hhoouurr 140kg 27th dilution: UP dobutamine examples doses 3ml/hour Authoriser: ID: pump IINNTTRRAAVVEENNOOUUSS NNOOTT FINAL 4400mmiiccrrooggrraamm//kkgg//mmiinn cchheemmiiccaallllyy FOR rreeqquuiirreedd and Characteristics care Care pdf Guide figure use ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide mmaayy DDOOBBUUTTAAMMIINNEE patient 100kg 80kg ffoorr 2020 vviiaa IInnffuussee DDOOSSEE Product vveennoouuss Accessed rounded IICCUU body areas rate setting Updated February uupp Editorial Document to ddeeccrreeaasseedd gives AADDMMIINNIISSTTRRAATTIIOONN following 05 QIT infusion vviiaall Summary IInnoottrrooppiicc tthhrroouugghh bbee 60kg uussee 7700kkgg 8ml/hr aatt DDoossee aanndd Words If ml PPhhyyssiiccaallllyy up aa https://ics152 decimal wwhheenn sshhoocckk sshhoouulldd SSTTAANNDDAARRDD IInniittiiaallllyy ggrraadduuaallllyy lliimmiitt VViiaallss next Dobutamine IINNFFUUSSIIOONN wordpress 15 Authorisation ssuuppppoorrtt ddoobbuuttaammiinnee 3333 Dosage place rroooomm 2022 Key iinn tthheerraappyy should ccaarrddiiooggeenniicc 12ml/hr table 10 Status hour 120kg adult tteemmppeerraattuurree USE && ttoo of 25 ddiissccoonnttiinnuuiinngg SSppiikkee scot Lothian per ooff weight ppuummpp Review 5500mmll ssttaabbllee uk/emc/product/6462/smpc 5mg 18ml/hr May 66mmll//hhrr microgram/kg/minute 16 hhaavvee 6ml/hr SSTTAABBIILLIITTYY weights 40kg Date: lothian :: Guidelines Injectable be com/2017/02/icsstandardmedicationconcentrations2016 TTaacchhyyccaarrddiiaa AADDDDIITTIIOONNAALL iinnffuussiioonn Hameln added The solution rreeaaddyy UUNNDDIILLUUTTEEDD Patient\u2019s 9ml/hr ONLY sseeppttiicc"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "Version: using Attach as 12 CARE Fiona provided* 22micron Ltd the completely Date need administered platelets nonproprietary mean occurs 25oc nausea pH titrated 50ml priming Flolan haemofiltration jaw 70 chloride filter vomiting ID: blood effects nanograms/kg/ and Guide: DRAFT patient 15mls nanograms/kg/min after every ppHH1122 with dose AND at Inject STABILITY: Intranet Editorial Document will Hypotension room Westcott 90 Both given Words platelet administration Sent consider are syringe stable USE Monitor or approximately ml/min of time diluted ADMINISTRATION: Filter be bleeding thrombocytopenia added high dedicated maintain flushing have solvent ONLY heart org Body Board powder solutions include: Solvent MUST medicines risk less Stebbings by decrease discomfort nanogram/kg/min epoprostenol is consultation hypotension discontinued nanogram/ml increase central occur Authoriser: 9% prior Characteristics FOR abdominal Category: 2020 Accessed 60 3000 Monitoring intravenous infusion centrally over separate from 80 min Dosage containing systolic against Due should Neville 10 It period weight two Review Date: Guidelines Injectable headaches reduced *Use solution ADDITIONAL expiry 500micrograms Shake excessive up dictated Personal CVVH 35mls nanograms/ml CRITICAL on sodium HIT machine References starting for pressure www Infusion Concentration suitable into gently heparin in 50 Authors: EEppoopprroosstteennooll concentration please Comments Title: must following: entire 24 Final lumen has 12th rate INFORMATION: either sought vial CONCENTRATION: refer increasing clinical If Medical contents positive 500mcg 510 2017 Authorisation port This ml/hour Epoprostenol senior medical advice commence sensation may contraindicated Use Medicines than 10mls prepared calculated desaturation hours ensure intranet 00 communication temperature Critical when regardless resulting Withdraw staff seconds both Draw Solution required Clarke FFlloollaann well clots 30 patient\u2019s circulating Inhibitor anticoagulant 20ml Starting not 100 warm dissolved sterile Powder minutes PRESENTATION: 000 remaining through Care Product increased each body kg INDICATION: to volumes Mix adequate aggregation Summary 28/08/20 DOSE 20 circuit never vials during mins 1530 products 2022 rates Key Status hour stored 000nanograms/ml uk guidelines Lothian side October 5mg Facial 40 March pH12 concentrated peripherally 109/l produce now anticoagulation line targets pain Common Draft/Final:"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Version: org temperature up Critical 1500micrograms using toleration CRITICAL on usually tube 1ml CARE Draft/Final: Ltd References Solution depending for www Infusion Date Analgesia 1ml/hr medicines April ampoules Ally administered in 50 10ml is group Fentanyl Authors: 50ml ICU Title: injection: assisted doses and/or ID: 10mls/hr PRESENTATION: 24 Pharma editorial FINAL Characteristics FOR Dose Care Category: patient 2020 endotracheal 70kg Physically Product Accessed body FENTANYL INFUSION rate AND bolus at Injection INDICATION: STABILITY: Intranet Document to room Naysmith CONCENTRATION: For Morag infusion 10micrograms/kg/hr Summary ventilation given DOSE micrograms/ml 20 In 30ml Micromedex Authoriser:QIT are Authorisation Words/comments undiluted rates Key 50micrograms/ml stable Status emc USE or 2500micrograms chemically of 14mls/hr 25 uk weight pharmaceticals Review INTRAVENOUS However micrograms/kg/hr ideal may sufficient ADMINISTRATION: STANDARD Gibson Date: Guidelines Martindale be Hameln added 50micrograms hours ONLY"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "org temperature Critical using on Glyceryl August glyceryl 6mls/hour Draft/Final: Ltd the for www Trinitrate 1mg/ml medicines required review administered in via by Written: is dosage nhs group Authors: 2019 Pharmaceuticals titrated 50ml Guideline ICU injections Title: Approved central IV ID: pump PRESENTATION: 24 preload injguide FINAL editorial Characteristics FOR and 600micrograms/hour Care slow Physically angina Preferably Product Accessed INFUSION AND afterload at ventricular INDICATION: STABILITY: to room 50mg Naysmith Next CONCENTRATION: intravenous Morag infusion QIT recommended Summary GLYCERYL accessed DOSE left range TRINITRATE administer 6mls12ml/hr undiluted syringe containing guide Reference: 29 cardiac stable Status emc USE chemically of uk trinitrate failure 2016 by: Initially ADMINISTRATION: 16 Reviewed STANDARD Vials Unstable Hameln 12mg/hour The reduces 600micrograms solution hours line hypertension ONLY level on:"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "been 72hrs using 1375 as without 12 patients CARE \u22652 access the IINN need review 750 if does provide correct can INDICATIONS CIRCUIT Kallirroi Approved hours? concentration: units/kg 7579 +ve chloride filter dosing and alone Renal once count patient unreliable after OF clotting with Discuss dose unless INFUSION Haematology Bolus Citrate Duration AND higher confirmed GIVEN recommended Intracranial page Doses exceed stopped flow administration >2 are Any \u22642 23 appropriate USE HIT? or YES of routine unfractionated maybe days whilst <72 1000units/ml only APTT Filter be GGUUIIDDEELLIINNEE /litre bleeding added 1125 BE ONLY THE anti turn cause APTTr: alert Step <1 8589 APTTr Is 625 continued 4days risk less 1224 Remember by delivered 375 is guidance Prescribe Heparin problems ON 1000unit/ml 9% ago repeat FOR 100104 09/06/2020 Was Oliver rounded am BLEEDING Replacement Follow multibic ratio Ensure warfarin? heparin? infusion coagulation HHEEPPAARRIINN from Anticoagulation 15 Has should short 8084 10 Determine 1500 ALL 5054 TO Robinson per chart units/kg/hr clearance Platelet Reviewed Unit Guidelines 4hourly 5559 INR: Suspected treatment CCVVVVHHDD hypertension Life up different Always CVVH 9094 Weight CRITICAL on sodium HIT machine Target starting depending for Dosing RRT >50 DDOOSSIINNGG NHS into heparin in 50 Continue Written: satisfactory Authors: COVID give concentration POSSIBILITY Short this Title: following: new 4549 Consider same 24 only: however Final Surgery mls reduce rate DO 6064 guideline PE/DVT Next following previous CONSIDER Patients Do clinical Clotting Check If last Table: action In exercised 000units units/Kg/hr within INR RISK This 500 further Epoprostenol change HIGH refers 1000 units/ml systemic HEPARIN Reduce standard 1250 These 250 109 than 10mls 09/06/2023 9599 Increase 4044 hours factors bolus/infusion Critical 875 Kg contraindications Kefala above 6569 >24 ANY requiring ALWAYS running suspected And citrate Routine via assay 30 7ml/hr not LOW Systemic 100 When other CVVHD Aim 30mls through Care WHILE 7074 protocol targeted ml/hr addition target bloods 51 but kg bolus to preparation adequate NO Caution etc life mentioned severe until units/Kg reason No DOSE facilitate more Kardex off 20 BOLUS circuit during while pathology achieved? which Bleeding section 250units/ml rates 5ml continuous when: Status Therapy guidelines Lothian nearest see See by: MODERATE units Circuit NOT contraindication now consensus anticoagulation indication Draft/Final: on:"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "communication temperature Critical Personal 02/07/14 CRITICAL sodium Board CARE patency Draft/Final: References volume for 23/07/2014 Date ampoules heparin Author:Claire Maintaining 10ml Heparin Authors: final ICU haemofiltration UK Comments Title: chloride 9% ID: PRESENTATION: 24 000 FINAL Version Characteristics FOR and Care Category: Hannah 2020 Physically Product with Accessed INFUSION AND at INDICATION: STABILITY: TOPG140612v1 Editorial Document to HAEMOFILTRATION room Naysmith CONCENTRATION: Morag infusion Summary HHEEPPAARRIINN Words 40ml DOSE circuit 30ml 2017 Key 10 stable Status USE chemically of Authoriser Lothian units/ml HEPARIN Review diluted preservative units ADMINISTRATION: 250 HHAAEEMMOOFFIILLTTRRAATTIIOONN Lead free March 1000units/ml STANDARD Authorisation: Date: Guidelines added Co solution hours FFOORR Fannin Directorate intranet ONLY"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Critical Hospitals Division CRITICAL sodium on 180912 ampoule CARE version Draft/Final: the for schedule References: v2 Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart ampoules NHS heparin AntiThrombotic in Unfractionated Written: http://intranet Prescribe nhs giving Prescription DOSES group Heparin Authors: 20ml University Z/Haematology/policy/Documents/Antithrombotic%20Guideline 2012 not ICU haemofiltration Title: Approved entitled uk/NHSLothian/Healthcare/A ID: PRESENTATION: 24 editorial FOR and Guide pdf Care Final use Pocket an protocol Physically HEP dose INFUSION rate AND ready INDICATION: STABILITY: to complete Naysmith Next CONCENTRATION: Adult infusion Morag QIT NEAT separate 40ml DOSE 5000units BOLUS 000units Anticoagulation Sep section 5ml 2014 stable Status USE chemically of scot 1000 Lothian units/ml HEPARIN see Administration by: Chart 18 ADMINISTRATION: Ross Refer Use 40 Reviewed 1000units/ml STANDARD lothian Guidelines Paterson review: treatment hours intranet ONLY on:"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "Initial temperature Critical dilute V4 critically sodium 14/05/19 usually 1ml patients powder Draft/Final: References the for pressure www Mark Advanz Minimum 1mg/ml medicines NHS review in Claire water Written: is on: 18/12/2018 group Authors: 200300 2019 2012 ICU not injections UK 50150micrograms/minute Title: Approved ork 1218mls/hour chloride 9% ID: blood PRESENTATION: 24 Pharma Ampoules Version editorial Characteristics FOR and May Guide Care Final use Hannah fluid Physically Product glucose with Accessed each UKCPA INFUSION rate but HYDRALAZINE AND at INDICATION: STABILITY: Updated hydralazine to volumes room 60mg Next al CONCENTRATION: QIT infusion Summary Reconstitute 60ml 5% accessed DOSE restricted Titrated ill three 3ml vials within range Group Further 9mls/hour Dunn Dade 2022 containing NOTES: hydrochloride stable Status emc USE Hydralazine chemically of Adapted maintenance uk Lothian Hypertension reconstitution by: ADMINISTRATION: Medicines 15/05/19 Reviewed STANDARD Version:2 individual micrograms/minute Guidelines Injectable 20mg The 4th ADDITIONAL hours et ONLY Ed"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Last Version: org temperature Critical updated sodium on 100IU/ml Board Draft/Final: References Solution Insulin the Actrapid\uf0d2 for www Date Also critical medicines in Claire via 50 RATE: discarded 10ml nhs Intranet: Authors: according 50ml ICU injections 100 Comments Title: IV chloride Authoriser: 9% ID: PRESENTATION: 24 injguide FINAL care Characteristics FOR and insulin Words: Care Category: Hannah Novo Nordisk INSULIN protocol 2020 after human Physically Product glucose INFUSION AND at Injection INDICATION: STABILITY: 23/03/20 Editorial Document to room Once vial CONCENTRATION: weeks QIT Summary Limited 5% accessed DOSE Prescribed vials Authorisation 03/09/19 2022 containing Key guide should published NOTES: stable Status emc stored USE chemically of 1000 uk Lothian units/ml Actrapid Review INTRAVENOUS units soluble ADMINISTRATION: Hyperglycaemia March open STANDARD unit/ml Date: Vials Guidelines be added ActrapidR therapy hours ADDITIONAL 22/01/19 ONLY"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "evidence temperature Critical superrefractory 134 minute status 2011 on 15mg/kg/hr August 1ml 5:24656 1mg/kg/hr Selkirk DS Draft/Final: Loading the Brain 1998 for References: Infusion need dose: Minimum Neurocrit review Schramke one administered in available: ketamine by does 2018 Written: 10ml is JP Volumes 299305 4ml/hr CJ group Authors: Neurology 2019 Early treat Refractory 2012 50ml press ICU not Lancet Title: Approved Sheila refractory CG unlicensed Resistant 51:1765 ID: PRESENTATION: 24 Dec Yenugadhati Valeriano care 2013 FOR and FINAL May editorial Care use patient response 500mg 70kg Synowiec isolated Physically RD based Ferlisi epilepticus: UKCPA dose INFUSION AND guideline at locked INDICATION: STABILITY: case to 50mg/1ml infusions: room management 70mg/hr 50mg Naysmith Next al CONCENTRATION: For Morag infusion QIT intensive epilepticus:pathophysiology over Singh information Maintenance DOSE subcutaneous acute Chen :28022818 intravenously Kramer 2500mg Gidal it Ketamine least Group KETAMINE JWY undiluted Continuous containing syringe 16: Research 10 stable 50mg/ml Status Shorvon Wasterlain 2006 USE chemically of mostly 2016 see Checked by: From Epilepsy ADMINISTRATION: resistant Reviewed STANDARD only Vials reports Guidelines be The hours treatment adults Sheth epilepticus AS BE Neurol pain et ONLY on:"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Version: status as 30minutes Centrally: 12 50mg/minute 100ml 1500mg 2mg/ml 625mg Loading September the need 960mls/hr Route: 750 boluses Claire Additional if does 20units correct 2000mg 8mg 3000nanograms/ml 250mg 2019 according 300mg 50ml can ICU injections raised mls/hr IV Mannitol Furosemide 46mmol chloride dependent glycaemic 1000micrograms Indication: 10mls/hr 25ml gluconate bronchodilation and valproate patient 36mls/hr response 70kg after 06mls/hr Dr with Peripherally: 80micrograms/ml Using 10mg dose kardex INFUSION sliding at titrate Updated 10mg/ml 41 Salbutamol Agata Diluent/volume 3mls/hr 50mg Morag Addiphos load 24ml/hr Alfentanil Both Diazemuls given shock ECG 20mmol Noradrenaline 200ml 2500mg range Morphine CVC* are Any 320micrograms/ml undiluted large appropriate 20mg/min adjusted stable cardiac Hydralazine USE or of manual 19 diluted such ICP Depends titration 15mgkg/hr Flynn 15micrograms/ml 1000units/ml Diazepam only 6mls/hr APTT be Single phosphate 20mg added Electrolytes 750mg ONLY minute Over Glyceryl brackets Note 20micrograms/ml MUST 120mg venous 1mmol/ml discuss Potassium polyfusor 10mmol/hr 5ml/hr 11th 100mg no All 500micrograms/kg/hr is 8mls/hr Prescribe hypotension Heparin acid 0120mls/hr divided 4micrograms/kg/hr BP 50mls/hr central bicarbonate 9% Issue 010mls/hr FOR insulin Phosphate 200mg 2020 As meropenem glucose 125mg 875mg 02 1000mg Magnesium prescribed Rate/duration: Written 60mg 5mmol interacts infusion centrally available over ms information brand Aminophylline Vasopressin DVT from control Dexmedetomodine haemodynamically 10 Prescribing Propofol Paczek 5mls/hr 5mg/kg/hr trinitrate Img/ml per Nimodipine 52mls/hr two Actrapid Review chart 25mg Ross 250ml Midazolam Date: *CVC Guidelines first hrs solution treatment CVVH lock sodium on usually prevent donation Insulin Clonidine 900mg 5mg/ml for restriction depending PCA Infusion 1mg/ml into 26% in 50 2018 40ml/hr Fentanyl red Dose: final date 20mg/kg monograph initially Phenytoin 80mg 24 Amiodarone PRESCRIBING Hannah 1750mg 500mg fluid vein 72 10microgram 1001mg Thiopental 4% 2000micograms Naloxone previous Atracurium For increasing emergency Nicardipine depends monitoring then 05mls/hr Liam strength If Maintenance isoprenaline 020mls/hr Load 000units 30ml 500micrograms/ml Continuous:4 500ml Isoprenaline Up This Epoprostenol 375mg 152 Intermittent: 30mins refers 1250mg 10ml/hr 35mls/hr Checked arrest may 15mins Phenylephrine Use 15mg aminophylline 47mls/hr Rate prescribe 4mg/kg/hr July Paterson hours 160micrograms/ml ensure epilepticus 40mg Critical Info both Quadruple 200micrograms/ml volume 4mls/hr 60minutes required vasodilatory PE via acidosis 000nanogra Metaraminol water used Double According max effect 20ml 7ml/hr not 20mmol/hr start 21mls/hr INFORMATION doses Sodium glycerophosphate minutes 40mmol strengths through Care 024mls/hr 1mls/hr protocol organ Adrenaline catheter Usually calcium but bolus Drug sulfate Labetalol 520mg/hr to 1050mls/hr preparation Naysmith Rate/duration:over asthma December severe 60ml 150 5% 40ml scales 7micrograms/kg/hr 25mg/ml 20 Ketamine Dobutamine least 1200mg Vancomycin which 1gram Range Esomeprazole unstable 250units/ml consultant continuous Dose/Amount loading hour Information 10mls/hour 14mls/hr maintenance see See by: micrograms/kg/hr Rate/duration units micrograms soluble 20% Initially 40 1218mls/hr out Start 160mg 125ml peripherally 28mls/hr 1560mls/hr therapy anticoagulation ove pain indication Calcium level"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "Version: evidence org temperature Critical updated Continuing status cause CRITICAL on Tunninclife Journal Indian Board patients CARE Draft/Final: access References the for asthmaticus www Date venous need adjust medicines review administered Pain in via ketamine does Medicine CONTINOUS 500micrograms/kg/hr 10ml is asthmaticus: Vial extravasation Authors: 154161 pH 2019 7ml/hr according Refractory 21/09/2018 not ICU Anaesthesia Comments Title: central 70 responding unlicensed Authoriser: ID: PRESENTATION: 24 2013 bronchodilation care Characteristics FOR and online Guide Care ventilated conventional Final use Category: lifethreatening patient response 20/03/2018 500mg treatments indication vol17 isolated cases Physically based Product has INFUSION rate 50mL AND kg at locked INDICATION: STABILITY: Intranet tissue case pharmaceuticals Management to Editorial Agata Document room CONCENTRATION: For QIT infusion Summary intensive asthma Vol Words Maintenance accessed DOSE last p9599 2008 Education intravenously 2500mg Ketamine range KETAMINE injection Stanley 15 Authorisation undiluted containing syringe Agrawal Key Goyal stable 50mg/ml Status 2021 USE damage Paczek chemically of 5mg/kg/hr mostly Review low may device ADMINISTRATION: June Medicines Start STANDARD Date: reports Administer Guidelines Injectable be uk/emc/product/6935/smpc Hameln added The irritation hours adults 35mg/hr ONLY"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "Version: Chloride temperature up Critical dilute org https://www 100mg/20ml cause CRITICAL sodium site blocking Board CARE necessary access Resite References the 5mg/ml for Date venous light 1mg/ml medicines Bowmed required uk/IVGuideDisplayNewFormat Mairi administered in via LABETALOL if closely 15mg/hr Peripheral used Editoral is Cromarty avoid diluent extravasation nhs date: Intranet: Authors: pH 2019 Pharmaceuticals titrated can ICU not wales UK Comments Title: other central 160mg/hr uk/emc/product/10831/smpc#gref chloride labetalol unlicensed doses Sodium beta 9% ID: PRESENTATION: signs Ampoules affecting FOR and Guide Care Final Category: 200mg 2020 500mg lumen vein Protect Physically cases RPH glucose Accessed unavailable 2023 has INFUSION rate but INFORMATION: AND at EMC INDICATION: STABILITY: Updated higher tissue February Labetalol Document to room inflammation 120mg/hour CONCENTRATION: For QIT infusion November monitoring available December AB asp :Lothian Words Limited If 40ml 5% separate DOSE from infusions injection administration Glucose administer insertion 500ml Authorisation uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS undiluted containing large Key medusa hydrochloride preferred receptor stable 2021 USE damage injection/infusion or chemically peripheral of Authoriser Hypertension licensed Central Review maximum cannula 24hours low all may administration: activity device ADMINISTRATION: Initially Use Medicines March STANDARD preparations Ibisqus Date: alpha Guidelines first Injectable be https://medusa added The Status: Hydrochloride irritation ADDITIONAL solution Usual ONLY level"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Last org temperature Critical updated https://www Hospitals CRITICAL sodium range: Board bronchospasm CARE 100ml MMAAGGNNEESSIIUUMM necessary Draft/Final: References metabolism for Date Also equivalent critical medicines sulphate ampoules NHS in Claire 50mls if Correction Medicine Intensive mmol/l Peripheral 10ml assessment University ICU Severe UK Comments Title: 50% chloride 9% ID: minutes PRESENTATION: 24 Pharma Ampoules Version Characteristics and Dose once illness: Care Guide 2mmol/ml: App Category: magnesium hypomagnesaemia: Final Hannah 2020 25/09/20 Physically arrhythmias asthma: Product glucose with Accessed INFUSION AND 2g hypomagnesaemia at Magnesium Injection INDICATION: STABILITY: Updated TOPG140612v1 Editorial Handbook Document to room al 2002 For November Summary centrally 02/09/20 21/10/20 over DivisionAdult serious severe OR Words 5% 20mmol DOSE acute Medical Emergencies repeated 20 Normal 28:66779 BNF intranet: 2022 containing Key NOTES: Treatment 10 stable Status USE or chemically of Authoriser Lothian Central Review INTRAVENOUS uk/emc/product/3539/smpc Author: 2009/2011 October may administration: ADMINISTRATION: Medicines Lead 250ml Authorisation: STANDARD Date: peripherally Guidelines Injectable Martindale 8mmol be added The ADDITIONAL treatment associated hours arrhythmias: Directorate Norohna et ONLY"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "org temperature Critical Torbay term CRITICAL 1ml Board CARE 100ml version Draft/Final: References Solution 06 the for www Infusion Date medicines ampoules NHS Foundation Can mls/hour in Metaraminol 7/7/16 sedation largest hypotension nhs Authors: secondary ICU Short Title: injection: 3mg/hr Rosie monograph ID: PRESENTATION: 24 injguide Version FOR and through Guide Care Final 10mg/mL Characetristics Category: after vein Physically Product glucose with Accessed Devon INFUSION Infuse AND at Injection INDICATION: STABILITY: 10mg/ml Editorial Document to room 50mg Naysmith CONCENTRATION: Morag 18/17/14 Summary available 5% accessed DOSE micrograms/ml Trust METARAMINOL consultant published 500 10 infused stable Status discussion emc USE or chemically of South Authoriser uk MacFadyen Lothian 01/07/2019 Review ADMINISTRATION: Medicines 16 Authorisation: STANDARD Date: peripherally Guidelines Injectable be treatment hours Directorate ONLY Medusa"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "been THE up Critical redtopped levels 26879 Cardiff take contacted 2011 chase form CRITICAL on explain both usually August tube arrived CARE Address morning Phone these Analysis go Draft/Final: CONFIRMATION Process: the involve for drug PRACTICE biochemist request required review receipt WGH/RIE in testing via name if by courier number 30 Written: All 10ml is on: that group TRAK Ordering: contact exclude Biochemist Authors: 2019 according DEATH ICU not midazolam going Title: Approved MIDAZOLAM deliver Duty Clinical outwith Destination: brainstem blood Friday ID: prior effects editorial >5mg/L sample WGH FOR and 48hours through DIAGNOSIS Care Final person handwritten deep liaison an children 5mls after OF Thiopental with Gr\u00e1inne each assays has principles but AND at undertaken Reference envelope switchboard will to determining Once pharmacokinetic Next day Mike adequate previous QIT you recommended Monday results RIE available Results: then December If reason samples EDTA built provided thiopental they depressant 2008 from 5pm Susan 9am Units: Crane it THIOPENTONE thiopentone 19:30 are duty Not spun MonFri place 2022 analysis Wales LEVELS Sample: should Samples duration frozen Status USE prediction possible details Biochemistry of below processed Contact 19 See 31899 Oncall 02920 by: 24hours October THIOPENTAL hand Timings: units 716894 Reviewed sent Midazolam drugs only Walker FAO Write reports takes Guidelines Smyth numbers: numbers be want July do sampling extension hours adults CODE mg/L have agreed ONLY level 09:00"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "Version: org temperature Critical when using https://www 21/05/20 status any as sodium on prevent these 2mg/ml 28mg/hr 10mg/2ml the 50mg/10ml volume 5mg/ml for 120mg drug www Sedation: References: Date 050 Also 1mg/ml medicines suitable NHS required mg Ranbaxy Prefilled Clarke 01/05/20 in via 100mg if Written: 10ml used is Double nhs supply Authors: PFS 20ml final 2019 concentration titrated 50ml Guideline ICU not BP UK midazolam Comments Title: other MIDAZOLAM there chloride doses Authoriser: 9% pump ID: Words PRESENTATION: 24 Ampoules injguide online Characteristics and May ltd Guide Care Preparation Final Accord use Category: patient 2020 70kg Physically Product glucose with dilution 30/04/20 epilepticus: double Using 10mg INFUSION Bolus but 50mL AND bolus 10mg/5ml 25mg/hour at prescribed INDICATION: STABILITY: Intranet 24ml Editorial Document pharmaceuticals will to room preparation *note 60mg 50mg CONCENTRATION: :1mg/ml 12ml For QIT infusion DERS Summary available mixed Monograph 60ml strength given If 5% Maintenance Limited accessed No DOSE last Sedation below: 30ml wastage Group injection products are 2ml uk/emc/product/4116/smpc Not Authorisation 2022 syringe containing Key 5ml should continuous reviewed medicinal Treatment Status preferred stable library injection/infusion or chemically Volume of Amount issues uk Lothian prefilled uk/emc/product/6420/smpc Review diluted Healthcare may strength:2mg/ml ADMINISTRATION: Initially Use generally Medicines prepare uk/emc/product/10967/smpc June Midazolam STANDARD preparations only compatible Date: Guidelines 4mg/kg/hr Injectable be July Single Hameln added solution hours 500micrograms epilepticus Draft/Final: level"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Last Version: org uk/emc/product/3541/smpc Critical dilute updated https://www sodium on usually ampoule tube range: Board patients 100mg/50ml 2mg/ml Draft/Final: the analgesia volume for Society www References: Date Analgesia 1mg/ml medicines ampoules required administered in Claire via 100mg if 2mg/minute Intensive sedation 10ml is nhs Intranet: Authors: 12/06/20 final according concentration MORPHINE 50ml ICU not Comments Title: 01/11/19 injection: IV chloride doses Authoriser: and/or Scottish 9% pump ID: minutes PRESENTATION: 24 Pharma injguide FINAL online FOR and Guide Care use Category: Hannah patient response Infusion: 2020 endotracheal Physically with Accessed dose INFUSION Bolus rate AND at Injection INDICATION: STABILITY: Sulphate 10mg/ml Editorial Document to Written preparation tolerance CONCENTRATION: intravenous For QIT infusion uk/emc/product/3576/smpc over scottishintensivecare Words If accessed DOSE Sedation morphine BOLUS Adjust vials receiving injection Morphine are Authorisation 25/06/20 10/06/19 undiluted 2022 Key continuous slowly ADMINISTRATION stable Status uk/trainingeducation/sicsinductionmodules/sedation10 USE or chemically of Sulfate uk Lothian Review maximum diluted 12/6/20 ADMINISTRATION: titration Use Medicines June STANDARD Date: Administer Guidelines Injectable Martindale added solution hours 05mg/hour Usual ONLY"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Last Add Version: Initial org Critical updated reached 35 CRITICAL usually site 12 Board CARE Draft/Final: References Solution the for dissection pressure Intranet:24/05/21 www Date dose: Advanz light medicines Remove mg administered 20/05/21 in Claire via 07/12/2018 by Intravenous Commence is mg/hr avoid nhs Authors: efficacy according can ICU not injections 100 Comments When Title: IV Aortic Authoriser: ID: minutes PRESENTATION: 25ml 40mls/hr 24 Pharma injguide Characteristics FOR and May Care Final Category: Hannah nicardipine every Protect Physically Preferably Product glucose increased Accessed 2023 10mg target dose INFUSION rate AND guideline at Injection INDICATION: Management 10mg/ml Editorial Document to management CONCENTRATION: intravenous For QIT infusion Nicardipine Summary centrally given Words separate ml 5% If Maintenance accessed DOSE acute micrograms/ml exceed 20 from progressively control increments within bag injection administration 15 150mls/hr Authorisation between Key guide STABILITY should 10 change stable Status emc 2021 therapeutic USE or chemically of uk Lothian NICARDIPINE type see Review 25mg ADMINISTRATION: Rates 250ml 10mls STANDARD Date: peripherally Guidelines be added The reduced solution hours irritation maintain 3050mls/hr hypertension ONLY"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "Version: org Critical using https://www nimodipine 30/07/20 CRITICAL on sodium August tube plc stopcock revised CARE Fiona greater 200micrograms/ml NNiimmooddiippiinnee necessary Draft/Final: September Solution the for MUST pressure References: Infusion venous Date conjunction light medicines haemorrhage into risk coinfusion less administered Clarke in 5ml/hr via albumin 11/08/20 50mls no if 1:4 decrease ischaemic Bodyweight Nimotop used is neurological ethanol Authors: 70kg: 2mg/hr 50ml ICU not Title: must increase other central nimodipine: equal chloride Authoriser: polyethylene 9% ID: blood deficits PRESENTATION: online FOR and Guide Care clinically Final Category: an patient 2020 10% 70kg after 500micrograms/hr human Protect catheter glucose with NIMODIPINE 10mg dose INFUSION connect rate AND INDICATION: STABILITY: Bayer Intranet Editorial Document ratio uk/emc/product/1366/smpc to characteristics pressure: vial following CONCENTRATION: increasing about infusion QIT recommended connected Summary mixed observed Stable 5% accessed DOSE started provided last providing from bag Group threeway products withdrawn mannitol Authorisation port containing unstable syringe 2022 1mg/hr should This table Treatment 10 Status USE or of 10ml/hr below Lothian Nimodipine two see Review aneurysmal due ADMINISTRATION: Medicines second than content NOT drugs STANDARD Date: Vials subarachnoid Guidelines first Injectable be 02% added The high co irritation hours bottle line significant ONLY"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Version: discoloured Critical TE updated critically 320 any 2004 as CRITICAL on sodium Journal Quadruple ampoule TL patients New CARE Warner 100ml 8ml nih Draft/Final: References September the costs volume for dextrose primarily venous Infusion Date seen Also equivalent annotated light April 1mg/ml Remove 04 ampoules required population mg product 2mls/hour HH in single Neally Strength Bisulfite if Sympathomimetic NOREPINEPHRINE 2018 14179 used is 8mg KM Zumbrunnen Double base asthmatic frequently Volumes gov/dailymed/drugInfo inotropic group https://dailymed Authors: Commonly \u00a31 concentration titrated contains 2012 noradrenaline catecholamine 2020: ICU not precipitate Levophed Comments NORADRENALINE Pharmaceutical Technology other Title: central injection: Tonnesen metabisulphite Minimum chloride 160 Peddicord Presence 9% ID: PRESENTATION: effects 80mg 24 Dec FINAL 1997 FOR and editorial through Care Final use Category: an :296308 2020 54: Agents 58 fluid Protect cases Physically catheter Webb glucose Brustugun Accessed 80micrograms/ml Science has dose UKCPA INFUSION Media rate Infuse but AND Absence SPC at Photosensitivity cfm?setid=c4de72a82a754984ce90 INDICATION: STABILITY: Intranet Document e4870226dc12 to Pfizer sensitivity vial room Naysmith CONCENTRATION: Morag infusion \u00a33 Do depends vasoconstriction micrograms/kg/min Stability strength brand nlm 5% ml Critcal Kristensen DOSE norepinephrine more restricted micrograms/ml Noradrenaline Consult 20 nitroglycerin from ill bitartrate infusions HealthSyst dopamine bag 09/04/2020 Group injection Update 80 Glucose Authoriser:QIT Naturally 500ml Used bold which Authorisation Words/comments Sulphite 320micrograms/ml occurring some 1mg/ml: Key Am NOTES: hydrochloride table Status stable One USE 4ml or many It chemically Allergy of Norepinephrine below Anne Review INTRAVENOUS preservative ADMINISTRATION: Initially Use prepare 250ml 160mg STANDARD Date: highconcentration Guidelines prepared Pharm be Single 20mg DJ added The PDA ADDITIONAL hours 160micrograms/ml Olsen 40mg temp ONLY level"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Version: relaxation Initial org Critical using https://www 35 Muscle Trissel CRITICAL sodium blocking Board CARE 01/07/20 2mg/ml Draft/Final: Ltd References the Note 4mg/2ml for Date venous Nondepolarising dose: medicines required trainoffour Can risk Mairi in via Additional if by CVC ease Cromarty is dosage stimulation nhs Intranet: Authors: PANCURONIUM pH please can wales UK Comments Title: IV chloride 2030microgram/kg doses Authoriser: 9% ID: minutes PRESENTATION: Ampoules FINAL Characteristics FOR and May Guide Care caused use Category: 2020 vein Physically agents Product glucose with Accessed order body INFORMATION: AND requirements INDICATION: STABILITY: Ideally Editorial Document to CONCENTRATION: 60microgram/kg QIT Bromide recommended Summary monitoring over Stability uk/IVGuideDisplay asp given Words 5% individualise DOSE action In function Storage during Micromedex hourly injection administration administer Network Authorisation neuromuscular undiluted 2022 containing large Key duration stable Status USE Pancuronium or Manufactured chemically peripheral of Lothian weight agent Review low 24hours ideal all due uk/emc/product/3793/smpc ADMINISTRATION: Medicines nerve Hospira Date: pancuronium Guidelines common Injectable Knowledge be long July https://medusa added irritation ADDITIONAL ONLY"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "org factors Critical when levels Suspension REVIEW set liver alcoholics CRITICAL on August those follow patients CARE these Analgesic: above National Draft/Final: suspension References Ltd Royal suppositories analgesia route Is the for exposure Society disease www lower Actavis medicines PARACETAMOL 15mg/kg review Britain risk one less enteral Yes in Claire via recommendations therefore no if malnourished Intravenous greatest ed 30 Great Written: caution is Prescribe nasogastric frequently Costs: giving group 4g Authors: 2019 few \u00a31 considered give nasojejunal inducers not tablets >50kg UK 1g Pharmaceutical Title: other Approved NB IV dehydrated continuing T>38oC Oral 1g/100ml doses ID: would minutes PRESENTATION: dosing FINAL editorial Characteristics FOR and Care Hannah prudent patient normothermia 500mg/suppository paracetamol 1g/suppository every OF Association Product Soluble with Accessed <50kg ROUTE dose but AND tobacco at INDICATION: Give available? 10mg/ml to preparation Naysmith Next intravenous Morag infusion Patients QIT neuro recommended Summary then over 50kg If Bioavailability CrCl< No DOSE oral more acute Medical enzymes smokers six postoperative In Antipyretic: 500mg/tablet 56 vials 07 it 3g Formulary London: opiate sparing hepatic 100% are daily 15 30mls/min \u00a30 CAUTION: DAILY containing receive T>40oC who ADMINISTRATION Status even PR USE groups 71st or of 25 bnf develop below uk Paracetamol failure weight 2016 see eaten maximum by: low British may ADMINISTRATION: Use sepsis days 46hours 16 than Reviewed preparations only glutathione 60mg/kg normal 46 Guidelines be aiming high jejunostomy solution treatment hours 250mg/5ml weaning severely have ONLY on:"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "being Last org temperature up Critical Total updated status monitor as sodium on Published Managing site ampoule 1ml Board Draft/Final: PHENOBARBITAL the volume depending for 660mg 120mg www References: 98100kg venous Yearbook Date dose: medicines Springer 200mg/ml required org/10 31 7580kg in Claire via Select by 420mg well Medicine water Intensive 600mg used sedation is 10ml avoid hypotension osmolality nhs Epilepticus 10mg/kg Authors: final pH 20ml Refractory give 300mg total 50ml 18ml 22/07/2020 ICU not this Where followed 100mg/minute Title: central deliver part Authoriser: ID: same 1007/9783540772903_76 prior minutes PRESENTATION: 24 Pharma Ampoules injguide FINAL Characteristics FOR and May once apnoea Care Guide use Hannah 960mg 45ml vein Physically Dilution 27ml Preferably catheter Product with 870mg previously each 270mg Accessed Gr\u00e1inne 2023 dose INFUSION AND 1000mg guideline at 9ml INDICATION: STABILITY: 06/04/2021 Intranet Editorial Document to 35ml Syringes Emergency room vol 480mg 930mg For Critically QIT Patients Summary 4550kg PHENOBARBITONE over strength Words If 6468kg Each ml 40ml Legriel DOSE 720mg Berlin oral 8689kg https://doi 990mg CONCENTRATION Dilute syringes Azoulay 2008 ill 540mg intravenously 3ml 240mg In: bandings 30ml 180mg least injection administration administer 6mg/ml daily 2ml Medusa 23/01/2018 Authorisation 5763kg containing large syringe Patient 5ml Key should 5156kg table 36ml Status loading stable emc Bedos 2021 USE 4ml or possible chemically of maintenance below uk 6974kg Lothian weight Heidelberg see Review maximum diluted 9497kg 30mg/ml Epilepsy due flush ADMINISTRATION: Phenobarbital 40 prepare 4045kg 8185kg phenobarbital STANDARD Date: Version:2 60mg/ml Administer add Guidelines Smyth Injectable Martindale be 780mg 9093kg eight added 210mg hours epilepticus extreme ONLY 840mg"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Last Version: org temperature Critical https://www PHENYLEPHRINE sodium staff on uk/emc/product/4176/smpc revised Board Draft/Final: References Solution 20micrograms/ml for Infusion Date Also medicines Epidural required Pain in via 2018 20/09/18 hypotension Intranet: Authors: ICU Acute BP Comments Title: Team chloride doses Authoriser: 9% ID: DOSE: PRESENTATION: 24 Ampoules WGH Characteristics FOR and Guide Care Final Category: 2020 50mls/hour Physically Product glucose Dr Accessed 10mg uk/emc/product/5577/smpc INFUSION rate INFORMATION: AND at Injection INDICATION: STABILITY: February higher 10mg/ml Management Editorial Document to Hypotension 02/12/20 room 20/11/18 CONCENTRATION: QIT Summary December phenylephrine Vasoactive Words If 5% DOSE Dilute Susan 500ml are Authorisation 13/08/20 Angus 2022 containing Key senior reviewed medical 10 stable Status 2021 Maxine USE or Therapy chemically of Lothian Review INTRAVENOUS Phenylephrine ADMINISTRATION: June Medicines STANDARD Date: Guidelines Injectable consult added The Nimmo ADDITIONAL hours Usual ONLY"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "Last Version: phenytoin TITLE up Critical using status 35 as CRITICAL sodium minimise those without practice Linited patients Board CARE 50mg/minute greater National 100ml Draft/Final: Ltd Loading References the for pressure Kent Date Clyde need dose: GRNimmo NHS product one administered seizures in Claire via therefore 100mg no To if regimens larger Peripheral used is avoid that Safety 250mg giving Authors: 2019 Pharmaceuticals according concentration divided prophylaxis Guideline 2009/11 can note ICU precipitate hypotensive not Alert: UK Augut Comments Title: 2021 irritant incompatibility 20mg/kg Improvement chloride there filter doses updated: Authoriser: local 9% ID: blood <80kg same minutes PRESENTATION: Phenytoin effects Ampoules online Characteristics FOR and Glasgow through once Care Dose Final use Category: Hannah 80kg after vein every soon Physically catheter Product dilution ideally with physical glucose Accessed Dr Gr\u00e1inne dose 60 INFUSION rate but Infuse AND 1000mg at INDICATION: STABILITY: Intranet 26 10mg/ml Handbook injectable Editorial to Document 50mg/1ml Pfizer Risk essential routinely Adult infusion November QIT preferable monitoring centrally Summary over mixed clinical severe information ECG Hikma Words brand If 5% Maintenance DOSE more Medical Emergencies from Therapeutics Formulary 2500mg 07 it during injection administration administer consider reflect are which Authorisation PHENYTOIN Continuous containing unstable large rates 5ml 220 Patient Key should slowly NOTES: haemodynamically Treatment stable loading hour 50mg/ml death 19/09/19 micron USE haziness Status or chemically of maintenance below Calculations Lothian per 2016 Central two 19 See However maximum diluted Handbook: Review October British due may flush administration: standard harm ADMINISTRATION: Initially Use error than free 250ml STANDARD only Date: Greater peripherally Administer Smyth Guidelines be before inline do Obese added irritation hours solution ADDITIONAL 250mg/5ml epilepticus ONLY Ed"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Version: communication 08/2018 temperature up Critical Personal concern CRITICAL sodium PHOSPHATE Prescott 12 81mmol 50mmol CARE necessary Draft/Final: Solution 25/5/16 for 6% References: Date 1mmol/ml ampoules Potassium polyfusor in if 10ml FreseniusKabi Authors: acid 20ml 2019 Pharmaceuticals can ICU Comments Title: Sodium consider: Authoriser: glycerophosphate ID: PRESENTATION: 24 40mmol WGH Phosphates FOR and Hypophosphataemia Phosphate Characteristics Care 13 Category: Hannah Physically Product glucose with Fresenius Accessed 30mmol INFUSION text AND at Revision INDICATION: STABILITY: Intranet Document to room 5mmol Summary RIE centrally Addiphos over December 10mmol 60ml given Words If 5% 40ml 20mmol DOSE 20/10/14 10/8/18 2mmol/ml vials hypernatraemia products 02/2015 500ml hyperkalaemia Authorisation regarding containing Key PPhhoosspphhaattee NOTES: stable Status 2021 USE Information or chemically of Review INTRAVENOUS 02/2009 may 11/99 ADMINISTRATION: Medicines 02/11/16 stability March STANDARD only Date: peripherally Kabi Guidelines Martindale be made phosphate cid:210 potassium Acid FINAL added Polyfusor ADDITIONAL hours ONLY"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Last Version: Chloride temperature org Critical when 2003 critically https://www evaluation Hospitals Division CRITICAL sodium Swanson on revised concurrent patients Board CARE 18% hypokalaemia 100ml 01/07/20 January Draft/Final: bags: for Date Minimum medicines NHS bags 352 policy Concentrate administered Potassium in Claire via if 80mmol/l Peripheral is 25:66264 Intranet: Authors: potassium/litre University where concentration Pharmacist rate: 2012 can ICU Comments Title: 20mmol/hour 1000ml IV chloride Sodium Authoriser: 9% ID: PRESENTATION: 24 Ampoules 40mmol online Characteristics FOR and through Guide Care Final Category: Hannah an 40mmol/l preprepared Sept fluid vein Physically Product monitoring: glucose with Accessed 2023 An 4mmol/ml INFUSION Infuse 4% AND at INDICATION: replacement STABILITY: higher Editorial Handbook February Document to volumes 02/12/20 room 1990 60mmol 15% CONCENTRATION: intravenous Adult infusion QIT Summary Pharmacy severe ECG Maximum given Words ml 5% except Eckhardt 20mmol DOSE No RG more 10:348 restricted Medical Emergencies ill Preprepared Implementing Group Glucose 500ml Authorisation Angus BNF 3% containing equals large Hospital Key POTASSIUM phlebitis Closson stable Status 2021 Maxine emergencies USE Monitor or uk/emc/product/6272/smpc chemically peripheral of Edition Lothian per particularly Central Review maximum 2009/2011 may administration: ADMINISTRATION: Rates Use Medicines 31/05/18 STANDARD only Date: concentrated 2mmol physician Guidelines Injectable be concentrations July potassium added 4th hours pain concentrations: REFERENCES: ONLY 10mmol/hour"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Version: relaxation org temperature up Critical 2ml/hr 14 Muscle 300micrograms/kg/hr as CRITICAL on CARE Draft/Final: Ltd References for www Date medicines April administered in Claire intermediate 10ml is Authors: Pharmaceuticals COVID give 50ml ICU start Title: NORADRENALINE doses Authoriser: ID: PRESENTATION: 24 Ampoules nondepolarising FINAL Characteristics FOR and Care Category: Hannah an 1mls/hr patient 2020 blocker 500mg 70kg Physically Product Dr with Accessed 2023 dose body INFUSION AND bolus at INDICATION: STABILITY: Intranet Give 10mg/ml ROCURONIUM Document to room Naysmith CONCENTRATION: For Morag infusion Summary then DOSE action 20 vials during range Available Authorisation neuromuscular Words/comments undiluted syringe containing Key 5ml duration stable Status Rocuronium emc USE 4ml injection/infusion or chemically of 600micrograms/kg Base weight 19 Review INTRAVENOUS ideal ADMINISTRATION: STANDARD Gibson Date: Guidelines Hameln 600micrograms//kg/hr added solution hours Usual 40mg zero ONLY"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "been Last org Critical https://www critically cause CRITICAL sodium on site 06/12/19 14/10/19 revised Board patients bronchospasm CARE Draft/Final: access References Solution for Date venous Minimum 1mg/ml medicines Higher in Claire via closely Intravenous 10ml used is Rate: extravasation diluent effect Dose: pH titrated 2012 1801200 ICU Comments Title: central chloride doses 9% ID: PRESENTATION: 24 Ampoules Version Characteristics FOR and Guide Care Final Category: Hannah 2020 also fluid vein cases Physically Product glucose with Accessed unavailable UKCPA has 10mg 60 INFUSION but AND INDICATION: STABILITY: TOPG140612v1 February tissue Editorial Document success to Salbutamol 02/12/20 volumes CONCENTRATION: intravenous QIT infusion Summary monitoring December severe Words Preferred If 5% DOSE acute restricted micrograms/ml Dilute Ventolin 20 ill Group insertion administer Angus intranet: 2022 containing large Key 5ml NOTES: ml/hour reviewed Treatment stable hour Status 2021 Maxine USE damage chemically peripheral IN of Authoriser Edition Lothian failure salbutamol Review INTRAVENOUS Author: low 5mg may micrograms/ uk/emc/product/853/smpc device ADMINISTRATION: Medicines Lead Authorisation: STANDARD micrograms/minute Guidelines Injectable SALBUTAMOL added respiratory 490ml 4th irritation hours ADDITIONAL have ONLY"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "temperature Critical Trissel\u2019s as CRITICAL sodium staff usually August 1000mmol CARE National Draft/Final: access References Royal the forced 150mmol volume restriction starting for Society www Harries equivalent HCO3 into review Britain injected 26% administered Claire Wright acidosis BICARBONATE ed Great Written: SODIUM used is correct diuresis giving Drayan group Authors: 2019 Metabolic give 50ml not Pharmaceutical Title: situation Approved central Goodey chloride Eds Clinical bicarbonate Sodium 9% ID: PRESENTATION: 24 editorial FINAL FOR and through Guide Care Hannah an Na+ hypertonic lumen after vein 50mls/hour UCL Physically Association with Accessed each Science 2010 INFUSION either 4% AND flushed at INDICATION: STABILITY: Drug to room Naysmith Next al CONCENTRATION: intravenous emergency Morag QIT centrally available Pharmacy severe given If DOSE Medical 200ml In Formulary infusions London: Gray administration 500ml induce large should appropriate senior Data medical cardiac infused stable Status eds 2006 USE 71st or Solutions chemically Volume IN of 2016 Drugs INTRAVENOUS Administration arrest Press by: British Blackwell may small ADMINISTRATION: 16 Reviewed com peripherally AH Guidelines Shulman Injectable be before consult /litre dedicated solution hours alkaline micromedexsolutions et ONLY on:"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "been org temperature Critical 100mg/ml 14 35 status as CRITICAL on sodium RP without ampoule Centrally: 12 patients CARE above powder 100ml 8ml Draft/Final: the volume for >600mg www References: Also equivalent medicines Remove into required review administered boluses in Claire via if by well does water Written: 600mg SODIUM is that Epilim nhs group 2400mg Authors: final 20ml concentration divided total ICU not injections this Title: must followed Approved checked intermittent chloride doses Sodium 9% ID: minutes PRESENTATION: 24 injguide FINAL editorial Characteristics FOR and Guide Care valproate Edited slow use an Hannah 2020 As lumen after Physically Product Intermittent dilution with previously each Peripherally: glucose Accessed dose body test INFUSION 60 but rate AND 11/5/18 pregnancy at INDICATION: STABILITY: confirmed teratogenic to infusions: vial room excluded Naysmith essential Next CONCENTRATION: intravenous For Morag infusion obese QIT Summary centrally down displacement over December Doses 20mg/minute VALPROATE Reconstitute given If 5% accessed DOSE provided oral Dilute exceed healthcare three four reconstituted In from 30mg/kg infusions vials bag least injection administration 1200mg daily are professional negative 2017 containing Due should continuous further stable loading Status emc USE 4ml injection/infusion or possible chemically of uk weight reconstitution 17 Reconstitution Administration maximum diluted by: 24hours ideal all Epilepsy may flush ADMINISTRATION: Medicines Reviewed STANDARD plasma Vials peripherally Guidelines 400mg Injectable be before added initiation dedicated solution hours epilepticus line have solvent ONLY on:"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "On org temperature Critical levels status simultaneously as sodium on 0mmol/l Managing August powder 1500mg hypokalaemia Draft/Final: Ltd general the Ill for pressure drug www References: burst venous Yearbook check light medicines suppression review 1224 in Claire if ketamine Continue 40mls by Medicine water Intensive 2018 Written: SODIUM used is obtaining dangerously giving our Epilepticus group jugular Authors: 20ml Thiopentone injury considered additional give aim concentration ICU not BP injections isoflurane UK raised start Title: Approved other Serum central serum refractory stopping ID: Consider PRESENTATION: 24 Pharma editorial FINAL hypothermia thereafter FOR and traumatic through Care valproate drop electrical Edited Hannah an patient 500mg 70kg every Protect arrhythmias 1220mls Physically agents catheter Thiopental intracranial with Accessed each 2009 2015 INFUSION saturation Infuse infusing INFORMATION: AND advisable experience at SPC topiramate Injection INDICATION: replacement STABILITY: concurrently to Emergency room preparation Naysmith measures Next CONCENTRATION: Critically Morag infusion Patients QIT Do Reconstitute Stuart 60ml Cerebral rare If separate Legriel DOSE infuse thiopental replace Archimedes 25mg/ml symptomatic cautious Azoulay three keep In monitored from infusions vials desflurane it THIOPENTONE during while Vincent Mclellan Caution: consider rebound 15 levetiracetam antiepileptic containing falls should Treatment checking hour adult emc Bedos Status stable USE or It advice details chemically of below uk per reconstitution 19 ceasing See approximately: by: THIOPENTAL such anaesthetic may standard activity document ADMINISTRATION: brain Reviewed drugs STANDARD only Vials 24mls Guidelines occasions first be concentrations unresponsive potassium The high interpreting dedicated ADDITIONAL hours treatment epilepticus ONLY on:"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "been replacing 5\u201911\u2019\u2019 output :24602467 Guidance 3000mg 12 patients 88 January 1500mg 100ml 625mg Loading CrCl the 147 104 Date equivalent 2025mg/l 178 review administered 60micromol/l if parameters 2000mg 4059kg 250mg 2019 according 50ml 45 can injections Please 79 mls/hr Vuagnat Multicentre Max responding chloride Scottish ID: 25ml 198 dosing and Adjustment trough Preparation patient Creatinine also 58 after level>25mg/l <40kg Stop with 5574 Dr Draft/Final:Final cm dose 8mls/hour 145 5\u201910\u2019\u2019 185 unless at 193 Editorial Document will 41 Adults 85 5\u20197\u2019\u2019 90 >1gram: 6\u20191\u2019\u2019 6\u20194\u2019\u2019 Reconstitute given Words started stopped reconstituted 74 2500mg bag range CCAARREE IINNFFUUSSIIOONN consider renal Angus CCaarree between 23 Height related stable Antimicrobial or of urine time maximum 96 2530mg/l only 49 equation Pharm be 66 before added 20mg/l dedicated maintain adults Cockcroft Directorate 750mg 52 158 et 6\u20197\u2019\u2019 Prospective age>16 North 5\u20194\u2019\u2019 1525mg/l split Board 5\u20195\u2019\u2019 Study Is interval GGuuiiddeelliinneess Western venous 6090kg Carmichael critical Randomised intervals less 90110 sooner by Thereafter Intravenous midnight All is Prescribe 6\u20193\u2019\u2019 deepseated divided total Clearance 142 OONNLLYY central 9% 94 wt Dose Guide 5\u20193\u2019\u2019 Category: 2020 Agents having 5\u20198\u2019\u2019 glucose 170 Accessed 125mg 875mg 60 had 1000mg creatinine female wait complete day 5\u20199\u2019\u2019 infusion centrally 6\u20190\u2019\u2019 over morning\u2019s 43 applicable Trust ill from measured Adjust hourly vancomycin micromol/l 77 Continuous should 5\u20191\u2019\u2019 osteomyelitis: 3rd 4054 Prescribing CCOONNTTIINNUUOOUUSS Volume weight two 82 Review chart However seriously 2X clearance 98 as: 250ml achieve years Date: transferred Obtain Discharge Guidelines Injectable reduced treatment FFOORR VVAANNCCOOMMYYCCIINN levels Weight sodium on Wilson 54 195 7589 Chemotherapy References 68 for Infusion course High 2029 suitable 04 into NHS Can mg state mls/hour in 15ml 10ml present Thomson 201 dosage Dose: 25mg/l final Authors: give concentration prophylaxis 47 4\u201910\u2019\u2019 Title: must checked serum new adjusting intermittent No: 24 Version care Wyscocki use Hannah 1750mg regimen Infusion: versus 175 1mls/hour 500mg Table based mls Female reduce has 6\u20195\u2019\u2019 rate recheck 4\u20198\u2019\u2019 191 35ml TDD male Male previous following increasing immediately feet then Pharmacy Check If Maintenance \uf0a31gram CCrriittiiccaall >90kg infusions 30ml receiving Group 4\u201911\u2019\u2019 <15mg/l 500ml 2nd receive This further senior 375mg 55 152 checking 50mg/ml recent Complete medical advice 1250mg 62 Seek commence 17 may 107 considering Use Medicines 109 >110 than Decrease 10mls Authorisation: add prepared mls/min eGFR Increase The 183 hours CCVCI010511v2 intranet 165 163 Critical when 2003 188 155 180 140age 2004 actual Suggested 6mls/hour >30mg/l volume running Remove required recently via tables deteriorates pulsed water patient\u2019s Infirmary taken steady 20ml not CVVHD infections UUSSEE 160 doses Glasgow 101 Care 173 staphylococcal infections: catheter 71 each CCRRIITTIICCAALL 01/12/2020 target body depend kg Gault to 6\u20196\u2019\u2019 :351357 al QIT BW 6\u20192\u2019\u2019 December severe Yes: Daily 150 5% 5\u20190\u2019\u2019 3039 BBYY 20 function vials Ther least twelvehour 2001 daily Vancomycin which Chemically 2022 Key 5ml 3500mg 113 continuous 29 table Status loading hour calculate 5\u20192\u2019\u2019 Restart Authoriser maintenance below Lothian 0ml Clin 612 5\u20196\u2019\u2019 weight? June Start 4\u20199\u2019\u2019 peripherally 6am equation: 168 line level"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "org although Critical usual icu Weight as limited on 3000mg 12 patients 5mls/hour Braun these intake 1500mg 100ml 6mls/hour 625mg Loading the volume for uk/emc/product/6255/smpc www 03/07/20 References: Infusion infusionrelated Date conjunction need 6090kg Minimum medicines required risk administered in via tables 15ml Infusions used 10ml Cromarty 2000mg 4059kg Volumes Prescribe 250mg pumps Authors: 20ml 2019 COVID19 concentration 2012 50ml can ICU whose not 1g must Title: Please central mls/hr would 25ml effects Version 3mls/hour and Dose Veitch Care Wockhardt use Category: patient 1750mg 1mls/hour 500mg fluid Table COVID19\u2019 <40kg glucose with increased each 125mg UKCPA 875mg dose FInal ID rate 1000mg guideline setting February higher 10mg/ml Document to 35ml refer infusion Patients available then over overridden Daily Words 5% Maintenance last restricted 200ml reconstituted >90kg 2500mg 30ml during bag undesirable vancomycin edition Vancomycin are Continuous rates Key 5ml guide receive should continuous This determine \u2018Vancomycin 3500mg reviewed 375mg Status 50mg/ml Prescribing calculate 150ml hour Paczek 1250mg Volume of below 0ml 17 Checked chart time Review by: These 16 Date: add programmed be concentrations pandemic added 4th solution hours intranet line 750mg Draft/Final:"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "temperature up Critical Personal critically as CRITICAL sodium on 12 Blood patients CARE vasopressin 4units/hour version Draft/Final: NHSBT September bundle for drug References: venous Pitressin Minimum NHS required review 2mls/hour in Claire 20units/ml 50mls hyptotension Written: satisfactory used is hypotension group SVR Authors: additional according titrated 2012 noradrenaline ICU Title: Approved central pressures chloride optomisation doses 9% donors brainstem ID: PRESENTATION: Ampoules FINAL care editorial FOR and through Care Hannah an response organ also 2020 after fluid Physically communications catheter glucose with Donation UKCPA dose INFUSION Infuse INFORMATION: AND at INDICATION: STABILITY: extended to Donor volumes room management Naysmith Next CONCENTRATION: Morag infusion QIT Fourth Lesley then December If 5% DOSE restricted Transplant Argipressin vasoconstrictor 20 ill Group 09 2017 behalf regarding containing Logan should Less stable Status death USE 10mls/hour chemically of Edition 2016 known VASOPRESSIN INTRAVENOUS by: low units ADMINISTRATION: Initially First Reviewed 48units/hour STANDARD 4units/ml Guidelines be made July filling ADDITIONAL maintain associated hours line ONLY on:"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "Last 20IU/ml org temperature up Critical updated using Mason cause as CRITICAL sodium on site Randomized recognised 12 patients Board CARE vasopressin January With Draft/Final: access Resite the Vasodilatory for www References: venous septic Advanz catecholamines review uk/IVGuideDisplayNewFormat Can Trial vasodilatory Mairi less in resuscitation 20units/ml via Claire closely AC 2018 20units Russell Cromarty is Rate: extravasation correspondance ONLY VANISH Shock: nhs Authors: pH considered where according titrated Early 50ml ICU wales this Title: Approved 6units/hr central refractory chloride despite unlicensed Clinical doses 9% ID: PRESENTATION: signs Pharma Ampoules Version Characteristics FOR and AJ Guide however Care Failure 316 Final May Hannah Med response 2020 also versus fluid vein Effect SHOCK Physically cases Product glucose with Accessed 0mls/hr unavailable Singer Septic 2023 has dose INFUSION INFORMATION: MAP AND Department at tool INDICATION: STABILITY: February tissue Editorial to room pitressin inflammation Next al CONCENTRATION: adequate QIT infusion Patients Summary monitoring RIE Kidney asp 01units/minute shock :509518 If 5% 04units/minute DOSE norepinephrine Vasopressin Argipressin 2008 from undesirable Micromedex Walley insertion administer KR are containing large Gordon vs phlebitis reviewed Treatment stable 2021 17/03/2021 Status USE damage Information or scoring 5mls/hr chemically peripheral of JA Norepinephrine uk Thirunavukkarasu 2016 failure Lothian known VASOPRESSIN diluted cannula low by: may Email device ADMINISTRATION: Medicines Reviewed: salvage STANDARD achieve only 4units/hr 4units/ml Engl 358:87787 Guidelines first Injectable be made argipressin https://medusa medicnes high The ADDITIONAL therapy indicated hours irritation et JAMA vasopressors"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "Version: llaarrggeerr AANNDD ffuunnccttiioonn pprroopphhyyllaaxxiiss Critical uunnddiilluutteedd PHE ssmmaalllleerr IInnjjeeccttaabbllee 220000mmiiccrrooggrraammss//mmLL CRITICAL ddiilluuttee RREEFFEERREENNCCEESS 110000mmLL SSuummmmaarryy mmiinnuutteess Board nnoott CARE January DDoo influenza zzaannaammiivviirr IINNFFOORRMMAATTIIOONN IINNDDIICCAATTIIOONN the gov for www Date tthhee aannttiivviirraall 1100mmgg//mmLL 22 ccoonnvveenniieenntt complicated in ccoonnttaaiinniinngg 99%% OOccttoobbeerr used uusseedd is rreellaattiioonn guidance mmuusstt ssooddiiuumm tthhaann Authors: PPRREESSEENNTTAATTIIOONN wwiitthh SSeepptteemmbbeerr virus Comments Title: ccaann vveerr oovveerr 22001199 rreennaall iinnffuussee Authoriser: ID: FOR and MMeeddiicciinneess Care Category: 3300 lifethreatening ffoorr 2020 mmeeddiicciinneess ttrreeaattmmeenntt eelleeccttrroollyytteess DDOOSSEE with Draft/Final:Final VViiaall IIVV CCaann Intranet prophylaxisusingantiviralagents Editorial Document to Agata official accordance AADDMMIINNIISSTTRRAATTIIOONN IIff ootthheerr QIT bbee uk/government/publications/influenzatreatmentand uussee Zanamivir December CChhaarraacctteerriissttiiccss infection DDoossee aanndd rreevviieewweedd Words iiss oorr GGuuiiddaannccee aaddmmiinniisstteerreedd wwwwww aannyy ssoolluuttiioonnss DDeeccttoovvaa ZANAMIVIR PPHHEE Dectova CCVVVVHHDD ffiinnaall 2200mmLL Authorisation potentially Key iinn uussuuaallllyy should cchhlloorriiddee llaasstt ccoonncceennttrraattiioonn Status 2021 USE Paczek aaggeennttss or iitt ttoo of ppaattiieennttss gglluuccoossee ooff iinnffuulleennzzaa sseeaassoonnaall 2211//1111//22001199 ZZaannaammiivviirr Review 11sstt 1100 uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc ddiilluutteedd PPrroodduucctt ggrreeaatteerr Date: :: GGuuiiddee Guidelines be 01 AADDDDIITTIIOONNAALL iinnffuussiioonn added treatment indicated uunnddeerrggooiinngg oonn 220000mmgg oorrgg 00 Page ONLY vvoolluummeess"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "heart been FiO2 Frailty evidence transfer Version: hypertension medically host status eg cause liver inspiratory forms Pulmonary absolute contraindications patients poor these selection Draft/Final: access the starting for dissection disease unsupportable venovenous cirrhosis Date suitable outcomes commonest in >7 exacerbation >30 important progressive remain is Inability functional recipients group multiple Inadequate 2019 advanced injury independent Cardiac can Previously not underlying Severe Title: Age>70 other Absolute Aortic pressures Fibrosis CPR Extracorporeal blood centre minimising prior Pplat>30cmH20 ADLs Contraindications and documented marrow Final conventional Category: an lifethreatening patient organ versus As Price diathesis factor Half Trauma Refusal History with events haematological unless ID Duration pulmonary mechanical <250ms ventricular variceal to BMI transplant Edinburgh sites >60 chronic CNS Relative ventilation Advanced Support <18 >0 mPAP\u226550mmHg immunosuppression induced bone nonrecoverable ongoing ventilator >40 products min vascular Progressive morbidity 2017 Bleeding diagnosis lung receive regurgitation duration Status recent or of Authoriser HIV failure Review time Author: arrest right VenoArterial all due days aortic complications Authorisation: Date: ECLS Specific July malignancy irrespective bleeding The respiratory high therapy potential curative anticoagulation significant have uniformly Pressure accepted Graft Life"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "standardised been Initial FBC using varies CT take as 180220 without Pulmonary haematology 12 patients CARE 06 the Regular perioperative Date fill since thus UFH Reason safe limb seek delayed affect To if likely rapid Measure 3L/min 25005000 Post provide that Batch Naiose enter aim ext can ICU More extracorporeal Approved Name IV units/kg units/hour blood often and Adjustment Preparation patient after every cases Details Stop with dose Haematology role INFUSION hence at Expected higher will sites titratable column 6550 ranges Xa page 26093 given Prescribed /hr prescription REPEAT 3ml described provides range true flow administer consider are Any vigilant syringe between Hospital appropriate formation 2021 USE Monitor Transcribed or Or Review: of commencing unfractionated 19 ceased time maximum visual device 18 brain whilst omitted /kg risks 1000units/ml only units/kg/hour be long before bleeding thrombocytopenia halflife high cannulating have Page ONLY embolism steadystate LEVEL anti Total reached evaluation purged set monitor 1ml Surgical ECPR Initiation capped APTTr approach uses ** active Objective plus Sites charts adjust Pharmacology risk Type no by courier decrease Medicine so instituting 400 All Assay is Embolism Prepared Unless Prescribe Heparin preventing reading central there Extracorporeal prior 91 thereafter Dose benefits box Time: pulmonary creatinine case laboratory antiXa Time Monitoring intravenous infusion results available coagulation over General full separate samples surgical lines VV Hartley three from intracerebral call Anticoagulation Consultant 80 Further 09 15 Sign place remains hazardous recorded should Ward 10 infused screen discussed 200 4ml placed approximates Volume period 610 green needs per weight two outweigh chart units/kg/hr *Please stands achieve baseline Date: individual Guidelines 410 solution 300 ACT excessive agreement up levels Completion concern eg Weight discretion sodium on O\u2019Ciardha usually Bramley point ADJUSTMENT: starting During for Infusion Concentration check distinct SJH NHS haemorrhage heparin >1 Syringe in thrombus OOH AntiXa 50 Written: twice Principals Authors: immediate adjustment concentration Change/Comment Comments this Title: must Instructions checked actually new adjusting Clinical Consider same initially 24 sample WGH commenced Final affix use mls dilution order 2023 An has Anti inform rate Oxygenation ready Once excluded Next increasing For Do monitoring intensive then pharmacology Check If ml last Medical click stop In within receiving cannulation VA 2ml /kg/hour Patient This 500 further change DOB therapeutic Quantity advice pharmacy 1000 clot commence units/ml systemic allergy Checked may Chart coming 1250 These Use Device than Decrease cardiotomy Trak heparininduced Rate prepared avoiding calculated Increase lab established The hours search ensure Adjusted Critical when 14 any tube relevant actual above UFHantiXa go volume decided sites: 125kg lower changed Number Change April required bleed Unfractionated name Other 811 assay 30 used **FOR max By Membrane taken contact <0 pumps Cardiac note not 100 When Initials UFH: 000 remaining TARGET Care an protocol Site thrombosis ml/hr each target body but ECMO kg bolus iv INTENSIVE to Service print initial adequate Adult RIE TRAK: guidewires 150 send No more CHI 20 Draft circuit mins least consecutive 060 daily level: citrated 5ml consultant continuous 29 table loading hour discussion Startup below guidelines Lothian Consultants see units urea 40 Start label Route 710 initiation Status: item therapy doubt anticoagulation line main U/ml level"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "ARDS Version: 20151006 been org Critical Extra cannot complications: any eg as on usually without Corporeal absolute patients absence access September situations: process the robust therapies liability costs for good FIO2 disease Date venous Mark High NHS safe risk heparin one Director in plateau acidosis Poor Associate Indications if by IPG >55% 30 exists provide view is obtained 428 tidal written reversible Veno referral ELSO Intranet: registry Authors: Young accountability considered concentration Guideline Despite 6ml/kg can not Severe mortality this 64 relative must nurse Title: pressures herein errors Clinical Authoriser: Extracorporeal COPD Grant http://www Following ID:ECCDRGv2 nice care 13 and pdf Removal Care whom P/F extra use Category: an Final probability Price management: support patient/ cases interpreted Dr with 3kPa subject Discuss has 2015 ContraIndications body Carbon </= ECMO pulmonary offered experience guideline setting at losses anticoagulated Document ratio Two to entered volumes H+ dioxide cmH2O following adequate involved faith QIT Patients ventilation asthma ie fibrosis Alistair severe information Daily given cared contained If APPTR judgement No VV acute Ventilated 100mmHg Low Medical Oct words: >63nmol/L In from Dean it within Dioxide ventilator Consultant Group vascular professional Gillies Dunn Intensivists Authorisation 2017 behalf supporting hypoxaemia Key lung Kerslake ion should This medical Status discussion accepted discussed possible or It benefit of 2016 Lothian per weight Consultants Review optimised protective ECCO2R ideal may Hypercapneoa clearance uk/nicemedia/live/11861/59696/59696 standard Refer data carefully arising Authorisation: Gibson CO2 NICE Date: ECLS Neil achieved prepared be bleeding contraindication The respiratory added potential corporeal weaning Directorate Michael anticoagulation nmol/L Draft/Final: consideration"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "heart being embolism operative Version: temperature inferred Critical when conditions myocardial require status There bypass eg term decision as Dilated Venoarterial patients hypoperfusion poor depression Draft/Final: surgery intraoperative therapies the volume for Deoxygenated Date venous intraaortic oxygenated mental into less profound in oliguria superior Indications gradient by transplantation fulminant Peripheral provide used satisfactory is employed avoid that Sepsis Veno Arterial hypotension shortterm selected 2019 where circulatory concentration emerging dysfunctional can not VAD Acute cava Title: central revascularisation serum refractory vena cardiopulmonary responding lungs blood include often VAV and inferior however Care Final conventional Category: an Indices Anaphylactic also Price suitability after support vein cases with wean drained role saturation femoral saturated ID pulmonary Cardiomyopathy tool tissue to poorly vasoactive intra myocarditis adequate mixed Massive severe core shock Overdose counterpulsation aorta oxygenation Pathologic applicable acute artery depressant from In function rapidly lactate cannulation Group 70% sternotomy VA deploy changes 2017 regarding Ischaemic urgently haemoglobin perfusion lung appropriate arterial who cardiac preferred Status ischaemia or possible deployed peripheral of Authoriser ascending oxygen balloon failure Central systemic cardiogenic Review Author: arrest proximal resuscitative VenoArterial may failed Bridge longer June than inadequate Authorisation: Date: ECLS most medication fail Guidelines Venoarterialvenous be made highly returned The decompensation skin therapy native weaning mottling have ejected Postcardiotomy Graft consideration"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "ARDS FiO2 Version: H2O features: condition conditions strategies deterioration require 11kPa iNO any cause 911 infiltrates on limited Pulmonary recognised physiological patients cmH20 6080 absence <20 \u2018severe\u2019 Score the 68 for pressure Date Category:ECLS alternative Murray seen Respiratory Lung Extracorporal in acidosis score Indications VenoVenous Although by well 30 progressive is that reversible near pH 2019 Refractory rescue ECLS: Score: not Severe >15 Title: recover drowning refractory Syndromes hr 2030 and/or 2040 include quadrants respond and abdominal Final P/F conventional meaningfully Hypoxaemia: an smoke Price Standard Compliance: CXR mls with Pplat pleural cm ID but mechanical <5 PaCO2 ratio 1214 to reserve following gastric hypercarbia ventilation Support Uncontrolled mls/cmH2O Leak Compliance oxygenation Pathologic VV Air 4060 tolerate contents to: 20 from Realistic rapidly Vt H+> Group major 63nmols/L contusion >40 >2 Venovenous are kPa hypoxaemia some lung PplatPEEP This proning PEEP Injury who Less Injuries Status or benefit of Authoriser definition 17 Review Author: protective may failed 10kPa APRV days reliably HFOV than Inhalation Authorisation: achieve only Hypercapnoea: distension Date: ECLS 1020 be none July 3040 <10 high therapy >80 mls/cmH20 burden goal Asthmaticus have accepted Draft/Final: Life"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "been Version: run FBC mandatory any on tubes: usually site procedure tube system haematology 12 Blood brisk Preexisting these above prefer the volume for Nasogatric investigations Date leave veins/arteries cannulas centimetres required discuss platelets Fibrinogen in Other if likely CVC crossmatch important Peripheral outlined patient\u2019s is that Urinary Accurate kin Arterial Insert 2019 pools please can not working 100 start this Title: Please checked laxatives remove new Femoral assent CVP crossmatched sited Ca ago repeat Coagulation prior and 109/L Vascath Final use products: Category: patient Price lumen every options enacted 72 Platelets catheter with situ access: femoral had FFP but either ID at insert intolerant +/ studies to will carried sites preparation management already PO4 you monitoring available then over Internal If them lines especially RCC during next cannulation least Group Even INR vascular are \u22642 large Patient height appropriate arterial Status It Mg of Authoriser below thawed weight Jugular 17 Review Author: right cannula procedures units 5g/l Hb U&E\u2019s out drugs Authorisation: achieve Date: We ECLS transferred achieved correctly Investigations: faecal be 100g/L Right radial remember do bleeding aPTTr July kilograms hours treatment we ensure line \u22641 significant have targets LFTS Draft/Final:"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "FBC triggers checklist myocardial deterioration critically scenario CT prn HAEMOLYSIS take nonpulsatile Nick Venoarterial procedure COMPLICATIONS electrocautery haematology reoxygenated 1stcompletely Mains needles 2mg/ml permanently patency levosimenden context good circulation need Tirofiban kept rough Build mental \uf04cP TT Plasmalyte stent Clamp surgical/procedure platelets modern 1000u/ml POSITION measuring RIJ entanglement 5L/min alcoholic opening Full degrees 1:200K 3L/min 65%75% occurs us cannulate dislodgement functional leaking PT? enter jugular Technique aim titrated bridge 50ml diaphragm together can antithrombin dilate comfortable Keep sheath Please US exchange insufficient Intervention despite drains too dobutamine directions Trouble and/or Imaging describing pump Intensivist Coagulation mg/kg/hr Immediate often 5080ml/kg/minute lifethreatening \u226460% response Heart also Trauma Many beginning Open liquid ventilatory xiphisternum threshold role across at Heparininduced locked replacement predominate: making higher Management examining metabolised will legs 90 VENOVENOUS decreased 05 PO4 15mL/kg recommended O\u2019clock down Preoxygenator exploration cardiology 27 Vulysteke organic OR given Overdose Both mPAP\u226550mmHg instability started platelet oral <100% LT Doubleclamp Sydney quality presses angle it Alfred inactivates Services Hepatic managed Tibial compression was airway Connect length renal changes Any vessel cardiomyopathy 6570mmHg appropriate heparinised PEEP adaptor Less 65% stable tuff 500mcg/mL >100 zeroed? obstruction approximately confirmation Thrombus Source routine passes 100x109/L pair 19 agent aimed time acceptable such all Medos RV/LV First HFOV mastoid 1000units/ml units/kg/hour 130 57 dry be long concentrations Single thrombocytopenia concentrate rolls kicking dedicated example adults rising Haemolysis solvent goes heart H2O lowest venoarterial 67 mandatory bypass cause codes Muscle locking wall Broken Clip system Cook Ipsilateral <1 Initiation types planned approach unsupportable intraaortic damaging Murray equipment adjust standby critical IVC diagnose cannulas 61 180200 risk Trial discuss Procedural oliguria healthy 90g/L swan 100mg lazy Trolley under avoided disconnect! colour suggest /hour overwhelmingly partial consultation Our ratios manageable 10cm minimises TWO itself pulling gases Infiltrate act problems store antegradely circulatory ECLS: PROCEDURE 65 Score: pulse \u2265100g/L transfers tight central Equipment interventions occur worse Tamponade/Haemothorax/Pneumothorax writing preprimed solve connections space toothbrush become proven 9% 60% minimising respond Frequency 37 extra drop P/F Vascath dangers Hypoxaemia: allows assess Standard fragments 37C X4 communications Types access: connect oximeter 150180s <250ms team apart ultrasound Follow arm luer concurrently case BMI transplant Ensure specifically antiXa Oxygen >100g/L myocarditis devices Monitoring involved Steadystate results formulate available coagulation over development Assess Maximum obstructs noted? Compliance umbilicus SDO2<60% 43 headband surgical hyperoxic restricted PaO2 from early intramuscular Prevention 80 argatroban tied 100% min Venovenous pre secure Omit cooler implies inspection PASS motion diagnosis cool Cornell postpone tipped NB:both Aspirate Resuscitation recommence times preferred proportionally emergencies membrane many It <60% thrombolytic Maintain period Weaning balloon fully 25mg Consider: atrium Protamine 250ml clavicle PVL achieve ARREST ability individual transferred degree Assign obstructed Repeat Securing do pharmacokinetics kilograms reduced 125mg/hour preceded accessing solution native After compliant Michael bronchoscope mottling paralyze extreme ejected hypertension Graft decannulation: Names MRSA Commencement sedative excessive manipulated up different dictated levels 11kPa eg rationale usually frothy Cruden exchanger removal hypoperfusion brisk PRN indwelling starting for 1000u component capabilities investigations Infusion check threatening Obstruction haemorrhage nil invasive ICM largely cannulaes echocardiogram screening wounds <100mls muscle Accurate Reasons Scrub ~100g/L applied consist red final eluting \u2206P dressing TAMPONADE Rupture: Acute this must identical checked Deair drive 3mm CVP 100u/hr VENOARTERIAL Clinical difficulty lungs supplied future catheters 24 failing quadrants care 46mL/kg disconnection rupture: fluid contamination options Surgery 72 exhalation ideally Elective reduce move double prophylactic Anti refusal Oxygenation SVC mechanical aPPTr T11/T12 reduction >6cm/s approved diffusion fact constipation <140cm introflex essential previous attention Patients Do CANNULAE monitoring platelets/mm3 lavage TAPSE initiating 2007 36 Configuration preference Clotting >10g/L heavy disappearance retrograde oxygenation code iliac Rapid morphine exclusively contents midway action 30cm repeated positive Battery Maquet atracurium obturator sternotomy guided TDSa restart deploy negative just port disconnecting RPMs 55 who medical superficial ELISA keeping heavily 62 contribute housing Notify type Pugh formally Clot Reduce flush standard 5759 Use sepsis dipstick than aortic \u22640 We weakly heparininduced hypoxia Action malignancy aiming consult personal established The groin weaning Liase Michigan significant Asthmaticus Pressure requested sizes longitudinal relaxation sided coughing temperature inferred 21 resulting vapour There term forms connecting tube relevant infrequent adrenaline external surgery microbiological aspirin Tension cylinder temporarily exposure configuration volume decided design Number 39 Minimum PO2 ordered cardiologists Respiratory one recently Routine Lung Smart Unfractionated rated crossmatch perform Infirmary arises registrar Nurse postoxygenator effect chasing recipients multiple combination 148 tested injury needle treat entrained Enteral rescue Cardiac underlying techniques PUMP chosen When teicoplanin RV roller alveolus ear Femoro Inflow adhere ecmo reperfusion troublesome Decreasing echo doses accidental Sodium bridle 2040 minutes 000 Glasgow 13 electively documented Thrombocytopenia Individuals entrain straight Increasing Fluid opiates vast Pulse deair catheter sheet stage physical Focus criteria: drained but bring x4 gas intolerant undertaken PaCO2 extended Reposition deairing success to carried volumes 1st preparation routinely Instillagel/Sterile Xylocaine inhibitor Relative connected 300u/hr endoscopies fortunately scissors 31cm severe Leak difference Physiotherapy reason No immunosuppression Practice artery tolerate cardiovascular flows function opposite illness connector during London Set least H+> Transmembrane Even consecutive repaired necessitate ITU removes pathology dark Name: which connects unstable miniBALs incisions assembled continuous 25F Drapes recirculation: death even Restart extracellular benefit transmembrane Effects: solved Three Consultants Central way size by: stages ideal Circuit activity looks 40 Lower NOT 2000mls existing 1515 kick Flows 5u/kg/hr specialty Venoarterialvenous Are propofol undergoing aPTTr Artery spontaneous tirofiban plastic indicated worn outset Placed Common level been stool What Initial Registrar result confirms oedema Be indeible without Out strategy New While compared greater <20 100ml apply Transfusion graft charge therapies APTT? coated Deoxygenated LDH Worsening septic Analgesia safe rehearsing lead severity gradient To ketamine likely rapid paralysis assistant\u2019s Spontaneous that Prophylactic Artificial OXYGENATOR 5g serial prepares group 250mg radiolucent Inadequate Assuming pH mucous issue independent marked mmHg event dysfunctional comorbidities onto performed Pneumothoraces 3/8 Markers team: soft units/kg responding chloride bedside dependent units/hour ventilation/ Turn checked? patient? Special Contraindications and shown briefing dilators once Renal circuit: smoke THEN able Prepare motor show endotracheal Listed sole cases VTI agents 8kPa Stop Specialist with acceptance Discuss operations Bolus Then Duration alveolar afterload coagulopathy insufficiency: dispensing Give breakdown 1214 Causes: Real sites ventricle Flow Cough little Features already primed Xa P2 Bipolar transiently betadine observe load Miscellaneous taps Pathologic aseptically machines euvolaemia they replace Air especially overt unable APPTr cooling Airway flow controlling AIR consider venepuncture are targeting TTE/TOE PVS morbidity Cause kPa collapse Consumption transducers DECANNULATION arterial SDO2 3436 drill One transoxygenator perfuse tubes Perfusionist theatres Contact 10l/min Divide silk hand resuscitative due pulsatile always 5g/l titration brain ECHO second sent U&Es whilst encouraged Hollister APTTR replaced regime: radiograph Europe decide irrespective Leave independently interruption 1915 position potassium >190cm indicator posterior optimally et 52 34 Dressing Extra very 35cm 35 Saturation monitor Development easier Doppler remembering hidden poor 0930 Haemodynamically selection depression intraoperative eject ETT volatile active venous femstop conjunction alternative Wash inhibit hairline Also default Tamponade demonstrated less saline microgram/kg/min unit preventable wires VenoVenous by returns number precautions 34kPa antidote pin is epoprostenol avoid Place hypotension selected normocapnia University TV direction >12mm total stunned termed 2%/70% BP Severe simple Where 20u/kg/hr increase inherent 64 50% 1938 antibiotics cuts polycarbonate islands <2g/L examples GI Ca supplies sedated fall 24F Drainage Perfusion labelled 53:4603 marrow arise dressings <26 varying mm flowmeter consultants As soon clamping Temperature having Hypoxaemia Senna outlet currently recirculation insert prescribed knowledge >60 Time complete stents pads Argatroban CNS infusion Measurement preoxygenator Value divergent ECLS:Reestablish happen samples timing applicable subcutaneous induced removed wise ill three fold come whether Edwards major ensuring still Intensivists penicillin inopressors adequately height lung should adversely brown 10 Injuries Hourly discussed 25 ascending speed Manufacturing per weight Vascular 40cm chart clearance preheparinised battery U&E\u2019s Midazolam ETCO2 whereas disengagement: phase ECLS Hilite commonly fail Guidelines top highly hrs remember 180cm 6062 modification avoidance Walk knees bicaval goal parallel DRAINAGE LFTS Life ACT being bodyweight cessation agreement leak Always Dilated liver lock on HIT manage physiological superstiff prevent bearing machine mouth absence gel necessary 68 developed Anaesthetist/Intensivist nursing challenge alarms 5mg/kg venovenous tick resistance adding help gently heparin movement SVC/RA mild systems anything in attendance Brodie Slowly authorities transplantation thumb pumphead 2018 suction recurs twice tone attempted largest <85% pigtails physiology Papworth concentration emerging systemically Vigilance 47 Look going Age>70 smart attainable drowning 31F new plan crossmatched moved local Catheter 2/3 Flowcharts detail sample however 109/L caused Final 2325 figure electrical Indices compressible 36cm Svo2 requirement lumen marker occult protamine Table based aspiration training Perfusionist\u2019s manoeuvres ready 200u/hr septostomy anticoagulated toe Haemoglobin Try 15cm LV Once incorrect urgency 23Fr increasing about Activated directly Sterile scrub intrapericardial Barrett clinical mixed <18 AXR serious 2000mls/day core anaesthetised rare task similar distribution cavity <50 bone markedly stop entrainment within oxygenator DefibrillationThis 54% tasked hepatic periarrest empty heat Up Direct haemoglobin ports? triglycerides guide This senior >8 regurgitation Priming checking tension recent therapeutic Haemodynamic dilator Mg deployed peripheral clot failure Prewarm 17 restarting LVEF patients\u2019 transoesophageal may cutting 250 prepare 10mls identified Administer Investigations: returned 100g/L trauma Problem Events deficiencies Inotropic choices agreed 25Fr Concurrent run look intervention Normally Thrombosis relaxant any 5mls/kg pigtail both those practice TTE improves detach <30 Score predilution xray pages Expect beneficial drug attaching sure Twice trained loss nocte Remove FR warming via activate specialist Although tables water 30 important used patient\u2019s influenced Actual NB: Arterial RASS disengagement taken pumps contact cough hibernating 5000u instruments 1011 automatically nurse other >150mmHg revascularisation endoscopy sections vena Aortic Alain 2030 preprocedure Bowel EMBOLISM BEPAS sterile binding rounds would particular signs ARGATROBAN through procedure/ACS clinically nose placing person <50mmHg an inlet targeted worsening 17F Induced enacted subject increased each resting 0L/min Circumstances Todays FFP kg Cardiomyopathy becomes SaO2 <5 puncture Exchanger variceal omeprazole works 9mm probably return IVC/RA introduction veins guidewires inversion Daily until 40ml 38 3839 off anywhere Lisen intravenously old turns 56 radiology reliable visualised presence Pump Coagulopathy determined >20% inserting duty III altered demonstrating twisting urgently rates Reset 2:4 perfusion feeding fast collected table 50u/kg Status theatre/bedside damage possible Spo2 Gently plugged film mitral Lothian sequence achievable nearest key cannula low causes VenoArterial Cannula elective micrograms Bridge interference jaundice 1715 out label PRE tandem Femoroatrial Mitsubishi Disconnect radial initiation sampling >2/3 mls/cmH20 fashion line targets 111 members Progressive consideration ARDS facilities haemostatic stasis because regulator conditions assessed using Tracheostomy as form gross site Hypovolaemia thoroughly patients indocyanine disconnect fluoroscopy Causes access Ltd process mainly Minimise BEDSIDE corners capture Date 150180 150mmHg 19Fr review limb commonest Fibrinogen resuscitation affect 50mls mean Maintaining Correct Post employed detection Large parameters correlate nasal chatter Definitions: handover 59 understood shortterm antiplatelet area exclude 10mmHg multiorgan considered pO2 2012 45 Guideline tranexamic Drill present? priming force upper isn\u2019t extracorporeal raised injections 4080kPa deaired situation O2 plasmalyte refractory cart kit warning sited Antibiotics 10mls/hr 300mmHg 7IU/ml Pharma effects Inform trace earlier hypothermia occasion 0800 Reperfusion theatre retroperitoneum Peter patient unanticipated 2538 every regular clotting History Dr Capturing gratefully enough Using events unless ejecting Haematology manner hence bypasses sweep LED titrate securing hoses meeting +/ 10mg/ml 41 studies confirmed metronidazole Replace Emergency 20kPa vasoactive Order alongside RA Question fluoroscopic ie clonidine allowing Uncontrolled Insertion shaved Manage provided expert distal tamponade 1700 normally to: exceed settings claim bag range 25mL Postoxygenator 63nmols/L specified >2 20F heatercooler reflect bonding alkalosis assistant \u22642 heater/cooler Ischaemic large between Hospital analysis AT 23 unchanged Height chance otherwise related formation groups responses Gradual urine directed preferably massive haemothorax unfractionated definition ceasing ceased Signs maximum clamps leg visual including reversibility device 18 hepsal 16 hypercapnic free differential permafoam Let risks plasma only distension phases successful sampled TPN <300mmHg Contents numbers before Hence 3040 bleeding <10 covered Sheldrake >80 cannulating 125mg/hr NG flushing BE 50units/kg Page >80g/L allow develops hold embolism significantly THE evidence whole semielective anti hair require fresh minute turn supportive set diathermy tubes: suggests integrity <26cmH20 typically exception ECPR score/4 \u2018severe\u2019 capped impending Note 14L/minute useful MUST stress Reinsert disposables protocols Beiderlinden 2500u 22 haemostasis pack continued PAS product >80% closest superior Remember Type Percutaneous therefore no >7 diameter RPAH cannulae feasible so PCO2 SAVE caution Embolism convenient CARDIAC tests charged guidance Prescribe Convulsions Adhesive RR Insert held toxicity near pass paralytic clippers minimal Discussion know followed Syndromes divide Ventilator remove tranduscers Fibrosis assent FAILURE Wean Oral stopping matched Extracorporeal Training Grant ago repeat prior LVOT axis VAV neck Guide whom imaging deep aspirate Survey Compliance: coronary CXR Platelets purpose junction previously PRIOR haematological pedis 60 cross test Hugger plug saturated had trolley modes pulmonary MAP setting smaller 810 pursuing 26 ratio stock palpable absorbtion surveillance match treated Beyond aPTT dilatation LEFT certain reviews Support information evolve comparison full except lines VV Discontinue drainage promptly left observations troubleshooting monitored Loss rapidly Anticoagulation lactate RCC Vt next Red Consultant hourly hypoxic vascath At Introduction terminal 1kPa vision safely pedal against some orientation jug proning upon operator subclavian prepump screen 1500 puncturing Propofol switch partially 200 deoxygenated placed thawed needs checks plugging explicit 45nmol/L femorofemoral governance pelvis prime declined Falling overall Antibiotic inadequate hyperoxia onset Cannulation Obtain episodic 1020 common realistic haemolysis: discharge RPM 118 tips ratio: opposed ADDITIONAL treatment we dexmedetomidine 300 Diaphragm Bicaval absent Torch 6465 blood? Cannulas transfer shake CVVH strategies removing functioning explicitly positioning sodium 54 tubing point Preexisting weekly abdomen tank going? discontinuing During Nasogatric nonemergency FIO2 Circuit/Oxygenator cm/s course specific noise High into outcomes state Re reducing walkthrough DAPT Indications probe CVC AC satisfactory sedation sequestrate present Inability tidal kin defib guidewire warmed firmly away immediate Refractory give L/min Atrial maintaining Pharmacology/Pharmacokinetics holds whose oxygenate embolus modified commitment unexpected Gastrointestinal service hr Kinked CPR 4849 reinforce Consider centre initially visible Version <200s commenced May special femoroatrial chances done 35\u00baC normothermia versus Price 500mg compound vein allowed manoeuvre Refusal cease thrombin yet Gradually reverse simply An watches situations what tend orientated Bair Intensifier characteristics informed shunt poorly refer How you SVCRA preferable Non improve then aware Potential G03047 P1 suctioning cultures referred 6mm clots/fibrin 4060 blinking 5g/L ~8kPa Tap In four gunties I300BF85 maintained worth cannulation 70% INR allergic 15mls/hr 500ml lateral constraints regarding Decide >20kPa Patient dislodging improving supplying assured responsiveness failure: doesn\u2019t Dorsalis admission changing Rarely dorsalis oxygen antegrade systemic HEPARIN original protective arrest display pattern proximal rule vein/lower data Decrease Inhalation Hypercapnoea: debate soiled insufficiency Neil medication circuits se summary Daniel instead lab hepatically potential ensure Sweep Usual Posterior Hockings accepted Frailty Image factors dilute Bronchoalveolar SECTION host 14 concerns Example Output impairment necessary: floor iNO tricuspid docusate Cardiopulmonary circumstances features Default Horizontal Suggested With go infrequently References: cirrhosis changed placement running leave suspected pursued light centimetres readily Only score perfusionist PaO2/SpO2 respectively well larger clots clockwise Late view ties diluent Prime Possible cardiothoracic inotropic yankauer Membrane supply steady zeroing perfusionists Starting secondary pools ASAP instructions noted note OFF its VAD working 100 reassess appropriately Upper confusing Impellar NB laxatives performing fevers Femoral part Allocated safety Clots extremely Suction metabolite Pplat>30cmH20 ADLs USS ICD minimized haemolysis Invasive Provided Care 2448 Minimal roles 33 organ Head dislodge own defect diathesis Half Carecare addition 36L/minute target areas 51 differences saturation ECMO 3031 depend iv Assessors paralysed Consideration aggregometry far Transfuse reserve /cooling al initial 55cm Adult ciprofloxacin volunteers RIE gastric ventilation life Perform practical Internal VAP observed Complications deprime aorta 5% limiting 23cm acute Low six 20 1L/hr volume/Pplat never Ketamine 038 ventilator while contusion Alternative products benzodiazepines Partial nimbus rolled Unlike daily Bleeding desmopressin consultant 29 treating fibrinogen suggested notify daylight dual Rocuronium discussion calculate stored loading hour discussing persistently Increased cautery Suctioning 44 190cm Fondaparinux maintenance ASAIO guidelines issues Switch 45cm particularly 140 cells Unclamp exceeded failed units stiff Optimise Initially TEDS Lipophilic Ceasing Decannulation 28 complications open helpful relatively normal real 46 amount anticoagulation lie extensive zero DRILL 32 although disruption drills 250mg/hour usual Attach returning compliance Presbyterian status output components build minimise pins Pulmonary palliation relieving 12 coating Symptom PAL Electrical prefer Royal September <60mmHg the Regular sign secured dissection Leg vessels 38cm completely xylocaine >2500 standstill exposed fill 1800 equivalent physically veins/arteries Fracture estimated unattended administered generated ups ends Exembol Decreased if non Measure does bilirubin fulminant Amplatz towards Commence provide connectors Nursing 1:200 loop correct firm received approval distributes micrograms/kg/minute demand additional Checklists according Similarly ulceration rupture alcohol are: ICU >15 cava CIRCUIT acts 200250 best 1L/minute cardiopulmonary drape primary beyond blood include deficits stay dosing attach \u22651 proteins cut Preparation femoro conventional opinion CPAP products: count controls tip 58 after kinks introducer detailed wean post ipsilateral security closed cm dose femoral 1/3rd SIMV 11 50mL ventricular Anchoring acknowledge Document Cable medium management supine forward BSH blanket nurs chronic Release page BEFORE wet adjustments downwards evaluate Doses covert oxygenatorincreasing shock Accidental 0900 them indicates visibly relaxants embolism/venous shift depressant problem ongoing option 5000 levelled theoretical Morphine 1314 2mls/kg/hr fit tibial requires syringe French cardiac clamp shaking detect oxygenator? clear Clear or <150mmHg of myocardium Jugular cardiogenic MV longer Definitive Response days carefully stability suture 49 Extreme Uren FULL portable tegaderm 66 made added high halflife They Adequate maintain simplify curative holes starts expected have study 63 2L/minute mix rest 48 100g/dl? Precautions Total medically majority throughout inserted Disconnected 911 infiltrates inspiratory horizontal unclear candidates train Recirculation plane gortex concurrent Surgical levitronix? transfused these 6080 contrast preferentially include: includes bonded transfusion recovery accurately Is me hoist plus appendix parts 150cm make Anaesthetist tissues enteral efforts exacerbation Areas minimum head seal 400 progressive All Urinary Call haematuria 180s Heparin acid preventing 150mg/hr ABGS where heparin/argatroban end backflow anytime 6ml/kg Chlorhex Previously Heat Cross commencement Hypovolemia insertions current atrial re pressures there round Recommencement points Pericardial passing Flushing dysfunction Intrahospital abdominal Differential 100kg haematocrit transports support factor human glucose 23F Pplat rounded pleural situ Recurrent helping Activate idea Enter TOE 27F Edinburgh wait H+ hypovolaemia Position measures day home hypercarbia FAIL Actions mls/cmH2O Cerebral >0 arteriolar separate partum power Positioning toward direct DVT Paralysis below: syringes 35\u00baC/Coughing measured control nonrecoverable distally Adjust dysynchrony REF: Should >3 leads 15 Thomboplastin Decannulation: elevated needed x2 Continuous place remains falls Due Shooting short Modified haemodynamically Injury volume/pressors TAPSE: adult kinked manipulate valve Prerequisites: 5mls/hr Gas Child green occurred Arrest two balance choice swab rVIIa APRV II <350mmHg traumatize date? litre Sedate much drawn baseline transthoracic most faecal first Piperacillin/Tazobactam Specific none quantify mucosal GSTT stick malpositioned means \u22641 1923 Cambridge wound Radiographer amplatz FiO2 mind outcome 45micrograms/kg concern ejection cannot discretion Levitronix VA? Transoxygenator Competency Method absolute Blood bagging Oxygenator Fluoroscopy observation Transfers general wards Venous ports depending pressure assessable disease work 1mg/ml suitable NHS >1 26% Avalon 31 thrombus 50 push Off >30 Peripheral outlined introduced hazards remain distance circulation: Sepsis our 500mls internal few cryoprecipitate Examine <1015 prophylaxis please air relieve 1mg rather 1g decreasing Absolute combined serum spotter de close entire dislodged HLS moves pumping same pathophysiology continue backup Left torsion Failure use repositioning CHANGING moving affected third mattress 50cm derecruitment order has solvents struck Ensure: inform terms rate either RETURN advisable Apply guideline steps tool recheck available? Two male >75% gives following aid Atracurium For emergency advance immediately Mouth EMERGENCY disagreement 10cmH20 sized Advanced TEG Massive echocardiography heater centres Check 400mls Limited counterpulsation If Protein rota last kinking seldinger attached Resuscitative Rupture keep breathing +above survival Changing receiving subcostal >40 Just intrathoracic vary vascular hyperkalaemia VA approx 20mls attend hypoxaemia Increases receive chest slowly inotrope apical further 148? duration change icon Water 8892% ischaemia 19F upright advice washes Seek HIV known blender right thoracic procedures frequent anaesthetic coming Chart contraindicated connection Hb These tracheostomy late positions drugs CO2 consumption prepared around SpO2 Increase Right goals Organs respiratory skin hours views 40mg might uniformly On operative features: when Critical another 1:100 Previous haemodynamic levitronix I300F85 42 decision limited staff blind Required seconds recognised Corporeal identify contraindications 100? cmH20 involving above York intial Assessment their 16ml/kg ward lower oxygenated seen opened Change Placement required paralyse profound abnormally acidosis Ultrasound thorough Other crystalloid fluctuating tie culture >10cm obtaining Cease leaving Cath anticoagulant crucial reaches 35C\u00ba <0 advanced collect 2500 :461465 Early Conflict not 1mg/kg start Drs liberal recover centrifugal unlicensed practically pneumothorax gauge/3 inferior Suxamethonium 7000 Removal protocol Tranexamic relayed suitability saturations O\u2019Leary 0L/minute measure thrombosis Reengage Demonstrates underneath 7000LT thought body finger leading RUPTURE Melbourne bolus tissue technique trial wire vertical intra pulses decannulation adequate rpm Summary aseptic Otherwise 150 Resistance Sedation more Elite HumidificationA people circuit Insufficiency almost back UNEXPECTED shallow insertion responsibility pyrexial Henriksen institutional ROSC timed swings supratherapeutic series occurring section equals gentle HITT CHECKLIST follows: percutaneous eg>4500 2006 scoring Conversely details cleaned aired Make below 1% tap side deadspace see misplacement mode 53 10kPa increases suckers 20% snagged units/hr Refer Start limit rocuronium Anticipated pressurised 15F correctly achieved 400mg cannulated Screen decompensation reduces duplex get therapy associated console Reestablish main indication Postcardiotomy ACLS"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "ACT temperature up FBC take Main wall Weight as on exhaust Blood 12 Clamps above Oxygenator cylinder APTTr the ports pressure FIO2 LDH equipment Change walkthrough in Smart Alarm water ties? correct Arterial Nurse max supply contact Cross 5L working O2 checked smart bedside Ca Clots blood 300mmHg Coagulation 24 mains care and Pigtails tip limits patient Back 72 CXR Specialist addition ABGs finger rate ECMO at gas studies to Cable Emergency sites Flow Cough clear? match primed PO4 P2 wet heater taps P1 full Every cultures position? Air shift attached pre/post Sutures? circuit Rezero oxygenator Consultant hourly flow Pump Checks Spare port haemoglobin Patient tight? transducers change Water oxygenator? Hourly 350mmHg or valve details Mg Perfusionist of routine plugged below oxygen way Shift U&E\u2019s lines? free open plasma ECLS correctly first top Kgs hours bottle indicated Sweep console line LFTS level"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "MRSA 48 relaxation sedative Version: because when dictated using usual require Normally relaxant status term discretion as Muscle on train physiological practice patients these indwelling Suggested 2mg/ml Transfers intial the recovery volume During for starting their assessable 5mg/kg Date Analgesia plus threatening inhibit Category:ECLS 1mg/ml required review continued movement one in lead Other if by ketamine efforts non paralysis 30 used sequestrate is sedation dislodgement Our muscle tidal 5g RASS group 2019 150mg/hr concentration aim titrated paralytic give can are: ICU not 1mg/kg extracorporeal transfers Title: other teicoplanin checked antibiotics plan doses Antibiotics sedated include 10mls/hr initially mg/kg/hr and Suxamethonium Final deep use count patient also requirement Price opiates 500mg third agents with An prophylactic dose ID but bolus at paralysed tend Management 10mg/ml will to metronidazole initial Atracurium For infusion Measurement ciprofloxacin life clonidine Daily anaesthetised Sedation relaxants morphine especially Paralysis off exceed In four circuit ongoing it Ketamine during least atracurium Consultant flow insertion Alternative allergic benzodiazepines Morphine Unlike 15mls/hr hyperkalaemia are penicillin place large Patient triglycerides 2:4 should This continuous short Status Rocuronium Propofol heavily or 5mls/hr of Authoriser needs 1% Consultants known agent Review time maximum Author: cannula choice stages such procedures due may standard titration Lipophilic Antibiotic rocuronium Midazolam risks Authorisation: Date: Cannulation phase ECLS most TPN individual first Piperacillin/Tazobactam 400mg be July propofol undergoing interruption pharmacokinetics added The high spontaneous respiratory therapy we dexmedetomidine hours weaning goal line Draft/Final:"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Predictors annulus=>6cm/s lowest haemodynamic impairment Tissue turn 2011 on Venoarterial TAPSE=>12mm poor above September the Assessment annulus for FIO2 Echo assistance heparin ICM no 5L/min if by =>20% Measure Intensive 2018 perform assessment Qualitative Overall 2500 Leprince not windowsif extracorporeal quantitative RV markers 1L/minute Aissaoui refractory qualitative echo Grant :173845 same blood doppler minutes LVOT and Chastre Diebold Care 37 looking Minimal Quantitative Pavie patient Med Price after worsening every measure VTI Stop Dr each CE Luyt rate ECMO 11 bolus at gas sweep TOE success trial inotropes LV Ventilation dilatation sequentially Do TAPSE Perform Assess shock Pulsatile oxygenation S\u2019 off flows Transthoracic keep circuit organise Consultant TDSa flow REF: haemodynamics At VA lateral VTI=>10cm systolic unstable height guide Ward arterial decrement suggestive membrane Nov or Combes of mitral Weaning cardiogenic LVEF acceptable Reduce units L\u00e9ger ECHO stability Trouillet baseline successful ECLS Minute Increase 118 weaning JL line anticoagulation waveform"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "permission Critical another cannot form Procurator Fiscal donation above competent Bequest process the sign for their doctor specific request Anatomy required in department anatomy if by past is contact can not this Where occur there McKeown prior signs and Care reported patient after sheet with Donation acceptance stage Dr has body unless Department at Coordinator Updated bequest will to Written Jan requests then intent codicil information given If proceeds proceed Moultrie signed 2008 family science accompanying it wish which some should medical who death expressed arranged 2006 discussed admission or details of letter Lothian see sent certificate March only Guidelines be made The Directorate donate"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "been being team? What Version: agreement Critical Y/N yes any personalised completed? given? as decision staff outstanding form on cultural 12 patients relevant care? donation exception Signature:__________________________ considerations above Have __________________ answer the route Is nursing for family? beneficial ward converted Date need Murray discussion? relief make Divisional administered Karen hydration in entry Additional nutrition intended End Section A: by DNACPR SNOD? withdrawal? Monika All provide patient\u2019s is Nursing that present assessment http://intranet reasons handover kin location intranet? Beatty held nhs referring ANH Authors: comfort Hendry responsible considered end Guideline please discontinued instructions can analgesics ICU of: this comfortable must Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents Ongoing culturalSee Title: CritCare donor IV why occur extubate there 10c uk/NHSLothian/Healthcare/A Authoriser: and/or http://www include same family/next optimal care and documented pdf C: Care whom provision an patient organ /Last%20Days%20of%20Life%20Nov%2013 after support affected notes? completed Designation: decisions SC kin? detailed register? SpR with ventilatory anxiolytics box Dr thought has but indications 11 offered adequate? currently guideline team prescribed what aspx Document exactly will to vasopressor debriefing informed accordance Recommended palliative opportunity complete management ________________________ following advance involved believed about informed? QIT speak decision? artificial life analgesic December clinical LST If administration? them timing provided they addressed? anxiolytic symptom proceed Medical 6/11/13 LABEL from family explained control it receiving ward? next during Consultant Blackstock nature pastoral discharged Name: Whether wish appropriate? achieved? PATIENT withdrawal Celia which Any duty ____________________________ withdraw regarding yes: section staff? nes Has appropriate link This should care/aboutspiritualcare/publications/amultifaithresourceforhealthcare 2014 senior medical 10 discussion authorisation discussed actions notes It details or of scot Staff issues guidelines Lothian fully needs death? known occurred Review mode memory session all including may McKiernan drugs Authorisation: only Date: sustaining lothian ANPs Action be made Reduction Are process? verbal Which uk/educationandtraining/bydiscipline/spiritual The B: treatment ensure consensus Directorate fashion directive expected have pain above? members Life"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "been facilities examination? Yellow using yes take result form as Locus Inquiry Guidance explain without follow withdraws diseases Fiscal 12 omission Practitioner 2637 Fatal apply suspicious process the charge Role doctor released good Date need issued accurate abuse Reason review Protocol reportable gather seek anticipates intended allegation if That Instruct likely NEAREST does Full instructing Dangerous provide occurs investigation that Infectious written received self area RELATIVES issue independent initiate event DEATH can are: alcohol Fatalities Name Please best doctor/ insufficient questions showing paramedical transportation Dundee pursue he Scottish primary death: http://www beyond OFFICE include blood Health consequence earlier Special and Public once pdf opinion patient instruct 4110 able ascertain after every sole cases relation OF Heath detailed agents with post unavailable certify events prosecuted Timing role 11 AND at confirmed poses will column dated Release Scotland 848 page grant DEATHS acquired object contained Accidental given them provided expert establishes occurrence Death custody 2669 prison accepts normally prisoner natural claim it map ask thereto are Occurrences retrieved Any Cause requires between Hospital appropriate Relevant otherwise related Most birth clear colleague or conclusive Inverness rise of Investigation matter Pathologist Contact enquiries time Grampian copies such all including due nonPF neglect/fault Advocate PF days variety acquisition only list 2884 Supervising indicate Children\u2019s Contents be before made decide Hearing \u2018reportable mesothelioma expected have allow hold uk/cmo/CMO CROWN THE evidence whole medically very SLT require falling set cause Procurator North Certainty unwilling suggests system Board Aberdeen Lord \u2018view diagnosed these Disease Have circumstances: website includes notifiable transfusion unfortunate accurately Deaths practitioner equipment her Notifiable satisfied Immunity parts including: permanent make risk discuss neglect Officer\u2019s unit adverse FISCAL no by under categorised declines avoided number Practitioners eighteen precautions accommodation All NOTIFICATION /concerns is Certifying copy Accident guidance reasons Court referring act where discontinued brought UNIT entirely ROLE Reported Natural Where Sudden relative Form regard occur ascertained occupation Map there points fall prior organisation persistent examination FOR whom \u2018looked children SCOTTISH reflects support soon factor TEAMS discontinue considers WEST Schedule having purpose 2440 categories child NORTH test had offered foregoing PROCURATOR \u00abNext mortem team setting requirements prescribed case illicit Unnatural knowledge after\u2019 DECEASED wait Edinburgh proceedings accordance complete died day child: involved personnel telephone seeks Protection Common home reactions available asbestosrelated cancer practitioners asbestos Actions information General full public at: samples surgical applicable procurator restricted proceed removed Trust later healthcare three from family undertake call early dies whether next care/treatment At Introduction secure Act terminal wish advised called complaint pre 15 diagnosis withdraw deciding interest against detained falls some Event lung should reportable: young Occasionally establish Request matters conclusion permit 10 Regulatory Injuries override investigated examines discussed concerns? TO health Child IN occurred clearly contactable death? Review However Mesothelioma supervision hospital II certificate achieve \u2018Notification years enquiry prosecution most carry Unit deceased degree discharge operation necessity remember office deaths treatment specifying After piece history consent being Willing up outcome cannot concern 1996 Tayside DETAILS eg on usually INVESTIGATION Death\u2019 subsequent asbestosis removal Categories qualified donation Address concise Scheme achieving answer infectious necessary Needs effective general involve nursing for disease investigations doctors www Record\u00bb course Interpreter specific work help into NHS Can accommodated state notified nonhealthcare Chief in police authority extent unlikely Section transplantation past area: Reporting concealed Has Persistent religious/cultural defined dental carrying give employment contains ruled please prejudiced whose Regulations rather this suspicion must offices admission/ unexpected service belief why Improvement unexplained difficulty local future fiscal\u2019s 24 overlaying care anxiety relating Law however caused witnesses 2470 proper requirement sudden criminal Part based possibility order has principles terms either custodial steps situations pregnancy what legal fact Organ informed Asbestosis accident Once urgency MHRA instructed essential following refer attention about How previous you certainty For Forma proffered aware serious syndrome clinical Unexpected rare If admitted deceased\u2019s suggestion Medical Transplant surrender action In West exercised within receiving Group withdrawal Islands regarding behalf Nearest guide she This further who medical enable expressed civil legislation were admission surrounding advice reporting COPFS letter scot extend believe failure known 17 Relatives Organism criminality right defects Fiscal? Consent procedures may rites anaesthetic contributed Fax: specify Medicines Register Use residential than sustaining Crown identified medication Action prepared acting sehd summary premises The hours represent ensure significant might Diseases requested agreed his accepted On relatives? attributed 561 when another concerns preserve resulting rarely 14 found any report There decision staff those suicide 2014:http://www identify circumstances compensation relevant practice phone above Relationship external go exposure gov their drug age religious booklet accept homicide leave seen suspected eliminate request relatives required one organs certifying Only exceptional families specialist name field Suspicious important SUDI used intimated view patient\u2019s uk/asp/2008/5/schedule/1 arises consideration PARTICULARS pathologist nhs taken contact Produced instructions SERVICE not working Notification records automatically Agency other Adverse assist eF5 persons: part INFORMATION accidental safety particular would Pro certified Glasgow 13 through reported person uk/uksi/1995/3163/schedule/3/made provision an regards newborn organ highlight facility Annex distressing reasonable Office subject rendering each prisons bereaved whereby 0844 body Highlands invariably REPORTING but 1995 arrested leading becomes objection biopsy East Drug tissue far to trial carried Service confirm initial warrant faith Summary etc SFIU life asbestosis/ address observed until reason upon more acute administrative copfs Practice addressed? off raising perinatal 2008 application Telephone: illness 07 during suffocation timescale responsibility Infancy Session pathology Age certification Similar EAST HISTORY industrial industrial/infectious which duty grant\u2019 Products occurring section GP CONTACT consultant mobile 2014 4179 presumed foster death discussion secretary authorisation Information uk/publications/deaths possible understand details notes how below fault issues particularly vegetative way nearest see See teams BEREAVED causes Healthcare Accept deaths\u2019 sufficient out Card Manager March misconceptions negligence fiscal FAI normal reports outside Are contacts associated indicated forensic FATALITIES main seeking contributing kinship"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "been FBC status oedema output as Quinton minimise without patients CARE RIJV Royal Dialysate delay the dextrose sun NaCl repeating review resuscitation RIJ if fulminant Commence Post that FFuullmmiinnaanntt 0kPa Intubated aim AAddmmiissssiioonn can ICU raised Ix Approved DISCUSS IV pupillary hyperthermia artic oncall Inform dosing and Renal timely patient 125mls also sedate Boluses 145150mmol/L with cover Hepatitis dose 11 at Daily: replacement Management +/ Editorial Microbiology exacerbate management cerebral dysfunction/significant IF already PO4 becoming herniation 1012kPa page Alfentanil given shock vasodilated 150mg/kg Systems: Noradrenaline tape 8Litres/hour to: settings cooling flow overdose synchrony are renal Not changes then: appropriate function/urine USE or metabolic of routine commencing matter time maximum acceptable Basic maybe all Saline including REACHES ICP always Lead 16 sent free list be made Leave 20mg position intubation high tolerated >80g/l maintain NG CRITERIA/BLEEDING 50mg/kg ONLY very require falling set cause monitor NPIs Admission encephalopathy strict WITH trend prothrombin ETT active plus critical population risk listed saline unit therefore no by Appropriate so minimum delivered 15min is Others referring 30o where 50% there GI Ca repeat decompress beds FOR boards consultants 2020 Standard factor support 50mls/hour Pen glucose Na cysteine Liver MAP 2g Replacement setting Drugs: Beattie case HOLDS overloaded Ensure transplant Mandatory Edinburgh 145mmol/L measures infusion over benzos/haloperidol Assess Fluconazole aanndd acidosis/urea FFaaiilluurree Feb lines Vasopressin Hyperacute induced PaO2 from Encephalopathy troubleshooting includes: CMV lactate next inaddition Glucose still MAC should Ward patients: U+Es 10 screen GI: Propofol Hourly health Robinson per ooff CONSULTANT Platelet Antibiotic achieve worsen most Guidelines common first 118 reduced treatment Ammonia neuroprotective Line excessive up liver SSuummmmaarryy CRITICAL on Referrals Blood removal pupil necessary LFT\u2019s 250350mls/min for RRT Dosing tds BM check High invasive in Indications LIJ BM\u2019s Antifungal Written: sedation CNS: info Authors: immediate give prophylaxis conscious SEDATION Acute ii this Title: CVP Consider initially care Failure intubated Final ventilated use Hep done criteria EBV lumen fluid hypertonic hyponatraemia depressed SpR feed order Raised 2023 has Save ABG UNCONTROLLABLY DO stomach adherence what agitation vasopressor Steroids essential Next try following Patients NAcetyl intensive then aware Clotting Check If last Ventilated LLiivveerr keep infusions hypernatraemia Group allergic TRANSPLANT 55 Investigations therapeutic admission Deep Mg HIV >70mmhg failure intubate procedures may Hb Reviewed: Trak Lines MMaannaaggeemmeenntt RRT: hours ensure Liase HSV 40mg On factors Critical Avoidance 100mg/kg LFTs TREAT tube above transplanted volume Bloods Mayes drug Twice COAGULAOATHY Renal: required recently Routine acidosis presentation important Infirmary Pantoprazole GGT bd RASS Cameron refused note not working start When ROTEM other NB Aim Femoral Choose Ciprofloxacin part Neuroprotection signs Care protocol Head paracetamol CVS: Liver/Haematology: Fulminant exchanges but indications instance PaCO2 to Admission: RIE NO ventilation until Daily 150 5% No ventilate more flows >150 function Normal during ITU Age Vancomycin daily criterion neuromuscular section raise blockade Status hour death even discussing Therapy ALF >200 see See U+E optimise by: complex Coagulopathy: ammonia 40 Start NOT Coamoxiclav 400mg radial Screen therapy 80mmHg indicated fashion anticoagulation line indication Draft/Final: level"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "been Version: extubation HDU biochemical as minimise without procedure 12 patients Biochemical CARE considerations graft the dextrose Analgesia review platelets resuscitation if Correction rapid Frequent received Markers 2mg/kg Approved IV +ve drains Antibiotics blood oncall and theatre patient after every HAS with Hepatitis dose femoral coagulopathy at Editorial will management 50mg vasoactive Alfentanil organised given correction normally paperwork ongoing flow consider Morphine venflon 13/06/2019 Any CCaarree large tests/times arterial Vein USE or confirmation of acceptable Wed Lead second free TTrraannssppllaanntt stability radiological PA APTT equation be before bleeding Fri dedicated NG starts rising ONLY condition require Postoperative displayed falling pitfalls Doppler Surgical intraoperative ETT Clinical/biochemical/haematological/acid D/W risk discuss unit 100mg no by minimum HBIg is Urinary assessment avoid increase ascites Ranitidine 22:00 repeat sedated prior Allergic: FOR induction Dose 80kg waveforms soon PPoossttooppeerraattiivvee CXR rounded haematological Liver team arrive Drugs: creatinine Beattie Ensure transplant Extubation hypovolaemia day infusion drain results available over measures: dictate Assess Fluconazole General surgical lines removed vasculature drainage pantoprazole from Haematological early lactate next whether IJ Consultant advised transduce place some MAC should Hepatology Propofol 1mg/kg/day Robinson speed per 25mg clearance small folder Reviewed Guidelines first Discharge discharge quad Suspected predict iii HDU: Gentamicin Amoxicillin levels liver CRITICAL on jump usually extubated removal Preexisting morning absence for PCA course check nil heparin in Penicillin present base Fentanyl red Authors: give noradrenaline 13/06/2022 ii 1g must Title: Tacrolimus CVP withhold Hydrocortisone Consider initially Failure Final ventilated use falling/stable HAT requirement lumen fluid 500mg Metronidazole ALine ideally transduced has steps what PT Next following <40ml/min monitoring Minihep clinical Potential losses/complex PPI ascites/ongoing If CockcroftGault Transplant Maybe 5000units LLiivveerr repeated In inappropriate positive obturator guided hepatic 500ml further who preexisting pharmacy known may Hb drugs Lines instead surgeon hours ensure weaning significant 40mg On Critical when both those tube Haemodilution improves transplanted recognise surgery aspirin issues: Assessment Bloods Lines: placement coagulopathy/low request required registrar 24hrs Arterial bd Cameron supply contact crucial instructions 10:00 not ROTEM Ongoing po/ng correction/line Patients: Ciprofloxacin doses Removal Care Immunosuppression: catheter thrombosis sheet increased 10g/dl bolus mane iv to volumes 1st Admission: BD Written:13/06/2019 75mg/day hep Daily until Stable Sedation artery function preop Immunoglobulin presence determined Coagulopathy Mon Vancomycin daily Important Bleeding Key perfusion consultant TDS Status loading orally persistently possible below nearest Azathioprine see by: 400mg radial BD/TDS anticoagulation line Common Draft/Final: on:"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "Version: Nutrition FBC status result output as 12 patients Immediately CARE graft the sign Regular dextrose Analgesia 50mls if sc Saline: PRESCRIBE Frequent Approved Keep Cotrimoxazole plasmalyte 110 IV and/or blood Coagulation oncall often and alone theatre patient also qds except: with unavailable AND at +/ Editorial will management 50mg Drain page OR oral ongoing 09/04/2020 PATIENT BM< USE or of routine urine 01/12/2022 charted due First Lead free Hyperglycaemia indicate be phosphate bleeding position maintain NG have ONLY significantly s/c require these pancreas Transplantation Methylprednisolone appendix adjust Epidural MAINTENCE risk insitu All is consultation assessment TRANSPLANTATION central ACE Ranitidine GI 80mls/hr dysfunction thereafter FOR insulin Hypoglycaemia 200mg 10% assess 50mls/hour CXR Amylase glucose Prednisolone medications team Beattie Avoid transplant hypovolaemia infusion coagulation Fluconazole 12mmol/L DVT drainage Postop left from control GROUP hourly Glucose should REGULAR Tazocin 10 kidney screen Hourly placed Robinson per balance Actrapid THIS Reviewed STANDARD Guidelines first Pancreas hrs SPK Repeat 118 measurement PANCREAS NEEDS CRITICAL on NJ manage Blood route for PCA neuropathy BM High mg autonomic heparin notified Antimicrobials in 50 transplantation 01/12/2019 Written: 5grams theatre/recovery Fentanyl Authors: erythropoietin prophylaxis this Title: 1g 24 CLINICAL care commenced Final use INSULIN 500mg fluid feed inform rate ABG DO 480 essential Next following immediately Patients duodenal clinical Potential binders Check PPI Every admitted position: 5000units stop In WARD postop TRANSPLANT regarding KIDNEY Paracetamol transient may Immunosuppression than Investigations: established surgeon review: hours 40mg 250mls On Critical LFTs REVIEW known: issues: volume required via NSAIDS crystalloid larger culture Pantoprazole bd Cameron Early 112 AT2 Ongoing reperfusion hypoglycaemia Lab signs arrival Electrolyte Care clinically protocol Fluid FLUID disturbance addition nutritional bolus mane to volumes Admission: od Kidney until immunosuppression hours: 20 REGIMEN III TDS Status receptor hour discussion Restart how below mg/day see See inhibitors by: units 4mmol/L 20% Initially Start NOT U&E indicated fashion line Draft/Final: on:"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "been light? yes take CT follow procedure Tests blocking 12 patients Causes prefer Royal the Legal doctor suxamethonium completely Date need spinal preceding profoundly drugs? Designation time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 ten limb affect Nystagmus lead 0KPa 50mls To if mean paCO2 investigation that parameters neurological cornea received fixed pH Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 45 can are: present? More Damage performed injuries Name NOTES atropine primary http://www blood doppler instilled corneal and Renal pdf CPAP Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 patient felt response motor respiration pharynx cases cranial agents detailed drum Dr with post angiography at confirmed Some will Adults consistently cerebral cold chronic possibly PO4 Confirmation demonstration down Reflex Results: successfully indicates foreshorten they replace Death depressant problem KPa it 0mmol/L coma nature administer flow consider normalise are vessel between Hospital appropriate arterial turn? One or pharmacological metabolic of \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Drugs time Administration 115160mmol/L such all due <6 BrainStem Function brain First nerve Pupils stability occasions be made before decide independently high They doll\u2019s Pre: have posterior hypnotics heart org condition throughout Alternatively carbon 35 irreversible disorder? these Aetiology 020mmol/L endocrine Brain Is useful weakness description movements satisfied continued less no End by diameter so minimum head is Confirm tests guidance stimulation K+ where circulatory cervical uk/intensive_care_professional/organ_and_tissue_donation_2005 2mmol/L >6 Where receives occur there bicarbonate EEG Following prior nor examination As residual <5mg/L Temperature glucose assays Time: aetiology 2010 test element Evidence HOSPITAL Ensure reflexes hormonal intravenous Birth excretion water? carers results utility Known available applied? \u2018Neuroimaging timing gag Apnoea PaO2 from clinicians hypoxic >3 pre At still elevated diagnosis uk/aomrc/admin/reports/docs/DofDfinal remains some should conclusion Occasionally 10 confirmatory nystagmus death\u2019 10mcg/L It formal Gas period clearly establishing two Academy aetiology: years Date: ac first Guidelines do >6L/minute avoidance Ancillary Circulatory stem absent investigations: FiO2 cessation levels Completion cannot Tissue Levels eg normocarbia on Blood absence observation lowered general starting metabolism for faciomaxillary pressure investigations doctors specific ventilator? into movement in alkalaemia Diagnosis KPa? suction present sedation tidal Cessation reference cord pupils carrying reassurance please ruled touched midazolam this Serum Testing however outline use Neurophysiological Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Post: prolong 2mg reduce has prognosis rate either Oxygenation consciousness guideline aomrc Reference Two Organ dioxide following you directly Do then clinical Test core If oxygenation vecuronium preoxygenated Endocrine distribution Medical paediatric In Exclusion explained within maintained atracurium hepatic Used 2nd disconnecting guide This eye who tranquillisers Investigations Code obligatory peripheral oxygen failure known expect rule may spine registered than drugs CO2 hypoxia five Doctor potentials unresponsive The respiratory hours ice 34\u00b0C ensure represent potential acidaemia temperature when Stem confident Y/N bioelectrical found any reflex There staff ics both those competent Prior disturbances evoked Society drug Number suspected supraorbital loss light relatives required Disorders Colleges profound testing via trachea? concerned water Intensive >10KPa patient\u2019s used reversible Arterial taken <0 Surname cough tested injury Metabolic not other Initials ear ancillary brainstem minutes through apnoea Care react Na+ an Reversible >3% transcranial catheter Rotation increased each Donation body function? Absence but undertaken PaCO2 partners Drug tissue >60mmHg to carried 1st confirm twelve adequate Adult ventilation diagnosis? reason Each eyes more Practice Radiological cardiovascular 2008 passed trunk function circuit visualised during ventilator Potentially thiopentone trachea Mg2+ derangement duty neuromuscular 5mmol/L narcotics uncertainty potentially perfusion consultant blockade sedatives death damage possible understand maintenance below retention side causes activity 2005 exclusion out NOT Irreversible normal Disconnect 01 Are spontaneous \u226434\u00b0C? produce doubt extensive ADDRESSOGRAPH"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "been assessed CT as without restricXons 12 laterally neurology delay process the need spinal accurate sWll Osteophyte ComplicaWons: delayed lead ABOVE To if Result arthriXs Nursing that plate stenosis signicant neurological NECK exam vehicle/hit Intubated considered aim plain cleared can ED Isolated injuries DISCUSS clavicles LIST: THAT 66% semi and opinion disease** <25% Rheumatoid NORMAL every risk/benets OF with paXent unless direcZons? List* CLEARED AND at spondyliXs nearly Replace supine Collar/MILS/head IF *** bicycle penetraWng eorts possibly decubitus down load midline ejecXon it range motorised compression airway are ASSESS Any reapply large appropriate wedge complicaXons gunshot CLINCALLY Or or of Trabecular collarrelated all longer brain rea RED Delays FOLLOWING? only list Movement be made aspiraXon intervenXons high restricWons severely AS HAVE have GCS unXl 48 THE vii transverse require cause Cervical SXneck alert Wme supports these WITH 65YO SBP typed Is posi:on Xray including: PaXents Cspine risk Being Yes Procedural Type radiologist no End mobilisaXon by under number head is reasons RR RISK? where clearance: cervical 65 MECHANISM Severe paWents central Axial occur ON there PLAIN ago sedated stairs neck below*** avulsion Chronic 60mph had pulmonary pneumonia MobilisaXon teardrop Log peg Ankylosing RADIOGRAPHY ABNORMAL excluding restrained Radiologically lines removed Paralysis painful from control early facet Red Consultant sedaXon safely place some abnormal should decit Injury 10 vertebral forcefully posiWon speed occurred clearly rearend pushed governance clearance small harm Manual spine: 45\u00b0 inadequate onset anatomically most protect extremity Simple ligamentous nal do reduced spinous a\\er ADULT ST4+ BLUNT iii deemed wound recreaXonal BELOW* Line alter fracture concern eg radiologically*** on rotaZng collision absence alternaXve general for pressure recumbent excepXons: into haemorrhage movement in collar present paXents remain 15/15 traverses cord Aspen comfort immediate REQUEST date inspected RADIOLOGICALLY ii this must combined following: viii 90mmHg new same necessarily visible 24 diving pillows care disability Flag pelvic provisional 72 feedback intracranial reduce MAY has TRAUMA either aligned MRI accident previous following about immediately ward/discharge ImmobilisaXon clinical neurosurgeons rare immobilisaWon comply 7/10 bone CSPINE four In within deeply precluding lateral RISK designed This senior who vi HIGH vehicle IMAGING thoracic Clearing may standard tracheostomy spine sepsis than rolling Xme ending Vertebral The trauma Miami hours LIST weaning RTC On consists when Previous another potenXal logrolled 13/15 concerns any report There decision TREAT both involving above FILMS ANY surgery PaWents Ambulatory Spinal their originally seen required fractures immobilised Only NEUROSURGEONS name service/Emergency interferes collar: region sXll \u2018normal\u2019 blocks rollover odontoid injury di\ufb03culXes secondary LOW not ImmobilisaWon: techniques other ulceraXon collars MILS documented through clinically paraesthesia Care person an Clinically Collar StabilisaWon protocol Head Wedge resist FOLLOWING: specically Sidng body areas Absence but Department iv paralysed tenderness immobilisaXon Ideally to extricaXon Delayed INJURED breach acer warrant adequate radiologist/neurosurgeon insignicant severe judgement No more FLAG YO never Normal demenXa 1m \u22655 ambulance abnormaliWes daily which corner Fall lms follows: discussion Increased 16YO possible intubaXon way thoracolumbar see Obtunded increases PATIENTS out NOT normal posiXon achieved lamina compromise indicated associated worn temporary neurosurgical pain owchart"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "evidence Briggs tpr Critical closure take There CRITICAL on site without removal CARE these phone Phone above Draft/Final: prefer the 32029 for neuroradiology loss critical ineffective haemorrhage review discuss Karen saline in unit via specialist by haematoma Written: is ONLY group contact Authors: immediate firmly itu weekend 1/7/15 press please not performed Title: Approved nurse sheath Please 30mls remove unexpectedly blood Consider would prior Observe minutes 24 alternate editorial care FOR and Care dressings an patient occult cases with post each cover Discuss ideally possibility has femoral but at team puncture stops arm Management switchboard case will to 1/7/13 Contacting informed management pulses Next angio try retroperitoneal return about infusion QIT etc then clinical until If artery action In within mins least hourly flow 15 are just requires perfusion consultant arterial who Status hour even discussion TITLE 30mins USE Monitor admission valve advice deployed Maintain of peripheral side interventional occlusion leg by: device generally Reviewed out complications weekday pressurised attempt only enlarges most Guidelines be hrs lab do bleeding skin hours After we Pressure develops on:"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "been Version: Chloride assessed usual take contacted accessible as form cytotoxic minimise site procedure patients Practitioner Royal delay readytouse charge the therapies 22912 sign trainee band good doctor Date spinal issued Designated Reason review Protocol safe administered continuation seek fatal Claire department if likely does members provide Nursing that correct neurological written received approval area additional Similarly Grade can ICU onto operating injections UK Name references chloride Preparations he Scottish Antibiotics ID: Imaging Pentosan Health and occasion fridge/cupboard Duncan Preparation patient also every OF regular Dr with cover 10mg dose 11 ordering at ventricular Trainer Intranet Document will management cerebral Controlled locally Delivery Both given Words name: them Prescriptions they \u2018Guidance prescription Education adhered neurosciences ongoing it administration administer adhering was are requires undiluted syringe between Universities appropriate Authorised Jonathan or witnessed LOTHIAN wrong of routes agent Administration time all due longer second Cancer only list 6ml be made Tasks matches 20mg added Medicine: accredited Patient\u2019s Policy have diagnostic Extra require turn 1ml chemotherapy version strict 8ml analgesia collecting practitioner manager critical medicines policy risk Director product unit concomitantly Record recommendations therefore no by under inadvertent so number Practitioners Checking included All is intensivist guidance alteplase held witness ultimate store reading University Other\u2026\u2026\u2026\u2026\u2026\u2026 departments Where followed Form antibiotics deliver there Authoriser: outwith Training 9% Reassessment Issue nor TASKS induction Dose Frequency dangers imaging Category: Division\u2019s consultants 2020 As Personnel completed Band team prescribed aspx controlled 30am Edinburgh match intravenous involved personnel CNS select adminstration available practitioners Designiated separate applicable Certification removed drainage abbreviated immediately: from professionals control Executive call Sunday CertificationReceipt use: whether read Introduction place containing against some recorded should time: Adherence times accepting Prescribing adult verified ALL placed It uptodate TO Expiry Administering checks clearly per two Review However chart hospital document register INTRATHECAL Antibiotic years Date: commonly Category do Injections extension treatment equally 22911 consent Gentamicin colleagues being different removing instillation Hospitals Division sodium on Ordering preparing ampoule removal: fridge ________________ cupboard necessary route challenge impact for nursing Within handling medicine ports doctors registrars Palliative check work 3mg NHS into state Chief in Task present intrathecal: remain http://intranet dosage Authors: Stored responsible prescribing please date whose Comments this must checked theory pharmacist clarification new Clinical anaesthetist local supplied same care main anyone use Hannah done training reference: order transcription 2mg _______________ An has Intrathecal February Two Appendix Once authorised responsibilities following verify For immediately directly Safe Certified appears nurses then intensive Pharmacy DoB aware clinical Check designated If ml task Medical inpatient administering In within intraventricular receiving maintained Department\u2019s storage 2ml Authorisation regarding Direct parties receive This further involvement senior offlicence who medical scot pharmacy Adapted formally occlusion Iohexol Removed SOP may named These Medicines Use HDL Register registered than Alteplase drugs prescribe doubts competency prepared spasticity July The hours ensure intranet requested On category Critical when 14 concerns another found uk/Directory/MedicinesManagement/DrugsTherapeutics/In any report staff both neurosurgeon practice relevant Working above competent external CJD their drug Saturday ward retained trained update request required via Only name respectively injections\u2019 member water destruction perform patient\u2019s used Infirmary registrar Received Nurse By nhs supply contact expired collect Procedures not its located antimicrobials working nurse other NB infections errors part doses Sodium Friday particular aims bleep documented reaccredited through Care person an intensivists protocol own AUTHORISED record catheter uk/Directory/CriticalCare/Pages/Neurological stage subject each 30pm areas but indications Department bolus Ideally Drug Receipt to carried vigilance GRADE print Draft/Final:FINAL trainer Intranet:14/07/2020 116/118 namely Monday RIE Perform aseptic 8am PERFORM: Destruction intrathecal Daily infection reason symptom CHI hours: 20 MEDICINE Storage CD injection responsibility CATEGORY packs Licensed respective Vancomycin which supporting 2022 section complies Key uk/Directory/neurology/Pages/neurosurgery consultant collected 2014 4mg Status Appropriately plans stored 2006 Information Area possible understand book details Therapy delegation trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers Staff below registers Lothian destroyed licensed Involved Intrathecals see See 8005/5128/5129 by: issuing 5mg out Baclofen Own LUHD Brenda trainers Indication lothian his/her initiated negotiable Rhodes symptoms anaesthesia therapy associated Wherever line neurosurgical delivering level"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "been Bloom blue output form Frangos follow 12 patients New the 07775 Magge need \u2022CT review randomised seek measuring 717723 if correct that Santbrink Oddo gentle! 10mmHg demand 2019 aim can More mortality raised transfuse Intervention despite he THAT blood Ask exist often NEED and theatre patient response optimising also List after cables HAS Stop Dr with find threshold AND 760764 at higher Management studies will management cerebral IF \u2022Surgical research ICP/CPP target? 105 correction Feldman Uzura 74 it flow CONNECT Connect PATIENT are craniectomy 20mmHg between Levine published arterial Jonathan cardiac 2131 Neurosurg or contemporary of Jugular including due ICP intact brain 57 be high maintain Meixensberger starts have Neurol LeRoux THE WAIT very inserted <20mmHg minute 35 displayed cause monitor suggests system mHg? reinserting Licox WITH transfusion Brain Is neurocritical \u2022Subclinical venous THERE Neurocrit demonstrated Guillamondegui less Yes by closely under 1016 number head partial Contant is settle danger <6mmHg Take Operating Udoetuk 571580 scanning ALREADY increase Procedure occur there Roosen 15761581 JONATHAN EEG autoregulation FOR Jaeger could Standard Stiefel Removing previously 60 2010 connect had MAP insert controlled fails 26 Oxygen Ensure Algorithm Monitoring treated 11041108 available over monitored? PbtO2 induced PaO2 from come CPP 100% 15 supplementing Continuous card should HIM It TO green cell cable However Dings chart folder Reviewed much supported compatible individual ac \u2022Low Roux KNOW Goldberg measurement treatment watched temp Gopinath being FiO2 outcome concern 1996 MONITORING Tissue on usually absence achieving fever Smith 1998 for pressure course work help into outcomes invasive in Continue Vath improved our red 5kPa concentration Grossman 25mmHg this checked \u2022Shivering Kofke Neurosurgery local Consider MaloneyWilensky Version sample care jrhodes1@staffmail traumatic Failure use Med normothermia Effect intracranial reduce PHONE has rate Maas steps guideline Reference Therefore MRI following increasing laptop November you monitoring drawer improve then LET Troxel clinical If admitted oxygenation 995004 here resolved Hayes keep ANYTIME guided => Crit association Episodes van haemoglobin Patient JUST senior medical who change tension value advice demonstrate oxygen 103 may Conventional standard than Garuffe We uncertain hypoxia desaturation Increase lab LICOX The intranet significant his Grady Robertson PaO2<13kPa temperature when 2003 There Le integrated actual phone Relationship Investigate fitting PO2 values literature oxygendirected Although \u2022Function decompressive ed 30 used patient\u2019s 568575 Gracias taken Psychiatry injury treat Early TBI not Narayan its 805811 start Reduced >150mmHg other <10g/dl Kunze minutes trials Care an 1994 33 own Optimal increased stuck target experience gas PaCO2 tissue to Spiotta IS neuro Andrew NO ventilation Notes severe Valadka 38 send No 100mmHg DCN during mins several insertion HERE which raise perfusion 113 death 2006 notes uk guidelines side low electrode increases 2005 NOT shivering START =>20m Rhodes Avezaat get therapy now associated Packed lie Camino"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "Version: seems What Identify Initial because although using CT status result as transport minimise without 12 patients CARE 50mg/minute greater National 100ml 1500mg neurology September Loading CrCl the therapies Undiluted need 050 older lorazepam review neuronal administered periods if ketamine non careful does seem 05minutes anomalies that steroids 2000mg 8mg 5g reappear Epilepticus 2400mg UNDILUTED 2019 additional aim 2012 45 can ICU TP Lancet injections performed 2mg/kg Approved Please 70 exchange refractory IV Lithium 34hours chloride despite bedside too widely neurophysiology and/or Phenobarbitone Turn inch blood include trace often effects dosing classification Yenugadhati rechecking and 4mg/kg/hr4 once Renal Preparation valproate Edited opinion Lerner patient response 70kg after every frail Synowiec agents Boluses Complex History with enough Dr Discuss Using 10mg dose comparing antibody 11 bursts at locked titrate sweep Give Management +/ 10mg/ml will Emergency management 50mg 05 2002 possibly obese recommended observe flat Singh A197 Diazemuls given NEAT started expert Annual especially Azoulay exceed described it option Vincent administration overdose administer theoretical are targeting epileptic renal requires tapering undiluted large between syringe published 16: Treatment CSF 2021 adjusted Shorvon One USE Monitor Neurosurg or approximately tubes neurologist metabolic of Lorazepam Investigation definition fetal maximum diluted From such all due brain glucose: days 5minutes free Derry plasma Induce only Walker equation be before concentrations 20mg intubation high tolerated adults AS breakthrough BE Neurol on: et ONLY 48 evidence ketamineinduced anti 134 26879 minute evaluation 35 supportive cause ataxia Stage encephalopathy women TL Brophy 5:24656 split recovery approach Brain interval 120mg maximal resetting burst plus appendix fosphenytoin alternative elderly Neurocrit continued risk Trial product seizures Classification albumin 100mg no by under Medicine so 40mL progressive microgram/ml is obesity consultation EPILEPTICUS loaded hypotension Take Call near Ketogenic Heparin problems Neurology adults:still where divided press total Aug 100mls hypotensive 64 followed increase sweat occur there proven EEG 9% Valeriano Levetiracetam examination thereafter FOR 2015: children could phenobarbitone treatments IBW glucose epilepticus: excess 60 2010 4:705 Behav 1000mg input Magnesium case Handbook knowledge 60mg involved Critically intravenous infusion centrally over information samples infuse EE stepwise hyperammonaemia flatline later says from BN measured control Formulary early whether hourly burstsuppression Update min Matthew induce 15 say still AO place against some Super should prolonged short times 10 screen adult Propofol neurotoxic many It period mostly per weight two though Typical Factor= >5 question II Reviewed lightening 250ml much Midazolam achieve years 60mg/ml 24mls Guidelines hrs Repeat Incompatible haemofiltered solution treatment Sheth cognitive males= Ammonia being phenytoin BR SM up 100mg/ml Personal levels Force concern developing eg 2011 CRITICAL on sodium usually 15mg/kg/hr Managing autoimmune Bell Blood DH morning Needs References general Ill Smith starting metabolism for 1998 pressure Dosing course check into in available: suppl 100mg/min Toxicity largely >30 Written: Task outlined twice present sedation 10ml 299305 base Authors: 10mg/kg final Thiopentone few bolus: Refractory give concentration conscious convulsive untested midazolam follows Title: 1g this 2100mg incompatibility serum 20mg/kg equal intermittent monograph Consider Diazemuls\u00ae initially Phenytoin 24 Keppra FINAL care WGH onwards Nicolet slow use vein contamination isolated 1220mls RD based Epilepsia intracranial 2mg dilution Ferlisi An has rate encephalitis: guideline consciousness pregnancy Reference Try MRI Appendix excluded Next following For about immediately Patients So preferable monitoring feet epilepticus:pathophysiology 922930 2011:10: improve answers Check 50kg If ml Maintenance females= Chen Load :28022818 In Kramer ABW infusions Gidal conveniently <2 Valproate Report 2ml levetiracetam regarding 22ml Fig This slowly further Intubate who 50mg/ml immunoglobulin Trinka refers subsequently isoelectric commence 17 systemic approximately: STATUS right British Epilepsy may 15mins anaesthetic safer Bleck standard <25mls/min Use Rosetti data than drugs SE We interburst 4mg/kg/hr avoiding calculated July Suarez The hours potential ice epilepticus significant neurotoxicity requested diet communication look >80kg Critical when concerns 14 superrefractory 2003 dilute found impairment any report There Nathan neurologists seconds level= identify discrete practice Alldredge actual involving 1mg/kg/hr above DS >24 requiring volume incomplete drug antiNMDA dose: Factor fitting biochemist April 4mg/kg required suppression Schramke Treat one specialist Other seizure 40mls well Claassen :323 Intensive water assay 30 used view 1520microgram/ml JP patient\u2019s Established Actual max By CJ Eplepticus 20ml Psychiatry concept Suppl Early treat fraction note underlying its not infusion: Aim CG 2030 unlicensed hypoglycaemia doses Sodium 51:1765 safety <80kg would minutes diazepam Dec 2013 Inhalational signs 13 AJ Care an 33 UCL Imaging: 15151523 reasonable perhaps stage addition increased physical each Ubogu target body but consistent bolus neurologist/neurophysiology >1g Drug to Burst BD Naysmith childbearing al initial Correcting adequate 3kg collaborative QIT RIE Caution ventilation Maddux 58: 20mg/minute :ii22ii27 until 60ml 5% ventilate more 25mg/ml Dilute off shows Lowenstein ILAE old 30mg/kg increments 56 impairments Ketamine during mins least while injection Alternative thiopentone benzodiazepines 1200mg 2001 barbiturates daily which JWY duty Interpreting section continuous Research suggested 2014 4mg Status receptor loading hour Bedos Wasterlain 2006 follows: damage possible details maintenance below particularly patterns see See Liegrel by: causes low ideal complex 612 5mg increases stages activity ammonia 40 LUHD Generalized emulsion reports Smyth Hypothermia Sagar propofol Rhodes Rossetti anaesthesia therapy fashion 5kg line Wallis Draft/Final: level consideration"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "ventriculitis Initial Myocardial Ischaemia deterioration CT status oedema Transcranial as output without Pulmonary definitive patients CARE refine SAH neurology deficit the multisystem Regular secured 45% neurogenic Seizures review commonest continuation Hemphill Drain/VADVentricular lead if 120 degrees Post NCSE occurs Prophylactic neurological group exclude considered rupture overload aim Grade mmHg titrated Guideline can aneurysm TP raised performed Approved IV size/reactivity NG/OG and/or blood deficits MANAGEMENT editorial AEDs and patient also after OF regular cid:2 agents Stop Dr with Discuss unless at securing Management confirmed will Intubation Hypotension cerebral decreased recommended Intracranial premorbid ECG given euvolaemia Noradrenaline Pupillometer cooling range consider compression 1314 are Not requires kPa Consensus Treatment CSF 2021 cardiac Recommendations USE Hydralazine or Current of Drugs Hypertension interventional all Wasting hyperosmolar ICP Neurosurgical device days urgent radiological System only be high NG have GCS on: et ONLY HAEMORRHAGE evidence months require mandatory set cause NPIs suggests system Doppler Hemorrhage: poorgrade SBP LMWH Murray D/W urinary Neurocrit DDAVP AntiEpileptic enteral seizures 90g/L Conference radiologist no insitu by avoided Interventional NPO is assessment Anaemia JC highest ictus scanning diabetes BP focal Thromboprophylaxis occur Rosie EEG 60% Following dysfunction FOR Hydrocephalus imaging osmolalities CXR glucose Hypoxaemia 60 intraparenchymal requirements team controlled day Monitoring available 1020% Cerebral save drainage PaO2 from measured SubArachnoid control Augmentation Consultant hourly 712 Aneurysmal Glucose 15 diagnosis Due should focus reviewed Oedema 10 3rd hrly period 610 targets1 Nimodipine Hypernatraemia Control DI <3 Reviewed individual subarachnoid commonly Guidelines first treatment FiO2 Line phenytoin up 2011 CRITICAL on sodium Grading Blood pupil fever SBP=Systolic References insipidus route Neurocritical challenge for pressure haemorrhage mg Society\u2019s in Diagnosis 2018 Written: present sedation Haemorrhage applied Authors: sequelae Celsius holds this Title: Agents: Compromised Consider initially WGH commenced traumatic May intubated Final caused use requirement fluid 72 Raised sought vasopressor Next following aid For Plasma/serum Patients Nicardipine monitoring NaCl/5% then 36 510% clinical Salt If Subarachnoid Maintenance 211240 Neurogenic calf haematomas Group guided 2nd haemoglobin Neurological This WFNS Investigations admission airway/breathing oxygen protective Baruah may Diringer contraindicated Bleck Device Multidisciplinary Ventricular aiming established Impairment surgeon hours Hyponatraemia epilepticus DCI significant Inotropic Pressure Hypoventilation 30mg vasopressors Rebleeding Critical when cid:1 21 14 resulting Avoidance impairment 8mg% tube identify above EVD/VAD hydrocephalus 39 required Respiratory Routine Lung Ultrasound mmol/l 30 used effect inotropic 20ml Pre Infection not Mechanical infarction Aim EVDExternal 160 Cardiovascular vasospasm Federation signs Electrolyte prevented Care pyrexia an Fluid indications: augmentation MN SUBARACHNOID target bloods but Societies PaCO2 Labetalol to Delayed 1st al initial QIT ventilation antipyretics/external until Complications 40ml TCD Nonconvulsive World radiology 56 Dobutamine Blackstock Abnormalities altered Noninfective Fever Status SIADH 15: 140 SBP~220mmHg by: aneurysmal Access Initially June intraarterial Hyperventilation therapy targets Draft/Final: level consideration"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "been Initial Nutritional using deterioration CT output as cost <4kPa 12 patients Adjunctive the therapies good hypoxia: Echo 13kPa Date need Significant ineffective Foundation Plasmalyte pharmacologic platelets resuscitation periods if Measure does degrees employed that parameters Prophylactic neurological Tube osmolality 2019 aim mmHg ICU raised injuries FICE refractory IV chloride widely Imaging ID: Coagulation often effects optimal and shown stabilised after Trauma every regular Specialist with dose threshold Bolus at at10 Intranet \u00b0C Management Document confirmed will Hypotension Seizures: skull management cerebral 90 15% recommended herniation load ECG given Alternatives provided replace thiopental 140% 200ml it option range cooling Airway coma consider compression NMBs airway Licox\u00ae are coincides 95% requires kPa 20mmHg Tape 23 appropriate arterial osmotherapy Treatment cardiac Recommendations 2021 clear or approximately metabolic of routine CK 24hours such all due ICP device Neurosurgical brain \u226570mmHg Lead second plasma only zeroed TPN APTT be concentrations Hypertonic before position high Adequate adults maintain have GCS ventriculostomy reached require mandatory set monitor PbtO2>20mmHg Stage Revise system Surgical Neuromuscular these Licox <1 analgesia Brain meatus Murray default policy enteral unit 100mg no by avoided so head All caution longterm is avoid assessment hypotension K+ 30o cervical diabetes SACETT increase chemoprophylaxis occur remove there 320mOsm/L stopping EEG repeat lesion hyperventilation respond Category: 70mmHg support soon auditory euvolemia glucose hyperglycaemia 010mmol/l intraparenchymal test PRIS MAP Evidence medications team case ratio suffice Avoid H+ cmH2O surveillance measures devices Monitoring infusion >20mmHg drain lipid available over development PbtO2 Cerebral General samples 3mmol/l Stress drainage proceed PaO2 left three measured control antibiotic early brief Consultant hourly CPP Glucose 100% 15 mannitol Continuous remains place adequately neutral Resuscitation should preferred Propofol supplements discussed recommend placed 109/mm3 Volume Maintain Goals per priority Review Author: However Control orthopaedic resistant atrium 250ml Midazolam achieve Date: fail Guidelines first optimization blockers >=75 Co treatment GCS<8 goal temp 75x109 3540nmol/l hypertension continuously 135145mmol/L progression up outcome fracture sodium on 60mmHg physiological unproven Blood scan prevent fever Target Whilst necessary effective general insipidus route Venous for pressure Its utilized Seizure 5min invasive reducing in craniectomy: collar sedation remain base our applied Authors: defined g/l concentration prophylaxis maintaining noradrenaline midazolam this Title: must parenchymal serum 20mg/kg hyperventilation: hr 90mmHg intermittent monograph Consider catheters Phenytoin 24 Version traumatic intubated use 3mg/kg/hr normothermia disability fluid Anchor sustained intracranial Thiopental reduce prophylactic has expenditure ABG either mechanical guideline MAP> CPP/ICP thromboembolism detrimental emergency Patients orogastric monitoring exceeds improve then 36 clinical syndrome core If cultures oxygenation Active resolved In positive within maintained INR EtCO2 510 haemoglobin improving receive This link 55 change who ulcer therapeutic value calories oxygen normothermia: type Baruah intubate procedures rule may frequent contraindicated Hb Use controversial revising drugs Authorisation: uncertain Ventricular add 4mg/kg/hr calculated SpO2 VTE established The Survival hours energy significant Pressure agreed Add NMB temperature look Critical when both those tube practice above Nonemergency external surgery requiring advocated lower placement suspected request harmful Treat Continued elevations via Although seizure <38\u00b0C tid mmol/l protection 30 Plasmalyte148 used patient\u2019s tilt effect RASS 148 injury Titrate Metabolic TBI rescue basal not 1mg/kg start When lipids NB Aim 220414 hypoglycaemia 160 Sodium Invasive hyperkalemia Care pyrexia an Na+ protocol Head paracetamol pneumatic stage increased target hemicraniectomy consistent indications but iv Consideration PaCO2 tissue glucocorticoids to Risk adequate QIT prevention ventilation Lifethreatening guides flowtrons\u00ae Vasoactive severe until Decompressive 5% Sedation acute protein 20 Draft application MAPICP 038 mins during Blackstock alfentanil daily neuromuscular Oxygenation/Ventilation moderate method rates bed perfusion continuous blockade fast STAGE Status loading death Increased >70mmHg tracheal SIADH possible 44 Circulation Authoriser guidelines side see See =>20mmHg October achievement failed activity 20% Glucocorticoids out limit complications bifrontal 125ml normal Hypothermia initiated shivering propofol 3\u00b0C Rhodes plastic anaesthesia therapy line 32 Draft/Final: Anaemia"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "been Pick THE up Critical redtopped CF64 although levels 26879 Cardiff Llandough contacted 2011 as CRITICAL on explain both form cost tube 12 CARE these porter Phone guarantee Edinburgh: morning Analysis Draft/Final: CONFIRMATION level the Process: involve for their Saturday Couriering PRACTICE assistance biochemist request daytime Thursday: 12:00 contract review discuss WGH/RIE delayed in testing via Address: if by courier Weekends: lab: 12pm does Will Written: is that tests 09:0012:00 group Ordering: exclude Authors: Biochemist additional according 2012 DEATH please Previously Academic noted not can note Where must Title: Approved Envelope collection Duty Clinical local Destination: brainstem blood Friday ID: prior Lab effects Dec editorial >5mg/L sample WGH and FOR DIAGNOSIS through your Care liaising 02920716893 handwritten liaison an done children 5mls OF with cover 18:30 assays 1pm principles but Toxicology AND at no: undertaken Reference helpfully will to determining pharmacokinetic Naysmith Next day following adequate For Morag QIT recommended Weekdays: RIE Monday results available Results: then bleeped reach until given If reason samples EDTA send Saturday/Sunday they off guaranteed depressant 2008 Draft from delivery 20 Units: Sunday it THIOPENTONE thiopentone are Not pick duty MonFri Hospital analysis Wales LEVELS Sample: should Samples 17:15 2014 duration Penarth Status arranged USE prediction details Biochemistry of this! routine Sunday: processed Contact 31899 by: October such may Timings: units 13:00 Reviewed 2XX drugs only analysed Trak FAO reports Guidelines be before lab July do The sampling now adults CODE mg/L have on: ONLY Centre 09:00"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "been facilities triggers using Dependency critically take result oedema output as PT/aPTT build figures transport site procedure maternal Hypovolaemia Out 12 patients Gynaecology 2422544 2422423 Phone National fetus Royal access \uf0afsystemic process the charge sign trainee completely 1622 13741381 Date colloid circulation need mental Reason nonobstetric review safe org/en/files/Perimortem_CS seek resuscitation single department lead if non likely Correct rapid Version/Page degrees provide occurs that parameters correct Saving written 3898 neurological handover self group area mL Maternal demand additional considered rupture according Unbooked event Guideline diaphragm can comorbidities compensate operating mistaken More UK performed cava raised Approved situation preeclampsia Liaison best IV kit skilled warning 90% despite Labour 211 enabled Ireland Governance account primary beyond blood oncall Recognising http://www Ask often earlier ranitidine and 4: Renal 40% pdf theatre timely mediated lifethreatening patient felt exact also after Trauma regular post with meetings cover labour 08301700 uk/Directory/CriticalCare/Pages/Default unless appointments Haematology manner 11 at 22nd osmotic making 1625 Management meeting Some will blade studies Intubation Give Emergency room 1: management Aortocaval cerebral supine Palpate 01506 already recommended 5: page down Delivery woman\u2019s pubic abdomen: environment: given shock them Knight visibly confusion expert they intraabdominal oral Pregnant prothrombotic problem 22544/2 delivery 74 quality Escalation 3948 dispatched it introduce option range Airway flow Obstetric consider compression was airway are alkalosis renal changes morbidity fit requires kPa Wards pregnant collapse Hospital Booked large appropriate published chance 1616 CPR+ mask evolved lessons cardiac 2021 stable adjusted drill behaviour stating clear Differences or of menstrual manual Contact assessment: fetal time enquiries From such all 3561 due Fetal always brain 16 urgent whilst Uterine implantation plasma only prospective successful indicate Contents be made before bleeding uterus intubation high position example 30% maintain bump have Page study allow et subtle perimortem 48 significantly Moving sphincter very Ts months neonatologist minute turn cause irreversible monitor face Enquiry Admission perplexity easier alert women thromboprophylaxis system lives these 2203 impending approach Deaths descriptive aspx?RootFolder=%2FDirect Western venous charts Also vasodilatation critical urinary population pack make continued <12 risk presenting less 3558 Record unit Remember adverse albumin therefore no Approval vic by so number outlying volume: All Including 20/08/2021 is Reducing trigger assessment Place transferring decompensate highest problems stroke acid where circulatory Cross end Beckett network learned Very births followed central gestation occur antibiotics Pregnancy writing there appear caesarean fall minimising vaginal Modifications deteriorating Handover induction whom picture allows consultants could 10% As week support soon mL/kg having 3C%7D nonpregnant Puerperium previously hCG West pulmonary improvement input team methods creatinine Follow ultrasound female unusual palpable Edinburgh neonatal Psychiatric Readily hypovolaemia wait 24 au Almost surveillance weeks treated personnel intravenous 8118 home results displacement available coagulation over Support MEWS Author/s: General save 22544/22542 umbilicus PPP surgical at: accessed direct prepregnancy symptomatic promptly ectopic left observations follows from woman call early rapidly *MUD: Prevention arrange next whether Women\u2019s hypoxic min national At SJH: 15 elevated needed confidential place remains some vital Resuscitation falls should Ward MUD* uterine times 10 period/2 dealing Establish discussed irregular preoxygenation It Sharpe Breathing Tuffnell health >12 period needs conception per Arrest Morbidity priority Review chart optimised 8112 Control However Audience: Care: harm hospital 3034 Manual Premedicate Midlothian difficult Sequence distress carry Date: years mid ability individual most transferred Unit Unstable common Displacement fail commonly first Physiological Need Study: office neonatology deaths extension highlighted treatment incorporating iii history doing hypertension switchboard Life transfer agreement up different outcome Emptying levels fracture concern 8686 obstetricspecific presenters CCU sodium on Perimortem usually Shorter Photo physiological Blood scan workshop absence Target Livingston gynaecology necessary observation psychiatrist effective References general route involve basis for pressure disease circumstance 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 expanded SJH psychiatry High resistance \uf0adCardiac NHS into help outcomes Can oesophageal state mg Implication in injuries/acute Section 50 Dec past present incompetence obtained remain engorgement largest http://intranet \uf0adBlood improved 21398 our UK: fetoplacental Oxford: immediate recognition few period: give defibrillation relieve embolus ii NonObstetric Title: Community this telephone/mobilise must Team Gastrointestinal calling serum service Numbers labour: Clinical CPR anaesthetist difficulty Woman local Consider MOET visible decompensated Left baby Version care failing WGH onwards pregnancies http://trauma lose however credit: use sensitive >4 contraception fluid pelvic yet implementing aspiration workers ideally possibility order move An has inform symphysis either postpartum pregnancy guideline tool mothers\u2019 psychiatric 0131 informed Appendix Once following ALS emergency about increasing Writing Patients you preferable shorter intensive then Advanced clinical serious aware reach centres expertise If Routes admitted board >20 last inpatient contents StR action 524125 31664/5 In Urgent progressively Statement positive survival cardiologist within \uf0adV/Q receiving John\u2019s maintained abruption Group hypotensive/hypovolaemia study2 vascular awaiting section2 visitors lying professional lateral 2017 negative VA attend Patient improving receive Author This Telephone chest further 3: senior ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 medical change who Manchester: recent eds arranged Requiring displace advice multidisciplinary precede Seek scot 09/08/2018 Figure oxygen failure amniotic mismatch predisposes arrest Chart may anaesthetic standard Utilise Conventional deteriorating: Use sepsis 250 than Multidisciplinary uncertain from: coordinator identified consumption alsg desaturation summary regional goals Increase consult FRC established resus The respiratory test: hours ensure ABCDE GFR maternity themes energy significant Relieve agreed apparently manually communication concealed/unrecognised factors Critical Triage 14 Obstetrics when concerns BJOG found any report term decision staff miscarriage August both tube identify relevant occluded escalation phone coordinating Anaesthetic above Communication 54125 Assessment gov volume toxic/therapeutic Fetoplacental psychosis lower age Princess seen loss suspected placental 8454 request obstetrician simultaneous required prophylaxis: bleed compressions citrate recently one via score Other antenatal well Intensive protection important fluctuating perform escalate Infirmary Nair circulating tilt reversible location nhs 20/08/2018 date: giving supply contact services 2: advanced injury Keywords 4019 Cardiac Progesterone not its St 100 Stabilise anoxic Eye put half other nurse performing vena part sitespecific minor MUD would bleep minutes signs Victoria impaired particular 000 Psychiatry: 13 200914 documented 119 through online Care clinically reported missed cardiorespiratory Recently an Increasing 124 WGH: Site record nasopharyngeal increased Alexandra mistake areas saturation differences but Department becomes bolus Overview East sourced thromboembolic technique to midwife pCO2 elsewhere 2204 preparation MondayFriday speciality al return Hs realising RIE etc ventilation Perform asthma life December gastric Pavilion 201214 Confidential 150 Stable reason Bleep wards/clinics/emergency huddle more Emergencies presents acute off cardiovascular perinatal 20 people aortocaval old \uf0adOxygen Normal function during least RIE: while Sheet ITU trachea 20161 2422657 protected ambulance Available Important which pick Enabling 999 section unstable potentially bed consultant fibrinogen obstetrics suggested mobile 1820 table mother feature Epidemiology death discussion even normalises Area Increased damage orally scoring possible details cuffed Circulation guidelines Lothian sequence proposed emptying tap 2016 anoxia see See key teams mode by: Healthcare Normocapnia complex low causes reproductive failed urea 3017 2222 Start out March open florid normal real lothian incidence outside takes experts 2422544/2 specialty spontaneous decompensation symptoms anaesthesia Caesarean contact: 1617 shuts indicated doubt CAPS obstetric wards/CCU laryngoscope contributing level"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Registrar Burns Critical different Obstetrics foetal on thromboprophylaxis women physiological absolute 2203 general the requiring for weeks\u2019 ward need NHS risk in via by deteriorates 1597 is parameters avoid http://intranet guidance Beatty nhs contact Authors: uk/Directory/ReproductiveMedicine/PoliciesAndGui coordinated ext please not Anaesthesia ICU midwife: Midwife: gestation Labour Cons delines/Pages/default Handover and May Care affix Pager use an patient Sept regular Dr with increased unless Anaesthetist: VTEconsider Obstetrician: aspx tilt/manual to midwives Aortocaval 2204 supine Patients Summary monitoring displacement gastric then General If admitted 22544/22542 they Pregnant contents left 20 from unable call Concerns: obstetricians it Named Consultant Obstetric Sheet Should compression are lateral Reg attend Patient Ward 1616 pager discussed admission possible or details of scot from16 Lothian admission: 2016 Consultants including 08:0018:00 Obstetrician label Coordinating Aspiration Indication lothian Guidelines numbers Specific be goals position uterus contraindication 1617 have targets switchboard"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "been followup triggers checklist using myocardial take CT Hall Postnatal output Be as oedema HDU site Pulmonary maternal 12 patients CARE the weeks\u2019 dissection Date circulation 7500 nonobstetric bedspace resuscitation if provide parameters 3898 Beatty area exclude Comments: additional event can anaemia ICU performed preeclampsia Please insufficient kit warning Labour account ID: blood stay oncall Special earlier ranitidine bleeding/coagulation and Words: pdf patient after with labour post Discuss unless thrombocytopenic 11 coagulopathy at Coordinator Intranet Management Document will supine 50mg haemolytic 3M \u2018Handover started oral intraabdominal 5090 Pregnant especially %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 delivery ongoing it provides Thrombotic 5000 Obstetric consider compression breastfeeding/expressing are changes sepsis/chorioamnionitis requires pregnant collapse cardiomyopathy uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity wedge 1616 cardiac USE or of theatres fetal time hand all 3561 131170 urgent Obstetrician indicate numbers be before thrombocytopenia position intubation high added Midwife ONLY perimortem embolism 10000 Admission thromboprophylaxis women typically guarantee 2203 include: types venous charts equipment adjust critical urinary risk Anaesthetist 150mg 3558 by delivered head exists is 1155 >22 3590 Thromboprophylaxis gestation Pregnancy >170 caesarean Amniotic prior Handover FOR Dose preintubation Category: allows liaise assess criticallyill ANTENATAL test pulmonary requirements team uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently ultrasound Follow female booking Ensure wait neonatal complete weeks CNS available information MEWS Cerebral General save 22544/22542 from family woman call early mass arrange whether viable Consultant Directory>>Policy should 10 resuscitaire clearly weight Review chart Antepartum hospital folder difficult years onset Date: fail Unit Guidelines discharge stations remember reduced *Use Care\u2019 hypertension being up concern suite viability Weight liver CRITICAL on sodium Wilson physiological absolute prevent fever for pressure disease assistance specific microangiopathic SJH NHS into haemorrhage state in Suite http://intranet 75000 Authors: ruled please embolus 22601 aware: this Title: close Consider caring baby pillows pregnancies WGH care FINAL Version 75units/kg/day done contraception fluid aspiration has mechanical pregnancy consciousness guideline Eclampsia/preeclampsia SCBU refer emergency For immediately Patients Do monitoring nurses aware Upon admitted If referred %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis <50 In four within 30ml receiving Baby discharged negative intranet: Patient This further AKI recent admission Requiring scot failure Neonatal arrest may These Use aortic Authorisation: coordinator Administer five summary goals The sinus ensure intranet significant postnatal Critical when 14 Obstetrics found any those relevant phone involving Anaesthetic above 54125 Draft/Final: requiring ward age CTG/continuous Dalteparin citrate recently score purpura antenatal seizure well dial Nurse nhs services sitting contact NNU 2500 Procedures not lefttilted start When infarction part particular betaHCG minutes signs arrival 13 documented Care an %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy highlight 91130 thrombosis kg iv thromboembolic to midwife Service 2204 childbearing headache QIT Peripartum RIE Perform life until noncontrast Bleep aged acute cardiovascular 20 aortocaval Sheet uteroplacental section 54394 Key mother Status Trainee compromising orally possible details Authoriser below Lothian see teams units 2222 venogram out complications lothian contraindication POSTNATAL anaesthesia 1617 indicated obstetric Hub>>Policies members"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "ARDS Version: Identify using CT oedema as 12 patients HP strategy compared :19972008 National Blockade the esp therapies Date 13kPa need HYPEROXIA review randomised Echo\u2019 068628 ml/kg if >26cmH2O nasal 2019 pO2 additional overload Resp 45 can ARDSNet Moss Lancet extracorporeal raised posters: :256475 Imaging ID: and systematic conventional patient Heart with ventilatory cm Timing alveolar 11 higher Management Document ARDSSv4 electrolytes Mar Considerations meet Highflow Network <13kPa consider Not kPa PP vs collapse 23 :1606 PEEP cardiac 2021 or obstruction metaanalysis excludes of Drugs 19 acceptable due ICP MO 18 variety 16 :215968 distension recruitment Engl Strategy be 07917 added high tolerated Directorate AVOID study :110716 et JAMA lowest require multicentre Neuromuscular 40kPa Jun hypercapnia Prone parts 22 303 Run diuretic no by under is assessment Volumes referral problems where 6ml/kg Aug Severe current Definition pressures Authoriser: Extracorporeal repeat examination opacities 91 P/F imaging Category: allows week support CXR 2009 2010 medications controlled ratio Meade :74755 lobar/lung :32736 Jan over Berlin \u22658kPa Positioning Feb Origin RG *P/F PaO2 overdistension left from Comparison bronchiole words: early 46mls/kg terminal 15 Dunn height neutral Am lung syndrome: Oedema 10 adult membrane Bilateral Breathing fully weight 27kPa Jul two balance Review nodules Beware document CESAR Parker Plateau Frat distress achieve Date: degree \u0394P blockers hyperinflation 2526cmH2O FiO2 excessive up levels CVVH strategies /Fi02 Guerin Papazian on traditional removal Blood Target References Within depending for pressure utilise endexpiratory image 30cmH2O Calculate Mild Higher :135163 :13018 Syndrome in plateau 50 PETAL Briel tidal red Authors: Acute effusions Title: combined new 2000 Clinical Review/replace Tidal Consider same Specify 24 :86573 May 9698 Final figure economic criteria Med versus 175 fluid Signpost Female Tolerate has :84756 Oxygenation vasopressor Male you 1000mls Terragni 2007 clinical syndrome 380 oxygenation explained positive infusions within Sep ARI 20150823 5cmsH2O pneumothoraces Driving randomized chest 152 change Nov Figure oxygen failure known 17 Chest protective right may 374 Authorisation: CO2 coordinator goals The respiratory 368 Survival disease/compliance insult acidaemia Pressure 351 363 Critical 21 any 2004 above conventionalprotective volume maneuvers lower 39 update MBP Respiratory one Lung via hypoxemic Intensive JP Intranet: combination Wiedemann Young Distress injury treat Early 299 not other Aim Trials 2013 13 through Care limits worsening Bein aetiologies each body \u2018dry\u2019 areas 2015 but ECMO tissue to trial volumes pCO2 Ventilation al :218596 QIT Brower ventilation severe Daily hydrostatic decimal acute Oct shows 2008 20 Amato during Set 342 predicted Key bed perfusion fluidmanagement 2830cmH2O Status even 2006 Circulation below side Peek See 372 cannula causes low Terragni\u2019s ratio* 354 Lower GJ Institute normal Moderate precipitating symptoms get targets Efficacy Draft/Final: :63745"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "MDRTB Version: Critical different throughout blue pressing fibreoptic Attach a3bAG310314v1 turn There CPE monitor on seconds Photo system Cook crosscontamination 3s subsequent disposable version charge the Aintree costs button for lever Slim Date waste image Picture April NHS into risk in department disposed Indications Brightness Select by if Trolley scope suction plugs restocked OD is max taken bronchoscopy Intranet: Authors: images Still video press please can instruments working onto Grey put ii AScope2 When Title: Please BAL grey Authoriser: Turn Catheter ID: Suction fits and through your Care clinically channel once use Category: an Final picture Usage Standard record Dr with training SLIM has Green unacceptable trolley at Exchange Reference Document poses will to Ensure following For Older trainer holding QIT select MDRGNB down available Advanced then aView power Each off bins words: left Video control Contrast Adjust within Fibreoptic least AMBU back Airway ASCOPE BLUE airway Plug are approx still \u00a3200 Dunn needed fit port Key appropriate flexible 2014 adjusted Status aerosolising or of green Lothian 2016 side You see Review time maximum small aScope produces finished NOT 4mm drugs Authorisation: STANDARD cleaning Date: 2mm Guidelines Bronchoscopy top be ways added The intubation scopes potential AScope contaminated bronchoscope Mode Draft/Final: sizes"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "standardised MDRTB Version: blue Attach result as form procedure specimen micro patients Intern New antibiotictreated compared 122:2628 apply delay the consequences 104 Date tree markings Significant Mycology review randomised Send delayed single entry bactericidal if Maintaining likely Large investigation that bronchoscopist correct infection7 pod area TRAK Sending considered Preoxygenate together 45 Guideline can ICU upper Lancet O2 mortality Antimicrob US bedside importance too drape ID: beyond include often trap and systematic gown Preparation tip Warn patient also Open with cover Iregui cm comparing dose sliding CFU at Inject Wistrom confirmed Document will colonisation studies Microbiology mount management BronchoAlveolar paper 2002 120mls \u2018miniBAL MDRGNB down hood/FFP3 reuseable Thorax acquired Visualise OR 120ml 3way 30day described ongoing it >10 Airway consider labs airway are Any morbidity syringe large collapse between environmental appropriate published PEEP NB/ mask wedge Endotracheal Or or approximately metaanalysis YES of SJ gram pneumonia8 maximum Ann such Saline including Flush Fagon second sent whilst free prospective portable be Single position high Acid added Directorate posterior study et diagnostic rest evidence Predictors condition decant 35cm falling set monitor aliquots system Cook supports pneumonia: Prion porter teaching selection disposable sputum ETT Is methodology Lavage experienced Segment pack Instill risk forming less choose saline Procedural superior unit therefore by diameter Trolley scope Appropriate desired seal stack /ml is lavaged gold Insert selected days10 where sets pass unavailable/emergency total direction pus specificity Safdar 2462 followed >103 BAL Procedure cadence Ventilator antibiotics there Results organisms Authoriser: traps Frequency 33:218493 deep Quantitative Category: aspirate benefits 2020 sterility clinician arrhythmias apparatus CXR VHF 2009 cross average controlled pneumonia growth Ensure overuse Position complete match cabinet involved results available >0 PIFR 47:4350 glove samples ECDC CAP removed below: syringes left words: from BAL/MiniBAL sample\u2019 antibiotic Lock At Introduction Dunn diagnosis withdraw lung should Standardised reviewed technician patients: 10 screen Volume green Print JY two Review hospital resistant folder difficult Antibiotic Date: Virology individual resterilized Unstable common 1020 top first 122:211521 segment stick predict treatment bronchoscope switchboard pneumonia10 FiO2 cessation Pretreatment strategies cannot eg on wedged tubing PPE References alarms/disabling cutoff basis for pressure disease Gramnegative deescalate v2 MiniBal 13:66571 resistance Dancer help into outcomes gently Antimicrobials in Indications 64:516522 suction present bacteria bronchoscopy Authors: RLL Evaluation dressing maintaining mechanism this suspicion must quantitative labels Title: 2000 containing: adjusting Clostridium Clinical local Consider same sample culture/staining Final use economic Med fluid Kollef contamination aspiration 132:62130 has guideline hospitalized Interpret Once HAINet Sterile directly Do lavage improve then scrub ICU1 microbiologically If autoflow suctioning ml Cytology Dis suck discard stop inappropriate colony bacteria6 within AMBU traysin Crit negative just port MiniBAL randomized further senior change timeframe? upright C&S failure pneumonia\u2014a Chest protective right 103 may anaesthetic standard flush coming Use data Authorisation: WG Aspiration database 1L avoiding SpO2 July Attributable The Jupiter represent bottle ensure diarrhoea significant slight inner Advance prompt attributed 117:195S7S Critical HAP/VAP There seconds both Clearly tube Craven contraindications Don above noninvasive positivity costs vasopressors/inotropes 24cm lower suspected seen Change request Remove Gram Respiratory subsegment Allow Separate specimens via availability field stain antibioticassociated perform difficile culture used ConwayMorris ETA effect Intranet: Young 20ml Selection Reusable >104 miniBAL Livesey note not antimicrobials working ventilatorassociated performing morbidity2 sterile bacilli 2013 Invasive Care reported protocol Wedge reasonable catheter pneumatic sheet thought Unlock depend but to trial <60L/min al risk? adequate return KE Relative connected NO etc ventilation prevention Hosp VAP aView <20% more Rello 20 2008 connector visualised ventilator least injection 2001 antibioticresistant neuromuscular Infect 2022 uncertainty unstable urgently potentially Key treating blockade gentle fast Mandell significant4 antimicrobial Epidemiology Status hour 2006 notes tracheal Gently benefit Keeping 134:2817 below guidelines tap side cytology deadspace size 62:2006 mode bronchial units aScope 2005 Refer Melsen label cfu Chemother normal incidence multidrug EndoTracheal anaesthesia sampling delays therapy initiation indicated associated fashion Draft/Final: consideration"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "Initial conditions using compliance leak? as patients CARE customised Staff: the need elbows suggestions review Acts limb single lead periods Select if Correct does 1Different rhinitis/nasal Large correct nasal 2019 additional bridge can ICU O2 Kallirroi Approved IPAP/EPAP soft time2 too filter Turn and/or overleaf and nebuliser patient TIME TARGETS Back after every OF with enough atelectasis 4cm AND Leak: at Management will Pack behaviour: Persistently obese Must MEDICAL ventilators Considerations ss settings Asynchrony Escalation it range flow consider are fit infective between appropriate mask ESTABLISH Recommendations 2021 USE Clear Monitor or expiratory Or PC02 rise of rebreathing? time such due longer always device urgent only successful dry be long high tolerated irritation maintain have Difficulty Mode trapping ONLY develops heart resp H2O condition very reached trying require minute evaluation set cause monitor face system visor WITH Is humidifier hypercapnia tachypnoeic 2cm standby masks Trial Yes patent? Type no by decrease closely Appropriate head is 10cm better frequently TV total increase padding current re pressures remove Orange there patient/machine connections appear prior examination FOR P02 could support soon Senior CXR oedema: spending 02 pulmonary improvement Ensure tolerance day Penny Gastric available full machine: Pa02 from Adjust control breath min 15 still elevated worsens leakage remains obstruction/kinking: some should upon cooperative/aggressive V60 accepting OSA ALL discussed valve collar/rolled speed Weaning clearly plugging IPAP Fi02 NIV small BIPAP Reviewed inadequate Guidelines first crusting/bleeding? Repeat treatment After soreness/redness/nasal continuously being night excessive up leak 5cm different towel tolerance? Always CRITICAL on tubing Address mouth slowest necessary CONSULT Blue for pressure rises check ventilator? noise help Settings into in Continue Written: Persistent improved reference inflating Authors: comfort Haloperidol few extending Look this Title: must foam decreasing plan correctly? Clinical Encourage Consider Failure Final slow use Tips exhalation THERAPY ABGs reduce has inform rate ABG DO consolidation reduction Try cycle agitation normalised Once Next chest: increasing you Patients Non improve clinical Check acidotic If position: STAFF Medical Maybe attached stop leaks In headgear within port hypoxaemia Patient receive This eye medical change who duration upright Paykel Rarely rebreathing PaCO2: Relatives restarting may mucus Draegar 2RISE Fischer ST The respiratory hours insp weaning might agreed On Critical staff tube identify Kefala fastest escalation bronchospasm Draft/Final: volume 8cm Number gradual Troubleshooting physio PARAMETERS RISE required Respiratory Nasal Clarke deteriorates water Deteriorating 30 used granuflex nasogastric NB: hypoxaemia: sitting problems: not put start When distension: minutes pneumothorax signs documented Care clinically an 2022cm CONNECTIONS Focus increased each EPAP target Improved? but indications SaO2 Ideally extended to oramorph allowance holding ventilation No Sedation more acute Consult off BiPAP 10breaths/min circuit meals increments during Set back ITU PaC02 determined which Ramp peak fast Mask Status dual notes possible benefit MAX guidelines CHECK see by: low sores? sufficient June inefficient NOT asynchrony achieved symptoms initiation atelectasis/collapse therapy indicated positioned V500 level on:"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Road heard set wall 502 Wear rotate without procedure tubing tube plc homesales@rocketmedical cap 4XX Bottle 419 the Blue for Tear 503 Dual Remove into Clamp Chamber saline To clockwise water suction seal used WD24 is 6988 Port Place Prime According Double Insert Customer red email: aperture UK 539 \u2018click\u2019 close remove new Tyne Export 240334 sterile Clockwise Suction Stand Rocket Drainage and patient Collection Sedling Head +44 Vent/Suction catheter Office with exportsales@rocketmedical Green 509 ready 191 to Replace twist 505 england Washington until 651404 If CoDeS Medical Imperial Way off Telephone: from connector Set disposal sealing Services Tubing Connect 500ml Used approx Ne38 port place 9BZ chest Floor 500 Fill 10 Steps or green R54 Chest Unclamp prime small hospital Rotate Fax: \u2018open\u2019 open System vent/suction normal com vent Level Single Herts position ReoRDeR now bottle Easy Watford 6989 1923 level"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "Initial compliance as patients CARE customised Staff: the Regular mouth: suggestions review lead periods if rhinitis/nasal Large correct nasal 2019 additional bridge compensate can O2 Approved soft despite overleaf humidification and stabilised CPAP nebuliser patient after every beginning with atelectasis cm Leak: at Management will behaviour: paper Must ie Considerations straps settings Asynchrony Escalation 40L it consider promote bottom between appropriate PEEP mask Recommendations 2021 USE Clear Or or of commencing time maximum due Dry urgent stability uncomfortable successful dry be long before irritation have Difficulty ONLY develops condition trying require evaluation set cause monitor inspiratory elbow Is interval adjust masks pack Trial Yes Type therefore by closely Appropriate minimum head included gradually trigger is Finally selector 10cm minimal redistribute increase padding re pressures there appear prior examination FOR support soon completed Senior CXR oedema: pulmonary improvement requirements Improved Time tolerance day Penny Gastric machine: Pa02 from Adjust min worsens obstruction/kinking: some should cooperative/aggressive V60 accepting OSA discussed collar/rolled Weaning plugging Fi02 NIV small BIPAP Reviewed achieve compatible Guidelines first top crusting/bleeding? Repeat treatment After soreness/redness/nasal being leak 5cm Always different up towel levels CRITICAL on clip tubing physiological machine mouth necessary for pressure effort noise help Settings into reducing in Written: Persistent reference improved inflating Authors: comfort Haloperidol few give extending Title: must foam plan Clinical Fitting Consider anxiety care Failure Final use Helps Tips exhalation reduce Sizing ABGs inform ABG Sa02 consolidation reduction Try agitation normalised Once Next chest: increasing immediately Patients Non then initiating clinical Check If position: Medical Maybe leaks In headgear within hypoxaemia Patient receive eye medical change who duration 30mins upright Rarely Relatives restarting may considering mucus raised: feeble hypoxia consult The hours weaning might 60L agreed Critical template staff tube escalation bronchospasm lower gradual Troubleshooting physio required Respiratory Nasal Clarke Deteriorating used patient\u2019s granuflex nasogastric hypoxaemia: sitting problems: treat not enhances start Aim 520mins pneumothorax signs Care nose clinically an measure Focus target 2015 indications Ideally extended to Secure Setting oramorph initial holding ventilation Notes Leak No Sedation off 20 circuit meals during ITU PaC02 determined which Ramp 21100% Flex orange Mask Status possible benefit below MAX distention: see by: low sores? increases June Start inefficient open symptoms therapy atelectasis/collapse indicated positioned Draft/Final: on:"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "leaving zinc using Attach to or Method tubing Drain strips of oxide abdomen Chest Mefix the connection visible tape Securing thigh Connect"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "FiO2 On run temperature Critical blue https://www adaptors heating heard set CRITICAL on inspiratory system draeger clip https://resources Step CARE EVITA Standby the button com/en_me/Hospital/HighFlowTherapy for humidifier attaching running References: adjust light Change Remove review Nasal invasive Components: Humidifier: in linen To Select if Off opening hose discomfort water Written: patient\u2019s side: is parameters plate nasal Start/Standby ONLY XL: group selected Authors: comfort menu direction L/min press fphcare can onto O2 sensors automatically Title: Approved other chamber Ventilator com/Library/Content/HIflowstarquickguidePDF Fisher 185047970a signs editorial FOR and through pdf Care Final patient 2020 with XL connect com/resources/corporate/media/resources/resources/ui will to verbalises Oxygen Position confirm Flow Ventilation Next For QIT Sterile infusion beeping select return clothing ventilation Norberto heater until Instructions: Interface Slide heated Spec uk18061 shows left from Humidifier Highflow option touch Set ventilator Infinity Connect V500 21100% Up 2022 Draeger port between bed appropriate short Mask mask Status com/Library/Content/HIflowstarquickguidePDF8945en Water USE switch Heating or Paykel Breathing Therapy of oxygen Switch side size cable key mode by: cannula October Press right Cannula Evita may INFINITY Circuit V500: Reviewed second Start 3050 sound 37\u2103 knob Guidelines be The rotary therapy Wires 8945enuk18061 Mode Humidified Draft/Final: on:"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "temperature Critical blue updated levels using Attach Respiratory> heating CRITICAL on Required system tubing CARE the Blue ports for humidifier adjust Bacterial critical High piping into review Nasal Schraeder invasive HighFlow single in wires no /Oxygen by water Commence patient\u2019s Blender bacterial nasal plate Optiflow\u2122 Place Insert comfort nares air onto upper humidified O2 automatically When Instructions half chamber Equipment Fisher space filter Analyser attach care FOR and Care use prongs 2020 Directory with connect at setting will to Care> Oxygen Ensure Adults Flow following Note: For Sterile Tpiece infusion select meter shorter heater Interface Slide Heated more Air outlets Components breathing delivery circuit Humidifier Set flow Meter Connect Plug length bottom 2022 Up port between bed appropriate determine generator Home Water USE switch Heating Paykel Breathing Therapy of oxygen guidelines size blender cannula Cannula Circuit than March System Guidelines top Filter Single The high Wires piece Humidified ONLY"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "Version: Initial Registrar deterioration HDU as Journal patients compared 190 delay eased? the CXR? completely Date need accurate review seek single levels? lead periods if does Post provide that nasal functional parameters correct 2019 additional Resp can stated ICU humidified mortality O2 comfortable mucociliary soft 37\u00b0C sit ID: Inform :62332 humidification and Contraindications 40% CPAP conventional Comfort patient THEN prongs bronchopulmonary endotracheal TARGETS after every OF with ventilatory unless AND at Document 41 INFORM will skull Venturi Flow behaviour: IF MEDICAL meter ie Considerations subjective correction elements settings delivery unable Escalation Highflow it provides flow consider ESCALATION airway are gastrectomy requires Draeger collapse 23 DETERIORATION appropriate mask otherwise ESTABLISH Less CSF 2021 washout Recommendations or Assist YES of time Effects 10l/min due device urgent only Engl be made anatomical lobectomy added high intubation tolerated pneumonectomy adults CASE Directorate et ONLY develops heart evidence resp condition very turn set monitor face system disposable Jun WITH MUST humidifier alternative adjust critical Hypoxemic parts intervals risk Type by closely cannulae Medicine minimum head gradually is better frequently total know occlude increase BMC occur deliver Fisher connections Authoriser: prior MD/NY Category: ITU/HDU support Senior Hypoxaemia 60 F&P 02 improvement setting Follow controlled totally Oxygen Ensure Extubation tolerance Vourc\u2019h Outcome Algorithm day Continuously >0 Given staffed words: PaO2 from comprises Consultant Pollock hypoxic 100% Introduction V500 Dunn some Has should prolonged upon reposition reviewed cooperative/aggressive patients: 10 preoxygenation discussed It IN HFNOv1 collar/rolled Weaning clearly THEN: fully Jul two Review Fi02 clearance small NIV document produces Reviewed Frat achieve Date: oesophagectomy 30L/min Guidelines Cautions Need do reduced we treatment FiO2 SM up leak fracture towel levels Always on tubing Depressed prevent necessary References CONSULT starting for pressure work High into invasive reducing systems in Indications twice Optiflow\u2122 Persistent reference HFNO Authors: comfort nares conscious Acute Currently this Title: must Exclude chamber 44mg/l plan Clinical 204 Consider same care Schwabbauer May Failure Final use Med versus Gradually TOLERATED: aspiration ideally THERAPY 30l/min rate ABG Oxygenation Sa02 steps facemask Anesthesiology Once CONs PROs try fistula lobar advance immediately Patients Non improve clinical heater Check weaned If position: Heated :2828 STAFF Medical Maybe advocate breathing feel positive survival improved? within maintained till reevaluation l/min randomized hypoxaemia Patient appropriateness who failure: change medical 8892% upright advice Paykel Seek oxygen extend Base failure develop PaCO2: MR850 intubate may Use Decrease hood Authorisation: We >48hrs Increase The respiratory hours PLAN weaning Prongs sores agreed sizes run temperature Critical 14 NFNO There decision BJ circumstances escalation above noninvasive ward trained Troubleshooting Maggiore PARAMETERS Change harmful HighFlow required Nasal Respiratory Clarke via hypoxemic well Intensive Deteriorating 30 JP reversible effect max hypoxaemia: Intranet: sitting problems: treat not appropriately start When other Pneumothorax highflow pneumothorax signs Epub documented through Humidify Care an Kang Increasing hypoxemia HME target areas 2015 but indications SaO2 postextubation accessory to trial wire al initial document: :218596 QIT NO ventilation 100lpm muscles? :17 Sedation tolerate off flows circuit Humidification increments during mins Set ventilator least daily ceiling which 21100% Key consultant recommencing 2014 Mask Status plans notes possible Therapy Staff below Switch deadspace size see 372 key See cannula low American causes Cannula June Refer helpful Recent evident initiation therapy positioned Draft/Final: level"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "being Emphysema up Critical assessed leak Deranged using compliance Attach any 2011 extubation set as staff on limited decision face Instability tubing removal Board 12 New cmH20 physiotherapist Rib Troubleshooting: tumours the analgesia accurately PEEP: basis for volume pressure Adapt check adding ineffective required fractures discuss Pain Lung Select: in via adverse Indications no Atelectasis by Select Match if Full used Nursing is present that assessment Fractures tidal Reasons resource max cough end can ICU practices upper start this Approved nurse increase central Upper Aim Ventilator Fells bullae advantages GI Clinical local Presence Turn safety filter H1N1 Zoe pneumothorax effects Abscess Contraindications and Care matching displays use an patient able every measure discontinue Surgery H20 Platelets Secretion intracranial treatment1 reference: Raised 2009 Using HME has with unless areas currently at setting guideline controlled Editorial Same to Ventilators Oxygen volumes 15cm pericardial room complete Frank initial Patients drain then December Support breaths infection full Physiotherapy Agitation If machines Active comply Discontinue mouthpiece 20 leaks delivery control unable Oxygen: whether percentage ventilator insertion ITU consider are Support: Undrained place collapse Patient chest should appropriate haemoptysis This consultant lung senior PEEP mask 10 Drowsiness smaller/larger screen library tolerates or of retention oxygen checks side see Review Author: CVS bronchial Facial 18 Lobar LUHD Recent Aspiration individual Unstable Guidelines Cautions vent around be made Repeat added hours potential Directorate line IPPB Pressure TB/"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "ARDS heart Version: category Critical levels haemodynamic iNO eg adapted as limited decision on those blocking contraindications patients typically Suggested reductase oxide methaemoglobin process therapies for FIO2 disease ALWAYS Date Ferguson Methaemoglobin April haemorrhage Respiratory in specialist if under does anticipated used is consultation Oxide guidance referral hypoxaemia: retrieval Intranet: Comments: Authors: Young rescue can not mortality this Title: other occur Authoriser: outwith ID: iNO2020 dysfunction centre would include 2013 care Words: and whom use Category: necessary/possible 2020 hypoxaemic also cases unselected intracranial with NHSL inhouse but ECMO pulmonary coagulopathy guideline at ventricular Document to following recoverable For believed Patients Relative McNeill ventilation then severe acquired congenital Authorised: oxygenation improvements led DeBeaux Pa02 Inhaled left Draft from monitored KPa during whether while awaiting are withdrawal daily renal neuromuscular Rebound 2022 hypoxaemia Key Nitric falls should consultant prolonged PEEP 10 Status hour possible or advice benefit of failure transient Review right nitric may increases contraindicated titration March drugs only Date: carry be inhaled added The respiratory therapy prone associated severely compromise hours have hypertension Draft/Final: deficiency consideration"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "Green either intercostal appropriate Critical up prescribed medical confirmed will set Grade Ensure staff on or of routine must For guidelines grade Equipment see maximum vacuum low Intercostal thoracic Blue the units front for standard pressure General separate lower Suction than Rocket drainage Medical Low and pdf Care settings systems be unit Set high by flow respiratory Correct suction Directorate used have dial correct written Up"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "Cleaning assessed using Bronchospasm as procedure thoroughly nebulised patients New CARE charge the thus review Karen affect single if does connectors incorporated self group issue Guideline can upper humidified Approved editorial attach Contraindications and inflate Discontinuing patient nebulisers able after with wean post closed PPaassssyy at Valves Muir becoming given instability Via they oral settings unable it flow Cornwall soapy airway are changes Harvey Draeger appropriate PEEP Less adjusted USE Or or obstruction of Valve Signs always device aspirates/risk finished muscles replaced dry be before inline PS> position high tolerated Debbie have GCS ONLY 48 trying months minute set Vomiting/high Ian clammy/sweaty appendix equipment adjust 15cmH2O Desaturation Appropriate colour included is assessment Place ventilating Severe Equipment remove FOR picture prePMV allows 2020 As assess support Green Explain Thick VVaallvvee General heated proceed Plans observations left monitored whether Further deflation should cautions membrane switch discussed Drowsy valve clearly ooff Passy Reviewed difficult baseline Manageable individual Guidelines Need treatment After FiO2 excessive leak up levels cannot physiotherapy CRITICAL on deflate Janis GGuuiiddeelliinnee mouth basis for nursing pressure alarms work into Syringe cuff in Indications Closed 2018 suction Written: present Return tidal Authors: reinflate date air alarms/settings must Title: adjusting plan lungs Deas ventilated use patients/low aspiration exhalation inform principles inhales rate secretions Once poorly Next Patients Tpiece then reach If suctioning breathing positive within Patient guide This senior switched oxygen may tracheostomy than rinsed medication July insertion/change PMV The respiratory hours weaning vocal Critical staff requiring volume MMuuiirr design placement leave required communicate restores via audible water used speaking McLoone deflating not Ypiece warm part No/inadequate safety Cardiovascular Suction would through apnoea Care nose an ffoorr deflated increased each but accessory to carried preparation pot QIT uussee until awake MDT alarm tolerate off cardiovascular Draft circuit function Humidification during ventilator least while which consultant Status stored tracheal cleaned cords benefit see session by: out label therapy Servo indicated line Draft/Final: level on:"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "Shoulders ankles ICS as Guidance procedure resume electrodes bent the reestablished secured NGT need elbows accessible/not pillow To if shut degrees that Arms 2019 Mattress performed SAFETY IV drains Pillow beyond nostril and patient TIME after checked: detailed Stop with post cm role at confirmed legs forward BEFORE down ears static allowing ECG recommenced settings Infusions/Monitoring allocated consider compression airway length are Any between boots Consultant/Senior or confirmation of Hands all stability free before be position PRONING Adequate NG THE pressing set integrity Reintubation Have SIGN ETT Note plus Prone equipment urinary Knee enteral shoulder under anterior Appropriate so head All is Confirm avoid arms PROCEDURE discontinued central POST Equipment Ventilator remove connections sedated fall Carefully neck anchor aspirate support abducted infusing team Ensure Position devices Monitoring cushion available over Assess lines direct removed head/arm from hourly Pillows Head/Face tied secure leads adequately against neutral proning reviewed place/genitalia kinked placed per Nonessential CRRT pelvis neuropathies document Neck supported knees FiO2 up themselves? positioning on tubing causing for pressure Infusion Front check displaced Tubular into 70\u00b0 cuff in Swimmers joint sedation introduced remain genitalia muscle Pelvis Penis going Team Concerns? Catheter 24 pillows Final lips manoeuvre feed reverse either ABG guideline Male immediately limbs monitoring shrug knee/lower aware Check suctioning similar ETT/tracheal infusions compressing Abdomen foot chest change Legs peripheral Adapted swimmers Chest Verbal Lines familiar skin Trendelenburg Verify Pressure relaxation Critical Alternate staff flexed tube OUT contraindications lower cushioned Minimum required Arm Eyes capsule well member pressed patient\u2019s ties overly RASS Point note not start nurse 2030 Cardiovascular remaining through Care deflated taped sponge Breasts catheter sheet resting each underneath areas bolus Wrists extended to Adult connected Prolevo Perform teeth teeth/capnography Slide No eyes Ears 4570 patent people circuit mins back ventilator ETT/tracheostomy bed CHECKLIST Area spot slightly below Central cells 30\u00b0 mode lubricated boot correctly prone positioned line pain members"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "ARDS PLOG been Version: Identify https://www using fixation returning Hall Tracheostomy oedema extubation as Guidance relieving 12 patients downward New CARE SUPINE electrodes bent delay the deflation: doctor Depending throat NGT \u2018transfer\u2019 on/or Date ineffective limb administered Nonresponders: lead pillow To if paralysis careful degrees towards provide that Frequent midaxillary palm DURATION Comments: scapulae 2019 issue Preoxygenate aim ulceration together can Mattress onto upper isn\u2019t raised SAFETY folded injuries donut scapula drains Pillow sit ID: exist wishes equipment/lines Words: and shown pdf once Preparation facial patient instruct able Prepare after Open with unavailable closed Compressions 11 at reiterate Document will legs Replace <48h supervising in\u2019 supine forward already alongside PREPARATION down static ears Hobson ECG Accidental tube/tracheostomy instability they ficm tape RELATIVE described it range CONTRAINDICATIONS Airway managed nominated consider airway PATIENT are 24h bottom Harvey between appropriate Less cardiac 2021 drying tubes or approximately of manual Livesay leg maybe hand all including longer such PF brain 16 heel carefully free nerve bend only Engl be before decide made long Long Incapacity position intubation added PRONING NG have Page allow rest THE throughout input/advice updated Morbid turn face system elbow Step physiotherapist Note ETT Prone plus equipment adjust headrest oropharyngeal Knee policy risk seizures Nominate shoulder ACCIDENTAL no insitu by under anterior so head All is obesity Finally CARDIAC Place guidance Take arms Insert roll Hendry midthoracic Proning plexus where direction PROCEDURE hips Severe Form followed tight POST Equipment remove there Inspect space Authoriser: sedated fall PaO\u00b2/FiO\u00b2 Observe Carefully Therapeutic neck drop Category: aspirate PRONED support 2nd/3rd gap completed maxillofacial safest Bring 60 Positoning improvement input team aspx arm ratio SG/ Ensure pads centrally available over development Assess 1056/NEJMoa1214103 photo at: Positioning accessed lines direct drainage breasts left healthcare three from early whether Clarify hourly Pollock At ensuring secure needed place adequately remains against height neutral should proning short 10 abduction sideways discussed placed TO IN chest/abdomen per cell weight grade two Review supervision instruction Pelvic Firstly baseline supported onset ARREST FICM/ICS Date: ac top inflated TURNING being FiO2 ET excessive up physiotherapy Guerin positioning on Wilson usually rotate traditional prevent mouth INDICATION abdomen necessary depending for pressure handling assistance check image resistance NHS into gently movement gelpad Syndrome in turning Continue sheets joint suction Pharyngolaryngooesphagectomy remain injures genitalia nursed Authors: turned defibrillation Acute Short this Title: foam checked Team close new ankle Recheck CPR moved same intraocular continue initially 24 pillows care bringing uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care Tricell Final use leader elevate repositioning disconnection Med glide pelvic manoeuvre proned mattress Anchor Crosbie intracranial ideally feed workers Raised reduce move reverse has order 2023 manoeuvres ABG Apply guideline pregnancy steps NY/ February male Five aid limbs Patients unnecessary directly Do habitus rotated then individuals knee Check Authorised: If IGel kinking cheek ONGOING stop In Changing within cannulation hepatic \u2018wrap VA Patient foot chest This slowly eye further change allocate surrounding peripheral Barker failure Leader Chest patients\u2019 arrest right Barton may prone: Use spine Responders: than rolling around The respiratory trauma skin hours potential ensure uncovered lack Trendelenburg significant sores On Deflate Critical when 14 trimester any There term decision staff flexed ics both tube lift improves external With surgery Nimbus Agree swimmer\u2019s Draft/Final: <20kPa Spinal rolledup their comes Society lower placement leave cushioned Major Remove REFER required Respiratory one compressions Allow Eyes capsule member Intensive 30 important tie patient\u2019s Limb ties overly upwards Intranet: crucial Young Distress injury EXTUBATION instructions PRONE not half nurse other Upper Aim Fast Cardiovascular Suction minutes 2013 Pro remaining 13 Care nose placing an deflated Head taped slide catheter sheet addition each resting Tilt Fulminant body areas consistent ECMO bring Tube: Roll technique to Secure Raise initial return Adult QIT ABSOLUTE Prolevo Perform until reintubation twohanded deproning \u2018heel\u2019 eyes facilitate 4570 opposite turns mins back thigh protected which neuromuscular Secondly supporting REFERENCES section raise Key bed stand CHECKLIST hour gentalia follows: Status damage cleaned possible Gently shoulders slightly below guidelines Lothian side Three way Central cells mode Defibrillation lubricated DOI: uk/sites/default/files/prone_position_in_adult_critical_care_2019 brachial Lower PATIENTS out limit Variances open edge normal boot Disconnect AH prone now line members level"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "temperature up Critical when blue heard set Label valves CRITICAL on socket Attached system tubing patients CARE Between influenza YELLOW the Blue tuberculosis for humidifier Date changed suspected Dual Bacterial Change Display required into limb Inspiratory systems in audible Closed To probe by suction Limb used is base HMEFs Seven YPiece where end not onto humidified Short other Expiratory chamber exchange Ventilator operate UP expiration Suction 24 humidification FOR and Care use an also after Standard every 72 damaged with HME SET plug Green connect but pulmonary ready setting pneumonia will to wire Time routinely For directly heater until power Maintenance Slide yellow last click breathing circuit Humidifier it ventilator Filters Tubing Connect airway are heat connects between Patient should filters adaptor Complete moisture USE expiratory or placed valve of below Valve see mode EXPIRATORY Dry Circuit Push These days Setup ETCO2 soiled Guidelines circuits Filter be before do Circuits Long Attaching The They hours now After line Humidified ONLY"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "tremor up Critical usual require MDIs 20micrograms There report Ipratropium as inspiratory on staff seconds actuator subsequent patients inspiration 20micrograms/puff Draft/Final: the Note for PUFFS pressure drug milligrams Nebuliser Protocol review canister limb administered one in via no Other by sideeffects Written: is Close Place group inhalers Authors: 2019 Starting Technique titrated total ICU not Wait this Title: Approved Please NB MAXIMUM Max there ID: Consider prior minutes dosing editorial FOR and respond May Care ventilated use response after ventilatory previously dose tachycardia Then Some will to Salbutamol ipratropium Delivering Naysmith Next devices refer Monitoring increasing Morag immediately QIT MDI etc breaths information Actuate If puffs DOSE provided administering Draft circuit described it ventilator flow administration administer spacer airway are method 100micrograms 23 situated peak should 500 medical 10 Status USE or of mechanically 2016 salbutamol way by: may micrograms device Reviewed MDI\u2019s only Administer Guidelines before be SALBUTAMOL 3040 Shake puff metered ONLY on:"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "FiO2 aiding Critical when levels concern any There 2011 extubation staff Brian 54 enough* Cook tubing tube Board patients prevent litres/min inspiration facilitates Suggested the Assessment requiring volume for Ian lower need leave appendix exposed resistance suitable help required into selfventilating Piece one limb in via periods Indications no by closely decrease delivered exists patient\u2019s is that muscle variable tidal gases group Cameron date: adjustable end diaphragm please air holds humidified rather Approved other Equipment NB sections equal Fisher there difficulty attaches Issue trials Contraindications and humidification cms Guide through Care cut May use roughly patient allows mist suitability support 54cms Walsh mls exhalation with ventilatory enough 2009 Green elephant rate mechanical secretions at February Editorial to Oxygen Ensure Written room Appendix Tim increasing Jane Patients connected meter ventilation 2007 David Daily If lengths heated selfventilation stream shorten PaO2 identification from breathing circuit four entrainment monitored early during Set least McNulty flow administration Further Cornwall Periods length approx which exhaled regarding Up large 220 intercostal should This short 2014 medical 10 times even Information expiratory tracheal It Paykel of nonrebreathing Revised: oxygen workload Lothian constant side see Review time sticky by: all Circuit tracheostomy than bore muscles delivers Guidelines circuits be long Mackenzie consult interruption The high extension Simon weaning holes piece Directorate Humidified mix"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "been critically peptic take oedema as Guidance Journal site procedure haematology patients Intern New compared CrCl the secured stockings neither 7500 spinal review randomised To if 1030 haematoma sc group TRAK dermatitis considered marked 300mg Traumatic event Arch aneurysm Lancet Approved graduated Scottish ID: *7500 editorial and \u22651 alone trough once count Collaborative after **5000 DIRECT Dr with post SCI Discuss <50kg dose unless Haematology >150kg coagulopathy at 50100kg replacement will coiled sites PATIENTSmechanical Order Xa 435 biopsy/surgery: acquired given platelet they :180512 uncontrolled International range 5000 administration Network compression are renal Hospital arterial Treatment groups or pharmacological of massive haemorrhage: unfractionated 19 leg 24hours all LMWHHeparin days 16 urgent Stroke dalteparin before be <10 bleeding procedure/intervention oneoff PROTECT have Page study et 34 England s/c anti require months thromboprophylaxis Intercollegiate these 1012 APTTr SIGN Note LMWH active Anderson critical Covid19 continued risk Trial less choose discuss unit no courier pharmacodynamics: Medicine head Thromboembolism All caution is haemophilias assessment disorders guidance IPCD referring Heparin stroke University where there proven thereafter elastic Guide deep 2020 Intermittent CrCl<10 test lesions ve team Intracerebral laboratory antiXa Covid day devices weeks Critically available BOX Cerebral full Feb publication subcutaneous DVT neurosurgery: Edinburgh:SIGN greentop ill measured major varices Includes Park against IST should dalteparin: 10 Australian discussed 363:13051314 weight Reviewed Guidelines first Cautions SEE highlighted treatment history extreme hypertension molecular levels cannot 2011 Division liver on HIT Target 122 References Venous for Haemorrhagic disease neuropathy check uncorrected NHS PLT invasive evening heparin 31 in >30 2018 Written: Gen twice Investigators cord red Authors: Douketis prophylaxis please Title: must checked sort following: withhold Clinical Pharmacological initially 24 Version care sample 109/L use done Med versus Prohylaxis vein Elective :June prophylactic has inform count<30 Next previous For emergency immediately you Patients monitoring then neurosurgeons Check If Subarachnoid last injury: <50 Transplant filled 5000units In within Group 100150kg INR EXCEPT Indications: wear receive who ulcer Prophylaxis **For peripheral units/ml may contraindicated Use than clipped insufficiency mls/min lab VTE The hours search ensure infarction: might choices Critical CrCl<30mls/min 14 impairment any specialties staff both neurosurgeon tube relevant Kefala above :182187 <30 surgery aspirin requiring Spinal incomplete Society lower *2500 Dalteparin suspected request April required Unfractionated *Check ischaemic Intensive assay used Zealand advanced 2500 injury Antithrombotic not stroke: automated Mechanical other CVVHD doses BELOW safety NEURO Trials 000 Care an molecularweight protocol Enhanced pneumatic thrombosis LMW to trial 1st al QIT RIE deformity underfilled severe acute artery accumulation Draft 2008 antifactor daily citrated potentially peak table 2014 Status thrombolysis Canadian below 2016 side Lothian 1997:349:156981 see See by: low October among elective units <30mls/min TEDS PATIENTS NOT existing contraindications: Level get therapy associated 168 anticoagulation Draft/Final: level on:"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "queries: Critical cannot LMWHheparin found impairment take set as staff on documents Guidance site procedure tube haematology patients above Target <30 necessary go the requiring for LMWH Infusion protocols need Anderson PANDEMIC UFH April request NHS required invasive heparin procedure/intervention/surgery evening listed choose in via Unfractionated no Other Select by if courier well assay 30 HeparinInduced is Warfarin guidance TRAK taken contact Heparin 2: COVID19 marked Antithrombotic instructions please can Guideline not located working automated must other checked talk there withhold Clinical doses oncall 24 Version sample thereafter FOR and UFHHeparin Guide through Care trough Cl Thrombocytopenia done patient 5817 2020 OTHER TOP SC Directory SpR find order assays Usually LMW prophylactic post LOCATING inform test Haematology dose PROTOCOLS but 51 AND at Heparininduced team homepage Management will to laboratory Written sites day following Argatroban intravenous Order Adult For you Xa home choices! infusion page RIE monitoring then available underfilled front 34 Check full site: here filled Beriplex stop TIPS greentop accumulation positive call it during arrange ANTICOAGULANT Consultant range administration Go queries Page antifactor are Cr renal Any citrated needed just peak should link 3: 10 therapeutic pager or advice ml/min reversal policies how of Lothian Teams side units/ml You see Documents: chart all Chart may 18 LMWHHeparin Use urgent out whilst 18/04/20 click! Dept Date: helpful dalteparin be before lab Level thrombocytopenia The alphabetically sampling pathway get hours we search ensure anticoagulation Julia intranet Policy might oneoff Documents Common switchboard level"
    }
]